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2D BN SDS-PAGE Two dimensional blue native sodium dodecylsulfate polyacrylamide 
 gel electrophoresis
2D IEF SDS-PAGE Two dimensional isoelectric focusing sodium dodecylsulfate   
 polyacrylamide gel electrophoresis
AOA Ammonium-oxidizing archaea
AOB Ammonium-oxidizing bacteria
APMS Affinity purification in combination with mass spectrometry
ATP Adenosine triphosphate
BN LC-MS/MS Blue native gel electrophoresis followed by liquid chromatography with  
 online tandem mass spectrometry
BNE Blue native gel electrophoresis
CID Collision induced dissociation
DIGE Difference in gel electrophoresis
DNA Deoxyribonucleic acid
ECD Electron capture dissociation
emPAI Exponentially modified protein abundance index
ER Endoplasmic reticulum
ESI Electrospray ionization
EST Expressed sequence tag
ETD Electron transfer dissociation
FDR False discovery rate
FWHM Full width at half maximum
GO Gene ontology
GRAVY Grand average of hydropathicity
GUI Graphical user interface
HCL Hierarchical clustering
HEK293 Human embryonic kidney 293
ICR Ion cyclotron resonance
ID Internal diameter
IMAC Immobilized metal ion affinity chromatography
IMS Inter membrane space
IPMS Immuno purification in combination with mass spectrometry
iTRAQ Isobaric tags for relative and absolute quantitation
LC Liquid chromatography
LC-MS/MS Liquid chromatography with online tandem mass spectrometry
LDA Linear discriminant analysis
m/z Mass to charge ratio
MALDI Matrix assisted laser desorption ionization
MALDI-TOF MS Matrix assisted laser desorption ionization time-of-flight 
 mass spectrometry
MELAS Mitochondrial encephalomyopathy, lactic acidosis, 
 and stroke-like episodes
MERRF Myoclonic epilepsy with ragged red fibers
MIM Mitochondrial inner membrane
Mr Relative molecular mass
mRNA Messenger ribonuecleic acid
MS Mass spectrometry
MS/MS Tandem mass spectrometry
mtDNA Mitochondrial deoxyribonucleic acid
Mw Molecular weight
MWDA Moving window discriminant analysis
NADH Nicotinamide adenine dinucleotide
nDNA Nuclear deoxyribonucleic acid
NMR Nuclear magnetic resonance
OD Outer diameter
OMM Outer mitochondrial membrane
ORF Open reading frame
OXPHOS Oxidative phosphorylation
PCA Principal component analysis
PCP Protein correlation profiling
PCR Polymerase chain reaction
pI Isoelectric point
PMF Peptide mass fingerprinting
PPI protein-protein interaction
ppm Parts per million
PTM Post-translational modification
ROC Receiver operating characteristic
ROS Radical oxygen species
RP Reversed phase
SDS-PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis
SILAC Stable isotope labeling by amino acids in cell culture
siRNA Short interference ribonucleic acid
TCA Tricarboxylic acid 
TIC Total ion current
tRNA Transfer ribonucleic acid
XIC Extracted ion current
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Cellular organization and mitochondria
The organization of mammalian cells into cellular compartments, referred to as organelles, 
allows the cell to create specialized aqueous environments to provide optimal conditions for 
proteins and processes to function. It also enables cells to physically separate incompatible 
cellular processes from one another or to store specifi c molecules or metabolites for various 
functions in diff erent organelles. Mitochondria are cellular organelles specialized in the 
generation of adenosine triphosphate (ATP) which fuels cellular processes and ultimately 
enables life. However, ATP generation is by far not the sole purpose of mitochondria as many 
diff erent cellular functions rely on mitochondrial processes. 
Mitochondrial shape and organization
Mitochondria are often pictured as bean shaped organelles. This, however, does not refl ect 
the intricate and diverse appearance of mitochondria in the cell. Microscopy studies have 
shown that mitochondria may appear punctuated to thread-like or even form interconnected 
networks. The ability to remodel its shape or even undergo mitochondrial fusion or fi ssion, 
allow this organelle to adapt to various functional states. Not only does mitochondrial 
appearance contribute to the dynamic nature of mitochondria, the intracellular localization of 
these organelles may also vary according to energy demands within a single cell. 
The organization of mitochondria into suborganellar compartments (fi gure 1) provides a 
further compartimentation within the organelle for optimal progression of specifi c processes. 
A clear example hereof is the electrochemical proton gradient across the mitochondrial inner 
membrane. Complexes of the oxidative phosphorylation (OXPHOS) system reside within 
the inner mitochondrial membrane and expel protons into the inter membrane space (IMS) 
between the inner- and outer mitochondrial membranes. Subsequently, the ATP synthase 
complex uses the proton motive force to generate ATP through conformation changes 
induced by the passive transport of protons from the IMS to the mitochondrial matrix. 
Here, compartimentation thus allows for the sustainability of an electrochemical gradient to 
fuel ATP generation. 
Figure 1. Schematic representation of a mitochondrion. Schematic view of a cross-section of a 
mitochondrion. Mitochondria are enclosed with the outer- and inner- mitochondrial membranes. 
The inter membrane space between both membranes is used to establish a proton gradient by the 
OXPHOS system to drive ATP generation by complex V. Respiratory chain complexes (amongst other 
proteins) are located within the inner mitochondrial membrane. Cristae are cavities formed by the inner 
mitochondrial membrane to maximize the surface for optimal reactions to occur. The mitochondrial matrix 
contains many diff erent proteins and the multiple copies of circular mitochondrial DNA. Suborganellar 
compartments are indicitated in this fi gure: Outer mitochondrial membrane (OMM), Inter membrane 
space (IMS), Matrix, Mitochondrial inner membrane (MIM), and Cristae.
> Chapter 1
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2 does not refl ect their real-life organization in mitochondria. Recent studies have shown 
that OXPHOS complexes associate with each other to form homomers and heterogenic 
supercomplexes with variable stoichiometric compositions [1, 2].
Mitochondrial OXPHOS disorders
Considering the great complexity of the OXPHOS system, it is not surprising that the majority 
of known metabolic disorders are caused by OXPHOS enzyme defi ciencies [3]. In addition 
to OXPHOS defects, defects in many other proteins result in a mitochondrial phenotype (e.g. 
mitochondrial carriers [4]). However, the term ‘mitochondrial disorder’ is nowadays restricted 
to indicate clinical syndromes associated with abnormalities in the OXPHOS system [5]. 
Mitochondrial disorders manifest themselves through a wide variety of diseases that range 
from fatal encephalomyopathies in early childhood up to severe adulthood diseases [6]. In 
general, the disease phenotype is thought to be related with impaired energy homeostasis, 
cell metabolism, and reactive oxygen species production [6]. However, the precise genotype-
phenotype correlations for many mitochondrial disorders are still poorly understood. 
Mutations in structural OXPHOS subunits encoded by the mitochondrial- or nuclear- DNA 
comprise the major subset of proteins that underlie respiratory chain diseases [7]. However, 
aberrant structural OXPHOS subunits do not exclusively cause mitochondrial disorders. 
Many other proteins involved in related processes are known to play a role in both isolated 
as well as combined OXPHOS enzyme defi ciencies. This is illustrated by the many diff erent 
processes required for the genesis of functional OXPHOS complexes. First of all, nuclear 
DNA encoded OXPHOS subunits need to be imported into mitochondria and correctly folded 
whereas mitochondrial DNA encoded subunits need to be generated by the mitochondrial 
transcription-, translation-, and folding machineries [8]. Secondly, assembly and maturation 
of OXPHOS complexes from their individual subunits requires proteins that act as assembly 
factors for the genesis of the holocomplex via defi ned subassemblies [9-13]. To date, an 
inventory of at least 92 genes are known to cause mitochondrial OXPHOS disorders that 
can be classifi ed into 5 functional categories [7]: OXPHOS subunits (34 genes), mtDNA 
ATP generation and the oxidative phosphorylation system
As mentioned previously, mitochondria generate the bulk of ATP in the cell. An overwhelming 
amount of more than 100 kilograms of ATP is generated through the OXPHOS system by an 
average human body in a single day. Conversion of metabolites to energy in the form of ATP 
by respiration is initiated by the glycolytic pathway in the cytosol. Glycolysis is responsible for 
the generation of 2 moles of pyruvate, nicotinamide adenine dinucleotide (NADH), and ATP 
from 1 mole of glucose. Generation of ATP is however not the primary function of glycolysis. 
The glycolytic products pyruvate and NADH play crucial roles in the second (citric acid cycle) 
and third (oxidative phosphorylation) stages of respiration. First, pyruvate is converted to 
acetyl coenzyme A (acetyl-CoA) by the pyruvate dehydrogenase complex which is used to 
fuel the mitochondrial citric acid cycle. Here, acetyl-CoA is broken down and re-generated to 
produce 8 NADH, 2 reduced fl avin adenine dinucleotide (FADH2), 2 ATP, and 6 CO2 for each 
acetyl-CoA that enters the cycle.
 
Glycolysis:
Glucose + 2 ADP + 2 Pi + 2 NAD+ -> 2 pyruvate + 2 ATP + 2 NADH + 
2 H2O + 2 H+
Pyruvate dehydrogenase complex:
2 Pyruvate + 2 NAD+ + 2 CoA-SH -> 2 acetyl-CoA + 2 NADH + 2 CO2
Citric acid cycle:
2 Acetyl-CoA + 6 H2O + 6 NAD+ + 2 FAD + 2 ADP + 2Pi -> 4 CO2 + 6 NADH + 2 FADH2 + 
2 CoA-SH + 2 ATP
Net reaction:
Glucose + 10 NAD+ + 2 FAD + 4 H2O + 4 ADP + 4 Pi -> 6 CO2 + 10 NADH + 4 H+ +2 FADH2 
+ 4 ATP
Together with the NADH produced in glycolysis, both NADH and FADH2 products from the 
citric acid cycle serve as substrates for the OXPHOS system in the third stage of respiration. 
Here, OXPHOS complexes I-IV use NADH and FADH2 as substrates to pump protons 
into the intermembrane space which serves as a proton motive force for complex V (ATP 
synthase) to generate ATP. The total ATP generation by the OXPHOS system from 1 mole of 
glucose is typically 34 moles of ATP. However, the typical net ATP yield through the OXPHOS 
system is 32 moles of ATP per mole of glucose as 2NADH produced in glycolysis need to be 
transported into the mitochondrion at the expense of 2 ATP. 
Oxidative phosphorylation:
3 ADP + 3 Pi + NADH + H+ + ½ H2O -> 3 ATP + NAD+ + H2O
The mammalian OXPHOS system is composed of 5 heteromeric complexes (CI-CV) 
embedded in the inner mitochondrial membrane (fi gure 2). Intriguingly, four of the OXPHOS 
complexes (CI, CIII, CIV and CV) are composed of subunits that are encoded by both the 
nuclear DNA (nDNA) and mitochondrial DNA (mtDNA). Out of the 89 diff erent proteins that 
make up the OXPHOS complexes, only 13 subunits (14.6 %) are encoded by the mtDNA. 
This bigenomic control is unique to OXPHOS enzymes throughout nature and adds to the 
complexity of these enzymes in addition to the large number of proteins that comprise each 
enzyme. Moreover, the (typical) simplistic representation of the OXPHOS complexes in fi gure 
Figure 2. Mitochondrial oxidative phosphorylation system. The mitochondrial respiratory chain is 
composed of 4 heteromeric enzyme complexes (CI-CIV) that together with electron carriers cytochrome 
c (C) and ubiquinone (Q) translocate protons (H+) into the inter membrane space (IMS) to drive ATP 
generation by complex V (CV). The number of mtDNA and nDNA genes that encode the subunits of 
complexes I-V are listed above the schematic OXPHOS system representation. 
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proteomics was introduced [19] to describe the large-scale analysis of the proteome, which 
is the total protein complement produced by a cell or system. Mitochondrial proteomics is 
thus the large scale analysis of the mitochondrial proteome.
Protein identification by mass spectrometry
In mass spectrometry, protein identification can be performed directly on the intact protein 
(top-down) [20, 21] or via the proteolytical peptides of a protein following enzymatic or 
chemical digestion (bottom-up) [22] . Bottom-up proteomics is by far the most common 
methodology thanks to its robust and sensitive performance as well as its relatively low 
demands on mass spectrometry technology and experience. We will therefore focus 
on bottom-up protein identification technologies in this section to provide the minimal 
background information to understand typical proteomics data.
From a generic perspective, two different approaches are mostly used in bottom-up 
proteomics for protein identification: peptide mass fingerprinting [23] and MS/MS database 
searches [22, 24-26]. Both methods compare mass spectrometry data with in-silico 
calculated data for all available protein sequences in a database to find the proteins or 
peptides that best explain the experimental data. In peptide mass fingerprinting the collection 
of measured peptide masses is compared with the in-silico calculated peptide masses 
for each protein sequence and subsequently scored. The calculated protein identification 
scores are used to determine which protein sequence(s) in the database provide the best 
(significant) match with the experimental data. This method relies on mass accuracy of the 
measurement and sequence-specific proteolysis to assign protein identifications. Peptide 
mass fingerprinting is commonly performed using matrix assisted laser desorption ionization 
Time-of-Flight mass spectrometry on tryptic digests of (nearly) pure proteins. Most often, 
peptide mass fingerprinting is used in combination with two dimensional gel electrophoresis 
to obtain (nearly) pure protein samples for mass spectrometry analysis as peptide mass 
fingerprinting is currently limited to low complexity samples of only a few proteins .
 
In contrast to peptide mass fingerprinting, MS/MS database searches can be used to 
theoretically identify an unlimited number of proteins in a sample through identification of 
the individual proteolytical peptides from each protein. The generic principle behind MS/
MS database searches is perhaps best explained by the following analogy which is quoted 
from Edward Marcotte [26]: “To explain by analogy, imagine you find a box of old-fashioned 
geared watches in an antique store and want to know which watch models you’ve stumbled 
across. The shotgun proteomics approach would be to dismantle each watch into its major 
assemblies (e.g., the movements, dials and escapements), smash each assembly into 
component parts, weigh the parts and look up the weights in a parts catalog, reading out 
which parts, and therefore which watches, you have-or rather, had.” Switching back to 
proteins, mass spectrometry data is acquired to determine the mass of each proteolytical 
peptide (MS level) and to obtain as much as possible information about the amino acid 
sequence of the peptide through controlled fragmentation of the isolated peptide (precursor 
ion) in a second round of mass spectrometry (referred to as tandem mass spectrometry; 
MS/MS or MS2 level). Database search algorithms use this data to first extract all peptides 
from the in-silico digested protein sequences in the database that match the measured 
peptide mass (MS level) with a predefined mass error tolerance. For each extracted 
peptide the algorithm will score the matching quality for the collections of measured and 
calculated fragment ions. The highest scoring (significant) peptide match for each spectrum 
maintenance and expression (14 genes), OXPHOS biogenesis and regulation (28 genes), 
nucleotide transport and biogenesis (8 genes), and membrane dynamic or composition 
(8 genes). 
 
Mitochondrial proteomics
Mitochondria are at the center of many cellular processes such as energy generation, 
intermediary metabolism, anabolic processes, production of reactive oxygen species, 
intra cellular signaling, and apoptosis [14]. Estimates for the total number of mammalian 
mitochondrial proteins are in the range of 1130 up to 1500 proteins [15] of which only a small 
minority is directly related to OXPHOS. It is therefore not surprising for mitochondria to be 
involved in many different cellular processes and various diseases [6, 14]. Thus far, aberrant 
mitochondrial function is linked to several non-OXPHOS disorders such as Parkinson’s 
disease, Alzheimer’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and 
diabetes mellitus [14]. The involvement of mitochondria in high prevalence diseases implicate 
mitochondria as potential therapeutic targets in diseases other than mitochondrial disorders 
[16]. Since proteins execute the various mitochondrial processes, their analysis is key to 
unravel the molecular basis of mitochondrial function.
 
Knowledge about the localization, expression, regulation, and interactions of mitochondrial 
proteins is crucial to understand mitochondrial function and dysfunction. The most basic 
level of information is to simply know what proteins actually localize to mitochondria. Such 
an inventory of mitochondrial proteins allows research to focus on proteins that govern or 
participate in mitochondrial processes. Protein levels are however dynamic and cellular 
adaptations commonly involve up- or down-regulation of individual protein levels to control 
biological processes. It is therefore essential to study the protein levels within mitochondria 
of cells under different conditions (e.g. basal, disease, treatment). Adding to the array of 
possible ways to control protein function, cells also possess various mechanisms to modify 
proteins through the addition and removal of chemical groups or even other proteins. Such 
protein modifications are termed “post-translational modifications” (PTMs) as they occur on 
amino acid residues of the protein after ribosomal translation of the protein coding mRNA into 
its respective amino acid sequence. PTMs enables cells to reprogram the specificity, activity, 
localization, and function of available proteins within a brief time span. This also presents 
the cell with a mean to transiently control protein activity instead of wasting ATP on the 
definitive and much slower genesis or breakdown of proteins to temporarily in- or decrease 
their activity. Additionally, PTMs efficiently allow for a single gene product to yield various 
protein forms that may differ in localization and/or function. Proteins, however, rarely perform 
in solo and are therefore frequently organized into homo- or heteromeric protein complexes. 
In addition, individual proteins or complexes may even spatially interact with one another to 
influence their function(s). 
Biomolecular mass spectrometry combined with various biochemical separation techniques 
is extremely suited for the analysis of proteins. It allows for the unambiguous identification 
and quantitation of proteins as well as molecular characterization of available PTMs. In the 
last decade, mass spectrometry has become the de facto standard method for the large-
scale analysis of proteins. The realization of (poly)peptide-compatible ionization techniques 
MALDI (matrix assisted laser desorption ionization) [17] and ESI (electrospray ionization) [18], 
together with the availability of whole genome sequences, allowed for the high-throughput 
analysis of up to thousands of proteins in a single experiment. Subsequently, the term 
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The mammalian mitochondrial proteome
In the last decade, numerous eff orts were made to elucidate the mitochondrial proteome of 
mammalian cells. At fi rst, this may seem as a straightforward task but the lack of a single 
targeting sequence and large diff erences in protein abundance present a major challenge 
to defi ne the mitochondrial proteome [7]. Another key challenge is posed by the variable 
or even specifi c expression of proteins in various cell types and diff erent cellular conditions 
[7]. Diff erent methodologies have been used to identify mitochondrial proteins, ranging from 
computational approaches up to experimental methods that rely on microscopy or mass 
spectrometry data. Computational methods to predict mitochondrial localization provide 
exactly what they state: a prediction. Proposed mitochondrial localization of proteins through 
any targeting signal prediction tool (e.g. Predotar [28], TargetP [29], MitoPred [30, 31], 
MITOP2 [32], and SubLoc [33]) should always be confi rmed by experimental data. On the 
other hand, microscopic techniques provide the best possible means to verify mitochondrial 
localization of proteins (disregarding technical issues), but is thus far limited by the low-
throughput nature of the technique. This makes the large-scale analysis of protein intracellular 
localization by microscopy an expensive and time consuming expedition. To date, mass 
spectrometry is the method of choice for the large-scale analysis of subcellular localization of 
proteins thanks to its high-throughput and specifi c detection of proteins [7].
Early work on defi ning the mitochondrial proteome primarily focused on the in-depth 
identifi cation of proteins in highly pure mitochondrial isolations. Pioneering work of Rabilloud 
[34], Taylor [35], Lescuyer [36], Da Cruz [37], and Gaucher [38] provided the fi rst inventories 
of mitochondrial proteins in human cells through the identifi cation of proteins in highly pure 
mitochondrial fractions. Around the same time, Mootha [39] identifi ed a substantial number of 
mitochondrial proteins in diff erent mouse tissues. Similar approaches were used in following 
years by Rezaul [40], Johnson [41], Reifschneider [42], Ruiz-Romero [43], and McDonald 
[44] to map the mammalian mitochondrial proteome from highly pure mitochondrial fractions. 
More recent studies by Zhang [45] and White [46] increased the number of identifi ed 
mitochondrial proteins in mouse and for the fi rst time mapped mitochondrial proteins in 
rabbit, respectively. All studies mentioned thus far used various proteomics technology to 
achieve the highest possible number of protein identifi cations in highly pure mitochondrial 
isolations. With respect to the number of unique protein identifi cations listed in table 
1, studies that use 2D isoelectric focusing sodium dodecylsulfate poly acrylamide gel 
electrophoresis (2D IEF SDS-PAGE) with MALDI-MS analysis appear to achieve a relatively 
low number of protein identifi cations. This is in part caused by the bias associated with 
the approach against small, hydrophobic, and basic proteins. Nevertheless, the number of 
unique protein identifi cations does not refl ect the number of unique protein forms identifi ed 
in these studies as proteins are typically resolved into multiple spots on gel according to 
molecular diff erences between diff erent forms of the same protein. 
In contrast with the simple approach of mitochondrial protein mapping through mere 
identifi cation of proteins in highly pure fractions, both Forner [47] and Foster [48] used a 
more advanced approach termed “protein correlation profi ling” (PCP) [49] to sort genuine 
mitochondrial proteins from contaminants. In both studies, organelles are separated by 
density gradient centrifugation. Unlike previous studies that also applied centrifugation to 
isolate mitochondria, Forner and Foster collected and analyzed all organellar fractions. 
Tandem mass spectrometry data acquired for the individual organellar fractions was used 
for protein identifi cation and to establish the relative abundance profi les of identifi ed proteins 
across all fractions. Subsequently, protein correlation profi ling was used to identify proteins 
that share a similar abundance profi le with a selected reference set of known mitochondrial 
is considered as peptide identifi cation. Finally, the collection of identifi ed proteolytical 
peptides is used to infer protein identifi cations. To increase the sensitivity, dynamic range, 
and number of peptide/protein identifi cations from tandem mass spectrometry experiments, 
liquid chromatography is commonly used in conjunction with online mass spectrometry 
detection (shotgun proteomics). Figure 3 shows a schematic representation of the typical 
steps in shotgun proteomics. Here, liquid chromatography is used to reduce the number 
of components that are co-detected within individual spectra for a sample by separating 
the available peptides in time for (ideally) individual mass spectrometric analysis via online 
electrospray ionization [27].
 
Figure 3. Schematic representation of the typical steps in shotgun proteomics. Proteins are cut 
into proteolytic peptides by peptidases or chemicals (typically trypsin). The resulting peptide mixture is 
desalted and concentrated by solid phase extraction prior to liquid chromatography with online tandem 
mass spectrometry (LC-MS/MS) analysis. Peptides are separated by reversed phase chromatography 
and eluting peptides are subjected to mass spectrometric analysis. In time, the mass spectrometer will 
fi rst acquire a survey scan (MS level) to measure the precursor ion mass-over-charge (m/z) value which 
is used to calculate the peptide mass. Next, the mass spectrometer isolates a single ion (precursor ion) 
from all other available ions and subject this precursor ion to controlled fragmentation (e.g. via collision 
induced dissociation: CID). The fragment ions are detected in a second round of mass spectrometry 
(MS/MS or MS2 level) before the mass spectrometer will start to acquire fragmentation data for the next 
precursor ion that was detected in the survey scan. This cycle is repeated during the analysis to collect 
tandem mass spectrometry data for as many peptides as possible. After the LC-MS/MS analysis, vendor 
specifi c software is used to extract data for the precursor- and fragment ions which is used in subsequent 
database searches. For each acquired fragmentation spectrum, the database search algorithm will 
attempt to match the experimental data with theoretical data for all available peptides in the sequence 
database. Ideally, each MS/MS spectrum provides an unique peptide identifi cation which is used to infer 
protein identifi cations in the fi nal stage of MS/MS database searches. 
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proteins. This approach allowed Foster and Forner to reduce the number of incorrectly called 
mitochondrial proteins. Interestingly, Foster also used the acquired data set to analyze the 
percentage of genuine mitochondrial proteins in several published mitochondrial proteomes. 
Not surprisingly, Foster showed that the percentage of true mitochondrial proteins varied 
from 61 up to 93% in the analyzed data sets. The most comprehensive inventory of 
mitochondrial proteins thus far was generated by Pagliarini et al in 2008 from 14 different 
mouse tissues [50]. Here, a subtractive proteomics approach was used to confidently identify 
mitochondrial proteins based on enrichment in highly pure versus crude mitochondrial 
preparations. Similar to the PCP method used by Forner and Foster, this approach used 
semi-quantitative shotgun proteomics data to selectively identify genuine mitochondrial 
proteins.
 
Proteome adaptations in mitochondrial disorders 
Proteomics technology can be used to compare abundance levels of up to thousands 
of proteins between samples. Quantitation can be achieved at the protein level or via 
proteolytical peptides from digests of complex protein samples. Protein level quantitation is 
typically performed by difference in gel electrophoresis (DIGE) which relies on distinct signals 
from fluorescent dyes that are used to label up to three different samples within a single 
electrophoretic separation. The advantages of DIGE over conventional protein stains include 
increased sensitivity, extended linear dynamic range, and minimal experimental variation (also 
gel-to-gel) via the use of an internal standard sample. Mass spectrometry based quantitation 
can be performed either labelfree or by metabolic- or chemical labeling of proteins or 
peptides. Labelfree quantitation can be performed by MS/MS count methods (e.g. spectral 
counts or emPAI [51]) or via extracted ion current chromatograms of eluting peptides in 
chromatographic separations [52, 53]. Labeling approaches rely on a defined mass offset 
between identical peptides from multiple samples in multiplexed LC-MS/MS analyses. 
Metabolic labeling is typically performed by stable isotope labeling of proteins through 
selective addition of light and have amino acids in culture (SILAC) [54-56]. Chemical labeling 
on the other hand is mostly performed on proteolytical peptides after digestion. At current, 
popular chemical labeling methods include iTRAQ (isobaric tags for relative and absolute 
quantitation) [57] and dimethyl labeling approaches [58-60]. Selection of the best suitable 
mass spectrometry based quantitation strategy to use in experiments should be based on 
several critical factors. First of all, labeling based methods minimize experimental variation as 
multiple samples are analyzed simultaneously. From the available labeling methods 
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Human
Human
Human
Mouse
Human
Human
Mouse
Human
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Rat
Human
Rat
Rat
Mouse
 
Mouse
Mouse
Rabbit
Tissue / cell type
Placenta
Heart
Heart
Liver
Placenta
Heart
Brain, heart, 
kidney, liver
T leukemia cells 
(Jurkat A3)
Liver, kidney, 
skeletal muscle, 
brain, heart
Liver, heart, 
brain, kidney
Chondrocyte cells
 
Skeletal muscle, 
heart, liver
Liver
Heart
cerebrum, cerebellum, 
brain stem, spinal cord, 
kidney, liver, heart, 
skeletal muscle, adipose 
tissue, sm intestine, 
ig intestine, stomach, 
placenta, testes
Heart
Subcellular fraction
Highly pure mitochondria
Highly pure mitochondria
Highly pure mitochondria
Inner Mitochondrial 
Membrane
Highly pure mitochondria
Highly pure mitochondria
Highly pure mitochondria
Highly pure mitochondria
Highly pure mitochondria
 
Highly pure mitochondria
Highly pure mitochondria
Inner Mitochondrial 
Membrane
Highly pure mitochondria
Organellar fractionation
Highly pure mitochondria
crude and highly pure 
mitochondria
Highly pure mitochondria
Proteomics methodology
2D IEF SDS-PAGE w/ MALDI-MS
geLC-MS/MS
MUDPIT (SCX x RP LC-MS/MS)
MUDPIT (SCX x RP LC-MS/MS)
2D IEF SDS-PAGE w/ MALDI-MS
sucrose gradient fractionation 
(protein complexes) followed by 
1D SDS-PAGE w/ MALDI-MS 
and LC-MS/MS
Gel filtration chromatography 
w/ LC-MS/MS
geLC-MS/MS
2D BN SDS-PAGE w/ MALDI-MS
LC-MS/MS
2D IEF SDS-PAGE w/ MALDI-MS 
and MALDI-MS/MS
2D LC w/ MALDI-MS & ESI-MS/
MS, 2D IEF SDS-PAGE w/ MAL-
DI-MS &ESI-MS/MS, RP LC-
MS/MS
geLC-MS/MS w/ PCP
LC-MS/MS w/ PCP & microscopy 
methods
geLC-MS/MS
geLC-MS/MS w/ SP, 
computational-, and microscopy 
methods
RP LC-MS/MS, MUDPIT (SCX x 
RP LC-MS/MS), 1D LC w/ ESI-
MS/MS, 2D LC w/ ESI-MS/MS
Proteins
46
573
463
182
98
615
399
680
152
527
49
348
887
297
940
1098
558
Table 1
Table 1. Overview of important mammalian mitochondrial proteome studies that focused on mass 
spectrometry data. Abbreviations: 2D IEF SDS-PAGE w/ MALDI-MS, two dimensional isoelectric focusing sodium dodecyl 
sulfate poly acryl amide gel electrophoresis with matrix assisted laser desorption ionization mass spectrometry; RP LC-MS/
MS, peptide centric liquid chromatography with online tandem mass spectrometry; geLC-MS/MS, gel enhanced peptide 
centric liquid chromatography with online tandem mass spectrometry; MUDPIT, multi dimensional peptide centric strong cation 
exchange (SCX) reversed phase (RP) liquid chromatography with online tandem mass spectrometry; LC-MS/MS, peptide 
centric reversed phase liquid chromatography with online tandem mass spectrometry; 2D BN SDS-PAGE, two dimensional 
blue native sodium dodecyl sulfate poly acryl amide gel electrophoresis; MALDI-MS/MS, matrix assisted laser desorption 
ionization tandem mass spectrometry; 2D LC, two dimensional protein centric liquid chromatography; 1D LC, one dimensional 
protein centric liquid chromatography; ESI-MS/MS, electrospray ionization tandem mass spectrometry; PCP, protein correlation 
profiling; SP, subtractive proteomics.
22 23
proteins are involved in protein quality control. The authors also suggest that mitochondrial 
VDAC1 could play a key role in mitochondrial signaling. In 2012, Farhoud et al published our 
results from a SILAC geLC-MS/MS study of primary fibroblast cells from three patients with 
homozygous mutations in different complex I subunits (NDUFS4, NDUFS7, NDUFS8) [65]. 
These results showed coherent altered expression levels of proteins involved in glycolysis, 
fatty acid oxidation, and branched chain amino acid degradation. Interestingly, some of 
the previously mentioned proteomics studies also described altered expression levels of 
proteins involved in glycolysis and fatty acid oxidation [62, 64]. In the same paper, Farhoud 
et al provide evidence for the possible association of deranged mitochondrial biogenesis 
with unfavorable stabilization of the PGC-1α protein level through inhibition of the ubiquitin-
proteasome system. 
Mitochondrial post-translational modifications
A variety of modifications have been reported for mitochondrial proteins. Some of these 
PTMs are functional modifications controlled by regulatory mechanisms, whereas other 
modifications are forms of protein damage that result from contact with radical oxygen 
species (ROS) [66]. Out of the regulatory PTMs several different modifications have been 
detected for mitochondrial proteins. These include proteolytical processing, phosphorylation, 
acetylation, and ubiquitinylation [67]. Proteolytical processing is one of the best known 
mitochondrial PTMs. Many nuclear genome encoded protein that are imported into 
mitochondria undergo proteolytical processing by the mitochondrial processing peptidase to 
remove the mitochondrial signal peptide [68]. Another well known example of mitochondrial 
proteolytical processing concerns triple A proteases that play an important role in biogenesis 
of mitochondrial proteins as well as quality control of misfolded proteins [69]. Similar to 
most other cellular organelles, mitochondria use ubiquitinylation (addition of ubiquitin protein 
chains to a protein via lysine residues) to target proteins for degradation by the proteasome 
[70]. Functional roles of phosphorylation, acetylation, and methylation are diverse and are 
often specific for the amino acid residue of the protein that is modified. A clear example of 
how phosphorylation, or rather lack of dephosphorylation, is involved in disease is pyruvate 
dehydrogenase phosphatase deficiency. Here, loss of activity in the pyruvate dehydrogenase 
phosphatase 1 protein (PDP1) increases the proportion of inactive pyruvate dehydrogenase 
complex (pyruvate dehydrogenase is inhibited by phosphorylation) [71].
Analysis of protein PTMs is a great challenge in proteomics. First of all, many of the PTMs 
are low abundant as often only a small percentage of a single protein population is modified. 
Additionally, some PTMs pose technical difficulties in mass spectrometric detection. A 
well known example hereof are labile modifications such as phosphorylation (especially 
phosphotyrosines). In typical tandem mass spectrometry experiments these modifications 
are lost during fragmentation via neutral loss of the phosphate moiety from the precursor ion 
[72]. As a result, only minimal peptide sequence information can be obtained as the majority 
of kinetic energy is dissipated through neutral loss of the phosphate group prior to backbone 
fragmentation of the peptide. Subsequently, any site specific information is lost that could 
be used to determine the PTM localization in the peptide sequence. Depending on the mass 
spectrometry instrument used, analysis of labile PTMs often require “fast” fragmentation 
methods such as electron capture dissociation (ECD) [73] or electron transfer dissociation 
(ETD) [74]. Both methods use electrons to initiate near-instant backbone fragmentation of the 
precursor ion, thereby preserving the modification. Mass spectrometers without ECD or ETD 
fragmentation methods (or analysis of single and doubly charged phosphopeptides) rely on a 
third round of mass spectrometry analysis (MS/MS/MS or MS3) to obtain peptide sequence 
SILAC provides the best possible solution as samples can be mixed and simultaneously 
processed to minimize even artifacts from sample handling. Unfortunately, SILAC can only be 
performed in living animals or cells as it relies on metabolic incorporation of light and heavy 
versions of the same amino acids into proteins. Another aspect that should be considered 
are the expensive isotopically labeled amino acids that are required for SILAC studies. Here, 
chemical labeling approaches provide an economical alternative. In contrast to labeling 
methods, labelfree quantitation by LC-MS/MS allows for integration or even retrospective 
analysis of samples. Sample complexity is also not increased by adding heavier forms of the 
proteome into a single analysis, as is the case with all non-isobaric labeling methods. Another 
distinct advantage is the fact that out of the labelfree quantitation methods exponentially 
modified protein abundance (emPAI) values can be used to compare abundance levels 
between different proteins [51]. However, labelfree quantitation methods that rely on spectral 
counts such as emPAI may be inaccurate and poorly reproducible for proteins that are 
detected by a small number of unique peptides (e.g. low abundant- or small size proteins) 
[53]. Here, methods that rely on extracted ion currents provide higher quantitative resolution, 
greater linear dynamic range, better reproducibility, and are generally better suited for the 
quantitation of low abundant or small sized proteins. 
Despite the great potential of proteomics for the analysis of protein abundances between 
samples, only a few studies have been documented that analyzed large-scale protein 
expression changes in mitochondrial disorders or models hereof. Chevallet et al analyzed 
changes in mitochondrial protein expression caused by the absence of mitochondrial DNA in 
Rho-0 cells by 2D IEF SDS-PAGE in combination with silver staining and MALDI-MS/MS [61]. 
Their analyses showed an expected decreased expression of subunits and assembly factors 
of the respiratory chain and mitochondrial translation machinery. Other down regulated 
proteins were primarily related to other energy metabolism pathways (mainly oxidation of fatty 
acids) or import systems. Surprisingly, not a single protein with increased abundance was 
reported. If true, not a single rescue or adaptation mechanism in mitochondria as response 
to devoid mtDNA would rely on higher protein expression levels. Even more surprising is the 
fact that variable levels are still detected for proteins that function in pathways that are known 
to rely on mtDNA (e.g. OXPHOS and mitochondrial translation). The authors present two 
hypothesis to explain this phenomenon of which the first would be the lack of fine regulation 
at the nuclear transcription and cytosolic translation level. This would imply that these 
proteins are merely produced since other mitochondrial proteins of still functional pathways 
need to be made. A second hypothesis is that these proteins may have yet unknown 
functions in mitochondria other than their known function. However, further research is 
obligatory to test these hypothesis.
In a 2D IEF SDS-PAGE DIGE study of an immortalized B-cell line that harbours the MELAS 
A3243G mutation, Felk et al reported activation of the mitochondrial protein quality control 
system and alterations of the actin cytoskeleton [62]. In the same publication, Felk et al also 
reported a marked decrease of complex IV subunits Vb and VIa. Decreased expression 
of complex I and complex IV subunits has been observed in other proteome analyses 
that investigated MELAS and MERRF cybrids[63], and in proteomics of osteosarcoma 
cells where complex I and complex IV were inhibited [64]. Similar to the results of Felk et 
al, the proteomes of CI and CIV inhibited osteosarcome cells show altered expression 
of cytoskeletal proteins and of proteins involved in protein quality control and redox 
homeostasis. In a more recent study of CI inhibitition in neuroblastoma cells by 2D IEF 
SDS-PAGE, Burté et al reported 27 differentially expressed proteins of which numerous 
24 25
 
Table 2. Proteomic studies of mitochondrial PTMs. Abbreviations: IMAC, peptide centric immobilized 
metal affinity chromatography; TiO2, peptide centric titanium dioxide affinity chromatography; ZIC-
HILIC, peptide centric hydrophilic interaction liquid chromatography; LC-MS/MS, peptide centric 
liquid chromatography with online tandem mass spectrometry; LC-MS/MS/MS, peptide centric liquid 
chromatography with online triple stage mass spectrometry; 2D IEF SDS-PAGE, two dimensional 
isoelectric focusing sodium dodecyl sulfate poly acryl amide gel electrophoresis; DIGE; difference in gel 
electrophoresis; 2D BN SDS-PAGE, two dimensional blue native sodium dodecyl sulfate poly acryl amide 
gel electrophoresis; MUDPIT (SCX x RP LC-MS/MS), multi dimensional peptide centric strong cation 
exchange (SCX) reversed phase (RP) liquid chromatography with online tandem mass spectrometry. * 
Study reported exclusively the number of modified protein spots from 2D IEF SDS-PAGE separations, 
which do not correlate with the unique number of modified proteins per se. ** Exact number of 
modification sites not provided and could not be deduced from the available data. This number presents 
the minimal number of acetylated sites that could be deduced from the data.
Mitochondrial protein-protein interactions in mammals
Analysis of the mitochondrial interactome, which is the complete inventory of mitochondrial 
protein-protein interactions, can be performed using various technologies. Popular 
approaches include yeast two-hybrid screening [84] or tandem mass spectrometry analysis 
of proteins from immuno or affinity copurifications [85] and fractions from native protein 
separations by e.g. centrifugation [49], size exclusion chromatography [86], and native gel 
electrophoresis [87, 88]. Interaction data from yeast two-hybrid screening methods are 
known for their possible high false- or low true-positive rates, which limits the use of these 
screening methods. Moreover, in mammalian systems an adapted version of the yeast 
two-hybrid system is best used which is less suited for large-scale analyses [89]. Recent 
studies to identify protein-protein interactions use affinity purification in combination with 
information through isolation and fragmentation of the neutral los peak after the initial round 
of fragmentation [75]. Subsequently, site assignment for the modification is not possible by 
this method. 
In recent years, proteomics has been used in a great number of studies to analyze protein 
PTMs in different organisms thanks to technological improvements in mass spectrometry 
equipment (ECD and ETD fragmentation) and development of purification methods for 
peptides with specific PTMs (e.g. phosphopeptides purification by IMAC or TiO2). In contrast 
with many available large-scale PTM studies from whole cell protein extracts, mitochondrial 
PTMs have been analyzed by only a handful of studies thus far which are summarized 
in table 2. Early work of Reinheckel et al in 2000 provides the first large-scale analysis 
of oxidatively damaged mitochondrial proteins [76]. Rat mitochondria were subjected to 
hypoxia and reoxygenation prior to protein extraction and two dimensional IEF SDS-PAGE 
separation. Derivatization of protein carbonyls with 2,4-dinitrophenylhydrazine and anti-
dinitrophenyl immunoblotting was performed and 59 proteins spots could be identified 
that result from oxidative protein damage. Later work by Choksi [77] and Wang [78] also 
applied 2D IEF SDS-PAGE with immuno detection to find oxidatively damaged protein spots. 
Both studies used MALDI mass spectrometry to identify the proteins from each relevant 
spot which led to the identification of 14 and 18 unique proteins with oxidative damage, 
respectively. Shotgun proteomics has been employed by Taylor et al in 2003 to identify 
39 proteins that were oxidatively damaged in human heart [79]. Protein phosphorylation is 
another mitochondrial PTM which has been analyzed at the proteome level. In 2007, Lee et 
al used IMAC to enrich proteolytical phosphopeptides in mouse in combination with LC-MS/
MS/MS analysis for phosphopeptide identifications [75]. This led to the identification of 62 
phosphorylated proteins and 84 phosphorylation sites. In a recent study by Gnad et al, 
TiO2 was used to affinity purify proteolytical phosphopeptides from mouse in combination 
with shotgun proteomis [80]. From their data, 74 mitochondrial phosphorylated proteins 
with 174 phosphorylation sites could be deduced. The most extensive mitochondrial 
phosphoproteome mapping performed thus far was published in 2011 by Zhao et al [81]. 
The authors used a wide array of phosphopeptide enrichment techniques in combination 
with shotgun proteomics to analyze protein phosphorylation in human skeletal muscle. Their 
analysis revealed 86 phosphorylated mitochondrial proteins with 174 distinct phosphorylated 
sites. A common theme in these three phosphoproteomes are proteins involved in OXPHOS, 
TCA cycle, fatty acid oxidation, and import machinery and transporters. The mitochondrial 
acetylome was analyzed in recent studies by Fritz [82] and Shinmura [83] in mouse and rat, 
respectively. Interestingly, several OXPHOS subunits (complex I: 1, complex III: 1, complex V: 
3) were found to be acetylated by Shinmura et al in response to caloric restriction in rat heart. 
Other acetylated proteins were involved in mitochondrial metabolic processes other than 
OXPHOS. Fritz et al performed extensive analysis of the mitochondrial acetylome by comined 
proteomics approaches in liver tissue from SIRT3 knockout mice. SIRT3 is a mitochondrial 
deacytylase that together with SIRT4 and SIRT5 are believed to regulate most protein 
function in mitochondria modulated by acetylation [82]. From this analysis, a total number 
of 116 acetylated proteins were identified of which the majority of proteins were involved in 
OXPHOS, TCA cycle, lipid metabolism, and fatty acid metabolism. 
PTM
Phosphorylation 
Acetylation 
Oxidative damage 
Reference
Lee (2007)
Zhao (2011)
Gnad (2010)
Fritz (2012)
Shinmura (2011)
Wang (2009)
Reinheckel (2000)
Choksi (2008)
Taylor (2003)
Organism
Mouse
Human
Mouse
Mouse
Rat
Mouse
Rat
Mouse
Human
Proteomics technology
IMAC w/ LC-MS/MS/MS
ZIC-HILIC, calcium phosphate 
precipitation, TiO2, LC-MS/MS
TiO2 w/ LC-MS/MS
2D IEF SDS-PAGE w/ immuno 
detection and LC-MS/MS; 
affinity purification w/ MUDPIT 
(SCX x RP LC-MS/MS)
2D IEF SDS-PAGE w/ immuno 
detection and MALDI-MS
2D IEF SDS-PAGE DIGE w/ 
immuno dection and MAL-
DI-MS/MS
2D IEF SDS-PAGE w/ immuno 
detection
2D BN SDS-PAGE w/ immuno 
detection and MALDI-MS/MS
geLC-MS/MS
Modification sites
84
138
174
>276 ** 
NA
16
NA
51
Modified 
proteins
62
86
74
116
7
18
59 spots*
14
39
Table 2
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Wessels et al showed the potential of BN LC-MS/MS to analyze (mitochondrial) protein 
complexes [93]. In the same paper, protein correlation profi ling was used to identify proteins 
that (potentially) act as chaperones in the assembly of complex I. In a follow up paper, the 
mass spectrometry (APMS) [85, 89]. Using this approach, proteins are tagged with (tandem) 
affi  nity purifi cation tags which allow purifi cation of the tagged protein (bait) with its interactors 
(targets) [90]. Here, the use of two or more affi  nity tags allow highly pure preparations of 
interacting proteins with reasonable recovery. Tandem mass spectrometry is used to identify 
the diff erent components within the interaction network. Figure 4A summarizes the typical 
steps in APMS. Despite the high purity preparations, false positives or contaminant proteins 
are commonly detected in affi  nity purifi cation samples which prompt the use of proper 
control samples and semi-quantitative comparisons to minimize false positives. Alternatively, 
one may tag multiple proteins within the interaction network and quantify the relative 
recovery of every target for each bait. This allows the construction of network diagrams to 
map interaction networks. The requirement to express exogenous constructs of the protein 
of interest with the desired affi  nity tags make this approach less suited for large-scale 
analysis of protein-protein interactions in mammals. Immuno purifi cation in combination with 
mass spectrometry (IPMS) is an alternative for APMS when the expression of exogenous 
constructs or the addition of an affi  nity purifi cation tags are not feasible. The use of antibodies 
to selectively purify a protein of interest together with its interaction partners for mass 
spectrometry analysis is however challenging [91]. First of all, antibodies may cross-react 
with multiple unrelated proteins which increases the number of false-positives. Another issue 
is that antibodies may selectively bind to a subpopulation of the protein of interest. Finally, 
background levels of the antibody may be present in the sample after elution or precipitation 
which reduces the sensitivity of the LC-MS/MS analysis for proteins of interest.
Alternative approaches to IPMS and APMS use various methods to separate and analyze 
protein-protein interactions. Complexes are typically separated by size (e.g. via centrifugation, 
size exclusion chromatography, or native gel electrophoresis) and collected into fractions 
prior to mass spectrometric analysis (typically LC-MS/MS). The shotgun proteomics data 
from separate fractions is used to identify the individual proteins. Advanced approaches use 
protein correlation profi ling in addition to protein identifi cation data to reduce false positives. 
PCP based method need to extract semi-quantitative information for peptides from each 
protein in every fraction to generate protein abundance profi les. Protein correlation profi ling 
is then used to identify proteins that comigrated/coeluted in the initial separation which is 
used to defi ne protein complexes and their individual components from the data [49, 86, 
92-94]. Figure 4B summarizes the generic steps of approaches that rely on the separation 
and fractionation of protein complexes in combination with PCP. More traditional approaches 
use two dimensional native electrophoresis with peptide mass fi ngerprinting by MALDI-MS to 
identify individual protein components from complexes (e.g. Reischneider et al [42]). 
To date, no large-scale analyses of mitochondrial protein-protein interaction networks has 
been performed by APMS. Presumably the costs and time involved in such studies pose 
signifi cant hurdles to most research groups. In mitochondrial research, APMS is primarily 
used as discovery or validation tool for a limited number of bait proteins. Examples where 
APMS was successful used to study mitochondrial systems include OXPHOS assembly 
[95-97], mitochondrial translation [98-100], and nucleoids [101, 102]. Similarly, only a limited 
number of studies have been performed that analyzed the mitochondrial complexosome 
through separation of complex protein mixtures rather than specifi c purifi cation of a single 
target protein with its interactors. Early work of Reifschneider et al used 2D BN SDS-PAGE 
with MALDI-MS to map the mitochondrial interactomes in rats [42]. Recent eff orts employed 
BN gel electrophoresis in combination with shotgun proteomics and protein correlation 
profi ling to overcome limitations associated with 2D BN-SDS PAGE MALDI-MS. In 2009, 
Figure 4. Overview of the typical steps in APMS and PCP based methods. Figure 4A provides 
an overview of the typical steps in APMS based methods: (1) The protein of interest with two additional 
tag sequences is expressed in a cell. After induced expression of the construct, proteins are extracted 
and added to the fi rst affi  nity resin. (2) The majority of contaminant proteins (black pentacles) are washed 
away and protein that bound to the column are eluted. (3) Proteins that eluted from the fi rst affi  nity 
purifi cation step are incubated with the second affi  nity resin and remaining contaminant proteins are 
removed. (4) The (highly) pure protein construct together with its interactors is eluted in the fi nal step of 
the tandem affi  nity purifi cation and cut into proteolytical peptides using trypsin endopeptidase. Following 
digestion, the tryptic peptides are analyzed by LC-MS/MS. (5) Shotgun proteomics data is used to 
identify the proteins that interacted with the expressed protein construct. Figure 4B shows the generic 
steps in methods that rely on separation of the native protein complexes in combination with protein 
correlation profi ling (PCP): (1) First, proteins are extracted in their native forms from cells using mild 
detergent (e.g. laurylmalotisde or digitonin) and separated by density gradient ultra centrifugation, liquid 
chromatography or gel electrophoresis and collected in fractions or gel slices. (2) Each individual fraction 
is subjected to tryptic digestion and resulting peptide mixtures are analyzed by shotgun proteomics. 
(3) LC-MS/MS data is used to identify individual proteins in every fraction and quantitative information is 
extracted to generate protein abundance profi les. The protein abundance profi les are then used to fi nd 
coeluting/comigrating proteins via protein correlation profi ling.
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Aim and outline of this thesis
Mitochondrial function and dysfunction are poorly understood at the protein level. In recent 
years, the field of proteomics has matured from highly experimental approaches to more 
robust technology. At present, mass spectrometry based proteomics technologies provide 
the means necessary for in-depth analyses of the mitochondrial proteome on all relevant 
molecular levels. This thesis describes part of the work that has been performed at the 
Radboud University Nijmegen Medical Centre to develop, optimize, and apply proteomics 
technologies to study the mitochondrial proteome. Part I (chapters 2-5) describes in part 
the proteomics workflow optimization that was required to setup and apply mitochondrial 
proteomics from square one. Part II of this thesis (chapters 6-9) highlights several 
important applications of the developed proteomics technologies to analyze protein-protein 
interactions.
Chapter 2 describes in depth the developed software tool “PROTON” which is used to 
process Mascot database search results from shotgun proteomics studies. The typical LC-
MS/MS setup and instrument settings used for most analyses in this thesis are described 
in detail in chapter 3. In chapter 4, a comprehensive LC-MS/MS proteomics benchmark 
dataset is described that was generated for the development of the PROTON software tool, 
optimization of chromatographic and mass spectrometric parameters, and benchmarking 
of available software tools and processing methods. A novel data analysis method for the 
identification of potential biomarkers from LC-MS data is presented in chapter 5 using the 
proteomics benchmark dataset described in chapter 4 and instrument setup from chapter 3. 
Chapter 6 describes the discovery of the human mitochondrial ribosome recycling factor 
and presents affinity purification mass spectrometry data to underline the interactions of 
mtRRF with, amongst other, the mitochondrial ribosome. Pioneering work to setup and 
refine two dimensional blue native SDS-PAGE MALDI-MS is presented in chapter 7 using 
Methanothermobacter thermautotrophicus strain ∆H as model organism. Because of 
limitations in human mitochondrial complexosome analysis by 2D BN SDS-PAGE MALDI-
MS (unpublished data) a novel approach was developed and introduced in chapter 8. 
Here, the use of shotgun proteomics data to establish protein abundance profiles and 
application of protein correlation profiling was interfaced for the first time with blue native gel 
electrophoresis. Application of PCP was performed to identify novel candidate complex I 
assembly factors for follow up studies. The initial BN shotgun proteomics dataset generated 
in chapter 8 was re-processed and made publically available in chapter 9. Hierarchical 
clustering of abundance profiles was performed to allow facile use of the data and to analyze 
mitochondrial ribosomal (sub)complexes. Finally, chapter 10 presents the general discussion 
where results from the experimental chapters are evaluated and discussed.
same authors published the complete re-processed data set from [93] and used this data to 
characterize mitochondrial translation complexes [92]. An important recent development in 
BN LC-MS/MS is the work of Heide et al which describes the application of an improved blue 
native gel electrophoresis protocol and hierarchical clustering of protein abundance profiles to 
analyze complexes of up to tens of megadaltons in size [103]. 
 
Protein biomarkers for mitochondrial disorders
At current, laboratory diagnostics of mitochondrial disorders is initially performed on skeletal 
muscle biopt material and cultured primary fibroblast cells from skin tissue [104]. Both tissue 
materials are acquired via rather invasive procedures that put additional strain on patients, 
which are often children of young age. Ideally, a primary diagnostics test should be performed 
on easily accessible body fluids such as serum from blood. This would significantly reduce 
the burden on patients, especially in cases where patients are erroneously suspected to 
suffer from mitochondrial disorders. Aberrant protein levels in serum may serve as markers to 
identify patients with mitochondrial disorders. Here, the expression level of specific proteins 
serve as biomarkers to indicate the pathological state of the patient. Use of biomarkers from 
serum should allow for successive disease monitoring in patients to better understand and 
treat mitochondrial disorders. This is especially important when treatments [105] need to 
be followed in time to monitor disease state and to recognize possible complications in an 
early stage.
Thus far only a single protein biomarker has been identified in serum for mitochondrial 
respiratory chain deficiencies: fibroblast growth factor 21 (FGF-21). This protein biomarker 
was identified by Tyynismaa et al in 2010 in skeletal muscle from a mitochondrial myopathy 
mouse model that expressed a dominant patient mutation in the Twinkle protein [106]. 
The FGF-21 protein is a fasting-related hormone of which the expression was found to 
be elevated in the Twinkle mouse model. The fact that FGF-21 serves as an endocrine 
cytokine [107] makes this protein an ideal biomarker candidate. The follow up study by 
Suomalainen et al showed that FGF-21 can be used as a biomarker for muscle-manifesting 
mitochondrial respiratory chain deficiencies with high sensitivity (92.3%) and specificity 
(91.7%) [108]. Here, the authors also show that the accuracy of FGF-21 to identify muscle 
manifesting mitochondrial disease was better than all conventional biomarkers used thus 
far (lactate, pyruvate, lactate-to-pyruvate ratio, creatine kinase). Nevertheless, additional 
protein biomarkers need to be established in mitochondrial disorders that indicate specific 
hallmarks in disease progression, non-muscle manifesting mitochondrial disease, and severe 
downstream complications. 
Closing remarks
State of the art proteomics technologies hold the potential to unravel the mechanisms that 
underlie mitochondrial function and dysfunction. Despite the great efforts that were made in 
the last decade, substantial work needs to be performed to fully comprehend the complexity 
of the mitochondrial proteome. Thus far, an estimated 85% of all mitochondrial proteins 
has been identified. However, tissue specific protein expression and selective expression of 
proteins under different cellular conditions dictate that the mitochondrial proteome needs to 
be analyzed in even more different tissues and cellular conditions than currently performed. 
Moreover, the still limited knowledge about proteome adaptations in mitochondrial disorders 
as well as the available minimal inventories of post translational modifications, protein-protein 
interactions, and protein biomarkers fuel the need for substantial future proteomic studies in 
order to comprehend mitochondrial processes. 
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Abstract
Hyphenated techniques such as liquid chromatography with online tandem mass 
spectrometry are known to produce large amounts of complex data. In shotgun 
proteomics, large collections of peptide tandem mass spectrometry data are 
searched against a protein sequence database to identify corresponding peptide 
sequences and, hence, proteins. Here, proper validation of database search 
results is critical to minimize false positive results. The PROteomics TOols 
Nijmegen (PROTON) software was developed for automated validation of Mascot 
database search results from shotgun proteomics experiments. It features both 
false-discovery-rate (FDR) based validation strategies for large data sets and 
fi xed criteria validation strategies for small data sets. This chapter describes the 
background, methods, and output for PROTON which was used for data processing 
in over 15 accepted peer reviewed journal papers thus far. Aim of this chapter is to 
provide background information and details for PROTON users. 
Introduction
Unambiguous protein identifi cation has been one of the most anticipated technologies in 
biochemistry. Biomolecular mass spectrometry has long held this promise that only came 
to reality two decades ago following the introduction of soft ionization techniques. The 
development of both matrix assisted laser desorption ionization (MALDI, [17, 109]) and 
electrospray ionization (ESI, [18]) revolutionized biomolecular mass spectrometry by enabling 
routine mass spectrometric analysis of (poly)peptides. Mass spectrometry companies quickly 
adopted the MALDI and ESI techniques to develop ever faster and more accurate mass 
spectrometers for protein and peptide analysis. Soon, protein mass spectrometry shifted 
from the analysis of (nearly) pure proteins and peptides to that of highly complex protein 
mixtures. The concept of large-scale protein identifi cation and quantitation [110] fi nally led 
to the introduction of the term “proteomics” by Wilkins in 1995 [19], which is the large-scale 
analysis of the entire protein complement (proteome) produced by a cell or system.
 
Although mass spectrometry hardware in the early 90s was capable of generating large 
collections of data, interpretation of tandem mass spectra to elucidate or identify peptide 
sequences was still in its infancy. This posed a signifi cant bottleneck in proteome studies 
where hardware developments increased the number of acquired spectra to a level where 
manual interpretation would be next to impossible. Thanks to the work of many mass 
spectrometry groups worldwide, both algorithms and software were developed for the 
automated identifi cation of (poly)peptides from mass spectrometry data through database 
searching [111-117]. 
In general, two popular approaches for the identifi cation of proteins and peptides are 
commonly used: peptide mass fi ngerprinting (PMF [23, 114]) and tandem mass spectrometry 
(MS/MS) ion searches [26]. In peptide mass fi ngerprinting proteins are cut into smaller 
peptide fragments using proteases or chemicals that cut N- or C-terminal to specifi c 
amino acid residues within the backbone of the protein amino acid sequence. Here, mass 
spectrometry is used to determine the exact masses of the peptide fragments after digestion. 
Database search software is then used to score the similarity between measured data and 
in-silico prediction of the enzymatic protein digest. Subsequently, scoring thresholds are 
applied to determine if a protein identifi cation is signifi cant or not. Inherent to the standard 
PMF approach is its limitation to very simple protein mixtures which requires a pre-purifi cation 
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when peptides that are readily available in the normal database search result are ignored in 
the decoy database search result which would be false negatives. Both search results are 
used to determine criteria that ensure that the ratio between normal and decoy database 
search results (at the peptide or protein level) stays below the user specified maximum false 
discovery rate. 
This chapter describes the PROTON (PROteomics TOols Nijmegen) software tool which was 
developed to process and validate Mascot database search results from shotgun proteomics 
experiments. PROTON features fixed criteria validation methods and commonly used FDR 
based validation strategies to process small (less than a few thousand MS/MS spectra) and 
large (up to millions of MS/MS spectra) proteomics datasets. PROTON takes Mascot html 
search result files as input and provides both text and MS Excel file types as output. The 
different validation methods provided through PROTON are described in detail in this chapter 
and characterized using large Escherichia coli [125] and Homo sapiens [92, 93] shotgun 
proteomics datasets. 
Materials & Methods
Generation of E. coli shotgun proteomics data
The E. coli shotgun proteomics data set is described previously in detail in Wessels et al [125] 
and is available from http://www.cac.science.ru.nl/research/data/ecoli. In short, 50 individual 
whole cell protein extracts were prepared from a single E. coli culture. From each extract, 
5 µg of protein was subjected to tryptic in-solution digest as described elsewhere [126]. 
Peptides were desalted and concentrated prior to LC-MS/MS measurements by stop and 
go elution (STAGE) tips according to Rappsilber et al [127]. Measurements were performed 
by nanoflow reversed-phase C18 liquid chromatography with online mass spectrometry 
using a linear ion trap Fourier-Transform ion cyclotron resonance mass spectrometer (LTQ 
FT, Thermo Fisher Scientific) equipped with a 7 Tesla magnet [128]. The mass spectrometer 
was programmed to acquire a single full MS survey scan in the ICR cell with up to four 
data dependent collision induced dissociation (CID) fragmentation spectra in parallel by the 
linear ion trap. Dynamic exclusion was enabled to prevent re-analysis of precursor ions. 
ExtractMSn (Thermo Fisher Scientific) software was used to generate Mascot compatible 
data files. 
 
Generation of H. sapiens blue native LC-MS/MS shotgun proteomics data
Full details for the generation of the H. sapiens blue native (BN) LC-MS/MS dataset can 
be found in [93]. Briefly, a mitochondrial protein fraction from human embryonic kidney 
293 (HEK293) cells was separated by blue native gel electrophoresis using a 5-15% acryl 
amide gradient gel. The resulting gel lane was cut into 24 gel slices at even distance and 
each gel slice was subjected to in-gel tryptic digestion. STAGE tips were used to desalt 
and concentrate the peptide mixtures prior to LC-MS/MS measurements. Duplicate 
measurements of each gel slice were performed by nanoflow reversed-phase C18 liquid 
chromatography coupled online to a 7T linear ion trap Fourier-Transform ion cyclotron 
resonance mass spectrometer (LTQ FT, Thermo Fisher Scientific). Mass spectrometry and 
data processing was performed identical to the E. coli experiments as described previously. 
Mascot database searches
All protein sequence database searches were performed using Mascot v2.2 (Matrix Science) 
[115, 129] with the following settings: 15ppm precursor mass tolerance, 0.8 Da fragment 
method such as two dimensional gel electrophoresis prior to mass spectrometric analysis 
of the protein mixture [24]. This is in contrast with MS/MS ion searches where tandem mass 
spectrometry data is used to potentially identify an unlimited number of proteins within 
mixtures via individual identification of their peptide fragments. The number of proteins that 
can be identified in a sample is essentially limited to the quality and number of tandem mass 
spectrometry experiments generated by the mass spectrometer. To extend the dynamic 
range and analysis time for samples, experiments are typically performed using peptide 
separations by liquid chromatography combined with online mass spectrometer detection 
via electrospray ionization. The liquid chromatography – tandem mass spectrometry (LC-MS/
MS) analysis of proteins in complex mixtures is commonly referred to as shotgun proteomics. 
Identification of peptides from mass spectrometry data is not possible through accurate 
mass measurement of the peptide by itself. Hence, (poly)peptides with identical amino 
acid composition may have a different sequence by which their amino acids are ordered. 
Structural information about the peptide is thus required from mass spectrometry 
experiments to unambiguously identify a peptide. In tandem mass spectrometry experiments 
the peptide mass is determined by a first round of mass spectrometry (MS level) and its 
structure analyzed by a second round of mass spectrometry (MS/MS level). Structural 
information for a peptide is obtained through isolation and controlled fragmentation of the 
precursor ion [118-120]. This allows peptides to be identified using both accurate peptide 
mass and similarity scoring of the measured and predicted set of fragment ion masses for 
each peptide [26]. The collection of peptide identifications in an experiment is used to infer 
protein identifications through sequence matching and clustering of protein identification 
results [25, 121]. 
Peptide identification scores on itself do not imply valid peptide or protein identifications 
as similarity scores are always calculated for peptides that match the precursor ion mass. 
Thresholds thus need to be applied on database search results to filter out false positive 
peptide identifications [122]. Different strategies can be used to validate database search 
results to minimize the false discovery rate (FDR) and to maximize the number of peptide/
protein identifications. In general, two approaches can be discerned. The most simple 
approach is to apply a set of fixed criteria to validate database search results [123, 124]. 
These criteria are determined a priori from previous experiments to ensure valid protein 
identification. Using fixed criteria for validation purposes can be tricky as search results 
may inherently differ due to non-similar sample preparation, protein constituent, sequence 
database, number of MS/MS experiments, and LC-MS/MS performance that all influence the 
false discovery rate. To circumvent this problem fixed criteria are generally very strict which 
leads to an increased specificity but decreased sensitivity [121]. Methods that rely on fixed 
criteria are generally used to validate database search results that do not provide enough 
data to use more elaborate methods such as controlled FDR based validation methods. 
Although intrinsically different methods are available, all methods strive to determine the 
least stringent criteria to reach a maximum specified FDR value. Reliable FDR calculations 
however require substantial amounts of peptide identification data to be accurate. These 
methods all rely on search results of the tandem mass spectrometry data against a normal 
database (that contains all expected or possible protein sequences for the sample, including 
known contaminant proteins) and a decoy database which contains the scrambled or 
reversed protein sequences from the normal database. The hypothesis for FDR calculations 
is that the normal database search results contain both false and true positives whereas the 
decoy database search results contain solely true negatives. Of course, this holds only true 
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their identified peptides. The total number of protein groups thus represents the minimal 
protein composition in a sample that explains all identified peptides [25, 121]. Proteins 
within a group share the same subset of peptide identifications and the protein covered by 
the highest number of peptide identifications is the most likely protein identification (group 
representative). Remaining proteins within a group might be present in the sample but no 
conclusive evidence was found to confirm their presence. 
PROTON: Fixed criteria validation
 
Figure 1. PROTON flow scheme for validation of Mascot search results using fixed criteria. In the first 
step, all peptide matches from the Mascot search result file are extracted and filtered. Extracted peptide 
sequences are matched with protein sequences in the database and protein identification groups are 
constructed. Next, user selected validation criteria are applied to the data and valid peptide identifications 
are used to generate the final protein identification groups. Output result files are generated in the final 
processing step.
Validation of Mascot search results by PROTON using fixed criteria follows the scheme 
presented in figure 1. All peptide identification information is parsed from the Mascot html 
result file(s) by the PROTON parser after filtering. Filters can be applied to the data to 
exclusively select peptides for parsing that fulfil the filter requirements in terms of peptide 
length (in amino acids), minimal Mascot ion score, peptide identity score threshold, or 
precursor mass error. Since different criteria can be used to validate proteins with single 
or multi peptide coverage, PROTON needs to determine the number of identified peptides 
for each non-redundant protein match. To this end, peptide sequences extracted from the 
Mascot result file are used by the PROTON clustering script to generate the grouped protein 
identification list with all corresponding peptide information. After clustering, PROTON is 
able to apply the user specified criteria to proteins with single or multi peptide coverage, 
respectively. Proteins identified by a single peptide (often referred to as single-hit wonders) 
ion mass tolerance, tryptic specificity, maximum of 1 missed cleavage by trypsin, fixed 
carbamidomethylated cystein residues, and variable methionine oxidation and protein 
N-terminal acetylation. The E. coli RefSeq release 33 and H. sapiens RefSeq release 44 
databases were used, respectively, with added sequences of known contaminant proteins 
(Trypsin, LysC, skin and hair proteins). Decoy databases were generated by PROTON that 
contain the reversed protein sequences from each database. Mascot searches against 
the decoy databases were performed with identical input data and search parameters as 
the normal database searches. Mascot search results were stored as .html result files with 
default settings, except for the minimum ion score which was set to 0.
PROTON: protein sequence database indexing
For tryptic peptides PROTON uses a pre-indexed database for matching peptides to protein 
sequences and clustering of results to reduce processing time. Protein sequences are in-
silico digested using tryptic specificity (C-terminal cleavage to arginine and lysine residues 
unless followed directly by proline) with 0 up to 2 missed cleavages. The protein index file 
lists all in-silico tryptic peptides for each protein sequence in the database whereas the 
peptide index file contains all proteins that contain each unique peptide sequence. N-terminal 
peptides for each protein are generated in-silico with and without the N-terminal methionine 
residue. Leucine and isoleucine residues are considered as identical amino acids by 
PROTON since both amino acids have identical mass. 
PROTON: calculation of protein physicochemical properties
Physicochemical properties for all protein sequences in each normal database were 
calculated by PROTON prior to data validation. For every available protein sequence 
PROTON calculated the molecular weight (Mw), isoelectric point (pI), and grand average of 
hydropathicity (GRAVY). Protein Mw was calculated as the sum of average isotopic masses 
from all amino acids in the protein sequence with the added molecular weight of a water 
molecule. The protein pI was calculated as the pH at which the overall net charge of the 
protein equals zero using pK values for the amino acids from Bjellqvist et al [130]. 
The GRAVY value for each protein sequence was calculated as the sum of all hydropathy 
values of all the amino acids in the sequence divided by the total number of amino acid 
residues in the sequence [131].
PROTON: clustering
Peptide identifications from Mascot search result files need to be matched with protein 
sequences in the database prior and posterior to data validation. For tryptic peptides 
PROTON uses the a priori generated protein and peptide index files whereas non-tryptic 
peptides are matched with protein sequences in the database prior to clustering to generate 
the protein and peptide index files. First, peptides are matched to protein sequences and 
proteins are sorted by descending peptide coverage. For each unclustered protein (k) (in 
order of descending peptide coverage), PROTON retrieves all peptides for the respective 
protein sequence. Each retrieved peptide is then used to check if it matches any other 
protein sequence (m) in the database. All peptides are retrieved for protein (m) and compared 
with those peptides of protein (k) to determine if any unique peptide was identified that 
confirms the presence of protein (m). If no unique peptide was identified for protein (m) the 
protein is added to the same identification group as protein (k) and is set as “clustered”. 
When the presence of protein (m) is confirmed by an unique peptide identification not shared 
with protein (k), the protein is set as “unclustered” and stays on the list of proteins that 
need to be classified. Finally, proteins within each group are ranked in descending order by 
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Equation 1.
PEPFDR(s) = Ndecoy peptide hits / Nnormal peptide hits
PEPFDR(s) Peptide level false discovery rate at minimal Mascot ion score (s).
Ndecoy peptide hits Number of unique peptide hits from the decoy database search result  
 file(s) with Mascot ion score at or above the current Mascot ion score (s).
Nnormal peptide hits Number of unique peptide hits from the normal database search result  
 file(s) with Mascot ion score at or above the current Mascot ion score (s).
PROTON: single class protein level false discovery rate based validation
Similar to the PEPFDR method, the single class protein level false discovery rate based 
validation method (PROFDR) uses Mascot search results from the MS/MS data against 
normal and decoy versions of the protein sequence database. Since FDR values are 
calculated at the protein level PROTON first matches the parsed peptide sequences with 
protein sequences in each respective database to construct protein identification groups. 
The group representatives (proteins with highest peptide coverage in each group) are used to 
calculate FDR values for each minimal Mascot ion score threshold according to equation 2. 
Equation 2.
PROFDR(s) = Ndecoy protein hits / Nnormal protein hits
PROFDR(s) Protein level false discovery rate at minimal Mascot ion score (s).
Ndecoy protein hits Number of unique protein hits from the decoy database search result  
 file(s) with Mascot ion score at or above the current Mascot ion score (s).
Ndecoy protein hits Number of unique protein hits from the normal database search result  
 file(s) with Mascot ion score at or above the current Mascot ion score (s).
The lowest minimal Mascot ion score that results in a PROFDR at or below the user specified 
value is used to separate valid from non-valid peptide matches. Following this validation step, 
all valid peptide sequences are matched anew with protein sequences in the database prior 
to output generation. 
 
require more stringent validation criteria than proteins with higher peptide coverage. PROTON 
therefore allows users to set different threshold values for available validation criteria for each 
of both protein identification classes. Criteria that can be applied here are the minimal Mascot 
ion score, minimal delta score, minimal modified delta score, maximum expectation value, 
and maximum allowed number of variable modifications. All peptides that fulfil the selected 
criteria are clustered anew to protein identification groups by PROTON as peptides unique 
to a protein group may have been removed after validation as non-valid peptides. Here, 
PROTON uses a temporary sequence database that contains all protein sequences that were 
matched with peptides in the initial clustering step to reduce computation time. Finally, output 
data is generated by PROTON as text files (tab delimited .txt files) and a MS Excel file (.xls).
PROTON: peptide level false discovery rate based validation
Figure 2. Schematic representation of the important steps in peptide level FDR based validation of 
Mascot search results by PROTON. Peptides are extracted from both normal and decoy Mascot 
database search results. Both search results are used to determine the lowest minimal Mascot score 
to achieve the maximum allowed (user specified) false discovery rate. Valid peptides are matched with 
protein sequences and identification groups are constructed prior to output data file generation.
Mascot search result validation by PROTON via the peptide level false discovery rate (PEPFDR) 
based method requires both normal and decoy database search results. Peptides are extracted 
from the normal and decoy database search result files for validation purposes. Here, validation 
is performed directly on the Mascot search parse data without any prior matching of the peptide 
sequences to proteins. PROTON calculates the FDR for all Mascot ion scores in the range of the 
lowest and highest Mascot ion score available from the parse data. FDR values are calculated 
for each Mascot ion score according to equation 1 and the lowest Mascot ion score that gives 
a FDR value at or below the set maximum FDR value is used as minimum score threshold [121]. 
All peptides at or above this minimum score threshold are matched with protein sequences by 
PROTON to construct the protein group identification list prior to data output. 
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Figure 4. Flowchart for the heuristic iterative protein level FDR based validation method implemented in 
PROTON. Extracted peptide matches from both normal and decoy database Mascot search results are 
matched with respective protein sequences and clustered to protein identification groups. From each 
group, the protein with the highest peptide coverage is selected for FDR calculations. In subsequent 
iterative steps PROTON calculates the minimal peptide score required to achieve the specified maximum 
FDR threshold for proteins identified by ≥6, 5, 4, 3, 2 and 1 peptides (c=6...1). First, starting for proteins 
identified with ≥6 peptides (c=6), minimal Mascot ion score tresholds are calculated by a stepwise 
increase of the ion score threshold until the FDR level drops below the set maximum threshold. Peptides 
that have scores below the applied ion score threshold are removed at the end of each iteration of 
the current protein identification class and stored for future calculations. In addition, proteins that have 
fewer peptides that fulfil the minimum ion score threshold than the current protein identification class are 
removed and stored for future calculations. When the desired maximum FDR threshold for a protein class 
is reached, all remaining peptides are stored as valid peptides for later use. The first score iteration of 
each subsequent protein identification class starts at the Mascot ion score that was required to achieve 
the specified FDR level for the previous protein class. Please note that proteins and peptides that were 
removed by previous iterations for the prior protein identification class are included again in subsequent 
calculation for each remaining protein class, respectively. Finally, when the FDR calculations for proteins 
identified by a single peptide (c=1) have finished, PROTON takes all valid peptide identifications to 
construct protein identification groups.
Figure 3. Protein level FDR based validation method used by PROTON. Extracted peptide matches from 
both normal and decoy database Mascot search results are matched with respective protein sequences 
and clustered to protein identification groups. From each group, the protein with the highest peptide 
coverage is selected for FDR calculations. Next, PROTON calculates the FDR at each available minimal 
Mascot ion score to select the lowest possible treshold to achieve the user specified FDR value. Protein 
identification groups are constructed from all valid peptide identifications and output data is generated as 
the final step.
PROTON: heuristic iterative protein level FDR based validation
The first and final stages in the heuristic iterative protein level FDR based validation method 
(HPROFDR) are identical to those of the PROFDR method. The single difference between 
the PROFDR and HPROFDR methods is that the HPROFDR approach determines minimal 
Mascot ion score thresholds to achieve the selected FDR for proteins with coverage (c) of 
≥6, 5,...,1 peptides (local false discovery rates) [121], as shown in figure 4. Starting with 
proteins with a coverage of 6 or more peptides (c = 6), PROTON calculates the FDR value 
for the minimal Mascot ion score according to equation 2 until the selected maximum FDR 
threshold for proteins with coverage (c) is achieved. After each round of FDR calculation for 
proteins with coverage (c), PROTON raises the minimal Mascot ion score with +1 until the 
desired FDR level is reached. At the beginning of each iteration, peptides with scores below 
the current minimal Mascot ion score threshold and proteins with coverage lower than the 
current protein coverage class (c) are rejected. When the desired FDR value for proteins with 
current coverage (c) is reached, PROTON will start to determine the minimal Mascot ion 
score threshold for protein with coverage (c – 1) until proteins with singe peptide coverage 
(c = 1) are processed. Proteins and peptides that are rejected at the end of each iteration for 
proteins with coverage (c) are used anew by PROTON for proteins with coverage (c – 1). All 
valid peptide identifications are matched with protein sequences and protein identification 
groups are used to generate output data.
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Parsing and filtering of Mascot search results
Peptide identification data is readily available from Mascot dat, XML or HTML result files. 
However, due to security settings on Mascot servers, users may have access to only HTML 
result files which were selected as PROTON input file type. Data extracted from the HTML 
result file by the parser is used by PROTON for further processing and is available as tab 
delimited .txt file for manual analysis. Besides data extraction from Mascot HTML result files, 
this module also allows users to apply a selection of filters to the data to remove ambiguous 
peptide identifications at an early processing stage. This has the added benefit of reduced 
data processing by subsequent processing steps to reduce computation time. All available 
filtering options are listed in table 1 and discussed in detail hereafter. 
Table 1. Available peptide filters when parsing Mascot search results.
By default, the PROTON parser will extract all identified peptides from the Mascot search 
result. This also includes peptides with unreliable identification scores (e.g. peptide 
identification score in the range of 0 to 15). Setting the minimum score filter to a selected 
threshold value ensures that solely relevant peptide identifications are used for further 
processing. Use of this score threshold has a dramatic impact on the number of peptides 
that need to be matched with protein sequences in the database. For the E. coli dataset 
a minimum Mascot ion score of 16 reduces the number of peptide matches for further 
processing from 355362 to 279981 (-21%). Similar results are obtained for the H. sapiens 
dataset where the number of peptide matches for further processing was reduced from 
355362 to 286337 (-19%). The minimum peptide length filter allows users to select peptides 
for further processing when their amino acid chain length is above the set threshold (please 
note that Mascot, by default, will not consider peptides with shorter than 5 amino acids in 
length). This filter may be used to remove short length peptides from further analysis to lower 
false positives and to increase peptide specificity at the protein level. Relationship between 
peptide sequence length and specificity is shown in supplementary figure 1 for the E. coli and 
H. sapiens RefSeq protein sequences. 
PROTON also offers the possibility to use individual score thresholds calculated by Mascot 
that indicate the minimum required identification score for a peptide hit to be significant 
(P<0.05) [129]. This “identity score threshold” assumes that the probability for a peptide 
match to be a direct function of the number of times that precursor ions were attempted to 
match. Therefore, Mascot first calculates the absolute probability for the peptide match to 
occur from the number of precursors ions that matched with this particular peptide within the 
specified mass tolerance with a (default) 1 in 20 chance (equation 5). Since the Mascot ion 
score (S) is defined as -10Log P, the identity score threshold can be calculated according to 
Exponentially modified Protein Abundance Index (emPAI) calculations
Protein abundances are available from the PROTON output as exponentially modified Protein 
Abundance Index (emPAI) values [51]. The emPAI value is calculated according to equations 
3 and 4 as described by Ishihama et al [51].
Equation 3
PAI = (Nobserved spectra)/(Nobservable peptides)
PAI Protein Abundance Index
Nobserved spectra Number of unique MS/MS spectra matched to the protein sequence
Nobservable spectra Number of detectable tryptic peptides from the protein sequence
Equation 4
emPAI = 10^PAI-1
emPAI Exponentially modified Protein Abundance Index 
PAI Protein Abundance Index
The number of observable peptides was calculated as the number of in-silico tryptic peptides 
with calculated mass-to-charge ratio (m/z) within the selected mass range of the full MS 
survey scan (350-1600 m/z) for chargestates (z) that were selected for CID fragmentation 
scans (z=2+ and z=3+) in the mass spectrometer instrument settings.
Results & Discussion
Figure 6 shows the typical steps in shotgun proteomics. The PROTON software tool 
comprises different modules that are written in Perl programming language with a graphical 
user interface. The validation strategies currently supported by PROTON use unique and 
shared modules among different steps of the data processing. Each of the modules will be 
discussed in detail in this manuscript.
 
Figure 6. Schematic representation of the typical steps in shotgun proteomics. Proteins are first cut into 
smaller peptide fragments by the endopeptidase trypsin. Following digestion, peptides are separated 
via liquid chromatography with online tandem mass spectrometry analysis. Fragmentation data from 
the MS/MS experiments are used to identify peptides and subsequently proteins via database searches 
(performed here by Mascot). Database search results are validated and processed further by PROTON 
which is used to generate the final results.
Filter
Minimum Mascot ion score
Minimum peptide length in amino acids
Peptide score above identity treshold
Mass error limit
Settings
0…n
1…n
True/False
1…n ppm
Function
Filter out peptides with identification scores 
below selected treshold
Filter out peptides with amino acid length 
below the set treshold
Select whether or not peptides should have 
scores above the Mascot identity score treshold
Filter out peptides by mass measurement error
Table 1
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Figure 7. Theoretical example of how protein identifications are inferred from shotgun proteomics data. 
A set of 7 peptides can be matched with 4 different proteins in the database. From these proteins only 
protein B is identified with an unique subset of peptides. For protein A two different isoforms share the 
same subset of peptides, whereas protein C only shares peptide 3 with both isoforms. Clustering of the 
data into protein groups would assign both isoforms of protein A to group 1. Protein C would be assigned 
to group 2 irrespective of the shared peptide 3 with group 1 as peptide 5 is unique to this protein. Group 
3 would contain protein B which is identified by a unique subset of peptides. Proteins within a group are 
ranked by their peptide coverage so that rank 1 within each group is the most likely protein identification 
(or group representative).
When the Mascot output is filtered, some peptides may be missing that previously 
determined the most likely protein identification. This implies that all peptide data after 
filtering need to be (i) re-matched with protein sequences in the database and (ii) results 
hereof clustered anew to conform with protein identification principles. Here, PROTON uses 
all peptide identifications from all analyses that are processed together. This solves possible 
protein identification ambiguities across analyses. In general, even re-analysis of the same 
protein digest will yield different subsets of peptide identifications due to the quasi-random 
nature of peptide identification data from shotgun proteomics studies [132]. This effect is 
even more pronounced when protein identities or concentrations differ between samples 
(which is almost always the case in comparative proteomics). When peptide hits from 
individual measurements are separately matched with protein sequences, the outcome 
may be influences by the specific subset of peptides that were identified in each sample. 
In other words, a protein that is present in two or more samples may yield different protein 
identifications in separate searches. Most often, this means that different protein isoforms 
or closely related protein sequences (e.g. keratin protein families) are reported differently 
between analyses. This complicates the analysis of shotgun proteomics data when searching 
for proteins that differ between samples. PROTON solves this issue by simply assigning 
protein identifications for all samples at once. However, since protein isoforms may actually 
differ between samples, the final PROTON output contains all protein identifications with their 
associated data for each protein identification group in the output.
 
PROTON currently supports two modes of operation for this module: “complete tryptic 
enzyme specificity” and “no enzyme specificity”. The difference between both settings not 
only influences the correctness of protein identification but has also a significant impact 
on analysis time. With “complete tryptic enzyme specificity” the software will only consider 
peptides from proteins that conform with the enzymatic specificity of the trypsin endopeptide 
(cuts C-terminally to arginine and lysine unless followed by proline). This ascertains that only 
tryptic peptide possibilities are used to determine protein hits. Without tryptic specificity 
equation 6. Please note that greater precursor ion mass accuracy lowers the identity score 
threshold by reducing the number of precursor ions that Mascot attempts to match.
Equation 5
P = 1/(20*N)
P Probability for false positive match
N Number of attempted precursor matches
Equation 6
S = -10 Log P
S Identity score threshold
P Probability for false positive match
Finally, the mass accuracy distribution of all peptide identifications can be used to filter out 
likely false positives. This filter allows users to remove peptides with mass measurement 
errors (in parts per million, ppm) that exceed the set threshold. In general, this setting should 
already be specified correctly in the Mascot database search as it may influence what 
peptide hits are reported by Mascot. 
Peptide blasts and clustering
It is necessary for subsequent validation steps to assign peptide hits to proteins. Mascot has 
already matched peptide hits with protein sequences prior to PROTON processing but needs 
to be repeated for multiple reasons. First of all, validation criteria that are applied in later steps 
by PROTON depend on the number of peptide hits per protein for the protein level FDR or 
fixed criteria validation methods (depending on the user specified settings). Since PROTON 
applies filters to the Mascot output the number of peptides per protein and the best protein 
match for subsets of peptides need be re-determined. Secondly, this processing step also 
offers an opportunity to resolve ambiguities with inconsequent protein identifications for 
subsets of peptides across different measurements of similar or identical samples. 
The essence of shotgun proteomics is the identification of peptide sequences that are 
used to infer protein identifications. Since the elution order of peptides from the column in 
(typical) LC-MS/MS analyses is completely independent of protein origin, peptides need 
to be matched with all possible protein sequences that may have provided those peptides 
after digestion. The most likely protein identification is then simply determined by the highest 
number of matched peptides. This is complicated by the fact that some peptides are unique 
to a single protein sequence in the database whereas other peptides may be shared by 
multiple protein entries. Moreover, all proteins that (partly) share a subset of peptides without 
any additional unique peptide identification to prove its presence should be considered as 
“possibly present”. To make sense out of all this data, protein identifications are reported 
as “protein groups” with the most likely candidate to be a “group representative” [25, 121]. 
Figure 7 illustrates how protein identifications from shotgun proteomics data takes place. 
Please note that the default Mascot output only contains the most likely candidate.
 
44 45
non-relevant protein sequences could be considered as identifications. It also has the benefit 
that the software is able to pre-index the database to significantly minimize analysis time 
in this step. When “no enzyme specificity” is selected the software will simply look for any 
protein sequence that contains the target peptide, irrespective of digestion specificity. This is 
required for the analysis of native peptides from samples where the responsible peptidases 
are unknown. Since no information regarding protein sequence cleavage is available in this 
mode the software is unable to pre-index the protein sequence database which makes the 
analysis a much slower process. 
Fixed criteria validation
Table 2. Parameters for validation of Mascot search results using fixed criteria.
Analysis of samples with low complexity (e.g. samples that contain only a few proteins up to 
tens of proteins) do not generally yield enough data for robust FDR calculations. Such data 
thus requires validation by a priori determined criteria. PROTON provides several parameters 
that can be used next to the Mascot parse filters for validation of “low complexity” data. The 
different validation criteria (peptide score, delta score, modified delta score, and number of 
variable modifications) can be applied with different settings for proteins identifications based 
on single or multiple peptide identifications. This allows users to apply more strict validation 
criteria to protein identifications that rely on a single peptide match (which is more sensitive 
for false positive results than protein identifications based on multiple unique peptide 
identifications). The minimum Mascot ion score criterion is commonly used for validation 
purposes. An alternative for peptide score thresholds for validation uses the expectation 
value calculated by Mascot. The expectation value is derived from the peptide identification 
score and the identity score threshold (equation 7) to indicate the number of times one could 
expect to get this peptide identification score or better by chance [129].
Equation 7
E=Ptreshold*(10**((Streshold-score)/10))
E Expectation value
Ptreshold Significance threshold
Streshold Mascot identity score treshold
The Ptreshold is applied to the data in Mascot database searches (Ptreshold=0.05 is the default 
setting by Mascot unless specified otherwise) and the Streshold is the Mascot identity score 
threshold. Smaller expectation values indicate better matches, whereas a complete random 
match has an expectation value of 1 or more [129]. The minimum delta score is defined 
as the peptide identification score difference between the best and second best peptide 
match for a given spectrum [133]. Here, the second best match may be a different peptide 
sequence or the identical peptide sequence of the best peptide match with a different post 
translational modification (PTM) or PTM site. This delta score is particularly useful to select 
peptides with PTMs where modification site assignments are required [133]. For validation 
of peptide identifications at the sequence level PROTON provides the modified delta score 
which is defined as the score difference between the first and second best peptide matches 
for a spectrum where the second best match differs at the sequence level compared to the 
best match disregarding leucine/isoleucine ambiguities. The difference between the delta 
score and modified delta score is illustrated in figure 8 by a peptide identification example 
from the H. sapiens dataset. Additionally, PROTON also offers the possibility to set a 
maximum allowed number of PTMs for individual peptide identifications.
 
Figure 8.Delta score and modified delta score. Match results for a single MS/MS spectrum from 
the BN LC-MS/MS (H. sapiens) dataset. Peptide IPSAVGYQPTLATDMGTMQER is identified with two 
possible sites for methionine oxidation. The best match has a Mascot Ion Score of 59.7 with methionine 
18 oxidized. The second best match has a score of 44.6 for the same peptide sequence but with 
methionine 15 oxidized. The delta score is thus 15.1 (59.7 – 44.6 = 15.1). At the sequence level the 
second best match is peptide MLEGRQTPASTLEQDATDYR with 0.1 Mascot ion Score. The modified 
delta score is thus 59.6 (59.7 – 0.1 = 59.6). 
FDR based validation: peptide level FDR (PEPFDR)
Research that focus on individual peptides requires robust peptide identifications. Although 
Mascot offers different parameters to assess the validity of peptide identifications (e.g. 
peptide identification score, homology/identity score threshold, and expectation value), older 
versions of the Mascot software (up to version 2.2) do not provide the score thresholds that 
need to be applied to the data in order to control the FDR. Control of the FDR is necessary 
to correct for multiple hypothesis testing in large LC-MS/MS datasets. Peptide level FDR 
(PEPFDR) validation by PROTON aims to find the lowest peptide identification score to 
achieve the user defined maximum false discovery rate while maximizing the number of 
peptide identifications. The relation between the number of normal and decoy database 
results, real discovery rate and Mascot ion score is shown in figure 8A. In figure 8A the false 
discovery rate is plotted as the real discovery rate (which is the inverse of false discovery rate) 
for visualisation purposes. Calculated minimal Mascot ion score thresholds by the PEPFDR 
method are shown in figure 8C at 0.01%, 0.1%, 1%, 2.5%, and 5% PEPFDR thresholds for 
Parameter
Multi peptide coverage
Minimum peptide score
Minimum delta score
Minimum modified delta score
Maximum expect value
Maximum allowed number of 
variable modifications
Single peptide coverage
Minimum peptide score
Minimum delta score
Minimum modified delta score
Maximum expect value
Maximum allowed number of variable 
modifications
Settings
0…n
0…n
0…n
n…1
0…n
0…n
0…n
0…n
n…1
0…n
Function
 
Sets the minimum peptide identification score
Sets the minimum score difference between 
first and second best peptide match
Sets the minimum score difference between 
first and second best peptide sequence match
Sets the maximum expect value for peptides 
Sets the maximum number of allowed 
variable modifications for a peptide
 
Sets the minimum peptide identification score
Sets the minimum score difference between 
first and second best peptide match
Sets the minimum score difference between 
first and second best peptide sequence match
Sets the maximum expect value for peptides 
Sets the maximum number of allowed 
variable modifications for a peptide
Table 2
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both the E. coli and H. sapiens datasets. As expected, higher minimum Mascot ion score 
thresholds reduce the false discovery rate. 
Figures 8A and 8C also show that the FDR as a function of the minimal Mascot ion score 
threshold differs between the E. coli and H. sapiens datasets. The FDR decreases more 
moderately for the H. sapiens dataset as a function of the minimal mascot ion score (Figure 
8A) which leads to higher minimal Mascot ion score thresholds to achieve the desired 
maximum FDR (figure 8C). This is likely a direct effect from differences between the H. 
sapiens and E. coli proteomes. First of all, the human RefSeq proteome database contains a 
significantly higher number of protein sequences (34274 vs 4132). A higher number of protein 
sequences simply yield more unique tryptic peptides to match with the acquired MS/MS 
spectra, which by itself already increases the number of random matches. Secondly, in-silico 
digestion of the H. sapiens RefSeq protein sequences generates a much greater diversity in 
tryptic peptide sequences than for E. coli, and thus a higher number of homologous tryptic 
peptide sequences with a near similar atomic mass for fragmentation spectra to match.  
 
Figure 8. Real discovery rates as a function of minimal Mascot ion score thresholds 
using single class PEPFDR and PROFDR methods. The number of (A) peptide and (B) protein 
identifications from the normal and decoy database search results at or above the Mascot ion score 
threshold are plotted for both the E. coli and H. sapiens datasets. (C) Calculated minimal Mascot ion 
score thresholds for selected FDR thresholds. Results here show that increasing minimal Mascot ion 
score thresholds reduce the false discovery rate and that minimum Mascot ion score thresholds for a FDR 
do not correspond with those at the protein level. 
FDR based validation: single class protein level FDR (PROFDR)
Most proteomics studies focus on the identification of proteins instead of peptides. Weatherly 
et al previously noted that a FDR associated with peptide matches does not correspond with 
the FDR for protein identifications [121]. PROTON therefore provides a single class protein 
level FDR (PROFDR) method for separating random from real protein identifications in small 
to moderate size shotgun proteomics datasets (few thousand up to tens of thousands of 
MS/MS spectra). Figure 8B plots the number of normal and decoy protein identifications at or 
above the Mascot ion score threshold with the associated real discovery rate for both the H. 
sapiens and E. coli datasets. Similar to the peptide level FDR results, higher minimal Mascot 
ion score thresholds increase the real discovery rate. Accordingly, higher minimal Mascot ion 
score thresholds are required to achieve decreasing FDR thresholds as shown in figure 8C 
at 0.01%, 0.1%, 1%, 2.5%, and 5% maximum protein level FDR. Again, results in figure 8C 
show that higher minimum Mascot ion score thresholds are required to achieve a specific 
FDR for the H. sapiens dataset compared to the E. coli dataset. 
Comparison between the PEPFDR and PROFDR results show that lower minimal Mascot ion 
score thresholds are required to achieve a FDR at the peptide level compared to the protein 
level (figure 8C), similar to the results obtained by Weatherly et al [121]. In the same paper, 
the authors explain that this phenomena is caused by the fact that the PEPFDR method 
does not account for the fact that random peptide matches cluster to individual proteins at a 
much lower rate than real peptide matches. This causes a set of random peptide matches to 
yield more protein identifications than an equal number of real peptide matches. Interestingly, 
the minimal Mascot ion score thresholds are identical at the 0.01% FDR level for both the 
PEPFDR and PROFDR methods with both datasets. This results from the fact that are no 
available random peptide matches at or above the required minimal Mascot ion score, and 
thus no random protein identifications.
FDR based validation: heuristic iterative protein level FDR (HPROFDR)
In shotgun proteomics proteins are identified with different peptide coverage. This is mostly 
caused by differences in abundance, number of detectable tryptic peptides, ionization 
efficiency, and fragmentation efficiency. As mentioned previously, random peptide matches 
cluster to individual proteins at a much lower rate than real peptide matches. This implies 
that protein identifications with a low peptide coverage are more perceptible to false 
discovery than proteins with higher peptide coverage. The heuristic iterative protein level FDR 
(HPROFDR) method of Weatherly et al therefore determines the individual minimum Mascot 
ion score threshold for proteins with 1, 2, ..., ≥6 unique peptide identifications [121]. This 
method is particularly suited for moderate to large shotgun proteomics datasets (at least tens 
of thousands of MS/MS spectra). Calculated minimum Mascot ion score thresholds for each 
protein class at selected FDR thresholds (0.01%, 0.1%, 1%, 2.5% and 5% FDR) are shown 
in figure 10. In general, higher minimum Mascot ion scores are required to achieve a specified 
FDR with decreasing peptide coverage. Similar to the results obtained with the PEPFDR and 
PROFDR methods, higher minimum Mascot ion score thresholds are required to achieve the 
same FDR for the H. sapiens dataset as for the E. coli dataset. 
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Figure 10. Minimal Mascot ion score thresholds per protein coverage class at selected 
maximum FDR thresholds for E. coli and H. sapiens datasets. The HPROFDR method determines 
the minimum Mascot ion score thresholds per protein coverage class to achieve the maximum specifi ed 
FDR. In general, higher minimal Mascot ion score thresholds are required to achieve the desired 
maximum FDR value with decreasing peptide coverage.
Comparison of FDR based validation methods
The diff erent criteria applied by the FDR based validation methods lead to divergent output 
results. To analyze the eff ect of PEPFDR, PROFDR and HPROFDR validation methods on 
data output the number of identifi ed proteins, peptides, and average protein coverage (in 
peptides) were determined for both datasets at selected maximum FDR thresholds (0.1%, 
0.5%, 1%, 2%, 3%, 4%, and 5%) as shown in fi gure 11. For both datasets the PEPFDR 
method provides the highest number of protein identifi cations. At the peptide level the 
PEPFDR method provides the highest number of E. coli peptide identifi cations but the 
HPROFDR method yields the highest number of peptide identifi cations for the H. sapiens 
dataset. Between the two protein level FDR methods, the PROFDR method gives the 
highest number of protein identifi cations in general whereas the highest number of peptide 
identifi cations is achieved by the HPROFDR method. Similarly, the HPROFDR method yields 
the highest protein coverage (in peptides) of all methods in both datasets up to 4% maximum 
allowed FDR. 
 
Figure 11.Output data characteristics for the PEPFDR, PROFDR and HPROFDR methods at 
selected maximum FDR thresholds. The number of protein and peptide identifi cation as well as the 
average protein coverage is plotted as a function of selected maximum FDR thresholds for each method 
using both the E. coli and H. sapiens datasets. 
As mentioned previously, random peptide matches cluster at a much lower rate to proteins 
than real peptide identifi cations. Given the fact that the PEPFDR method does not consider 
this phenomena and that the PROFDR method uses a single class validation strategy one 
may expect diff erent eff ects on protein and peptide FDR levels using the three methods. 
Figure 12 shows the achieved peptide and protein FDR values for selected FDR thresholds 
using all three methods on both datasets. Ideally one would like to achieve a similar FDR 
at the protein and peptide level at selected maximum FDR thresholds. The optimal plot is 
shown in fi gure 12 as a dashed line for ease of interpretation. It is apparent from fi gure 12 
that (i) the PEPFDR method leads to unacceptable protein FDR levels for selected peptide 
FDR thresholds, (ii) the PROFDR method applies criteria which are too strict at the peptide 
level which results in a much lower FDR at the peptide level compared to the protein level 
FDR, and that (iii) the HPROFDR method achieves similar false discovery rates at the 
peptide level and protein level for selected maximum FDR thresholds. The results in fi gure 
12 show that the PEPFDR method should not be applied for data validation at the protein 
level as it neglects the protein false discovery rate. A selected 5% peptide false discovery 
rate would result in protein false discovery rates of 24.2% and 42.1% for the H. sapiens 
and E. coli datasets, respectively. The PROFDR method achieves a slightly higher number 
of protein identifi cations than the HPROFDR approach but with lower peptide coverage. 
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It is important to note that proteins with a low peptide coverage are more prone to false 
discovery and that these are most likely underestimated by the PROFDR method. This may 
cause the PROFDR method to achieve a higher number of protein identifi cations with a 
higher local false discovery rate for proteins with low peptide coverage. Another advantage 
of the HPROFDR over the PROFDR method is that higher protein coverage is advantageous 
when comparisons are made between samples based on the number of identifi ed peptides, 
spectral counts, or exponentially modifi ed protein abundance index (emPAI). The HPROFDR 
approach thus presents the best possible solution of these FDR validation methods for most 
shotgun proteomics studies.
 
Figure 12. Achieved protein and peptide level false discovery rates for E. coli and H. sapiens 
datasets by the PEPFDR, PROFDR, and HPROFDR methods at selected maximum false 
discovery thresholds. This fi gure shows the false discovery rates at the peptide and protein level for 
each method at selected maximum FDR thresholds. Ideally, one would like achieve a similar FDR at both 
the peptide and protein level using any FDR based validation method (indicated by the dashed line). The 
PEPFDR method is capable of controlling the peptide level FDR whereas the protein level FDR increases 
signifi cantly higher to unacceptable levels. At the protein level both the PROFDR and HRPOFDR methods 
achieve the desired FDR values. However, the PROFDR method clearly presents a bias at the peptide 
level where FDR levels are much lower than the optimal values. Results for the HPROFDR method show 
similar FDR values at both the protein and peptide level, close to optimal values.
Valid peptides clustering
After validation peptides need to be re-clustered to proteins as protein identifi cation groups 
may collapse when specifi c peptides are rejected during validation. The method applied by 
PROTON is identical to the fi rst round of peptides clustering. However, since there are no 
novel peptides or proteins introduced during validation, this round of clustering is performed 
against the collection of protein sequences that were previously matched with peptide 
identifi cation to reduce processing time. 
Output results
Output data from PROTON is provided as both tab delimited text (.txt) fi les as well as 
a Microsoft Excel (.xls) fi le. The MS Excel fi le provides all available information at the 
experiment, protein, and peptide level. The diff erent sheet types available in the PROTON 
output will be discussed in detail below.
The “overview” sheet provides information about the Mascot searches as well as the 
PROTON settings that were used for data validation. Information presented here can be 
used to easily check parameters used in data searches and validation as all available meta 
information is documented in detail. A full list of all available information for the overview 
sheet is shown in table Y. Some of the parameters documented here allow users to 
quickly notice abnormalities for any of the data fi les. The average precursor mass error and 
according standard deviation can be used to assess mass spectrometric performance in 
terms of mass accuracy. For the LTQ FT Ultra these values should be in the range of 0-4 
ppm average precursor mass error with a standard deviation of 2-4 ppm. Another parameter 
shown here is the “% Matched spectra” which shows the percentage of MS/MS spectra 
that was matched to peptides by Mascot prior to validation. The typical range for LTQ FT 
Ultra mass spectrometer data is between 40-60% for H. sapiens or 50-70% for E. coli data. 
Lower values may point to issues with mass spectrometry performance, Mascot database 
search settings, or protein sequence database. Finally, the “Number of queries” corresponds 
with the number of acquired MS/MS spectra from the LC-MS/MS analysis, which should be 
in the range of 8000-10.000 MS/MS spectra for a one hour long linear gradient up to 35% 
acetonitrile. Lower number of MS/MS spectra may result from low sample concentrations, or 
poor chromatographic and/or mass spectrometric performance. 
Information that can be used to analyze diff erences in protein composition or abundance 
between samples is provided through the “emPAI crosstable” and “Peptides crosstable”. 
Here, available protein level information is presented for all analyses in a single table to 
accommodate sample-to-sample comparisons. The “emPAI crosstable” sheet provides 
the abundance values for each protein in every analysis as exponentially modifi ed protein 
abundance index (emPAI) values. EmPAI values can be used to compare abundances 
for a protein across samples but also to compare abundances between diff erent proteins 
[51]. The emPAI values are calculated according to equation 4 which uses the correlation 
between the number of acquired MS/MS spectra and protein concentration to indicate 
protein abundance. The calculation also normalizes for the number of detectable peptides 
from each individual protein sequence to allow inter protein abundance comparisons. 
Alternatively, the number of identifi ed unique peptides can be used to compare protein 
abundances between samples. However, comparisons between diff erent proteins cannot be 
made as the number of detectable peptides diff er substantially between proteins as a result 
of sequence length and amino acid sequence diff erences. Care should be taken when using 
either emPAI or peptide counts values for protein abundance estimations as the accuracy 
52 53
and robustness of both parameters is determined by the number of detected peptides. As a 
result, low abundant proteins and/or proteins that yield only a few detectable peptides may 
prove difficult to compare using either emPAI values or peptide counts.
Detailed information per experiment for each protein is available from the “PROTEINS FILE 
X” sheets where X corresponds with the file index number listed at the overview sheet 
with the corresponding file name. Besides the group, rank and protein descriptions this list 
also contains meta information for the protein database sequence such as the number of 
observable peptides by LC-MS, calculated protein molecular weight, isoelectric point of the 
protein, and protein hydrophobicity (calculated as grand average of hydropathicity, GRAVY). 
Measurement data is provided at the protein level as protein amino acid sequence coverage 
(%), protein identification score (sum of all highest scoring unique peptide matches), number 
of unique peptide identifications, number of unique ions that are matched to peptides, and 
finally the emPAI value.
The “PEPS FILE X” sheets contain all available information at both the protein and peptide 
ion level for each peptide identification of sample X. Similar to the PROTEINS FILE X sheets 
the X here corresponds with the file index number listed at the overview sheet. A full list 
of all available features that are presented in the “PEPS FILE X” sheets is shown in table 
3. The first set of columns contains the same protein level information as the “PROTEINS 
FILE X” sheet for every peptide identification. Peptide ion level information is presented in 
the next set of column which show the measured precursor ion mass-over-charge (m/z) 
value, measured peptide monoisotopic mass, calculated monoisotopic mass of the peptide, 
mass error in ppm, and chargestate of the precursor ion. The next set of columns contain 
the basic peptide identification data from the Mascot searches such as Mascot ion score, 
expect value, peptide sequence and the corresponding amino acid residue numbers in 
the protein sequence. Information about available post translational modifications of each 
identified peptide is also provided and include the type of modification present, localization 
of the modification suggested by Mascot, and the total number of PTMs for each peptide 
identification. The following set of columns contain the homology- and identity-threshold 
scores calculated by Mascot as well as the delta score and modified delta score information. 
The final column contains the Mascot .html search result file name. 
Table 3. Reported characteristics of each peptide identification by PROTON in the output result file. 
Parameter
Group
Rank
Protein
Observable peptides
Protein mass
Protein pI
Protein GRAVY
Protein AA coverage (%)
Protein score
Peptides (NR)
Ions (NR)
emPAI
m/z
Mr(exp)
Mr(thr)
ppm
Charge
Miss
Score
Expect
Rank
Scan number
Query number
Sequence
Peptide
Start residue
Stop residue
Variable mod X
Mod locations
Mods
Homology threshold
Identity threshold
Firstmatch score
Firstmatch peptide
Secondmatch score
Secondmatch peptide
Deltascore
mDelta match score
mDelta match peptide
Html file
Description
Protein identification group number
Protein identification rank within group. Rank 1 protein identification is used as group representative
Protein identifiers and description
The number of detectable peptides calculated for the protein sequence in the database
Mass in kDa calculated for the protein sequence
Isolectric point (pI) of the protein sequence
Grand average of hydropathicity of the protein sequence
Relative protein amino acid sequence coverage (%) by identified peptides
Sum of the non-redundant peptide Mascot ion scores for the protein identification
Total number of identified unique peptide sequences
Total number of identified unique precursor ions
exponentially modified protein abundance index (emPAI) value 
Measured mass-over-charge ratio of the precursor ion
Measured mass of the precursor ion
Calculated mass of the peptide sequence
Precursor mass error in parts per million (ppm)
Measured charge state of the precursor ion
Number of missed cleavages by trypsin
Mascot ion score for the peptide match
Expect value for the peptide identification to be a random event
Peptide identification rank. Only rank 1 peptide matches are used from Mascot searches
Spectrum index number in the original RAW data file
Query index number by Mascot for the MS/MS spectrum
Amino acid sequence of the identified peptide
Sequence of the identified peptide with flanking protein sequence amino acid residues and reported 
variable modification(s)
Amino acid residue number in the protein sequence corresponding with the first amino acid of 
the identified peptide
Amino acid residue number in the protein sequence corresponding with the final amino acid of 
the identified peptide
For each available variable modification type “X” a “1” (present) or “0” (absent) is reported for each 
peptide identification
Proposed localization of variable modification(s) in the peptide sequence by Mascot.
Total number of variable modifications for the peptide identification
Calculated homology score threshold by Mascot
Calculated identity score threshold by Mascot
Non-rounded Mascot ion score for the reported (rank 1) peptide identification
Peptide amino acid sequence of the best matching peptide sequence with the MS/MS spectrum
Non-rounded Mascot ion score for the second best peptide match by Mascot
Peptide amino acid sequence of the second best match for the MS/MS spectrum
Absolute score difference between the firstmatch and secondmatch peptides
Non-rounded Mascot ion score for the second best match with a different amino acid sequence than the best 
match disregarding leucine/isoleucine ambiguities and variable modifications
Peptide amino acid sequence of the second best match peptide with a different sequence than the best 
matching peptide (disregarding leucine/isoleucine and variable modifications)
File name of the Mascot search html result file
Table 3
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Taken together, all available (important) information at the experiment, sample, protein, and 
peptide levels is readily available from the PROTON output. This allows in-depth assessment 
of data quality and in most cases provide essential clues to pinpoint problems or even 
causes of poor data quality. It also provides all required information for publication of shotgun 
proteomics data. Users may simply select the required information from the PROTON output 
to comply with most journal guidelines.
Graphical user interface
The diff erent Perl script modules that make up PROTON are controlled via the graphical 
user interface (GUI, fi gure 13). Here, all available parameters can be set and stored in a 
confi guration fi le that is loaded the next time PROTON or any of its methods is selected. 
When a particular method or tool is set up and started through the GUI, PROTON will 
automatically run the required sequence of Perl script modules and inform the user when 
processing is fi nished. 
 
Figure 13. Screenshot of the PROTON graphical user interface (GUI). The GUI allows full control of 
all available functions and settings in PROTON. It also accommodates fully automated data processing by 
starting the required sequence of Perl script modules.
Conclusions
PROTON is a versatile software tool for the automated validation of Mascot search results 
from shotgun proteomics experiments. It has been used successfully to process data for 
various publications in diff erent journals [92, 93, 95-100, 125, 126, 134-142] and served 
as the standard software tool used by the Radboud Proteomics Centre. However, recently 
developed software tools and algorithms such as MaxQuant [143] and Mascot percolator 
[144, 145] outperform PROTON in terms of versatility, sensitivity and output data quality. 
Nevertheless, we still expect to use PROTON as research tool in the future next to other 
software alternatives to explore novel data processing and analysis methods.
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Abstract
During the last century, the research on aerobic ammonium-oxidizing bacteria 
(AOB) lead to many exciting physiological and biochemical discoveries. 
Nevertheless the molecular biology of AOB is not well understood. The availability 
of the genome sequences of several Nitrosomonas species opened up new 
possibilities to use state of the art transcriptomic and proteomic tools to study 
AOB. With the current technology, thousands of proteins can be analyzed in several 
hours of measurement and translated proteins can be detected at femtomole and 
attomole concentrations. Moreover, it is possible to use mass spectrometrybased 
proteomics approach to analyze the expression, subcellular localization, 
posttranslational modifi cations, and interactions of translated proteins. In this 
chapter, we describe our LC–MS/MS methodology and quality control strategy to 
study the protein complement of Nitrosomonas eutropha C91.
 
Ammonium is a major pollutant (toxic to animals and plants, causes eutrophication) in 
municipal and industrial wastewaters and its discharge to water bodies is regulated 
worldwide by strict legislation. In natural ecosystems and in conventional wastewater 
treatment plants, in the presence of O2, ammonium is oxidized to nitrate via nitrite by two 
clades of microorganisms. The fi rst step of this process is mediated by aerobic ammonium 
oxidizing bacteria (AOB or archaea, AOA) and is followed by the oxidation of nitrite to nitrate 
by nitrite oxidizing bacteria (NOB). AOB oxidize ammonium via hydroxylamine to nitrite 
and there are two major groups of bacteria that are thought to be important: beta-and 
gammaproteobacterial AOB.
 
In the betaproteobacterial linage, many strains affi  liated to two species of 
Nitrosomonadaceae (Nitrosomonas europaea and Nitrosomonas eutropha) are among the 
AOB that have been studied over a hundred years since the fi rst isolation of an ammonium 
oxidizing microorganism by Winogradsky in 1892 [146]. Physiological and biochemical 
studies have resulted in the identifi cation and in some cases isolation of main catabolic 
enzymes of AOB [147]; still, the molecular biology of AOB is not well understood. For 
example several strains of N. eutropha have been shown to oxidize ammonium with NO2 
under anoxic or microaerophilic conditions [148] and H2-dependent growth was shown for 
N. eutropha N904 [149-152]. However, it is currently unknown how these alternate pathways 
function or are regulated. 
Recent publications of the genome sequences of several Nitrosomonas [153, 154], 
Nitrosococcus [155] and Nitrosospira [156] species have facilitated the application of state 
of the art technologies for the in depth analysis of the molecular mechanism of AOB. The 
fi rst publication of such an approach was on the transcriptomic analysis of N. europaea 
[157]. This study revealed that mRNA concentrations of catabolic proteins such as amoA 
(ammonia monooxygenase subunit A) and hao (hydroxylamine oxidoreductase) could 
be correlated to activity and growth rates of bacteria under aerobic conditions. Under 
anaerobic conditions, the transcription levels of these genes were reduced and those of nirK 
(nitrite reductase), norB (nitric oxide reductase), and nsc (nitrosocyanin, red copper protein) 
were signifi cantly increased. 
The recent elucidation of the N. eutropha C91 genome sequence enables the use of a mass 
spectrometry database search driven proteomics to analyze the protein complement of 
Nitrosomonas in great detail. Analyses of the expression [158, 159], subcellular localization 
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[48], post translational modifications [160, 161], and interactions [49, 87, 93, 162] of 
translated proteins by high-throughput mass spectrometry approaches provide a wealth of 
information to help unravel biochemical pathways and other cellular processes.
 
Although the analysis of the transcriptome of a given microorganism gives us valuable 
insights, the current technology allows us to look one step further: amount of translated 
proteins can now be detected at very low concentrations (i.e. fmol, amol). The sensitive 
and robust performance of LC-MS/MS based proteomics makes it an attractive system 
to use for studying prokaryotic proteomes. Low femtomole to attomole protein sensitivity 
and high-throughput analysis of samples are crucial when biomass is limited or when 
multiple samples need to be analyzed within a short time span. Modern LC-MS/MS 
equipment (when handled correctly) is now capable of identifying and quantifying up to 
thousands of proteins across multiple samples within just hours of measurement time [163]. 
Performance is not only instrument type dependent, but it is also determined by the quality 
of sample preparation, chromatographic separation, mass spectrometer operation, data 
processing and fractionation approach. It is therefore important to optimize (and monitor) the 
performance of the entire procedure in advance to any large scale proteomics experiments. 
Although sample fractionation at protein or peptide level can be used to increase the 
proteome coverage, it also significantly increases the amount of time and costs needed to 
perform the experiment [164]. The tradeoff between an increased proteome coverage and 
required throughput is thus unique for each research group and question, and is therefore 
an important aspect to consider when designing experiments. The approach described here 
was used to study the top 500-1000 most abundant proteins in N. eutropha cells of which 
many are involved in primary and secondary cellular processes, but may easily be applied 
to other microorganisms. It is important to realize that parts of the method described here 
might be equipment specific. Nevertheless we believe that the majority of our approach and 
quality control can be incorporated into existing protocols using different instrumentation. The 
method described in this communication is currently our optimal approach for the analysis of 
the unfractionated N. eutropha C91 proteome.
 
LC-MS/MS instrument setup
The LC-MS/MS setup uses a splitless nanoflow liquid chromatograph (Easy nano LC, 
Proxeon) for C18 reversed phase peptide separations coupled online to a 7 T hybrid 
quadrupole linear ion trap Fourier-transform ion cyclotron resonance mass spectrometer 
[165] (LTQ FT Ultra, Thermo scientific) via a modified nano-electrospray source (Thermo 
scientific). Generic performance of the LC-MS/MS system is assessed on a daily basis by 
evaluating more than 46 performance metrics obtained from a standard Escherichia coli 
proteome LC-MS/MS measurement using the software of Rudnick et al [166]. Peptide 
separations are performed using 15 cm long 100 µm internal diameter emitters (PicoTip 
emitter FS360-100-8-N-5-C15, New Objective) packed in-house with 3 µm particles (120 
Å pore) C18-AQ ReproSil-Pur reversed phase material (Dr. Maisch GmbH) shown in Figure 
1. Column packing is achieved by pressure loading (40 bar) of the C18 particles into the 
emitter using a pressure bomb and high purity He gas [167]. Upon packing, the emitter outlet 
forces the particles to form a self assembled frit as long as the outlet size to particle diameter 
ratio remains below 5:1 [167]. The advantages of using these reproducible in-house packed 
emitters include versatility, very low costs, and most importantly, high chromatographic 
resolution. Hence, there is virtually no possibility of post column peak broadening as peptides 
are immediately ionized and analyzed when they leave the column outlet. Signal stability and 
intensity of the nano-electrospray source depend (amongst other factors) on the quality of 
the emitter outlet which needs to be evaluated prior to any analytical LC-MS/MS analysis. 
We consider our ion source stable when the average total ion current (TIC) signal deviation 
for buffer ions is less than 12% for at least 150 survey spectra acquired at a constant flow 
of 300 nl•min 1 0.5% acetic acid. We recommend to document and monitor performance 
characteristics of the system on a regular basis. This may help as an early diagnosis for 
possible performance deterioration and ensures consistent quality throughout large-scale 
experiments.
 
Figure 1: Schematic representation of the nano-electrospray setup. The 50 µm internal diameter (ID) x 
360 µm outer diameter (OD) flow line is connected via a micro tee to both the column and a gold wire. 
The column, which is a 15 cm long 100 µm ID x 360 µm OD emitter packed with 3 µm C18 reversed 
phase material, is placed just a few millimeters away from the mass spectrometer capillary inlet. The gold 
wire is used to apply a 2.2 kV electrospray voltage directly to the liquid flow in front of the column via a 
zero-dead volume micro tee fitting.
Growth of Nitrosomonas eutropha C91 pure culture
A 7 l glass vessel with a working volume of 4 l is used for growing N. eutropha C91 (Figure 
2A). The reactor is fed continuously with a flow rate of 1.4 ml•min-1. The influent mineral 
medium is modified from Schmidt and Bock 1997 [148] and contains 50 mM of NH4Cl and 
following nutrients (per 1 liter of medium): 585 mg NaCl, 147 mg CaCl2•2H2O, 74 mg KCl 
, 54 mg KH2PO4, 49 mg MgSO4•7H2O, 12 g HEPES and 1 ml trace elements solution 
containing 0.02 M HCl, 973 mg FeSO4•7H2O, 49 mg H3BO3, 43 mg ZnSO4•7H2O, 37 mg 
(NH4)6Mo7O24•4H2O, 34 mg MnSO4•H2O, 16 mg CuSO4. The medium was adjusted to 
pH 7.0. A high ammonium concentration (40-50 mM) is recommended for a rapid start-up 
of the bioreactor. For the homogeneous distribution of substrates the vessel is stirred at 
200 rpm with one 6 bladed Rushton and one marine impeller (60 mm). Disappearance of 
ammonium and production of nitrite should be monitored by daily. We use the rapid nitrite 
and ammonium determination protocols as described in Kartal et al. 2006 [168]. A heating 
blanket is used to keep temperature at 30°C. A gas mixture of Air/N2 (90/10%) with a flow 
of 500 ml•l-1 is sparged through the reactor for O2 supply. A pH controller unit is used to 
supply a solution of Na2CO3 (100 g•l-1) when necessary to keep the pH stable at 7.0. If 
desired, a dissolved O2 probe may also be used to monitor the dissolved O2 concentration.
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Figure 2. A. N. eutropha C91 pure culture. B. Fluorescence in situ hybridization micrograph of the N. 
eutropha C91 pure culture. A triple hybridization with the probes NEU (Wagner et al., 1995), Nso1225 
(Mobarry et al., 1996) and EUB338 (Daims et al., 1999) is applied. Bar = 5 µm.
Sample preparation
The N. eutropha cells (5 liters, OD600 ~ 0.2, Figure 2B) are centrifuged at 5 °C and 
4000 • g. After centrifugation, the pellet is resuspended in 1 volume 20 mM potassium 
phosphate buffer, pH 8. Cell suspensions are passed three times through a French 
pressure cell operated at 138 MPa. After centrifugation for 15 min at 1700 • g at 4 °C, 
the cell-free fraction is obtained as clarified supernatant. Proteins are diluted 1:1 (v/v) in 8 
M urea 10 mM Tris-HCl pH8 and placed at room temperature for 30 minutes to allow for 
protein denaturation. Reduction of cysteine disulfide bridges is performed by adding 2 µl 
10 mM dithiotreitol solution and incubating for 30 min at room temperature. Reforming of 
disulfide bridges is prohibited via alkylation of reduced cysteines by adding 2 µl of 50 mM 
chloroacetamide and subsequent incubation for 30 min at room temperature in the dark. 
The use of chloroacetamide is preferred over iodoacetamide as Nielsen et al. reported 
that iodoacetamide induces artifacts that mimic ubiquitination [169]. As trypsin digestion 
is incompatible with the 4 M urea concentration, a primary incubation of the sample with 
the protease “LysC” can be performed in a 1:50 (w/w) LysC:protein ratio for 3 h at room 
temperature. This step results in the cleavage of proteins into smaller peptides through 
cleavage at the c-terminal side of lysine residues under strong denaturing conditions. 
Next, the sample is diluted 1:3 (v/v) with 50 mM ammoniumbicarbonate to allow trypsin 
digestion to take place in a less denaturing environment. Trypsin is added in a 1:50 (w/w) 
trypsin:protein ratio and the sample is placed at 37oC for overnight digestion. Subsequently 
the resulting peptide mixture can be concentrated and desalted using Stop And Go Elution 
(STAGE) tips as described by Rappsilber et al [127]. A popular alternative to this STAGE 
solid phase extraction step is the commercially available alternatives such as Millipore 
ZipTips. However, we prefer the use of in-house constructed STAGE tips because of the 
low costs and reduced handling steps. Briefly, acidified peptides bind to the activated C18 
reversed phase material which is fixed in a standard pipettor tip allowing the peptides to 
be washed using 0.5% acetic acid and eventually eluted in 20 µl 80% acetonitrile 0.5% 
acetic acid. The acetonitrile buffer can be removed by centrifugation under vacuum after 
which samples are taken up in a total volume of 20 µl 0.5% acetic acid prior to LC-MS/MS 
analysis. We use acetic acid here to dissolve the sample as it is used later on as ion pair 
reagent in buffers used for C18 reversed phase LC-MS/MS analysis.
C18 reversed phase LC-MS/MS analysis
For RP LC-MS/MS analysis we load samples directly onto the analytical column at maximum 
flow rates determined by a set maximum pressure of 240 bar. Peptides are eluted from 
the analytical column directly towards the mass spectrometer capillary inlet via a nano-
electrospray source which is used to apply a distal electrospray voltage of 2.2 kV to the liquid 
flow using a standard micro tee setup (figure 1). Peptide elution is best performed using an 
increasing linear gradient of 10-40% acetonitrile in 90 min with a constant concentration 
of 0.5% acetic acid as ion pair reagent. To prevent carryover, the system is washed by 
increasing the acetonitrile concentration from 40 to 80% in 5 mins followed by a 10 minutes 
isocratic flow of 80% acetonitrile at a flow rate of 600 nl•min 1. Finally, the system is 
equilibrated with 3% acetonitrile at 600 nl•min 1 for 10 min. The mass spectrometer settings 
described hereafter are specific for the type of instrument and manufacturer. In general they 
should be optimized for the type of application and sample characteristics and may thus 
differ significantly between experiments and research groups. For the experimental design 
described here we program the LTQ FT Ultra instrument to acquire 4 data dependent MS/
MS spectra of the four most abundant peptide ions (with charge z=2+ or z=3+) from a survey 
scan by the ion cyclotron resonance cell. The acquisition of MS/MS spectra in the ion trap 
is performed in parallel to a long transcient ICR cell survey scan. This parallel acquisition is 
achieved by selecting precursor ions for collision activated dissociation experiments in the 
linear ion trap from a first short part of the ICR cell measurement. This allows the ion trap to 
perform multiple MS/MS analyses while the ICR cell completes the accurate (long transcient) 
measurement. Repetitive MS/MS analysis of identical ions is prohibited by the use of dynamic 
exclusion with settings optimized for the typical chromatographic performance of our system. 
Our instrument method uses a dynamic exclusion time of 180 seconds in combination with 
early expiration settings that remove m/z values from the dynamic exclusion list when 10 
spectra are recorded with a signal-to-noise ratio below 2 for each individual ion. We highly 
recommend users to optimize the dynamic exclusion parameters as it may yield more than 
100% performance increase for the number of identified unique peptides. Survey scans by 
the ICR cell are set to cover a range of 350-1600 m/z with a resolution power of 100,000 
Full Width at Half Maximum (FWHM) at 400 m/z. The low mass cutoff of 350 m/z is used 
to prevent the detection of buffer ions (that reduce the effective dynamic range for peptide 
ions) and peptides shorter than 6 amino acids sequence length. In general shorter peptides 
have low protein specificity and significantly contribute to the relative proportion of false 
positive identifications [143]. Tryptic peptides are generally observed below m/z 1600 which 
is therefore used as high mass cutoff. Raw data files are evaluated manually to check for 
chromatographic (over)loading, resolution, and absence of interfering chemical contaminants 
like polyethylene-glycols. In our opinion, ion maps are ideally suited for this purpose as 
these (unlike total ion chromatograms) are capable of visualizing all critical characteristics for 
individual LC-MS/MS runs of very complex samples as shown in figure 3. 
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Figure 3. Ion map view of the analytical LC-MS/MS data acquired from a N. eutropha C91 proteome 
sample. This map plots the m/z values versus elution time with corresponding intensity in grey scale 
values. Ions are visible as dots using this large time range. Zooming in on the data allows for manual 
evaluation of chromatographic performance and intensity dependent mass accuracy. Constant 
background ions from fused silica or buffer components are visualized as horizontal lines that may span 
the complete time range (prominent ions are indicated using arrow heads). Sample contamination by 
polyethylene-glycols and other (similar) polymers is easily recognizable as a series of diagonal dots with a 
consistent increase of m/z value and retention time in the analytical part of a reversed phase separation. 
Polyethylene-glycol ions are encircled in this figure for ease of interpretation. In our experience we always 
find low amounts of polyethylene-glycols to be present in reversed phase separations, presumably 
originating from laboratory plastics or reagents.
Database searches and validation of results
Depending on the database search software and the type of mass spectrometer used, raw 
data needs to be converted to a format that can be used by the software of choice. Many 
different search engines are available nowadays (both commercial and open-source [170, 
171]) that can be used for protein identification or quantification purposes. Some well known 
search engines are Mascot [115], X!Tandem [172], SEQUEST [117], OMSSA [173], Peaks 
studio (http://www.bioinformaticssolutions.com), ProsightPTM [174], and Phenyx [175]. We 
prefer to use Matrix Science Mascot for which we convert the Thermo raw files into generic 
mascot files via in-house developed Perl scripts (this can also be performed using freely 
available software packages (http://msquant.sourceforge.net; [143, 176]). All database 
searches are performed using the Refseq N. eutropha C91 sequences supplemented with 
sequences of known contaminant proteins. It is important to add these contaminant proteins 
to the database to ensure that corresponding spectra do not erroneously match N. eutropha 
C91 sequences. Some of these contaminants are added on purpose during digestion 
(LysC and Trypsin) whereas other proteins (e.g. skin proteins such as keratins) contaminate 
samples via the air or reagents. We first perform a loose mass accuracy search of the data 
allowing a mass error of 20 ppm (which is a relatively large error for our type of instrument). 
This database search result is then used to assess the mass accuracy of each measurement 
and can be used to recalibrate the data offline prior to conclusive database searches. The 
best suitable method for offline mass recalibration depends on the type of instrument and 
error (e.g. general transponation, m/z dependent mass error or signal intensity dependent 
mass error). For this particular measurement we calculated the average parent ion m/z errors 
for precursor m/z bins of 100 Th. This data was then used to obtain equation 1 which was 
used for m/z dependent parent ion m/z recalibrations.
Equation 1: (m/z)calibrated=(m/z)measured-(-0.0000005*(m/z)measured-0.0009).
This precursor ion recalibration improved mass accuracy from -2.0 (± 1.17) ppm to -0.17 
(± 1.13) ppm as visualized in Figure 4. 
 
Figure 4. Parent ion m/z errors for validated peptide identification before (top graph) and after (bottom 
graph) offline recalibration. Recalibration improved the average precursor ion m/z accuracy from -2.00 
(± 1.17) ppm to -0.17 (± 1.13) ppm.
For the LC-MS/MS dataset of N. eutropha C91 samples we specified a precursor 
mass tolerance of 10 ppm for ICR cell spectra of precursor ions and 0.8 Da mass 
tolerance for fragment ions analyzed by the linear ion trap. Database search parameters 
include specific trypsin cleavage with a tolerance of 1 missed cleavage. Furthermore, 
carboxamidomethylation of cysteines by chloroacetamide is set as fixed modification and 
variable modifications include N-terminal protein acetylation, deamidation of glutamine and 
asparagine, and oxidation of methionine. Result files are downloaded automatically from the 
server using a custom-made Perl script which is triggered by the Mascot Daemon search 
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tool after each search completion. Subsequent validation of search results is of utmost 
importance considering the nature and amount of retrieved data. By now there are numerous 
software packages available for search data parsing and validation purposes such as 
MSQuant (http://msquant.sourceforge.net), Trans-proteomic pipeline [176-178], PROVALT 
[121], MaxQuant [143], Scaffold [179], and Mascot Distiller (www.matrixscience.com). Many 
more excellent software solutions may be found in literature, but it is beyond the scope 
of this manuscript to list and describe them all. Successful approaches for large dataset 
validation often use false discovery rate validation or even posterior error probabilities (local 
false discovery rates). Both approaches require an additional database search of the data 
against reversed or randomized sequences from the normal database [180]. These decoy 
search results are used to calculate the false positive rate or posterior error probabilities. In 
general, both methods require high numbers of matched MS/MS spectra to be accurate 
and are therefore not suited for every type of sample and/or purpose. We generally use 
false discovery rates at the protein level for datasets that encompasses 10,000-100,000 
MS/MS spectra and posterior error probabilities for datasets that include 100,000 or more 
MS/MS spectra. Validation of smaller datasets can be performed using the random match 
probabilities calculated by the search engine in combination with additional parameters to 
ensure confident protein identifications.
 
We currently cannot use FDR based validation strategies for datasets generated using 
the described experimental design due to the low number of protein identifications found 
in decoy database searches (using reversed protein sequences). The decoy database 
search using the N. eutropha C91 data yielded only 44 protein identifications (exclusively 
single peptide identifications) with Mascot identification scores in the range of 16 to 33 
(we do not parse peptides with identification scores below 16). When we use this decoy 
database search result to calculate Mascot score thresholds to achieve a 1% FDR we find an 
exceptionally low Mascot peptide identification score threshold of just 27. We therefore apply 
a low sample complexity validation strategy using the in-house developed PROTON software 
package (PROteomics TOols Nijmegen, HJCT Wessels, J Gloerich, et al. unpublished). The 
criteria used by PROTON for data validation were empirically determined from previously 
acquired (much larger) datasets from various organisms and cell types to achieve an overall 
protein false discovery rate of 1% or better. Criteria used for validation require a minimum 
Mascot score of 30 for peptides originating from proteins identified with multiple unique 
peptide sequences. Single peptide matches require a minimum Mascot score of 49 and a 
modified delta score of at least 10. The modified delta score is calculated as the difference 
in score between the first and second best unique sequence match for a given spectrum. 
This value differs from the original delta score which is calculated between the first and 
second match regardless of the peptide sequences and may thus differ only by the position 
of a variable modification site. We further allow a maximum of 3 variable modifications 
for individual peptide matches. When we apply the same validation criteria to the decoy 
database search result we can calculate an infinite small false discovery rate for our data, 
which is an underestimation of the true FDR due to the low number of decoy database 
hits. Our software is also used to calculate estimated protein abundance for all identified 
proteins using the exponentially modified Protein Abundance Index (emPAI) [51]. This spectral 
count method uses the correlation between the number of identified unique peptide ions 
(normalized between proteins for the number of theoretically detectable peptides) and protein 
concentration [51, 181]. The number of theoretically detectable peptides can be calculated 
in-silico for each protein using the physicochemical properties of predicted peptides in 
combination with the mass spectrometer settings. Ideally the physicochemical cutoff values 
are calculated a priori using the properties of identified peptides from large datasets that 
are generated using an identical protocol. The exponential modification of the PAI value is 
needed to obtain a linear correlation between PAI and protein concentration [51]. Calculated 
emPAI values may be used to compare abundances between different proteins in one or 
multiple samples. It is important to note that a comparison of protein abundances between 
samples requires the samples to be comparable in terms of complexity and data quality. A 
limitation of this technique can be its accuracy which depends on the number of theoretically 
detectable peptides and the number of identified unique ions. We therefore emphasize that 
care should be taken when using emPAI values of low abundant and/or small proteins.
Dataset description and protein identification example
A single LC-MS/MS analysis of nonfractionated N. eutropha C91 proteome using our system 
identified about 2000 unique peptides corresponding to approximately 600 unique proteins 
(approximately 24% coverage of the predicted proteome, Kartal et al. unpublished). On 
average each protein is identified using 4 unique peptides. Representative protein sequence 
coverages are shown as a relative frequency histogram in Figure 5. These were calculated 
as the percentage of identified amino acid residues using unique valid peptide identification 
sequences. As an example, one of the most abundant proteins identified by our LC-MS/MS 
analysis is the alkyl hydroperoxide reductase (Neut_2366, abundance based on emPAI). This 
protein is likely to function as a hydrogen peroxide scavenger to protect N. eutropha C91 
cells from oxidative damage. This protein is identified using 9 unique peptides with combined 
protein sequence coverage of 60% (Table 1) and a Mascot protein identification score of 
513. This protein identification score implies a chance of less than 1*10-51 for this protein 
to be a random event. The data in Table 1 shows all relevant characteristics generally used 
to describe protein identifications. Details for the protein identification at both the protein 
and peptide level are included in this table. From information at the protein level, it may be 
deduced that we predicted a total of 11 peptides to be theoretically detectable using our 
approach, of which 9 peptides are identified using 13 unique MS/MS spectra. These data 
are used to calculate a protein abundance of 14.2 using emPAI. The peptide level information 
shows each best non-redundant peptide match data in detail. The first series of columns 
describe each peptide identification at the mass spectrometry level and include the mass 
over charge (m/z) value of each peptide ion, measured peptide mass as Mr(exp), theoretical 
mass of the peptide Mr(thr), peptide mass error in parts per million (ppm), and charge state 
of the ion. The next series of columns contain the database search information. First, the 
number of missed cleavage sites by trypsin is shown (miss) followed by the peptide match 
score and the expect value for the match to be a random event. The modified delta score is 
also shown (mDelta) which is the difference in Mascot score between the best and second 
best peptide sequence match. Please note that there is no other candidate peptide match 
if the modified delta score equals the Mascot match score. Here we also report the amino 
acid residue numbers from the protein sequence that correspond with each peptide match. 
Finally, the peptide match sequence is shown along with detected variable modifications (if 
any) and residues from the protein sequence that flank the peptide match. 
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Figure 5. Protein sequence coverage histogram of N. eutropha C91. Values on the x-axis represent 
upper values for each bin whereas the y-axis is used to show the relative frequency for each respective 
bin. This figure shows for example that about 25% of all proteins in the dataset were identified with a 
sequence coverage between 5 and 10 percent.
Table 1. Identification data for the abundant alkyl hydroperoxide reductase (Neut_2366) of 
N. eutropha C91.
Conclusions
Here we describe the application of LC-MS/MS based proteomics for the detection of 
nonfractionated proteome of N. eutropha C91. With the implementation of such state of 
the art technology future studies could focus on the molecular mechanism of ammonium 
oxidation by N. eutropha C91 under different growth conditions. Moreover, it is also possible 
to apply similar protocols to any other microorganism with an available genome sequence.
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Abstract
An important prerequisite for the development and benchmarking of novel analysis 
methods is a well-designed comprehensive LC-MS/MS dataset. Here we present 
our dataset consisting of 59 LC-MS/MS analyses of 50 (individually) urea extracted 
Escherichia coli K12 proteomes spiked with diff erent concentrations of carbonic 
anhydrase II and/or ovalbumin, according to a 2 x 3 full factorial design. Data 
was acquired over a two months period using multiple reversed phase columns 
and instrument calibrations to include real-life challenges faced when analyzing 
large proteomics datasets. Moreover, so-called ‘ground truth’ data, comprised 
by LC-MS/MS measurements of the pure spikes are included in the dataset. The 
current manuscript elaborates this comprehensive benchmark dataset for future 
development and evaluation of analysis methods and software.
 
A critical requirement for the development, evaluation, and objective comparison of novel 
data analysis strategies is the availability of comprehensive benchmark datasets. Such 
sets should have the intrinsic quality to present the methods with a challenge and come 
with an associated ground truth. Many research areas have specifi c datasets that are 
frequently used to benchmark the performance of new algorithms, visualization tools, 
statistical methods, etc. A famous example in the fi elds of pattern recognition and machine 
learning is Fisher and Anderson’s iris fl ower dataset [182]. In the fi eld of Genomics, spike-in 
benchmark datasets are readily available [183, 184]. Other widely used datasets from fi elds 
as diverse as the social sciences, computer sciences and life sciences can be found at 
the UCI Machine Learning Repository (http://archive.ics.uci.edu/ml/). Surprisingly, despite 
being a very data-intensive fi eld of research, the LC-MS/MS based proteomics fi eld does 
not seem to have many standard LC-MS/MS data sets at its disposal that are specifi cally 
suited for benchmarking data analysis procedures. However, in the last years, a number 
of LC-MS/MS data sets that have merit as benchmark sets have been deposited online 
by Mueller et al [185], Klimek et al [186], CPTAC (http://cptac.tranche.proteomecommons.
org/data.html) [187-189] and ABRF (http://www.abrf.org/index.cfm/group.show/
ProteomicsInformaticsResearchGroup.53.htm). 
The dataset described in this manuscript presents unique features that are currently absent 
from available resources, such as included ground truth, individual sample preparation, and 
the possibility for extraction of meaningful subsets of suffi  cient size. It was generated exactly 
for the purpose of benchmarking data analysis tools, which is illustrated by the development 
of our recent LC-MS alignment and biomarker identifi cation strategies [134, 190]. The current 
manuscript provides the fundamental characteristics of the dataset in terms of design and 
measurement. More details are available from the supporting information, which also contains 
NISTMSQC [166] evaluations of the chromatographic and mass spectrometric quality of the 
measurements. Besides characterization of the dataset, we also performed Mascot [115] 
database searches to provide a comprehensive collection of validated peptide identifi cations 
for evaluation purposes.
In short, we spiked carbonic anhydrase II (CA) and ovalbumin (OVA) in Escherichia coli (E. 
coli) homogenates prior to tryptic digestion, with concentrations according to a 2 x 3 full 
factorial design. Such an experimental design is simply a systematic way of varying factors 
(in this case: concentrations) with the purpose of obtaining a dataset that contains as much 
relevant information as possible in as few measurements as possible. Many diff erent designs 
and ways of devising them exist [191]. Specifi cally, a 2 x 3 full factorial design varies two 
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factors (here: CA concentration and OVA concentration) on three levels (here: concentrations) 
in such a way that all 32 = 9 possible combinations are measured (see table 1 for the 
design matrix). Apart from the 0-0 combination, each combination in the design matrix was 
prepared, worked up and measured five times in independent fashion. The 0-0 combinations 
(pure E. coli homogenates) were prepared, individually worked up and measured ten times. 
Finally, for each combination, a technical replicate was measured of one sample for each 
class, leading to a total number of 59 LC-MS/MS measurements. All measurements were 
conducted in randomized order, spread over five days in a period of two months, using six 
chromatographical columns and retuning/recalibrating the LTQ-FT instrument once. Details 
for each analysis are available from table S1. Carry-over effects were avoided via the analysis 
of blank samples in between every LC-MS/MS run. For evaluation purposes, LC-MS/MS 
measurements of pure CA and OVA tryptic digests were performed as an addition to the 
dataset. 
In more detail, fifty Escherichia coli K12 samples were spiked with either 0, 0.125µg, or 0.5µg 
of carbonic anhydrase II (CA; Sigma: C2273-1VL) and/or ovalbumin (OVA; Sigma: A7642-
1VL), according to table 1. Proteins were digested (in-solution) using trypsin as described 
elsewhere [126]. Both the spiked E. coli samples and pure CA and OVA tryptic digests were 
prepared in the same manner. 
Table 1. Experimental design matrix. All nine classes corresponding with the full factorial 2 x 3 design at 
two levels are shown. CA; carbonic anhydrase II, OVA; ovalbumin, 0; no spike, L; 0.125µg spike, H; 0.5µg 
spike, # samples; number of individually prepared samples. A single technical replicate, indicated by (+1), 
was measured for each class.
All E. coli LC-MS/MS measurements were performed using nanoflow reversed phase liquid 
chromatography coupled online via a nano-electrospray ionization (NSI) source to a 7T linear 
ion trap Fourier-transform ion cyclotron resonance mass spectrometer (LTQ-FT, Thermo 
Fisher Scientific). The LTQ-FT was operated in data-dependent mode so that each duty 
cycle encompassed a survey scan in the ICR cell in combination with parallel CID MS/MS 
acquisition by the linear ion trap targeting the top 4 most abundant ions. Raw LC-MS/MS 
data (proprietary Thermo Scientific .RAW format) was converted to mzXML [192] files using 
ReAdW version 1.1 [176]. Resulting mzXML files are available for download from our server 
(www.cac.science.ru.nl/research/data/ecoli). For database search purposes we generated 
Mascot compatible peaklists using extractMSn (Thermo Fisher Scientific). All database 
searches were performed using Mascot v2.2 (Matrix Science) [115] and a curated Refseq 
[193] release 33 E. coli database. A decoy database with reversed protein sequences was 
used for false discovery rate (FDR) estimates. Protein identifications were validated according 
to Weatherly et al [121] specifying a false discovery rate (FDR) of less than 1%. Briefly, this 
method calculates peptide score cutoffs for proteins identified by 1-5 and 6 or more unique 
peptides to achieve the specified FDR for each protein identification class using the normal 
and decoy database search results. Only peptides with Mascot identification score >16 and 
with a minimum peptide length of 6 amino acids were considered
 
Additional LC-MS/MS analyses of pure CA and OVA digests were performed using an Easy 
nano LC (Proxeon) coupled online to the LTQ-FT Ultra mass spectrometer with settings 
for CID and ECD spectra acquisition as described above. Mascot search parameters were 
identical to the ones mentioned above with the following exception: ECD fragmentation 
data was searched with 0.05Da fragment ion mass tolerance and specified “FT-ECD” as 
instrument type. Peptide identifications with a minimum peptide length of 6 amino acids and 
Mascot peptide identification score ≥30 were considered valid. 
Recovery of the spiked proteins was analyzed using quantitation data generated by 
the IDEAL-Q [194] software tool (v1.0.3.5). The label free quantitation strategy applied 
by IDEAL-Q uses accurate mass, normalized retention time, charge state, and isotope 
distribution pattern to quantify peptides that were not identified via database searches in 
individual LC-MS/MS data files to maximize the number of quantified peptides. The top 50 
proteins (based on unique peptide identifications) from E. coli were used to normalize the 
quantitation data via median centering. Sample EC09, which was spiked with high levels of 
both CA and OVA, was set to 100% to determine the recovery of CA and OVA in relationship 
with their spike-in levels.
Chromatographic and mass spectrometric performance across all experiments was found 
to be excellent as described in detail in the supporting information. Figure 1 visualizes the 
total ion current chromatograms from all analyses as a heat map for ease of inspection. This 
figure shows that analyses performed using column number 4 are generally of lower intensity 
compared to the analyses with other columns. As described in detail in the supporting 
information, we could not relate this phenomenon to emitter performance issues which would 
have been identified from the NISTMSQC data.
A total number of 482603 MS/MS spectra were acquired for the E. coli samples. The Mascot 
database search results were validated using the false discovery rate validation strategy of 
Weatherly et al. [121]. Mascot peptide identification score thresholds to achieve 1% FDR 
or better were calculated to be 18, 20, 23, 28, 31, and 45 for proteins identified with ≥ 
6, 5, …,1 unique peptides, respectively. A total number of 304321 MS/MS spectra were 
successfully matched with peptide sequences in the database, leading to the identification 
of 10166 unique peptides, or 968 proteins in total. On average, each protein was identified 
using 10 unique peptides. For identified peptide ions, supplementary figure S1 shows 
histograms of their m/z ratios, sequence lengths, charge states, and Mascot identification 
score distributions. Supplementary figure S1a shows that the majority of identified unique 
peptide ions are distributed around m/z 550. The overwhelming majority has a charge state 
of z=2+ (supplementary figure S1). Sporadically, ions with charge states z=4+ have been 
selected for CID fragmentation scans. The relative frequency of ions with z=4+ is negligible 
(2.6%). Supplementary figure S1c shows that the majority of unique peptide ions derived 
Class
1
2
3
4
5
6
7
8
9
CA
0
L
H
0
0
L
L
H
H
OVA
0
0
0
L
H
L
H
L
H
# samples
10 (+1)
5 (+1)
5 (+1)
5 (+1)
5 (+1)
5 (+1)
5 (+1)
5 (+1)
5 (+1)
Table 1
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from peptides with a sequence length of 6-15 amino acids. The Mascot peptide identification 
scores in the range of 20-151 show a tailed distribution with an average score of 46, as 
shown in supplementary figure S1d. 
 
Figure 1. Heatmap visualization for the signal intensity (color scale) versus retention time (y-axis, rows) for 
each of the 59 analyses (x-axis, columns). Analyses are ordered on column and respective measurement 
order. The top part of the figure shows the total relative signal intensity for each analysis. The numbers on 
top of the bars correspond with the numbers in table S1 (EC1, EC2, etc). Chromatographic columns are 
indicated with their respective index number. The different liquid chromatography stages (sample loading, 
analysis, wash and equilibration) are indicated on the right side of the figure.
For CA we were able to identify 41 unique ions, corresponding with 19 unique peptides 
and a protein sequence coverage of 87 percent. From the OVA tryptic digest we identified 
17 unique ions for 8 unique peptides with a protein sequence coverage of 26 percent. This 
relatively low sequence coverage of OVA is presumably caused by tryptic peptides with a 
high mass (more than 27 amino acids) and poor mass spectrometric detection. Therefore, 
missing only the three largest peptides already leads to a dramatic decline of 25 percent in 
protein sequence coverage. Recovery of spiked in levels of CA and OVA are shown for each 
sample class in figure 2a and the expected recoveries are shown in figure 2b. From figure 2 
we conclude that the measured levels of CA and OVA correlate with the expected levels for 
each sample class.
With respect to the relevance of this dataset, we used a digested E. coli protein homogenate 
as background for each sample to achieve a high level of complexity typical for most 
proteomic analyses. E. coli was selected as the model organism because of its well-
annotated protein FASTA database and its common use in proteomics and biochemical 
research in general. At the same time, the use of characterized CA and OVA protein spikes 
according to a 2x3 full factorial design provides a well-defined situation needed for the 
development and evaluation of data analysis tools. In combination with the repeated, but 
completely independent, work-up and measurement of the samples, several useful subsets 
can be extracted from the full dataset, a feature that is lacking in most other available 
proteomic datasets. An example hereof is provided by the research described in Bloemberg 
et al. [134], in which a 17-sample subset of the current 59-sample set is analyzed. The 
subset consists of all eleven samples of the 0-0 class of samples (i.e. the un-spiked E. coli 
proteome, see tables 1 and S1) and the six samples of the H-0 class (the E. coli proteome 
with a ‘high’ concentration of CA spike). Other subsets can be selected to obtain even more 
challenging problems and / or to emulate more realistic situations than the binary ‘present’ / 
‘not present’ behaviour of the 0-0 vs. H-0 set. 
 
Figure 2. Measured (2A) and expected (2B) levels of CA and OVA for each sample class. Measured 
CA and OVA levels were determined by labelfree quantitation. Sample EC09 was arbitrary set to 100% 
(class H-H) after median centered normalization using the top 50 E. coli proteins (based on the number of 
unique peptide identifications).
Since sample preparations and measurements were performed in randomized order, possible 
effects of time, column and tuning are not confounded with the effects of the factors in 
the experimental design and can thus be studied separately; even more so because of the 
replicate preparations and analyses.
As described in the supporting information, chromatographic performance across all samples 
was excellent. Nevertheless, chromatographic reproducibility for the 59-sample set is (as in 
any LC-MS/MS study) not perfect. Chromatographic alignment of LC-MS data is still one 
of the most challenging aspects in LC-MS data analysis, as is illustrated by the ongoing 
development of novel alignment techniques [185, 190, 194-200]. As such, the 59 LC-MS/
MS analyses are also well suited for benchmarking and developing these techniques. All 
normal variation that would be expected in real-life proteomics studies is readily available 
in the data. As an example of this, the feature-rich part spanning the ranges of 400-1600 
m/z and t=2000-5500 s of all eleven 0-0 measurements was used as a benchmark set for 
chromatographic alignment using an improved version of parametric time warping [201] in 
Bloemberg et al.[190].
Besides its application in the development of chromatographic alignment and quantitative 
analysis methodologies, the dataset may readily be used in research that focuses on 
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improving peptide or protein identification approaches. Particularly interesting is the 
availability of many redundant MS/MS fragmentation spectra with varying spectral quality for 
the majority of E. coli peptides thanks to the 59 repeated analyses of the E. coli peptides. 
This collection of redundant fragmentation spectra may be particularly useful to develop 
novel methods for classifying or filtering MS/MS spectra based on their spectral quality. 
Another application could be the improvement of database searching algorithms with respect 
to spectrum quality and false discovery rate control. Even more important is that this large 
collection of 482603 high-quality ion trap MS/MS spectra in combination with the available 
mzXML files allow for benchmarking any type of quantitative analysis, be it MS or MS/MS 
driven (or even synergetic methods).
In conclusion, the dataset described in this manuscript presents a unique resource for 
researchers due to its design, available ground truth, high quality data, and in-depth 
characterization. We therefore believe it to be important in future development and 
benchmarking of various types of novel analysis methods for proteomics data. 
Data Deposition
The complete dataset in mzXML format, together with validated individual Mascot database 
search results, Mascot DAT files, peak lists and matrix representation of all samples in .mat 
(Matlab, The Mathworks, Natick – USA) and .RData (R) formats are publicly available. The 
mzXML files encompass profile type survey scans and centroided MS/MS fragmentation 
scans. Peak lists used for database searches are compliant with the Mascot generic peak 
list format. All validated database search results are readily available from the deposited 
Microsoft Excel files. Detailed information regarding the deposited files is provided with the 
deposited data. The related LC-MS/MS measurements of pure CA and OVA tryptic digests 
are also included for evaluation purposes. All data can be downloaded from our server 
(http://www.cac.science.ru.nl/research/data/ecoli).
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Abstract
The identifi cation of diff erential patterns in data originating from hyphenated 
measurement techniques like LC-MS is pivotal to proteomics. Although ‘shotgun 
proteomics’ has been employed successfully to this end, this method also has 
severe drawbacks, because of its dependence on largely untargeted MS/MS 
sequencing and databases for statistical analyses. Alternatively, several MS signal 
based (MS/MS independent) methods have been published that are mainly based 
on (univariate) Student’s t-tests. Here, we present a more robust multivariate 
alternative employing Linear Discriminant Analysis. Like the t-test-based methods, 
it is applied directly to the LC-MS data, instead of using MS/MS measurements. We 
demonstrate the method on a number of simulated datasets as well as on a spike-in 
LC-MS dataset and show its superior performance over t-tests. 
Introduction
Liquid Chromatography-Mass Spectrometry (LC-MS) has become the de facto standard 
as a platform for proteomic biomarker discovery studies [202, 203]. In a typical proteomic 
biomarker search, samples originate from a tissue biopt or bodyfl uid (plasma, urine, 
cerebrospinal fl uid) of two groups: a case group and a control group [204, 205]. Currently 
the most important methodology for fi nding systematic diff erences between these groups 
of samples by means of LC-MS is shotgun proteomics[26, 206]. This methodology 
comprises MS/MS sequencing measurements in combination with database searching to 
identify proteins in the sample, after which the abundances (based on MS signal intensities 
or spectral counts) of the identifi ed proteins are compared. There are intrinsic problems 
associated with this approach: the MS/MS sequencing is largely random and quantitation of 
peptides is dependent on their identifi cation. 
The sequencing problem is immediately obvious from the term ‘shotgun’. Although peptide 
sequencing by MS/MS is often referred to as data-dependent, this means in practice that 
only the most intense peptide signals in a certain retention time range will be selected for 
sequencing. Thus, many peptides will not be sequenced at all and the choice of peptides 
to be sequenced is random insofar that it is generally unrelated to the problem under 
investigation. Moreover, when multiple samples are considered—as in a biomarker search—
there is no assurance that a protein that is present in certain samples will actually be 
detected in all of them.
On top of the limited number of sequencing events, a general problem that any MS/MS 
based biomarker search strategy faces is its dependence on peptide identifi cations and 
quantitations [26]. Any peptide ion not readily identifi ed via database searches (typically 
about 70-80% of the acquired MS/MS spectra after validation, in our experience) is therefore 
not quantifi ed (and thus neglected), even when it might be the most signifi cant dissimilarity 
between sample sets. Alternative strategies for the identifi cation of peptide sequences 
from fragment ion spectra, such as computer-assisted de novo sequencing or manual 
interpretation, might help to alleviate this problem. However, these methods also have a 
limited success rate and are extremely time and computer intensive. With the hardware 
and software currently available, it is therefore simply impossible to successfully identify the 
majority of peptides in a sample, thus presenting an intrinsic problem for MS/MS driven 
quantitation strategies.
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For the abovementioned reasons, there is an incentive for database-free and MS/MS-free 
analysis methods that are able to extract differential patterns from LC-MS data without 
the need for a peptide or protein identification step in the search process [207]. Several 
such methods have been described in literature [208-210]. Commonly, they employ some 
modified version of a t-test to locate differential patterns in LC-MS data. For perfect data, 
with a large number of samples, no noise or intensity changes and no misalignments in the 
chromatographical direction, these methods perform adequately. Unfortunately, real-life data 
are far from perfect; noise is omnipresent and the requirement for many samples opposes 
that of no misalignments due to, e.g., column replacements and variable performance of the 
ionization source, liquid chromatograph and mass spectrometer over time. 
In this paper, we introduce the concept of Moving Window Discriminant Analysis (MWDA). 
This approach uses a combination of Principal Component Analysis (PCA [211-213] and 
Linear Discriminant Analysis (LDA [212-215]), collectively known as PCA-LDA [216-220] to 
compare complete mass chromatograms or mass spectra extracted from the LC-MS data 
rather than single intensities, as in t-tests. We show that, for perfect data, its performance 
is similar to that of multiple t-tests, but that it is far more robust to imperfections, thus 
outperforming t-tests in realistic situations. We also apply both methods to a set of spike-in 
LC-MS data (the ‘E. coli dataset’) that will be made publicly available as a benchmark model 
for complex samples with biomarkers [125]. We show that MWDA has a much steeper initial 
true positive rate than t-tests for these real data also and that it is capable of identifying a 
significant number of spiked-in peptides in the data. We expect the method to be of use in 
current bottom-up (peptide-based) as well as in upcoming top-down (whole-protein-based) 
proteomics [221, 222]. 
Theory
Figure 1. Images of the matrix representations of (A) the first LC/MS measurement of the E. coli 
data set and (B) the first sample from the illustration data set. Columns are mass spectra; rows are 
chromatograms. In both panels, the blue chromatogram at the top is the sum of all ion intensities at each 
fiven time point: the total ion current (TIC). The red mass spectra at the right are the total mass spectra. 
The color scales for the two panels are similar but relative to the samples’ intensity distributions. The 
rectangle in panel A indicates the part of the E. coli samples that was analyzed in this work.
After the typical data processing steps described in the Supplementary Information, an LC-
MS sample can be represented as a matrix. Figure 1 shows matrix representations of sample 
1 from the E. coli dataset and sample 1 from a small noiseless dataset that was simulated 
purely for illustrative purposes (the ‘illustration dataset’). The columns of both matrices are 
mass spectra separated by (elution) time, and their rows are chromatograms distinguished 
by mass-over-charge (m/z) ratio. Generally, complete proteomic LC-MS studies consist of 
several tens of samples. Stacked on top of each other, their matrix representations form a 
3-dimensional array or data cube of dimensions # m/z-values × # time points × # samples. 
Figure 2A shows such a data cube of samples 1–4 of the illustration dataset; the horizontal 
slices are matrices like the one in Figure 1 representing the individual LC-MS measurements.
 
Multiple t-tests
A basic univariate approach for finding potential biomarkers applies two-sample Student’s 
t-tests [223] to the intensities of the case and control samples in the vertical columns (Figure 
2C) at all time-m/z combinations in the data cube. Formally, when a set of multiple inferences 
is considered simultaneously, a multiple testing correction is indicated to prevent the null 
hypotheses from being rejected incorrectly too often. In the context of biomarker searches 
however, it is not so much the particular p-values for the individual hypothesis tests that are 
of interest, but rather their order [210]: the smallest p-value is most likely to be caused by 
a true biomarker. Since multiple testing corrections are one-to-one functions of the input 
p-values, their order does not change and the correction can safely be left out. 
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Figure 2. Part of the data cube of the illustration data set. The black horizontal slices in panel A 
represent the fi rst four LC/MS samples of the data set. The blue vertical slice is an LC matrix, containing 
chromatograms; the red slice contains mass spectra and thus is an MS matrix. The vertical column in 
panel C contains a single intensity per sample. These intensities can be subjected to a t-test, whereas the 
LC and MS matrices are amenable to multivariate analyses such as LDA.
Figure 3. The MWDA procedure applied to LC matrices of the illustration data set: PCA-LDA is applied 
to the subsequent LC matrices of the small simulated data set. Each application results in a discriminant 
coordinate a (a vector) and a Fisher quotient F (a scalar). Combined, the Fisher quotients make up a 
vector f that can be plotted as a mass-spectrum-like structure, with the intensities representing the 
classifi ability of the corresponding LC matrices. The discriminant coordinates together make up a matrix 
A that is similar to the matrix of an LC/MS measurement (Figure 1). A high Fisher quotient means that the 
corresponding LC matrix is well-classifi able and, thus, is likely to contain one or more chromatographic 
profi les that distinguish between the sample classes. The profi le of interest can be found from the 
associated discriminant coordinate.
Moving Window Discriminant Analysis
Instead of just columns, it is also possible to take complete vertical slices from the data cube 
(Figure 2A, B). There are two options: slicing along the retention time axis gives matrices 
containing chromatograms (LC-matrices, blue slice in 2B), whereas slicing along the mass-
over-charge axis results in a matrix of mass spectra (MS-matrices, red slice in 2B). These 
matrices are amenable to multivariate analyses, which are commonly employed for regular 
one-dimensional spectroscopical or spectrometrical data (e.g. infrared spectra, NMR spectra, 
mass spectra, etc.) and chromatographical data [216, 217, 219, 220, 224]. 
MWDA proper comprises the application of PCA-LDA (see Supporting Information) to the 
subsequent mean-centered LC-matrices in the data cube. Moving the window along the 
mass-over-charge axis or along the time axis, MWDA produces a scalar Fisher quotient F 
and a discriminant coordinate vector a for each subsequent matrix (Figure 3). Combined, all 
the Fisher quotients make up a vector resembling a mass spectrum. Complementary to the 
Fisher quotients, the individual discriminant coordinates resemble chromatograms. Taken 
together, all discriminant coordinates form a matrix A of dimensions # m/z-values × # time 
points, i.e. resembing a sample from the original dataset. 
Potential biomarkers are now expected to be found in A at the m/z-values (rows) specifi ed 
by high values of the Fisher quotient and in the orthogonal time direction (columns) by 
the highest peak (absolute value) in the previously specifi ed row. In the original samples, 
disregarding misalignments, the peak of the biomarker-peptide is located at that same 
position.
 
Here, we use the LDA Fisher quotients F to determine whether or not an LC-matrix contains 
a biomarker signal. The percentage of correctly classifi ed samples (PCC) in a cross-validation 
setting can be used to the same end. As opposed to F , which is on a continuous scale, 
the discrete nature of the computationally intensive PCC can obscure interesting diff erences 
between the LC-matrices for small sample numbers, however. Apart from optimizing the 
settings of PCA-LDA in MWDA, it may also be worth considering other discriminant methods 
(e.g. PLS-DA, elastic nets [225]) in similar fashion. Similarly, regression methods (e.g. PLS, 
PCR) would be of interest to use in a similar approach for data from time series or other 
settings that diff er from the typical two-class case-control setup. 
Experimental
Both simulated and real LC-MS datasets are used in this paper. A short description of both 
types of datasets follows below; more elaborate information is presented in the Supporting 
Information, including the functions and scripts that were used for simulating data. 
Thirty-two datasets were simulated in R [226], to assess the relative performances of MWDA 
and t-tests for diff erent amounts of misalignment. All of these datasets have the same 
dimensions (1000×2000×17). The number of samples (seventeen) and their class distribution 
(eleven from class one, six from class two) are equal to those in the real E. coli dataset. All class 
one samples in all thirty-two datasets contain one-thousand compounds, characterized by a 
single gaussian elution profi le, but diff erent numbers (between one and ten) of MS-peaks. That 
is, the number of peaks may diff er slightly between datasets A and B, but is the same within 
dataset A. Compared to class one samples, class two samples contain fi ve extra compounds 
that represent the biomarkers. The peak width along the m/z axis is a single datapoint; along 
the retention time axis it gets wider gradually according to sd = max(1,1+log10(t)), i.e. the 
standard deviation for the gaussian lineshape goes from 1 at t = 0 to 4 at t = 1000. 
The parameter of interest in the simulated data is the misalignment between identical 
compounds in diff erent samples. To investigate its infl uence, the thirty-two simulations consist 
of four groups (1-4) of eight datasets (A-H) each. Each group is essentially a copy of the other 
ones, i.e. the compounds in dataset A of group 2 are exactly the same as those of dataset 
A in group 1, but the groups diff er in one main aspect: in group 1, identical compounds in all 
samples are located at the exact same positions along the elution time axis, whereas in groups 
two, three and four they have a random normal shift with standard deviations of ten, fi fty and 
one-hundred datapoints, respectively.
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The E. coli set is a real 1801×2000×17 (# m/z values × # time points × # samples) 
proteomics dataset that consists of LC-MS measurements of tryptic digests [227] of 
Escherichia coli protein homogenate. Six of the seventeen samples are spiked with bovine 
carbonic anhydrase. As opposed to the simulated datasets, there is no ground truth (i.e. 
prior knowledge about carbonic anhydrase peptides) available for this set; MWDA and t-tests 
results are assessed afterwards, based on two further types of experiments: LC-MS/MS 
measurements and direct infusion nano electrospray ionization (‘nanospray ionization’, NSI) 
MS measurements of tryptically digested carbonic anhydrase only. 
Data Analysis
Simulated Sets: MWDA and t-tests
In principle, MWDA can be applied to either the LC-matrices or the MS-matrices of LC-MS 
data. Misalignments along the retention time (LC) axis inhibit its application to MS-matrices, 
however. Thus, MWDA was applied only to the LC-matrices of each set. The performance 
of PCA-LDA is sensitive to the number of principal components that is retained prior to LDA. 
We therefore opted to use the first three datasets (A, B and C) out of each group of eight as 
a training set to determine a tentative optimum for the number of principal components to 
retain. The number of PCs was then fixed for the subsequent MWDA analyses of the five sets 
(D–G) with similar characteristics per group (the test sets). For each set, the thousand Fisher 
quotients of the respective LC-matrices were used to determine which matrices to designate 
as positives.
 
For comparison, two-sample, two-sided Student’s t-tests were applied to the intensities at 
the two million individual m/z–time points of each set, using pooled variances. The resulting 
two million p-values cannot be directly compared to the thousand F -values obtained by 
applying MWDA to the LC-matrices. Therefore, to enable comparison with MWDA, the 
lowest p-value out of the two-thousand for each LC-matrix was used to determine if the 
matrix was a positive according to the t-tests. 
E. coli Benchmark Set: MWDA and t-tests
After the data processing steps described in the Supporting Information, the LC-matrices 
of the real spike-in set were analyzed using MWDA in two steps: first, the complete 
1801×2000×17 array was analyzed, similar to the simulated sets. The number of PCs to 
use could not be based on a training set with a known ground truth in this case and was 
therefore determined as the rounded average of the first ’knees’ or ’elbows’ in the scree plots 
[211] of ten randomly chosen LC-matrices, resulting in five PCs being retained for every LC-
matrix. Assuming equal null-distributions for MWDA on all LC-matrices, a permutation test of 
18010 total permutations was performed by making ten class permutations per LC-matrix. 
The significance level was set at 0.10, i.e. only Fisher quotients that were higher than the 
90% lowest Fisher quotients of the permuted datasets were designated positive. Fifty out 
of 1801 Fisher quotients were larger than the corresponding threshold. Put differently: fifty 
out of 1801 null hypotheses of ‘no difference’ were rejected. About half of the peaks were 
identified as corresponding to (m + 1)/z, (m + 2)/z and (m + 3)/z peaks of isotope patterns of 
which the monoisotopic peak was also identified. These isotope peaks were retained in the 
further analysis.
To increase the precision of the fifty m/z-values, binning, as described in the Supporting 
Info, was performed again, starting all over from the LC-MS data in mzXML format and 
making fifty-one new bins of width 0.01 Th spanning the range of each original 0.5 Th wide 
bin that was positive in the first analysis. The resulting 2550 new chromatographic matrices 
were subjected to MWDA again and for each group of fifty-one sub-bins, the m/z-value of 
the one with the highest Fisher quotient was noted down. These fifty precise m/z-values 
were subsequently used for comparison with the additional LC-MS/MS and direct NSI MS 
measurements (i.e. without chromatographic separation) of carbonic anhydrase only.
For the t-tests, a similar procedure was followed: again the complete E. coli array 
was analyzed, similar to the simulated sets. Rather than making use of the theoretical 
t-distribution, permutation tests were used here as well: the class labels were permuted ten 
times and after each time the complete E. coli array was analyzed, using the permuted class 
labels. Both for the permuted and original class labels, the lowest p-value per LC-matrix was 
determined, as for the simulated sets. Next, the positive LC-matrices, with p-values below 
the 0.10 significance level were determined, resulting in eighty-five positives. For these, the 
LC-MS data were re-binned and re-analyzed and the precise results were again compared 
with those from the additional measurements.
Finally, after comparing the performance of MWDA and t-tests for the E. coli set, we decided 
to compare the performance of the t-tests with that of random m/z values, to assess the 
baseline level for the procedure. To this end, the entire t-test procedure was applied to the 
E. coli set with permuted class labels. Since a permutation test for permuted data would 
be meaningless, an arbitrary number of seventy-two p-values were designated positive, 
corresponding to an integer percentage of 4% of the total number of p-values, and in 
between the numbers of positives for MWDA and t-tests. The rest of the procedure was as 
described for the t-tests on unpermuted data, above
 
Results
For a comparison of classifiers, it is good practice to draw ROC-curves. In short, an 
ROC-curve is a plot of the true positive rate (the fraction of positives that are true positives) 
versus the false positive rate (the fraction of negatives that are false negatives). For a 
comprehensive explanation, the reader is referred to the excellent paper by Fawcett [228]. 
A prerequisite for making an ROC-curve thus is the identification of both positives and 
negatives as being true or false positives and negatives, respectively. Identification of the 
positives for the E. coli set is already a cumbersome task, but manageable in this particular 
case, since the spiked protein is known and can be measured separately, after which its NSI 
MS or LC-MS signals can be compared with those on the limited list of positives. Identifying 
and quantifying the number of negatives in an objective manner is a problem of a different 
order, however, since it involves many more signals, often of lower quality, and the number of 
true and false negatives is very dependent on the exact criteria that are chosen. Therefore, 
for ease and objectivity, instead of ROC-curves, we choose to plot the true positive rates 
versus the total number of LC-matrices designated positive for the E. coli set, as well as, 
consequentially, for the simulated sets. For the latter, the two types of plots are near-identical, 
as can be seen from comparing the ROC-curves in the Supporting Information with the plots 
below, and in all cases discussed in this paper the plots convey the same message, namely 
that the curve that shows the steepest ascent near the origin represents the best biomarker 
identification method. 
84 85
Figure 4. Average percentage true positive rates for the simulated training sets, using t-tests and MWDA. 
The shaded blue areas represent the interesting regions of the plots where up to 10% of the LC matrices 
were designated positive.
Simulated sets
Figure 4 shows plots of the average percentage of true positives vs. the number of LC-
matrices designated positive for the training set. The curves are constructed in similar fashion 
as ROC-curves [228], by simply ordering the F - or p-values from high to low ‘significance’ 
and comparing the associated LC-matrices with the list of LC-matrices known to contain 
an isotope peak of an added component. Percentages rather than numbers are used, since 
the total number of true positives in each of the eight datasets varies, because components 
can have different numbers of isotope peaks. Averages are taken over the three datasets 
from each group with similar shifts. Based on Figure 4, the numbers of principal components 
retained for MWDA analyses of the test sets are five for the perfectly aligned set and ten for 
the consecutive misaligned sets. The shaded blue areas are the arbitrary ‘regions of interest’ 
where up to ten percent of the LC-matrices is designated positive. For ROC-curves, the 
partial area under the curve (pAUC) could be calculated in the similar region. 
Figure 4 shows the results of MWDA analyses of the test sets, using the numbers of PCs 
indicated by the training sets. It is clear that for the perfect case of no misalignment, t-tests 
and MWDA perform likewise. For a small misalignment on the order of the peak width, the 
performance of the t-tests is hardly affected and the performance of MWDA drops. For 
stronger misalignments comparable to the ones observed in the E. coli set, however, the 
performance of the t-tests drops rapidly and becomes significantly lower than that of MWDA.
 
Figure 5. Average true positive rates for the simulated test sets, using t-tests and MWDA. The number 
of principal components used for MWDA are based on the results of the training sets. The shaded blue 
areas represent the interesting regions of the plots where up to 10% of the LC matrices were designated 
positive.
 
E. coli Benchmark Set
MWDA and t-tests were applied to the E. coli set blind to any ground truth. Subsequently, 
LC-MS/MS and direct NSI MS measurements of tryptically digested pure carbonic anhydrase 
were performed and the results were compared with the MWDA and t-tests lists of positives. 
The final results of these comparisons are summarized in table 1. 
Table 1: Results for MWDA and t-tests (baseline: data with permuted class labels) applied to the E. 
coli set; P: the number of positives as determined by the methods, TP: the number (percentage) of 
true positives, FP: the number (percentage) of false positives, # CA ions: the total number of carbonic 
anhydrase peptide ions identified via LC-MS/MS, m/z (NSI): the number of m/z-values for which a peak is 
identified in the direct NSI mass spectrum.
Two things are immediately clear from this table: 1. both the real t-test and MWDA perform 
substantially better than the baseline level, given by the application to t-tests in the 
permuted-class situation, and 2. MWDA leads to much better results than the t-tests: Even 
despite the much larger number of positives for the t-tests, the number of true positives for 
MWDA is considerably higher. This fact is also clearly visible in Figure 6, which shows the 
Method 
MWDA 
t-tests 
t-tests (baseline)
P 
50
85
72
TP 
44 (88%)
28 (33%)
9 (13%) 
FP 
6 (12%) 
57 (67%)
63 (88%)
# CA ions 
44 (88%) 
25 (29%) 
8 (11%) 
m/z (NSI) 
41 (82%) 
23 (27%) 
3 (4%)
Table 1
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initial true positive rates for the three biomarker searches. Conversely, the number of false 
positives is much lower for MWDA than for the t-tests. Finally, as is also clear from Figure 7, 
most true positives are already identified by the relatively simple direct NSI measurement of 
carbonic anhydrase. For MWDA, a number of positive F -values clearly stick out and match 
with peaks in the mass spectrum. For the t-tests, some matches can also be observed and 
the t-tests on permuted data do not show obvious matches, as expected. The LC-MS/MS 
measurements supply a few additional identifications.
 
Figure 6. Partial true positive rates for MWDA, t-tests, and t-tests with permutated class labels applied 
to the E. coli set. Solid lines represent evaluation based on identifications by LC/MS; dashed lines are for 
evaluation based on direct NSI MS. The dotted gray line presents the maximally achievable true positive 
rate, that is, when all LC matrices designated positive are true positives.
 
Figure 7. Direct comparison of (A) the carbonic 
anhydrase direct NSI mass spectrum, (B) the 
square roots of MWDA Fisher quotients, (C) –ln 
p for the t-tests, and (D) –ln p for the t-tests on 
permuted data, obtained for the E. coli data set. 
The green dashed horizontal lines in panels B 
and C are the respective 10% significance levels 
obtained from permutation tests. The similar line 
in panel D is the 4% cutoff used for the permuted 
data. Yellow dashed vertical lines were drawn as a 
guide to the eye from F/p values that are positives 
(i.e., above the significance level/cutoff).
Discussion
With respect to the simulated data, the similar performance of t-tests and MWDA for 
perfectly aligned data is not unexpected. A complete LC-MS measurement contains many 
correlated features, e.g. peptides originating from the same protein, or peptides originating 
from proteins that are part of the same biochemical pathway. However, these peptides are 
far more likely to display different retention behaviors and to have different mass-over-charge 
ratios than identical ones. Therefore, apart from chance effects and near-perfect correlations 
within a peak or isotope pattern, a perfect (i.e. perfectly aligned, noiseless, etc.) LC-MS 
dataset will show very little correlations in its individual mass spectra or chromatograms. 
As Zuber and Strimmer [229] point out, for non-correlated data LDA reduces to Diagonal 
Discriminant Analysis (DDA), for which t-tests provide the optimally achievable results 
[229, 230]. 
When peaks are shifted, however, a t-test applied at the top of a peak in sample x, will partly 
or completely miss the corresponding peak in sample y. Thus, the test ‘observes’ a large 
variance (top and baseline) which ultimately obscures any remaining variance from differences 
between case and control samples. PCA-LDA, on the other hand, is able to combine 
variables that are stronger correlated within the case and control groups, respectively, than 
between the two. Thus, as long as shifts are not overly large and the number of samples is 
not exceedingly small, shifted peaks can still be compared. For a large number of samples, 
it can be expected that the performance of the t-tests catches up with MWDA again, simply 
because of the 1 / n1/2 relation in the test statistic. 
As mentioned in the Theory section, the importance of the exact p-values or F-values that 
are obtained for t-tests and MWDA, respectively, is limited. Their rank order is of greater 
importance here. Therefore, in retrospect, the significance levels that we used to separate 
LC-matrices into positives and negatives are rather arbitrary. Another reasonable choice 
could have been to use a predetermined cut-off for the number of positives, based on 
reasonable limits for the number of sequencing events in the final LC-MS/MS measurements 
used for identification purposes. All in all, the choice of a cut-off level should strike a balance 
between the work-load associated with the identification and validation of larger numbers 
of positives and the need or wish to find more true positives by analyzing more and more 
positives with a decreasing likelihood of being true positives.
It is an interesting observation that MWDA selects multiple isotope peaks of the same pattern 
more often than t-tests. This increases the confidence that an actual biomarker has been 
found. One could argue about whether positives should be defined on the level of peaks, 
isotope patterns, peptides (including multiple charge states, adducts and intramolecular 
rearrangements) or proteins (which is not really an alternative in this case). Here, we have 
chosen to present the positives as they are found, without an additional interpretation step.
Instead of using a fixed number of PCs in MWDA for all LC-matrices, it may seem that 
optimizing the number of PCs per LC-matrix, using a cross-validation approach for instance, 
might enhance the results. This is not the case, though! Generally, classification methods 
are applied to single matrices, and the hypothesis is that class information is contained 
in the matrix. Optimizing the number of PCs in that case is warranted. For the LC-MS 
data discussed here, however, the majority of the LC-matrices is expected to contain no 
classification information. The effect of optimizing the classification performance on each and 
every matrix is that the positives get lost in the noise of negatives (results not shown) that are 
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also optimized to give the best classification result possible. Therefore, choosing an overall 
number of PCs based on the discrimination between positive and negative matrices of the 
training set is actually the better approach. In practical situations where no training set with a 
known ground truth is available, like for the E. coli set, the optimal number of PCs needs to 
be chosen in a different, but still unbiased, way. Here, we have adopted the frequently used 
approach of picking the number of PCs before the first ‘elbow’ or ‘knee’ in a scree plot [211]. 
The rounded average number of PCs for ten randomly chosen LC-matrices was used for all 
LC-matrices. Other methods are conceivable, however.
In this paper we have only applied MWDA to the LC-matrices of LC-MS datasets. In 
principle, it is also possible to apply it to the MS-matrices, in which case the F -values form 
a chromatogram-like structure and the discriminant coordinates resemble mass spectra. 
However, in that case misalignments larger than the chromatographical peak width along the 
retention time axis truly prohibit analysis: since the shifts are orthogonal to the mass spectral 
direction, corresponding peaks will simply not be present in the same MS-matrices anymore.
In principle, it is possible to correct for shifts by using alignment techniques [190, 231, 232]. 
When a good alignment is obtained, the results of both t-tests and MWDA will improve, 
with MWDA being robust over a wider range of (remaining) misalignment. In our experience, 
obtaining a good alignment is not trivial, however; although in general alignment techniques 
will improve the agreement between retention times, perfect alignment in practice is never 
achieved. Preliminary experiments for the E.coli data show that it is very well possible for 
biomarker search results to deteriorate upon using data that have been aligned and are well-
aligned according to generally used criteria like the correlation between samples and visual 
inspection. Further investigations in this direction are under way. 
Although we have focused on comparing a univariate and a multivariate technique for the 
analysis of LC-MS data, it should be mentioned that LC-MS data have an extra level of 
complexity; not only are they intrinsically multivariate, but they are also of multiway nature 
[233, 234]. Multiway data need multiway data analysis, but the more sophisticated multiway 
methods like PARAFAC and Tucker modelling impose very strict conditions on the data, 
which LC-MS data does not fulfill. We have, however, applied averaging and unfolding, 
two basic techniques from the field of multiway analysis that reduce the data cube to a 
single matrix and subsequently apply multivariate techniques in the normal fashion. The 
performances of these methods were considerably lower than those of both t-tests and 
MWDA and we have therefore not discussed them further here. 
Finally, the MWDA method described here offers not only a solution for current bottom-up 
(peptide-based) proteomics but holds great promise for future top-down (protein-based) 
proteomics by LC-MS. Current advances in top-down instrumentation enable routine analysis 
of intact proteins by LC-MS. Electron transfer dissociation (ETD) on these instruments allows 
for intact protein identification but requires manual optimization of MS/MS fragmentation 
settings for each individual protein. This criterion thus implies a limit to the number of proteins 
amenable for ETD analysis and therefore depends on methods such as MWDA that select 
ions of interest for further identification from MS level data. We therefore believe that our 
current MWDA method holds great potential for application in top-down LC-MS based 
proteomics in contrast to identification driven quantitation strategies. 
Conclusion
In this paper, we have extended the use of a multivariate pattern recognition technique to 
complex LC-MS data. We have applied the technique to a number of simulated datasets, 
as well as to real spike-in LC-MS data. We have shown that the method is inherently more 
robust to misalignment imperfections than the commonly applied t-tests – resulting in 
significantly higher true positive rates – and that it identifies more biomarkers in a practical 
setting, characterized by a relatively low number of samples, misalignments and noise. 
The current paper is mainly a proof of principle and more research to establish the exact 
application ranges of the method is warranted. However, given the robustness of the method 
to data imperfections, we believe the method to be of importance for the identification of 
biomarkers in current proteomics studies as well as in upcoming top-down proteomics and 
other LC-MS analyses of complex samples (e.g. metabolomics).
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Abstract
The molecular mechanism of human mitochondrial translation has yet to be 
fully described. We are particularly interested in understanding the process 
of translational termination and ribosome recycling in the mitochondrion. 
Several candidates have been implicated, for which subcellular localisation 
and characterisation have not been reported. Here, we show that the putative 
mitochondrial recycling factor, mtRRF, is indeed a mitochondrial protein. Expression 
of human mtRRF in fi ssion yeast devoid of endogenous mitochondrial recycling 
factor suppresses the respiratory phenotype. Further, human mtRRF is able to 
associate with E. coli ribosomes in vitro and can associate with mitoribosomes 
in vivo. Depletion of mtRRF in human cell lines is lethal, initially causing profound 
mitochondrial dysmorphism, aggregation of mitoribosomes, elevated mitochondrial 
superoxide production and eventual loss of OXPHOS complexes. Finally, mtRRF 
was shown to co-immunoprecipitate a large number of mitoribosomal proteins 
attached to other mitochondrial proteins including putative members of the 
mitochondrial nucleoid. 
Introduction
Mitochondria play a vital role in a wide variety of cellular processes in eukaryotic cells. They 
possess their own genomic DNA (mtDNA) that encodes 13 proteins, along with 22 tRNA 
and 2 ribosomal RNA [235]. All protein products of the mitochondrial genome are part 
of the multi-subunit complexes involved in oxidative phosphorylation. Synthesis of these 
proteins is carried out on a specialized translational apparatus located within the organelle. 
The components of the mitochondrial translational machinery - translational factors and 
mitoribosomes - are distinct from those in the cytosol and generally resemble bacterial 
counterparts [236].
Our understanding of the mechanisms of mitochondrial translation is far from complete. 
A limited number of factors involved in mitochondrial translation initiation, elongation and 
termination have been identifi ed and characterised [237-241]. The mechanism of the last 
step of protein synthesis, the disassembly of the post-termination complex, has not yet been 
explored in human mitochondria.
Due to the monophyletic α-proteobacterial origin of mitochondria, our knowledge of 
ribosome recycling in prokaryotes can serve as a rough model for mitochondrial processes, 
although it is highly likely that there will prove to be important variations. In the bacterial 
system, when a ribosome reaches a stop codon, the nascent polypeptide is released by 
the coordinated actions of a sequence specifi c class I release factor (RF1 or RF2) and a 
sequence independent class II release factor (RF3 reviewed in [242]). The resulting post-
termination complex containing mRNA and deacylated tRNA in the P/E site [243], has to be 
disassembled and ribosomal subunits need to be recycled to initiate a new round of protein 
synthesis. This process is catalysed by the ribosome recycling factor (RRF). RRF is universally 
conserved in eubacteria and deletion of the gene encoding RRF (frr) has been shown to be 
lethal for E. coli [244]. Mycoplasma genitalium, with one of the smallest genomes reported to 
date, retains RRF despite losing RF2 and RF3, further supporting a key role for this factor in 
prokaryotic translation [245].
The mechanism of bacterial ribosome recycling has been addressed by several independent 
laboratories (for example [246-248]). Conformational changes mediated by RRF bound 
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The glutathione-S-transferase (GST)-fusion constructs were made of the full length (FL) or 
N-terminal deleted (NDel) mtRRF. These were generated by amplifying nt 116 or 324 to 940 
respectively. The FL forward primer incorporated a Bcl1 site whilst the NDel included an 
EcoR1 site. (FL for - 5’ CACACCTGATCAATGGCCTTGGGATTAAAG 3’ ;NDel For 
5’-CACACCGAATTCCCAGAGTGAATATTAATGCT-3’) and the same reverse primer was used 
for both amplification reactions (Rev 5’-AATTATGCGGCCGCACTGGGCTCTGGAGTATT-3‘ 
containing a Not1 site). Amplicons and vectors were digested to allow in-frame downstream 
fusion of mtRRF-GST in pGEX- 6P-1 or pGEX-6P-2 respectively (GE Healthcare).
To generate a FLAG-tagged-mtRRF construct, the following primers were used to amplify 
nucleotides 115 to 900. The region corresponding to the FLAG tag are italicised and EcoRV 
sites are underlined. For 
5’-CTTTCTTGATATCCCACCATGGCCTTGGGATTAAAGTGCTTCCGCATGGTCCA-3’ and 
Rev 5’-CTCTCCGATATCCTACTTATCGTCGTCATCCTTGTAATCTCCAAGGAGTTCTTTGG-3’.
A full length mtRRF PCR product (nt 101-980) was generated using primers For 
5’-CACACCTGATCAGGAUUGUCUUCAGUCAUG and 
Rev 5’-CACACCTGATCAGAGAGAAGTCCCAATGTGC-3’ (Bcl1 site underlined). 
This product was cloned into pGEM-Teasy (Promega), excised by Not1 digestion and 
subcloned into Not1 digested S. cerevisiae URA3 expression vector pFL61 [251] or the S. 
pombe ura4 expression vector pTG1754 (a gift from Transgene, [252]), which both contain a 
strong constitutive promoter. 
Transient transfection of HeLa cells, microscopy and image capture
HeLa cells were grown on coverslips to 50% confluency, transfected with GFP fusion vector 
(1 µg) using SuperFect (Qiagen) as recommended and cultured for a further 24 h prior to 
incubation with Mitotracker Red CM-H2XRos (1 µM final, Invitrogen). After brief fixation (4% 
paraformaldehyde/PBS, 15 min at room temperature), cells were mounted in Vectashield 
(H-1200 Vector Laboratories Inc) and visualised by fluorescence microscopy using a Leica 
(Nussloch Germany) DMRA. Images were recorded as a Z-series (0.5 µm slices) using a 
cooled CCD camera and imaging system (Spot–II Diagnostics Instruments, Sterling Heights 
MI, USA). 
Immunocytochemistry
HeLa cells (3 x 105) plated on coverslips were incubated with Mitotracker Red CMH2XRos, 
as described above, fixed in 3% paraformaldehyde, incubated with anti-mtRRF polyclonal 
antibodies (1/300) for 4 hr, washed, and then incubated with AlexaFluor-488 conjugated 
anti-rabbit antibodies (Molecular Probes) for 1 h. Signals were visualised by microscopy as 
described above. 
Mitochondrial import assays
Assays were performed and assessed using isolated rat liver mitochondria following the 
methods described in [240] but with reticulocyte lysates programmed with the relevant 
RNA species. 
Over-expression and purification of mtRRF-GST
E. coli strain Rosetta(DE3)pLysS (Novagen) was transformed with constructs for the 
overexpression of the human mitochondrial RRF. Bacteria were induced at 0.5 A600 with 1 
mM IPTG, overnight at 16°C. Pelleted cells were resuspended in 50 mM Tris-HCl pH 7.4, 
to the 70S ribosome can disrupt the intersubunit bridges leading to separation of the 
monosome. This process requires GTP hydrolysis that is triggered by elongation factor G 
(EFG). Subsequently, initiation factor 3 (IF3) binds to the 30S subunit preventing reassociation 
of the free subunits. More recently, emphasis has been placed on the exact role played by 
bacterial RRF in this process. Cryoelectron microscopy data on E. coli RRF binding to 70S 
post-termination complexes is consistent with a spontaneous movement of RRF from around 
the peptidyltransferase centre in the monosome to a site on the 50S subunit, resulting in the 
cleavage of intersubunit bridges and subunit dissociation [249]. However, no such structural 
reorganisation was found on X-ray crystallography of a similar but not identical 
T. thermophilus system [250].
To date, no human mitochondrial ribosome recycling factor has been characterised. A 
candidate, mtRRF, was proposed several years ago from bioinformatic analyses of several 
overlapping EST sequences [241] but with no supportive functional studies or investigation 
of subcellular localisation. In this paper we report that this putative mitochondrial recycling 
factor is indeed a mitochondrial protein. Furthermore, we show a direct interaction of purified 
mtRRF with ribosomes of both bacterial and mammalian mitochondrial origin in vitro and in 
vivo. To assess the physiological function of mtRRF we have examined the ability of human 
mtRRF to rescue yeast strains deleted of their endogenous factor and the effect of mtRRF 
depletion in cultured human cells. We observed aggregation of mitoribosomes, increased 
ROS and profound changes in mitochondrial morphology. Our results imply that analogous 
to the bacterial situation, this protein is essential for mitochondrial function and viability of 
human cells. 
 
Methods
Tissue culture manipulations
Human HeLa cells were cultured (37˚C, humidified 5% CO2) in Eagle’s modified essential 
medium (Sigma) supplemented with 10% (v/v) foetal calf serum, 1 x non essential amino 
acids and 2 mM L-glutamine. Flp-In™T-Rex™-293 cells (HEK293T, Invitrogen) were grown in 
Dulbecco’s modified Eagle’s medium supplemented with 10 % FCS, 50 µg/ml uridine and 1 x 
non essential amino acids in the presence of 10 µg/ml Blasticidin S and 100 µg/ml Zeocin 
(Invitrogen). Post transfection selection was effected with Hygromycin B (100 µg/ml). For 
growth on respiratory substrates, medium was glucose free DMEM (Gibco), 0.9 mg/ml 
galactose, 1 mM sodium pyruvate, 10% (v/v) foetal calf serum, non essential amino acids 
and 2 mM L-glutamine. For growth curve analyses galactose medium included 50 µg/ml 
uridine.
Production of GFP-, FLAG- and GST-fusion constructs and cloning into yeast 
expression vectors
The original human mtRRF clone was obtained from MGC (MGC:17776; Acc No BC013049) 
but primer positions described below are relative to the reference sequence NM_138777.2.
To generate a fusion construct that would allow expression of mtRRF with GFP at the C 
terminus, nucleotides 102 to 894 of the mtRRF cDNA were amplified using primers For 
5’-CACACATGATCAGATTGTCTTCAGTCATGG-3’ and 
Rev 5’-CACACATGATCAAGTTCTTTGGTCTTCACTGC-3’ (Bcl1 sites underlined). This was 
digested and cloned in-frame upstream of GFP in pGFP3 (pcDNA3.1 Invitrogen, containing 
the GFP open reading frame and multiple cloning site kindly donated by Dr D Elliott, 
Newcastle University).
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Mass spectrometry analysis and protein identification
Mass spectrometric analysis of immunoprecipitated complexes was performed as described 
in Supplemental Data.
 
Yeast growth conditions, plasmid and general strain constructions and 
complementation assays
All yeast strains used in this study are detailed in Table S2. General yeast media and genetic 
techniques/transformation protocols were as described in [252]. In brief, fermentable media 
contained 2% glucose, non-fermentable conditions were 3% (v:v) glycerol/ethanol or 2% (v:v) 
glycerol with 0.1% glucose or for S. pombe only 2% (w:v) galactose/0.1% (w:v) glucose.
Production of an S. pombe Δ rrf1 strain
A single S. pombe protein, encoded by the gene SPBC1709.09, was found to have 
significant similarities to both S. cerevisiae Rrf1 (Fig S4) and E. coli RRF. The ORF was PCR 
amplified from genomic DNA and cloned into the NotI site of the pTG1754 and pFL61 
expression plasmids for S. pombe and S. cerevisiae, respectively. An S. pombe ∆rrf1::KanR 
strain (NB331) was constructed in the wild type recipient strain NB205-6A by using a PCR 
disruption strategy with hybrid rrf1-KanR oligonucleotides as described in [253], removing 629 
bp encompassing the 735 bp rrf1Sp ORF (starting 8 bp before the ATG). Twenty two of fifty 
clones showed delayed growth on glycerol medium and were proved to contain the correct 
insertion by PCR. Crossing to wild type followed by sporulation and tetrad analysis showed 
a 2:2 cosegregation of the geneticin resistance and slow glycerol growth. Transformation 
with the Rrf1pSp-encoding plasmid restored growth on galactose, confirming that the 
mitochondrial DNA was intact in this strain.
Spectroscopic analyses
Cells from ∆rrf1Sp transformants were dried, mixed with sodium dithionite to fully reduce the 
cytochromes and frozen in liquid nitrogen before recording the absorbance of the samples at 
wavelengths from 630 to 490 nm (spectrophotometer Cary 400Ò). Peaks were the following: 
cytochrome c (548 nm), cytochrome c1 (554 nm), cytochrome b (560 nm) and cytochrome 
aa3 (603 nm). 
siRNA constructs, transfection and RT-PCR analysis
The following sequences targeting mtRRF were tested for efficiency of mRNA 
and protein depletion. Nucleotide positions are relative to reference sequence 
NM_138777.2, siRNA ORF1 5’ GGACACCAUUAGGCUAAUA dTdT 3’ (nt 211-229); 
siRNA ORF2 5’ GAGAAAUGCUGGUGAAACU dTdT 3’ (nt 684-702); siRNA ORF3 
5’GACAGUGCAUGAAAGACAA dTdT 3’ (nt 799-817). Experiments were performed with 
siRNA ORF2 unless otherwise specified. Treatment of stably transfected and induced 
HEK293T cells was performed with siRNA UTR1 5’
GUAUUCUUGUUGCACUUAA dTdT 3’ (nt 1633-1651) targeting the 3’UTR region that 
was absent in the inducibly expressed form of mtRRF. Transfections were performed on 
20% confluent cells with Oligofectamine (Invitrogen) in Optimem-I medium (Gibco) with final 
concentrations of 0.2 µM siRNA. Control non-targetting siRNA and custom siRNA duplexes 
were purchased purified and pre-annealed from Eurogentec. Quantification of mtRRF 
mRNA was performed with TaqMan Gene Expression Assay (Applied Biosystems) using 
ABI Prism sequence detector system. Data was normalized to GAPDH as an endogenous 
control. Probe kits were ordered from Applied Biosystems – HS01067555_g1 (mtRRF) and 
HS999999905_m1 (GAPDH).
150 mM NaCl, 1 mM lysozyme, 1 mM EDTA, 1 mM PMSF and sonicated on ice 10 x 10 s 
(Soniprep 150). Post centrifugation (30,000g for 20 min, 4°C) the supernatant was filtered 
(0.45 µm Corning) and incubated for 3 h at 4°C with glutathione Sepharose 4B beads (GE 
Healthcare). Beads were extensively washed prior to elution in 50 mM Tris-HCl pH 7.8, 150 
mM NaCl, 20 mM reduced glutathione, 1 mM PMSF.
For cleavage and removal of the GST on the Sepharose, beads were incubated at 4˚C 
overnight in 50 mM Tris-HCl pH 7.8, 150 mM NaCl, 1 mM PMSF supplemented with 1 mM 
EDTA, 1 mM DTT and 24 µl/ml PreScission Protease (GE Healthcare). Eluted recombinant 
protein was stored at 4˚C. 
Production of anti-mtRRF antibodies
Recombinant human mtRRF purified as described above was used as antigen to raise rabbit 
antisera. Antibody generation and affinity purification was performed by Eurogentec, Belgium
. 
In vitro ribosome binding assay
E. coli ribosomes were prepared as described in [240]. Reactions (50 µl) combined purified 
recombinant mtRRFD69 and 70S ribosomes (1 µM) in 10 mM Tris-HCl pH 7.2, 10 mM 
Mg(OAc)2, 80 mM NH4Cl, 1 mM DTT at room temperature for 30 min. The mixture was 
centrifuged through 10% (v:v) sucrose (150 µl in binding buffer) for 1 h in Beckman-Coulter 
air-driven ultracentrifuge (30 psi). Fractions (4 x 50 µl) were collected and analyzed by 
Western blot. 
Stable transfection of HEK293T cells with FLAG tagged mitochondrially 
targeted proteins
Cells were transfected at ~30% confluency using Superfect (Qiagen). The vectors, 
pOG44 expressing FRT recombinase, and pcDNA5/FRT/TO containing sequences of the 
genes to be expressed (FLAG tagged mtRRF or mitochondrially targeted luciferase) were 
combined to give a total of 2 µg DNA in a 9:1 ratio, and mixed with Superfect prior to a 3 
hr incubation with the cells. Selection with Hygromycin B (100 µg/ml) commenced 2 days 
later. Independent colonies were isolated, propagated and analysed for induction (1 µg/ml 
tetracycline) by Western using anti-FLAG antibodies (Sigma).
 
Isokinetic sucrose gradient analysis of mitochondrial ribosomes
Total cell lysates (0.5 mg) were loaded on a linear sucrose gradient (10-30% (v:v), 1 ml) in 10 
mM Tris-HCl pH 7.2, 10 mM Mg(OAc)2, 80 mM NH4Cl, 1 mM PMSF and centrifuged for 2 h 
at 100 000 g at 4˚C. Fractions of 100 µl were collected and analysed by Western blot.
 
Affinity purification and elution of FLAG peptides
Mitochondria were isolated from HEK293T cells overexpressing FLAG- mtRRF or 
mtLUC essentially as described in [240] and treated with proteinase K (5 µg/1 mg of 
mitochondria; 30 min 4˚C) followed by PMSF (1mM) inhibition. Pelleted mitochondria 
were resuspended in lysis buffer (supplemented with 10 mM Mg(OAC)2 as indicated, 
although no difference in the composition of protein precipitate could be measured without 
supplement). Immunoprecipitation was performed with a-FLAG-Gel following manufacturer’s 
recommendations (Sigma Aldrich, St Louis MO). Elution was effected with FLAG peptide. 
RNase A (5 µg/ml) and EDTA (50 mM) were added as indicated.
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Results 
MtRRF, the human homologue of bacterial RRF, is a mitochondrial protein 
To confirm mitochondrial localisation of the putative human mtRRF predicted by in silico 
studies [241], a mtRRF-GFP fusion construct was used to transfect HeLa cells. This chimera 
included all but the terminal 2 residues of mtRRF fused N-terminal to GFP. Cells were 
cultured for 24 hr prior to staining with Mitotracker CM-H2XRos, to visualise mitochondria. 
Fluorescence microscopy images and line scan analysis (Fig 1A left panels) of transfected 
cells demonstrated co-localization of mtRRF-GFP with Mitotracker Red. In contrast to the 
well-defined, discrete pattern produced by mtRRF–GFP, expression of the GFP protein alone 
produced a diffuse stain (data not shown).
To verify if localisation of the mtRRF-GFP fusion protein reflects the behaviour of the 
endogenous protein, immunocytochemistry was performed. Polyclonal antisera against 
full length recombinant protein were raised and anti-mtRRF antibodies affinity purified. 
Immunocytochemistry (Fig 1A right panels) indicated similar mitochondrial localisation of both 
the endogenous and mtRRF-GFP.
To confirm that mtRRF is indeed imported into the mitochondrial matrix and not merely 
localised to the organelle, import assays were performed with isolated mitochondria and 
in vitro translated 35S-labelled mtRRF (Fig 1B). Resistance of the radiolabelled protein to 
proteinase K (lane 2) confirmed successful mitochondrial uptake. Import resulted in cleavage 
of the mitochondrial targeting presequence of Su9-DHFR but interestingly not of mtRRF. This 
is consistent with bioinformatic predictions (www.cbs.dtu.dk/services/TargetP) being unable 
to identify a clear cleavage signal in the mtRRF sequence [241]. Alignment of the mtRRF 
sequence with bacterial counterparts indicates that optimal alignment begins at position 80 
of the full length mtRRF (Fig 1C). Since our results show that this long N-terminal extension is 
not a cleavable import signal but an integral part of the mature protein it suggests that it may 
be of functional importance specific to mitochondria. 
mtRRF binds E. coli ribosomes in vitro and can associate with 
human mitoribosomes 
Direct interaction of prokaryotic RRF with ribosomes in the absence of other translation 
factors has been demonstrated [250, 258]. Binding experiments were therefore performed 
to determine if human mtRRF could play a similar role to its bacterial homologues. Isolation 
of full length overexpressed mtRRF showed that the protein tended to aggregate (Fig S1). 
Therefore a short N-terminal truncation mtRRFΔ69, was used as this deletion significantly 
increased solubility of the recombinant protein. Comparative circular dichroism analysis of 
both the full length and truncated mtRRF confirmed that removal of the N-terminus did not 
cause any major structural changes (data not shown). In vitro binding assays showed that 
mtRRF localised to the rapidly sedimenting ribosomal fraction only in the presence of E. coli 
ribosomes (Fig 2A), indicating a direct interaction.
 
 
Cell preparations, Western analysis and Blue Native–PAGE
S. pombe mitochondria were purified from cells grown either in complete glucose medium or 
in minimal glucose medium lacking uracil as described in [253] with Roche protease inhibitors 
present at all stages. Yeast proteins were separated by 12% SDS-PAGE and immobilized on 
nitrocellulose (Schleicher & Schuell) by wet transfer in 25 mM Tris, 192 mM glycine, 0.02% 
(w/v) SDS and 20% (v/v) ethanol. Blots were hybridized with mouse [anti-human Hsp60, 
Sigma H-3525; anti-FLAG, Sigma H-1804] or rabbit antibodies [anti-mtRRFHs (this work); 
-Cox2Sp, [254] -Arg8Sc [255]; -EFTuSp [252]].
Human cell lysates were prepared, separated by SDS–PAGE and immobilized by wet 
transfer as described (6). Proteins of interest were bound by overnight incubation (4°C) 
with antibodies [mtRRF, GDH (Lightowlers Group); Porin, COX I, COX II, SDH 70K and 
ND6 (MitoSciences); β-actin (Sigma); DAP3, MRLP3 (Abcam)] followed by HRP-conjugated 
secondary antibodies (DAKO) and visualized by ECL-plus (GE Healthcare).  
Blue native gel electrophoresis was performed as described in [256] with 30 µg protein 
loaded per lane and wet transfer as above. 
Free radicals and mitochondrial mass measurements
MitoSOX (Molecular Probes) prepared in DMSO, diluted to 5 µM in DMEM medium lacking 
serum was added to cells for 10 min at 37˚C. Cells were washed before resuspension in 2 ml 
DMEM-lacking serum and passed through a FACScan flow cytometer (Becton Dickenson, 
equipped with 488nm Argon laser). Data was collected for forward and side scatter together 
with autofluorescence of unstained cells, gating eliminated debris and apoptotic cells 
from the analyses. After acquisition, data was analysed by WinMDI software (version 2.8). 
Experiments were performed on four independent occasions with triplicate measurements 
based on 10,000 events. Dihydrorhodamine 123 (DHR, Molecular Probes) and nonyl acridine 
orange (NAO, Molecular Probes) were resuspended in DMSO, diluted to 30 mM (DHR) or 10 
mM (NAO) in DMEM-lacking serum and incubated with cells at 37˚C for 30 (DHR) or 10 (NAO) 
min. Cells were then washed before resuspension in 2 ml DMEM-lacking serum and green 
fluorescence emission analyzed as above. 
EM studies
Cells were grown as detailed above, pelleted and resuspended in 2% glutaraldehyde in 
Sorensen’s phosphate buffer. The samples were then processed by the Newcastle University 
EM Facility. 
In vivo Mitochondrial Protein Synthesis
Protein translation in HeLa cells was performed essentially as described [257]. Cells were 
incubated with radiolabelled methionine for 15 min.
Respirometry
High resolution respirometry was performed at 37˚C with an Oroboros Oxygraph-2K 
(Oroboros Instruments, Austria) essentially as detailed in [240]. 
Statistical analysis
Students unpaired t-tests were used to determine the significance of values as indicated in 
Figure legends. Values of p<0.05 were recorded as statistically significant. 
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gradient centrifugation. This mtRRF overexpression was not deleterious to cell growth (data 
not shown) but led to a slight decrease in mitoribosome formation (Fig 2C cf. Fig 5A). No 
association of mtRRF with mitoribosomes at steady state was detectable. However, binding 
became evident on incubation (3 hr) of the lysate prior to centrifugation (mimicking the IP 
procedure) potentially due to dissociation or hydrolysis of charged tRNAs that would naturally 
occupy most A/P sites. This dependence on preincubation was not a consequence of 
mtRRF overexpression, as a similar effect was noted with HeLa cell lysate (Fig 5A, data not 
shown). Further, association was not due to non-specific interactions promoted by the pre-
incubation step as interactions were lost either on RNase or EDTA treatment (Fig 2E, lanes 1 
and 2). 
 
Figure 2. Human mtRRF associates with bacterial ribosomes in vitro and mitoribosomes in vivo. (A) 
Human mtRRF binds E. coli ribosomes. Recombinant mtRRF (mtRRFΔ69) was incubated with or 
without 70S ribosomes prior to sedimentation through 10% (w:v) sucrose. Fractions were subjected 
to western analysis. (B) mtRRF associates with mitoribosomes. FLAG-mtRRF and mtLuc HEK293T 
cells were induced, mitochondria isolated. Lysate was prepared (lane 1) from which proteins were 
immunoprecipitated via the FLAG epitope (lanes 2–3). Western blot analysis used antibodies to mtRRF, 
large 39S and small 28S mitoribosomal subunits (MRPL3, DAP3), mitochondrial chaperone (mtHSP70), 
complex IV (COX 2) and a matrix protein (glutamate dehydrogenase -GDH). (C) Pre-incubation of 
mitochondria allows detection of mtRRF binding to mitoribosomes. Lysate was prepared from HEK293T 
cells after induction of FLAG-mtRRF and was either separated immediately or post 3 h incubation on 
a 10–30% (v:v) isokinetic sucrose gradient. Fractions were analysed by western blot with antibodies 
to mtRRF, MRPL3 (39S mitoribosomal subunit) or DAP3 (28S mitoribosomal subunit). A similar time-
dependent mitoribosomal association in HeLa cell lysate was noted for the endogenous mtRRF (data 
not shown). (D) HEK293T cells were induced (±Tet) for FLAG-mtRRF (lanes 1–2) or control mtluc (lane 3) 
expression and mitochondria isolated. Co-immunoprecipitating proteins were separated through a 12% 
SDS–PAG and visualized by silver stain. mtRRF, mtluc and anti-FLAG IgG are indicated. (E) Preparations 
of the mtRRF IP were also treated with EDTA (lane 1) or RNase A (lane 2). Mitochondrial lysate is shown 
in lane 3. 
Figure 1. mtRRF is a mitochondrial protein with an extended N-terminal pre-sequence. (A) Human 
mtRRF is targeted to mitochondria. Left panels show HeLa cells transiently transfected (24 h) with 
a mtRRF–GFP fusion construct. Cells were stained to visualize nuclei (DAPI blue) and mitochondria 
(Mitotracker red). Fluorescence images and linescans confirmed mitochondrial localization of mtRRF–
GFP by superimposition of green and red signals (lower left). The image reflects three-independent 
transfections. Endogenous mtRRF in HeLa cells was visualized by immunocytochemistry (upper right) 
using affinity purified anti-mtRRF and FITC secondary. DAPI-stained nuclei (blue) and Mitotracker the 
mitochondria (red). Mitochondrial localization of mtRRF was confirmed by superimposition of linescan 
green and red fluorescence (lower right). The image reflects three-independent transfections. (B) Human 
mtRRF is imported into mitochondria. FL 35S-radiolabelled mtRRF was in vitro synthesized and incubated 
with rat liver mitochondria (lane 1). Under import conditions a single product is visible (lane 2) that is 
protected from proteinase K (lane 3), but degraded by treatment with proteinase K and FCCP uncoupler 
(lane 4). Control import reactions contained DHFR with a mitochondrial pre-sequence (Su9) showing the 
FL pre-protein and the matured form under import conditions. (C) Sequence alignment (CLUSTALW) 
indicates an extensive N-terminal pre-sequence when compared with E. coli or Thermotoga maritima. 
Identity to these RRFs is indicated in blue and by *, high levels of similarity by a colon ‘:’ and lower levels 
by a fullstop
To determine whether mtRRF could interact with mitoribosomes in isolated organelles, 
FLAG epitope tagged mtRRF was inducibly expressed in human Flip-In T-REx HEK293 cells 
(HEK293T) as described in procedures. Subsequently, complexes containing the fusion 
protein were isolated from solubilised mitochondria by anti-FLAG affinity purification and 
FLAG peptide elution. To control for non-specific binding, FLAG-tagged mitochondrially 
targeted luciferase (mtluc) was expressed in cells and immunoprecipitated (IP) by the same 
procedure. Western analysis revealed a specific interaction of mtRRF and mitoribosomal 
proteins (Fig 2B). Mitoribosomes were very efficiently precipitated with FLAG-mtRRF. Taken 
together these data show that mtRRF can tightly associate with mitoribosomes.
Bacterial RRF is only transiently associated with ribosomes in vivo, partially occluding the P 
and A sites on binding to the post termination complex [243, 249] so it was surprising to find 
that the majority of mtRRF was bound to mitoribosomes. To investigate this further, HEK293T 
cells were induced as above and lysates were immediately subjected to isokinetic sucrose 
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Human mtRRF improves the respiratory competence of S. pombe Δrrf1 
To gain insight into the in vivo function of human mtRRF, we first examined whether it could 
replace the endogenous mtRRF of the budding yeast S. cerevisiae. Respiratory deficiency 
due to loss of S. cerevisiae mtRRF (∆rrf1Sc) was reportedly associated with depletion of 
cytochrome c oxidase activity [264] or total loss of mtDNA [265]. Thus, for complementation 
analysis we used ∆rrf1Sc strains with different nuclear and mitochondrial backgrounds 
(Supplemental Data). In the W303 background, ∆rrf1Sc cells showed a mild to pronounced 
respiratory deficiency depending on the mitochondrial intron content (Fig S2) but retained 
wild type mtDNA. This allowed direct complementation tests by transformation with 
expression plasmids carrying either the natural S. cerevisiae gene, or human or S. pombe 
(fission yeast) homologues. However, neither the S. pombe nor the human homologue 
complemented the S. cerevisiae mutant (Fig 3A, data not shown).
 
Figure 3. Human mtRRF suppresses a partial respiratory deficiency in Δrrf1 fission yeast. (A) Human 
mtRRF cannot rescue the Δrrf respiratory defect in budding yeast. Saccharomyces cerevisiae 
transformants of Δrrf1 strain MG38 carrying the control vector pFL44L or URA3 plasmids producing 
the S. cerevisiae, S. pombe or human mtRRF were replica-plated on non-fermentable media (eth/gly 
+ glycerol 0.1% glucose) and incubated at 28°C. (B–D) Human mtRRF restores respiratory capacity 
in Δrrf1 fission yeast. Schizosaccharomyces pombe lacking endogenous RRF (Δrrf1Sp, NB331) was 
transformed with vector alone (vector) or expressing human (RRFHs) or S. pombe (RRFSp) mtRRF (B). 
Serial dilutions of three Δrrf1Sp transformants were spotted on complete glucose, uracil-free minimal 
or complete gly/eth media and grown at 28 °C for the times indicated. (C) Δrrf1Sp transformants were 
grown on 2% glycerol/0.1% glucose (vector) or ethanol/glycerol medium (RRFSp or RRFHs) before 
recording whole-cell cytochrome spectra. Cytochrome b + c1 and aa3 correspond to Complex III and 
Complex IV, respectively. (D) Mitochondria and post-mitochondrial supernatants from transformants 
grown in glucose medium minus uracil were separated by 12% PAGE and analysed by western blot with 
antibodies recognizing human mtRRF, S. pombe mtEF-Tu and mt-encoded Cox2, human mt-Hsp60 and 
S. cerevisiae mtArg8 (this also recognizes S. pombe Arg1 in mitochondria and an unknown protein in the 
supernatant)
Mitoribosomes associated with numerous mitochondrial proteins are 
co-immunoprecipitated with mtRRF 
Immunoprecipitation (IP) experiments using mtRRF as bait revealed an association with two 
mitoribosomal proteins, presumably indicating the presence of the large (39S) and small (28S) 
ribosomal subunits (MRPs) (Fig 2B). To confirm the presence of other MRPs and determine 
which if any additional proteins were present, IP experiments were performed on lysates 
from a protease/DNase-treated HEK293T mitoplast fraction. After elution of specifically 
bound proteins with FLAG peptide, the eluant was separated by gel electrophoresis and gel 
slices subjected to LC-MS/MS as detailed in Supplemental Data. The mitoplast enrichment 
procedure yielded a total of 167 identified mitochondrial proteins (Tables 1, S1), 73 of which 
were indeed MRPs. Although MRPs constituted most of the purified IP proteins, detailed LC 
MS/MS analysis revealed some remaining cytosolic contaminants (data available on request) 
but also allowed us to identify other mitochondrial proteins that co-immunoprecipitated 
with mtRRF (Table 1). The second largest group were proteins that had been previously 
reported as components of human mitochondrial nucleoids [259-261]. Among other proteins 
interacting with mitoribosomes were factors involved in intra-organellar translation, nucleic 
acid binding proteins and chaperones/proteases, all proteins that might be expected to 
associate with ribosomal components or nascent peptides. Several polypeptides known to 
be involved in metabolism were also identified. 
Table 1. Predicted function of the mitochondrial proteins identified after anti-FLAG mtRRF affinity 
precipitation. A Known or predicted function of identified mitochondrial proteins. B Immunoprecipitation 
from mitoplasts after protease and DNase shaving. C EDTA/washed immunoprecipitant from crude 
mitochondria. D RNase/treated immunoprecipitant from crude mitochondria. E Mitoribosomal subunits 
identified by Koc et al. 2001 [262] and Cavdar Koc et al.[263]. F Putative nucleoid proteins as recently 
classified by Bogenhagen et al. [259] (of total proteins). G Putative nucleoid proteins as identified by He et 
al. [260] (of total proteins). H Mitochondrial ribosomal recycling factor, mtRRF. I Three cytosolic ribosomal 
proteins were identified in the precipitation following EDTA treatment. J Does not include any non-
mitochondrial, hypothetical or predicted proteins that were found.
Protein typeA Immunoprecipitation
Mitoribosomal proteinsE
NucleoidF
 Class I
 Class II
 Class III
NucleoidG
Translation associated
Nucleic acid 
binding/modifying
Metabolic
Chaperone/protease
Transporter
Unknown function
TOTAL
mtRRFB
73
25 (31)
6 (10)
6 (16)
5 (6)
6
13
23
5
4
6
167J
mtRRF + EDTAC
1
2
0
0
1
1H
0
0
0
0
0
7I
mtRRF + RNaseD
0
0
0
0
0
1H
0
0
0
0
0
1
Table 1
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proteins of up to 40% when compared to nontargeting controls (day 6). These results 
were consistent with the decreased levels of fully assembled OXPHOS complexes after 6 
days siRNA treatment, as revealed by Blue Native gel electrophoresis (Fig 4E). Moreover, 
polarographic measurements showed that respiration rates of the siRNA treated cells 
decreased, consistent with affected function of OXPHOS complexes (Fig 4F). 
To further decipher the exact mechanism of mtRRF function in mitochondrial translation, we 
looked at the sedimentation profile of HeLa cell mitoribosomes in isokinetic sucrose density 
gradients following mtRRF depletion. Western analysis of mitoribosomes from cells treated 
for 4 days with NT or mtRRF siRNA (Fig 5A) showed a striking contrast in distribution of 
DAP3 representing the small ribosomal subunit. mtRRF siRNA caused a shift from fractions 
5-8 to mainly 7. This fraction has proteins from both mitochondrial ribosomal subunits 
and represents monosome accumulation. Moreover, only after mtRRF depletion were 
both ribosomal subunits detected in the heaviest fraction (F11), suggesting aggregation of 
the ribosomal proteins. We conclude that on depletion of mtRRF, monosomes are poorly 
dissociated into single subunits and non-functional monosomes accumulate, producing 
aggregates. These data are consistent with mtRRF functioning as a factor responsible for 
disassembly of ribosomes in human mitochondria. 
Figure 4. Depletion of human mtRRF severely affects cell viability and compromises mitochondrial 
translation. (A) siRNA-mediated depletion of human mtRRF. HeLa cells were exposed to three different 
siRNA molecules all in the mtRRF-coding sequence or an control siRNA for 6 days and RNA or cell 
lysates were prepared. Levels of mtRRF transcript compared to control siRNA transfected cells were 
quantified by real-time PCR (upper graph, mean ± SEM from four-independent transfections). Western 
blots (30 µg lysate/lane) in the lower panel were performed with antibodies against mtRRF to confirm 
.As the fission yeast S. pombe is regarded as a closer evolutionary relative to human 
than S. cerevisiae particularly in mitochondrial physiology [253], we inactivated the gene 
coding the S. pombe mtRRF homologue (rrf1Sp) to test if it could be replaced by human 
mtRRF. Deletion of rrf1Sp slightly but significantly impaired growth on non-fermentable 
carbon sources (Fig 3B), lowered overall content of mt-encoded cytochromes (Fig 3C) and 
decreased steady state levels of mt-encoded Cox2 protein (Fig 3D) consistent with a role in 
mitochondrial translation. In addition, western analysis of S. pombe mtRRF protein confirmed 
mitochondrial location (Fig S3). Transfectants of this strain expressing full length human 
mtRRF were able to fully restore normal growth on non-fermentable medium, levels of mt-
encoded cytochromes and Cox2 protein, correlating with weak but reproducibly detectable 
mtRRFHs in only the mitochondrial fraction (Fig 3B-D). Thus human mtRRF clearly performs 
the same function as S. pombe mtRRF consistent with interaction with the S. pombe 
mitochondrial translation machinery. 
Loss of mtRRF in human cells results in reduced growth rate and cell death
To determine the function of mtRRF in human mitochondria, 3 siRNA specific to the human 
mtRRF mRNA were designed and used to transfect HeLa and HEK293T cells. A non-
targeting siRNA (NT) was used to confirm specificity. A reduction of 80-90% of mtRRF mRNA 
levels was observed 2 days post transfection with a consequent dramatic reduction in mtRRF 
protein by day 3 (Fig 4A). To investigate the long term effect of mtRRF depletion, HeLa cells 
were retransfected with siRNA on the third day of the experiment. Interestingly, the cells 
transfected with mtRRF siRNA(ORF2) showed a significant reduction in growth compared to 
NT controls (Fig 4B). After 3 days of mtRRF siRNA treatment cells developed morphological 
changes and depletion for more than 6 days was lethal. If cells were cultured in glucose free 
media supplemented with galactose to force dependence on oxidative phosphorylation, the 
effect of mtRRF depletion was even more profound (Fig 4B). These observations suggest that 
mtRRF is an essential protein and its loss affects mitochondrial functions.
To further ensure that the growth phenotype was specific to mtRRF depletion, an siRNA 
designed against the 3’UTR of mtRRF was introduced to HEK293T cells, concomitant 
with inducible expression of the exogenous FLAG-mtRRF lacking this 3’UTR. Expression 
of mtRRF after transfection of the cells with 3’UTR specific mtRRF siRNA restored normal 
growth (Fig 4B) consistent with the growth phenotype being solely due to depletion of 
mtRRF. 
Depletion of mtRRF partially affects mitochondrial translation and inhibits 
mitoribosomal disassembly 
What is the mechanism causing the growth phenotype? It has been shown that in bacteria 
and yeast mitochondria, inactivation of RRF inhibits protein synthesis [246, 265]. To 
determine if the same is true for the mtRRF, we investigated the effect of protein depletion 
on in vivo mitochondrial protein synthesis. In the presence of mtRRF siRNA, there was 
partial inhibition of mitochondrial protein translation (Fig 4C). Although the effect was not as 
dramatic as in S. cerevisiae Δrrf1 [265] it must be recognised that even partial translation 
defects result in instability and loss of mtDNA, which in turn produce a greater impairment 
of mitochondrial protein synthesis. The relative synthesis of most of the components was 
significantly altered (Fig 4C, data not shown). Consequently, the steady state levels of mtDNA 
encoded proteins were progressively affected as detected by western blot (Fig 4D). Although 
we did not observe significant reduction of the protein levels after short siRNA treatment (2-3 
days), longer treatment resulted in decreased steady state levels of mitochondrially encoded 
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Figure 5. Reduction of mtRRF results in redistribution of ribosomal proteins, increased ROS and 
mitochondrial dysmorphism. (A). HeLa lysates were prepared from cells treated with mtRRF or non-
targeted (NT) siRNA (3 days). After separation through 10–30% sucrose gradients, fractions were 
analysed by western blot using antibodies against the small (DAP3) and large (MRPL3) mitochondrial 
ribosomal subunits, mtRRF, porin as a mitochondrial membrane marker and glutamate dehydrogenase 
(GDH, matrix). (B) Superoxide levels are increased after mtRRF depletion. HeLa cells were exposed to 
mtRRF (white) or non-targeted (NT, black) siRNA over 6 days and superoxide and peroxide levels were 
measured with mitoSOX (superoxide) or DHR (peroxide) and compared to untreated controls. The fold 
increase is shown as a mean ± SEM from minimally three repeat experiments. Mitochondrial mass per 
cell was also measured using the cardiolipin selective dye NAO. (C) HeLa cells depleted of mtRRF show 
altered morphology. EM micrographs show HeLa cells treated with mtRRF (3 and 6 days) or non-targeted 
(NT, 3 days) siRNA. The images reflect mitochondria from two preparations.
 
Discussion
Our studies presented here provide the first evidence that this candidate functions as the 
human mitochondrial ribosome recycling factor: (i) mtRRF is a mitochondrial protein, (ii) 
mtRRF is able to bind bacterial ribosomes in vitro and can tightly associate with human 
mitoribosomes in vivo, (iii) expression of human mtRRF suppresses the partial Drrf1 
respiratory deficiency in fission yeast in vivo, and (iv) upon depletion of mtRRF, the relative 
level of mitochondrial monosomes increases whereas the free ribosomal subunits are 
reduced, indicating a defect in ribosome disassembly as has previously been reported on 
depletion of the bacterial counterpart [246].
Our results show that although mtRRF can associate tightly with mitoribosomes, the 
amount of interaction is enormously increased by pre-incubation. There are many possible 
hypotheses to explain this observation, but it is interesting to note that high resolution studies 
have shown that RRF binds bacterial ribosomes that have adopted a ratchet conformation 
at a site spanning both P and A site [249]. Therefore, it may be speculated that tRNA bound 
depletion and β-actin as a loading. The blot accurately reflects three experiments. (B) Depletion of 
mtRRF causes a severe growth defect. Multiple aliquots of HeLa cells (left and centre panels) were 
exposed to targeted (mtRRF, open triangles) or non-targeted (NT, black squares) siRNA for 6 days in 
glucose (left) or galactose (centre) media, cells counted and presented in a semi-log plot. Counts were 
made of HEK293T transfectants (right panel) treated with non-targeted siRNA (NT, black squares) or 
siRNA directed against the endogenous mtRRF 3’-UTR with (open circles) or without (open triangles) 
concomitant inducible expression of FLAG-mtRRF. Numbers are a mean ± SEM of four independent 
wells. (C) In vivo mitochondrial proteins synthesis is partially affected by mtRRF depletion. HeLa cells 
were grown in the presence of control (NT) or targeted (mtRRF) siRNA. Cytosolic protein synthesis was 
inhibited with emetine prior to labelling mitochondrial proteins with 35S-methionine (15 min). Equal 
amounts of lysate (20 µg) were separated by 15% SDS–PAGE and gels analysed by PhosphorImager. 
Polypeptides designation is as described in ref. (23). (D) Steady-state levels of mtDNA-encoded proteins 
are affected by depletion of mtRRF. Western blots show analysis of cell lysates after 3 or 6 days siRNA 
treatment (mtRRF or NT) with antibodies against mitochondrial translation products or proteins sensitive 
to mitochondrial translation inhibition (cytochrome c oxidase subunits I and II—COX I and 2; complex I 
subunit NDUFB8) or nuclear-encoded complex II SDH 70 kDa protein and β-actin as a loading control. 
The blot accurately reflects three repeat experiments. (E) OXPHOS complexes are reduced at steady-
state levels after mtRRF depletion. HeLa cells were exposed (6 days) to mtRRF- or NT-targeted siRNA 
prior to BN–PAGE. Complexes were visualized with antisera to complex I, anti-39 kDa; complex II, 
anti-SDH 70 kDa; complex III, anti-core 2, complex IV, anti-COII. The blot accurately reflects three 
experiments. SDH is a complex only comprising proteins encoded in the cytosol. (F) Respiratory coupling 
is modestly affected in cells depleted of human mtRRF. HeLa cells were exposed (3 days) to mtRRF-or 
NT-targeted siRNA prior to high resolution respirometry (as in Methods), three measures of respiratory 
control and capacity were made.
Depletion of mtRRF causes increased mitochondrial ROS and changes in 
mitochondrial morphology 
The observed aggregation of mitoribosomes may have a direct influence on mitochondrial 
function and may be a primary cause of cell death. Stress conditions in mitochondria are 
frequently associated with elevated levels of reactive oxygen species (ROS). To assess stress 
due to ROS accumulation in siRNA treated cells, superoxide and peroxide/peroxynitrite levels 
were measured by mitoSOX and dihydrorhodamine 123 (DHR) respectively. A statistically 
significant increase of ROS levels over the NT control was seen at day 3, a difference that 
was maintained through to day 6 (Fig 5B).
Increased ROS is often paralleled by augmented mitochondrial biogenesis and mtRRF 
depletion also resulted in a significant increase of mitochondrial mass as measured by NAO 
fluorescence, a dye that binds selectively to cardiolipin in the mitochondrial inner membrane 
(Fig 5B).
These abnormalities were reflected in the progressive morphological changes of mitochondria 
revealed by EM (Fig 5C 3 and 6 days mtRRF siRNA) where the longer treatment resulted 
in a dramatic increase in mitochondrial density. Many more tightly packed membranous 
sheets were observed, which was consistent with increased mitochondrial biogenesis, 
whereas the numerous ‘black spots’ detected in the matrix compartment are consistent with 
mitoribosome aggregates. 
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previously measured in the gram positive bacteria B. subtilis, with this association being 
dependent on active transcription [271]. Coupling of transcription and translation in human 
mitochondria has been frequently suggested (see [272, 273]), but there has been only one 
report showing interaction of mtRNA polymerase with a mitoribosomal protein, MRPL12, 
an interaction that was shown in vitro to stimulate transcription [274]. In a recent report on 
proteins associated with nucleoids, 15 mitoribosomal proteins were identified, along with 
assorted factors that also function in protein synthesis [259]. This observation is consistent 
with our data, but the authors were concerned that MRPs may have been present due 
to adventitious co-purification. Such a criticism could also be levelled at our observation, 
particularly as we were unable to completely remove cytosolic contamination, even in the 
mitoplasting experiments. Without further experimentation, this remains only tentative 
evidence of a direct physical link between mitoribosome and nucleoid. However, these 
proteomic studies also revealed several other candidate proteins that may be associated 
with the translational machinery and/or nucleoids. These findings open exciting avenues for 
further investigations.
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to these sites may prevent interaction with mtRRF allowing occupancy only when these sites 
become vacant.
Why does expression of human mtRRF restore the respiratory function of an rrf1 mutant 
only in S. pombe and not in S. cerevisiae? Human mtRRF shows a stronger identity to S. 
pombe than the S. cerevisiae orthologue (EBI tools 21.1% vs 16.8%; Fig S4). There is an 
overall greater similarity between fission yeast and human mt-RNAs [266] and these two 
species share a highly conserved set of general translation factors [252]. In bacterial systems, 
functional studies with heterologous RRF and EF-G proteins showed poor activity on the 
post-termination ribosomal complex compared to assays using RRF and EF-G from the 
same species, underlining the importance of interplay between RRF and EF-G (for example 
[267, 268]. In light of these findings, it is also possible that human mtRRF was unable to 
rescue the growth phenotype of S. cerevisiae ∆rrf1 due to a weak interaction with the 
budding yeast 70S mitoribosome or mtEF-G that also has only limited similarity with the 
human mtEF-G.
Depletion experiments revealed that mtRRF is essential for cell viability, with depletion 
causing gross mitochondrial dysmorphology and dysfunction. One of the primary effects 
of mtRRF depletion, which seemed to precede measurable translation abnormalities, was 
elevated ROS production (evident by day two post transfection). The mechanisms that 
lead to mitochondrial ROS overproduction, although often associated with mitochondrial 
dysfunction are not always clear. Our recent work on depletion of the mitochondrial release 
factor mtRF1a also resulted in a profound increase in mitochondrial ROS without any 
measurable effect on mitochondrial translation [240]. It is possible that increased ROS 
production could be a direct result of mitoribosome aggregation, but other subtle indirect 
effects cannot be ruled out. Our results are another example that even a small disruption 
of interplay between mitochondrial translation, respiration and ROS production may lead to 
profound cellular dysfunction.
In this study, lack of ribosome recycling led to a variety of deleterious downstream 
consequences. Shortage of available functionally active mitoribosomes eventually affected 
translation, and subsequently resulted in decreased steady-state levels of mitochondrially 
encoded proteins hence reduced amounts of fully assembled complexes (6 days post 
transfection). It was surprising, however, that a measurable decrease in mitochondrial protein 
synthesis took so long to manifest. It is possible that mitoribosomes are in excess in human 
organelles [269] with translation being initiated by mitoribosomes that had spontaneously 
disassembled. A similar process could explain the partial growth defect in yeasts lacking 
RRF. Another intriguing explanation could be that translation may be able to initiate from 
monosomes that have terminated translation, processed back along the mt-mRNA in a 3’ to 
5’ manner to reach the 5’ terminus and then scanned to locate the closest initiation codon, 
all without the monosome being dissociated. Although controversial, it must be considered 
that there is currently no model to explain how the mitoribosome naturally locates to the 
mt-mRNA initiation codon in the absence of a 5’ cap or Shine-Dalgarno sequence.
Finally, proteomic analysis of the factors that were eluted from immunoprecipitated mtRRF-
FLAG, revealed 73 MRPs, several translation-associated factors and putative nucleoid 
proteins on the production and protease/DNase treatment of mitoplasts (Table 1). Nucleoids 
are dynamic structures containing mtDNA and proteins involved in maintenance, replication 
and transcription of the mitochondrial genome (reviewed in [270]). These structures are well 
described in bacteria and close association between nucleoids and ribosomes has been 
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Abstract
Methanothermobacter thermautotrophicus is a thermophilic archaeon that 
produces methane as the end product of its primary metabolism. The biochemistry 
of methane formation has been extensively studied and is catalyzed by individual 
enzymes and proteins that are organized in protein complexes. Although much 
is known of the protein complexes involved in methanogenesis, only limited 
information is available on the associations of proteins involved in other cell 
processes of M. thermautotrophicus. To visualize and identify interacting and 
individual proteins of M. thermautotrophicus on a proteome-wide scale, protein 
preparations were separated using blue native electrophoresis followed by SDS-
PAGE. A total of 361 proteins, corresponding to almost 20% of the predicted 
proteome, was identifi ed using peptide mass fi ngerprinting after MALDI-TOF 
MS. All previously characterized complexes involved in energy generation could 
be visualized. Furthermore the expression and association of the heterodisulfi de 
reductase and methylviologen-reducing hydrogenase complexes depended on 
culture conditions. Also homomeric supercomplexes of the ATP synthase stalk 
subcomplex and the N5-methyl-5,6,7,8-tetrahydromethanopterin:coenzyme M 
methyltransferase complex were separated. Chemical cross-linking experiments 
confi rmed that the multimerization of both complexes was not experimentally 
induced. A considerable number of previously uncharacterized protein complexes 
were reproducibly visualized. These included an exosome-like complex consisting 
of four exosome core subunits, which associated with a tRNA-intron endonuclease, 
thereby expanding the constituency of archaeal exosomes. The results presented 
show the presence of novel complexes and demonstrate the added value of 
including blue native gel electrophoresis followed by SDS-PAGE in discovering 
protein complexes that are involved in catabolic, anabolic, and general cell 
processes.
 
Methanothermobacter thermautotrophicus is a thermophilic archaeon that generates 
energy from the reduction of carbon dioxide to methane. In contrast to mostly mesophilic 
methanogens, M. thermautotrophicus can use hydrogen and carbon dioxide only as 
substrates and is therefore regarded as a metabolic specialist. It has a relatively simple 
primary metabolism comprising eight consecutive steps [275]. Methane production, or 
methanogenesis, starts with the reduction of carbon dioxide to a formyl moiety that is bound 
to the C1 carrier methanofuran. The endergonic reaction is catalyzed by a membrane-bound 
formylmethanofuran dehydrogenase complex and is driven by a gradient of sodium [276]. 
Next the formyl moiety is transferred to a second C1 carrier and reduced by individual, 
cytosolic enzymes to a methyl moiety. Hereafter the methyl group is transferred to coenzyme 
M by the membrane-bound N5-methyl-5,6,7,8-tetrahydromethanopterin:coenzyme M 
methyltransferase complex that simultaneously generates a sodium gradient [277]. Finally 
the methyl group is then reduced to methane by the cytosolic methyl coenzyme M reductase 
complex [278]. Next to methane, the mixed disulfi de of coenzyme M and coenzyme B is 
formed. The heterodisulfi de is reduced by the heterodisulfi de reductase complex that is 
supplied with reducing equivalents by the methylviologen-reducing hydrogenase [279]. 
The proton motive force that is generated in this step is fi nally used by a membrane-bound 
ATP synthase complex for the production of ATP [280]. Next to the generation of ATP, 
methanogenesis also provides carbon for cell growth through the activity of the acetyl-CoA 
decarbonylase/synthase complex [281]. In natural ecosystems the amount of hydrogen 
is the limiting substrate for growth and can vary 4 orders of magnitude in availability. As 
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Experimental Procedures
Cultivation and Preparation of Cell-free Extract of M. thermautotrophicus
M. thermautotrophicus (DSM1053) was cultured in a 12-liter fed-batch fermentor containing 
10 liters of medium. Cells were cultured under two different conditions, one favoring the 
expression of MCR I and the other favoring MCR II expression (8). “MCR I” cells were cultured 
in N medium [288] at 65 °C with a gas flow of 2.0 liters/min of 80% H2, 20% CO2 (v/v) and 
harvested at an optical density at 600 nm of 5. “MCR II” cells were cultured in MII medium 
[288] at 55 °C with a gas flow of 5.0 liters/min of 80% H2, 20% CO2 (v/v) and harvested at 
an optical density at 600 nm of 1.8. After centrifugation, cell-free extracts were prepared by 
suspending the pellet in 1 volume of 50 mM TES, pH 7.0, 1 mM DTT, including both DNase 
and RNase at a final concentration of 10 μg/ml. Cell suspensions were passed through a 
French pressure cell operated at 138 megapascals. After centrifugation for 15 min at 10,000 
× g at 4 °C, the cytosolic fraction was obtained as the clarified supernatant, and the resulting 
pellet is referred to as the membrane fraction. Both fractions were stored at −20 °C.
Sample Preparation
Before protein solubilization, the membrane fraction was washed three times with a solution 
containing 400 mM sorbitol, 25 mM NaCl, and 7.5 mM imidazole, pH 7.0, to reduce 
contaminating cytosolic proteins. Cytosolic and membrane protein preparations were diluted 
with 2–3 volumes of solubilization buffer (50 mM NaCl, 5 mM 6-aminocaproic acid, 1 mM 
EDTA, and 50 mM imidazole, pH 7.0) containing either 2% (v/v) laurylmaltoside, 1% (v/v) 
digitonin, or 1% (v/v) Triton X-100. After a 15-min incubation on ice with occasional vortexing 
samples were centrifuged for 30 min at 12,000 × g at 4 °C. Supernatants were transferred to 
clean tubes, and protein concentrations were determined with the 2D-Quant kit (Amersham 
Biosciences). Finally 4 μl of 750 mM 6-aminohexanoic acid with 5% (w/v) Serva Blue G was 
added per 100 μl of supernatant.
Chemical Cross-linking
To investigate the association of membrane-bound complexes, the proteins present in 
the membrane fraction were treated with the 8-Å linker dimethyl 3,3′-dithiopropionimidate 
dihydrochloride (Sigma) and the “zero-length” carbodiimide cross-linker 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDAC, Molecular Probes) in the presence of 
N-hydroxysulfosuccinimide (NHSS, Molecular Probes) [289]. For this, an aliquot of 200 μl 
of the membrane fraction of MCR I cells was diluted with 600 μl of a solution containing 
75 mM imidazole, pH 7, 400 mM sorbitol, 25 mM NaCl, and 0.03% laurylmaltoside. The 
chemical cross-linking reaction was started by adding 40 μl of freshly prepared 10 mg/ml 
dimethyl 3,3′-dithiopropionimidate dihydrochloride or 12 μl each of an 80 mM EDAC and 80 
mM NHSS solution and proceeded for 1 h on ice with occasional mixing. The reaction was 
stopped by the addition of ammonium acetate to a final concentration of 0.1 M. As a control, 
immediately after addition of the cross-linkers, a 200-μl aliquot of the reaction mixture was 
quenched by adding 50 μl of 0.5 M ammonium acetate. Protein complexes were isolated 
immediately with either laurylmaltoside or digitonin as described above.
 
BN-PAGE and Gel Staining
Blue native/SDS-PAGE two-dimensional gel electrophoresis was performed as described 
elsewhere [256, 290, 291] and performed on a Protean II xi system (Bio-Rad). For the blue 
native first dimension, protein preparations were separated on gels containing the following 
bis-/acrylamide gradients: 4–13, 5–15, 6–18, 8–20, and 10–22%. The ferritin monomer 
an adaptation, M. thermautotrophicus expresses isoenzymes with a high or low affinity 
for hydrogen, e.g. methyl coenzyme M reductases I and II are expressed under culturing 
conditions with low and high hydrogen gassing regimes (“MCR1 I and MCR II culture 
conditions”), respectively [282].
In a closely related species, Methanothermobacter marburgensis, it was shown that 
complexes of the primary metabolism that are coupled functionally can also interact 
physically. The purification of heterodisulfide reductase activity resulted in the purification 
of the heterodisulfide reductase protein complex that also contained the methylviologen-
reducing hydrogenase complex [279]. In M. thermautotrophicus, similarly it was speculated 
that the association into high molecular weight complexes in concentrated solutions of 
purified methyl coenzyme M reductase and F420-dependent hydrogenase proteins could 
also play a role in vivo [283]. Electron microscopy studies of enzymes and complexes 
involved in methanogenesis of Methanococcus voltae and Methanosarcina mazei Gö1 
showed the associations of methanogenesis enzymes into supercomplexes, named 
methanoreductosomes [284]. These results corroborate the generally accepted idea that 
the protein content of a cell is not merely a pool of individual and inert proteins but that the 
proteome of a living cell is an intricate network of proteins that interact and communicate. 
So far, research on M. thermautotrophicus has focused mainly on the enzymes and enzyme 
complexes that are involved in methanogenesis, and therefore only limited data are available 
on interacting proteins involved in other cellular processes.
To explore interacting (and non-interacting) proteins of an organism on a proteome-wide 
scale, only a limited number of techniques are available. One established method is the use 
of blue native electrophoresis followed by SDS-PAGE (or BN-PAGE) [285]. In this method, 
proteins and protein complexes are solubilized by a mild detergent, charged with Coomassie 
dye, and separated natively in a first dimension depending on charge, size, and shape. In a 
second dimension, proteins and protein complexes are reduced and denatured with SDS 
and subunits, and individual proteins are separated by molecular weight. So far BN-PAGE 
has been applied mainly to membrane-associated complexes of organelles [256, 286] 
sometimes after dialysis of protein preparations [285] and often in combination with the use 
of antibodies.
In this study we present the results of a proteome-wide examination of interacting and 
individual proteins of M. thermautotrophicus using blue native/SDS-PAGE combined with 
mass spectrometry. This resulted in the identification of 361 proteins, corresponding to 
almost 20% of the predicted proteome, and visualization of a significant number of proteins 
that are part of enzyme complexes. These allowed, among others, the identification of an 
exosome-like complex of M. thermautotrophicus. Next to the homologs of four exosome 
core subunits identified previously [287], the M. thermautotrophicus exosome additionally 
contains a tRNA-intron endonuclease.
In summary, the results presented here give, for the first time, an overview of interacting and 
individual proteins of the archaeon M. thermautotrophicus on a proteome-wide scale using 
BN-PAGE. The genome coverage and the protein complexes identified by this technique 
clearly indicate the added value of including BN-PAGE in proteomic research and allow 
the study of protein complexes involved in primary metabolism, anabolism, and general 
cell processes.
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45 and contained mostly matching peptides that did not contain a miscleavage. Similar 
criteria applied for the identification of multiple proteins in a single spot. Here proteins 
were regarded as identified when peptides unique to that protein matched the above 
mentioned criteria.
LC-MS/MS Measurements and Protein Identification Procedure
All nanoflow LC-MS/MS experiments were performed on a 7-tesla Finnigan LTQ-FT mass 
spectrometer (Thermo Electron) equipped with a nanoelectrospray ion source (Proxeon 
Biosystems, Odense, Denmark). The LC part of the analytical system consisted of an Agilent 
Series 1100 nanoflow LC system (Waldbronn, Germany) comprising a solvent degasser, 
a nanoflow pump, and a thermostated microautosampler. Chromatographic separation of 
the peptides was performed in a 15-cm fused silica emitter (100-μm inner diameter; New 
Objective) packed in-house with methanol slurry of reverse-phase ReproSil-Pur C18-AQ 
3-μm resin (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) at a constant pressure (20 
bars) of helium. Then 5 μl of the tryptic peptide mixtures were autosampled onto the packed 
emitter with a flow of 600 nl/min for 20 min and then eluted with a 5-min gradient from 3 
to 10% followed by a 25-min gradient from 10 to 30% acetonitrile in 0.5% acetic acid at a 
constant flow of 300 nl/min. The mass spectrometer was operated in the data-dependent 
mode to automatically switch between MS and MS/MS acquisition. Survey MS spectra 
(from m/z 350 to 2,000) were acquired in the FT ICR with R = 50,000 at m/z 400 (after 
accumulation to a target value of 1,000,000). The three most intense ions were sequentially 
isolated for fragmentation in the linear ion trap using collisionally induced dissociation with 
normalized collision energy of 29% and a target value of 1,000. Former target ions selected 
for MS/MS were dynamically excluded for 30 s. Total cycle time was ~3 s.
Proteins were identified via automated database searching (Matrix Science, London, 
UK) of all tandem mass spectra against both NCBInr and an in-house curated M. 
thermautotrophicus database. Carbamidomethylcysteine was set as fixed modification, and 
oxidized methionine and protein N-acetylation were searched as variable modifications. Initial 
mass tolerances for protein identification on MS and MS/MS peaks were 10 ppm and 0.5 
Da, respectively. The instrument setting for the MASCOT search was specified as “ESI-Trap.”
Protein Annotation and Similarities and Genomic Organization of Encoding Genes
The proteins identified were annotated on basis of the presence of domain signatures of the 
Pfam database [295]. Sequence similarities were determined using Blast 2 sequences [296] 
at default settings. The organization of genes into operons was determined from the gene 
organization at the PEDANT website [297]. Genes were considered to be part of an operon 
when the intergenic distance was smaller than 55 bp.
(440 kDa) and ferritin dimer (880 kDa) were included as markers. Samples were separated 
overnight at 15 °C at 100 V and typically finished after 16 h.
The second dimension was performed as described elsewhere [292] with some 
modifications. Individual lanes of the first dimension gel were excised with a razor blade 
and incubated in 1% (w/v) SDS and 1% (v/v) 2-mercaptoethanol for 1–2 h at room 
temperature. Next the first dimension lane, which was rinsed with milli-Q to remove excess 
2-mercaptoethanol, was placed on top of a separation gel consisting of a 10% Tris-Tricine-
SDS gel, which was cross-linked with piperazine diacrylamide. The flanking regions of the 
first dimension lane were filled with 10% native polyacrylamide gel. Using a notched inner 
glass plate, the Protean II xi system was converted into a four-gel system and started 
at a constant current of 5 mA per gel, which was raised to 10 mA after 45 min. Second 
dimension gels were run overnight at 15 °C and typically finished after 20 h. After the second 
dimension, gels were stained with colloidal Coomassie as described elsewhere [293] and 
scanned using an Amersham Biosciences Image Scanner.
Trypsin Treatment
After spot picking, protein present in gel plugs was first reduced by incubating for 10 min 
in 50 μl 10 mM DTT at 60 °C followed by an alkylating incubation of 45 min in 50 μl of 50 
mM iodoacetamide at room temperature in the dark. Hereafter in-gel trypsin digestion 
was performed as described elsewhere [294] except that overnight trypsin treatment 
was performed in 5 μl of 50 mM ammonium bicarbonate containing 5 mM n-octyl 
glucopyranoside per plug. Next protein fragments were extracted by adding 1 μl of 0.5% 
(v/v) trifluoroacetic acid, 5 mM n-octyl glucopyranoside and incubating for 2 h at room 
temperature and a final 1-min sonication step. After extraction, peptides were stored at 
−20 °C until further analysis.
MALDI-TOF MS Measurements and MASCOT Search Parameters
For MS analysis, 0.25 μl of extracted peptides was pipetted on a MALDI-TOF sample 
plate and directly mixed with an equal volume of sample buffer containing 20 mg/ml 
α-cyano-4-hydroxycinnamic acid in 0.05% (v/v) TFA, 50% (v/v) acetonitrile. MALDI-TOF MS 
measurements were performed in the mass range of 650–2,600 Da on a Bruker Biflex III 
mass spectrometer, set to reflectron mode, after calibration using a mixture of bradykinin 
fragment 1–7, angiotensin, synthetic peptide P14R, and adrenocorticotropic hormone 
fragment 18–39. Mass spectra were determined as the sum of 180 measurements. 
Monoisotopic peaks were manually selected, excluding background peaks. Peptide masses 
were exported to Biotools software and used to perform a MASCOT search in an in-house 
database of the M. thermautotrophicus predicted proteome. Search parameters allowed a 
mass deviation of ±0.3 Da, matching peptides containing one miscleavage, fixed modification 
of carbamidomethylated cysteines, and a variable modification of oxidized methionines.
Protein Identification Criteria
Proteins were regarded as identified proteins when the MASCOT search resulted in a Mowse 
score higher than 45 (corresponding to an expect score <10−4.5), which was calculated 
from the database size by the MASCOT software. A filter was included to recognize false-
positives. A 2D gel electrophoresis study currently in progress has shown that proteins that 
are identified with matching peptides that mostly contain one miscleavage do not show a 
correlation between the predicted and experimental location on a 2D gel. Therefore, proteins 
were only regarded as significantly identified when they showed a Mowse score higher than 
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Identification of Homomeric Protein Complexes
A considerable amount of protein migrated as protein complexes. To identify true protein 
complexes, different first dimension gradients were applied to track complexes and to 
exclude any accidental co-migration of proteins. This was, however, limited to complexes that 
were resolved by gradients starting at 4% bis-/acrylamide or higher and not for complexes 
migrating at an extremely high apparent molecular mass (>1.5 MDa). A number of homomeric 
complexes were identified that were isolated previously from M. thermautotrophicus. 
Coenzyme F420-dependent N5,N10-methylene tetrahydromethanopterin dehydrogenase 
migrated as a 200-kDa complex, corresponding with the molecular mass of 216 kDa of the 
hexameric complex as determined earlier [299]. The most prominent protein present in cell-
free extracts of M. thermautotrophicus, MTH1350,3 a F420-dependent oxygen detoxification 
flavoprotein, was purified previously as a 170-kDa homotetrameric complex [300]. Here the 
protein complex could be clearly visualized migrating at an apparent molecular mass of 150 
kDa. Next to the previously characterized complexes, a number of uncharacterized, putative 
homomeric complexes were recognized. These included an 800-kDa complex of the 15-
kDa riboflavin synthase MTH1390 indicating an organization of this enzyme into a 50-mer, 
which is consistent with earlier reports [301, 302]. A 700-kDa complex of the 73-kDa protein 
MTH632 containing a putative sugar kinase domain was identified, suggesting a decameric 
organization. A 300-kDa complex was identified for the 28-kDa MTH579 fructose-1,6-
bisphosphate aldolase, suggesting an 8–12 multimeric organization of this protein [303]. 
Similarly porphobilinogen synthase, MTH744, migrated as a complex of 300 kDa. This value 
corresponds with a homooctamer, and this quaternary organization is known to be intrinsic 
to the allosteric regulatory mechanism of these enzymes [304]. A putative dimer and trimer 
migrating at 100 kDa were found, respectively, for MTH1476 encoding a homolog of the β 
subunit of the tryptophan synthase and MTH1512 encoding a homolog of the H2-dependent 
N5,N10-methylenetetrahydromethanopterin dehydrogenase (Table I).
Results
The proteome of M. thermautotrophicus was analyzed using BN-PAGE to investigate the 
presence of enzyme complexes and individual enzymes. Biomass was collected after 
culturing under MCR I or MCR II conditions (see “Experimental Procedures”). For both 
culture conditions, lysed cells were separated into a cytosolic and a membrane fraction 
by centrifugation to reduce the complexity of the sample. The protein preparations were 
subjected to blue native gel electrophoresis directly without any additional cleaning 
procedures.
Different first dimension gradients were applied to achieve maximum resolution of individual 
and complexed proteins. Typically individual proteins were optimally resolved with a first 
dimension gradient running from 10 to 20% bis-/acrylamide, whereas protein complexes 
showed maximum resolution with gradients starting at 4% bis-/acrylamide. Next to an 
optimization of the electrophoresis procedure and protein load, the identification of proteins 
also was optimized. The use of colloidal Coomassie staining in comparison to silver staining 
or traditional Coomassie staining enabled a high sensitivity while remaining completely 
compatible with mass spectrometry. Another improvement was the alkylation of cysteine 
residues after spot picking, which greatly reduced the number of background peaks after 
MALDI-TOF MS measurements and allowed the identification of multiple proteins in a single 
spot. An initial analysis of protein spots from duplicate gels and duplicate biological samples 
confirmed the reproducibility of BN-PAGE.
Identification of Proteins after BN-PAGE
The complete data set comprised the analysis of 1,550 protein spots by peptide mass 
fingerprinting. The data set included the optimization procedures, the appropriate reference 
protein spots from duplicate gels, and the identification of putative complex components 
originating from multiple blue native gels with different bis-/acrylamide gradients. The 
analysis showed that only a minor portion of the proteins identified appeared at multiple 
positions on gels and that no detectable protein degradation had taken place. The analysis 
of ~875 protein spots of the proteins extracted from the membrane fraction allowed the 
identification of 300 different proteins, whereas the analysis of 675 protein spots from the 
cytosolic fraction identified 223 proteins. A total of 361 different proteins (for a reference 
map see Supplemental Fig. 1) were identified with an average Mowse score of 122 (which 
corresponds to an expect value less than 10−12) and an average protein sequence coverage 
of 37% (see Supplemental Table 1). Five percent of the predicted membrane proteins (34 
of 407 proteins containing one or more predicted transmembrane-spanning regions) were 
retrieved. This was also reflected in the coverages of the different protein function categories 
that were recognized after initial analyses of the M. thermautotrophicus genome [298]. 
A relatively low coverage of proteins involved in transport or in membrane and cell wall 
synthesis was apparent. In contrast to the results for hydrophobic proteins, 22% of the total 
number of cytoplasmic proteins was recovered. These 327 proteins distributed more or less 
equally along the different protein function categories, and all of the previously characterized 
methanogenesis enzymes were identified. However, only a small number of hypothetical and 
conserved hypothetical proteins were recovered (34 proteins identified of 538 predicted). 
A higher coverage was obtained for enzymes involved in primary metabolism, amino acid 
metabolism, and other anabolic processes and included a relatively high coverage of 
ribosomal proteins (31 proteins identified of 63 predicted) and aminoacyl-tRNA synthetases 
(22 proteins identified of 26 predicted).
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Table I. Homomeric complexes from M. thermautotrophicus. Complexes are listed by MTH number. 
The complexes identified are given with the calculated molecular mass of the subunit, the Mowse score, 
sequence coverage (%), the observed and reported molecular masses of the complexes, and the derived 
number of subunits. Molecular masses are given in kDa.
Homomeric complexes from M. thermautotrophicus
Complexes are listed by MTH number. The complexes identified are given with the calculated 
molecular mass of the subunit, the Mowse score, sequence coverage (%), the observed and 
reported molecular masses of the complexes, and the derived number of subunits. Molecular 
masses are given in kDa.
Although the quaternary structures determined by BN-PAGE correspond well to values 
reported for homologs purified from other hosts, it should be noted that BN-PAGE cannot 
discriminate between monomeric enzymes and homomeric complexes. Proteins that migrate 
poorly in the first dimension (because of an extreme amino acid composition or protein shape) 
and enzyme complexes that are composed of a single subunit species can, theoretically, 
migrate equal distances in blue native gels. This can be excluded for complexes consisting of 
different subunits. Next to the homomeric complexes mentioned, a considerable number of 
heteromeric complexes were identified that can be divided roughly into complexes involved in 
energy generation and those involved in anabolic and general cell processes.
Heteromeric Complexes Involved in Energy Generation
To evaluate BN-PAGE as a mild technique that can be used to identify protein associations, 
specific attention was given to the analysis of protein complexes involved in methanogenesis. 
Because of the extensive biochemical research that has been performed on methanogenesis, 
these complexes were regarded as internal standards. The use of BN-PAGE followed by mass 
spectrometry visualized and identified all enzyme complexes involved in methanogenesis (Table II).
MTH
579
632
744
1350
1390
1464
1476
1512
Annotation
Fructose-1,6-bisphosphate aldolase
Putative phosphofructo- 
(sugar) kinase
Porphobilinogen synthase
Flavoprotein AI
Riboflavin synthase β subunit
F420-dependent N5,N10-methylene 
tetrahydromethanopterin 
dehydrogenase
Tryptophan synthase, β subunit 
homolog
H2-dependent N5,N10-
methylenetetrahydromethanopterin 
dehydrogenase homolog
Calculated 
molecular 
mass of 
subunit
28
72.7
35.8
46
15.5
29.6
47.5
37.3
Mowse 
score
123
260
140
210
91
121
215
82
Sequence 
coverage
46
46
48
44
56
40
57
27
Observed 
molecular 
mass
300
700
300
150
800
200
100
100
Reported 
molecular 
mass (Ref.)
 
 
 
170 (27)
 
200 (26)
 
 
No. of 
subunits
10
10
8
4
50
6
2
3
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MTH
 
1164
1165
1168
 
1129
1130
1132
 
1557
1558
1559
 
1156
1157
1158
1159
1161
1162a
1163a
 
1381
1878
1879
 
1134
1135
1136
 
1297
1298a
1300
 
953
954
955
956
 
957
958
960
961a
Annotation
Methyl coenzyme M reductase I
α subunit
γ subunit
β subunit
Methyl coenzyme M reductase II
α subunit
γ subunit
β subunit
Tungsten-dependent formylmethanofuran 
dehydrogenase
Subunit A
Subunit C
Subunit B
Methyltransferase
Subunit H
Subunit G
Subunit F
Subunit A
Subunit C
Subunit D
Subunit E
Heterodisulfide reductase
Subunit A
Subunit C
Subunit B
Methylviologen-reducing hydrogenase
α subunit
γ subunit
δ subunit
F420-reducing hydrogenase
β subunit
γ subunit
α subunit
A1 subcomplex ATP synthase
Subunit D
Subunit B
Subunit A
Subunit F
A0 subcomplex ATP synthase
Subunit C (γ)
Subunit E (ε)
Subunit I
Subunit H
Acetyl-CoA decarbonylase/synthase
Mowse 
score
 
209
156
177
 
178
303
103
 
101
124
137
 
160
113
77
63
58
45
128
 
210
106
96
 
233
54
89
 
103
120
164
 
173
248
316
75
 
105
163
266
109
Sequence 
coverage
 
39
45
42
 
33
73
34
 
24
54
49
 
58
58
51
38
16
5
17
 
43
31
34
 
38
23
46
 
34
14
33
 
71
44
55
51
 
34
73
34
20
Molecular 
mass of 
subunit
 
60.5
29.1
48.1
 
60.7
30.6
47.5
 
62.9
28.6
48.9
 
33.4
9.5
7.4
25.66
27
22.8
31.2
 
73.5
36
33.5
 
52.9
33.8
15.9
 
30.8
25.8
45.2
 
24.5
51.9
64.9
11.8
 
42.4
22.7
74.5
11.8
Complex 
molecular 
mass
250
 
 
 
250
 
 
 
100
 
 
 
900
 
 
 
 
 
 
 
300/400
 
 
 
100/400
 
 
 
1,000
 
 
 
400
 
 
 
 
600
 
 
 
 
1,200
Reported 
molecular 
mass (Ref.)
275 (4)
 
 
 
275 (4)
 
 
 
130 (32)
 
 
 
670 (3)
 
 
 
 
 
 
 
250/500
-5
 
 
500
-5
 
 
800 (37)
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was found in the cytosolic fraction for the catalytic portion of the tungsten-dependent 
formylmethanofuran dehydrogenase complex. It migrated at an apparent molecular mass 
of ~100 kDa and contained the subunits A, B, and D [305-307]. The subunits of the N5-
methyl-5,6,7,8-tetrahydromethanopterin:coenzyme M methyltransferase (methyltransferase) 
were predominantly present in the membrane protein fraction and migrated as a complex 
composed of subunits A, C, D, E, F, G, and H with an apparent molecular mass of 900 kDa 
[277]. The heterodisulfide reductase complex was detected predominantly in the cytosolic 
fraction and appeared as two separate complexes of ~300 and 400 kDa, respectively. 
Both complexes contained the three subunits A, B, and C. The heterodisulfide reductase 
complex migrating at the highest apparent molecular mass further showed the presence 
of methylviologen-reducing hydrogenase subunits α, γ, and δ, which were also detected in 
a separate complex migrating at ~100 kDa [308]. The heterodisulfide reductase complex 
migrating at the highest apparent molecular mass represented an association of the 
heterodisulfide reductase complex with the methylviologen-reducing hydrogenase complex. 
Interestingly the relative amount of individual heterodisulfide reductase complex and 
heterodisulfide reductase complex associated with the methylviologen-reducing hydrogenase 
differed in cytoplasmic protein preparations obtained from cells grown under MCR I and MCR 
II culture conditions. As estimated from the relative staining intensities, cells cultured at MCR I 
conditions contained at least 3-fold more of the individual heterodisulfide reductase complex 
and the same complex associated with the methylviologen-reducing hydrogenase than cells 
cultured under MCR II conditions (Fig. 1).
Figure 1. The expression and association of the heterodisulfide reductase complex with 
methylviologen hydrogenase is regulated by culture conditions. Protein samples were prepared 
as described under “Experimental Procedures,” and 500 μg of cytosolic protein from cells cultured under 
MCR I and MCR II conditions were analyzed on 5–15% blue native gels in the first dimension (depicted 
horizontally) and 10% Tris-Tricine-SDS gels in the second dimension (depicted vertically). The gels were 
stained with colloidal Coomassie. The expected positions of heterodisulfide reductase subunits in the 
MCR II protein preparation are indicated with arrows. The apparent molecular masses of the individual 
and associated heterodisulfide reductase complexes are given in kDa. The subunits of the methylviologen 
hydrogenase are not shown.
The expression and association of the heterodisulfide reductase complex with methylviologen 
hydrogenase is regulated by culture conditions. Protein samples were prepared as described 
under “Experimental Procedures,” and 500 μg of cytosolic protein from cells cultured under 
MCR I and MCR II conditions were analyzed on 5–15% blue native gels in the first dimension 
(depicted horizontally) and 10% Tris-Tricine-SDS gels in the second dimension (depicted 
vertically). The gels were stained with colloidal Coomassie. The expected positions of 
heterodisulfide reductase subunits in the MCR II protein preparation are indicated with arrows. 
The apparent molecular masses of the individual and associated heterodisulfide reductase 
complexes are given in kDa. The subunits of the methylviologen hydrogenase are not shown.
Table II. Overview of heteromeric complexes in M. thermautotrophicus. Complexes are listed in the order 
of appearance in the text. The complexes are given with the Mowse score and sequence coverage (%) of 
the subunits identified, the calculated molecular masses of the subunits, and the observed and reported 
molecular masses of the complexes in kDa.
Overview of heteromeric complexes in M. thermautotrophicus
Complexes are listed in the order of appearance in the text. The complexes are given with 
the Mowse score and sequence coverage (%) of the subunits identified, the calculated 
molecular masses of the subunits, and the observed and reported molecular masses of the 
complexes in kDa.
One of the most dominant complexes present in both cytosolic as well as membrane 
fractions were the MCR complexes I and II, migrating at an apparent molecular mass of 
250 kDa [278]. Both MCR complexes contained the highly similar α, β, and γ subunits in 
apparently equal amounts as was judged from their relative staining intensities. In agreement 
with literature, protein preparations derived from cells grown under MCR I conditions 
predominantly contained the subunits from the MCR I complex, whereas protein from MCR 
II culturing conditions contained the MCR II subunits [282]. Also experimental evidence 
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1710
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793
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1150
 
686
1202
 
540
728
 
682
683
684
891
250
Annotation
α subunit
β subunit
γ subunit
Lipid biosynthesis precursor
3-Hydroxy-3-methylglutaryl-CoA synthase
Acetoacetyl-CoA thiolase
Phenylalanine-tRNA synthetase
α subunit
β subunit
Fe-S cluster assembly complex
Ycf16 (homolog SufC)
Ycf24 (homolog SufB)
Proteasome
α subunit
β subunit
Proteasome regulator
Rad50 ATPase
Proteasome-activating nucleotidase
Exosome
RNA exonuclease (Rrp42)
Ribonuclease PH (Rrp41)
Conserved protein (Rrp4)
DnaG homolog
tRNA-intron endonuclease
Mowse 
score
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144
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138
 
110
176
 
184
129
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205
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149
94
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14
30
33
 
27
44
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22
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58
 
29
32
 
22
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28
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35
Molecular 
mass of 
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86.1
51.7
50.2
 
37.1
40.5
 
58.5
69.4
 
27.7
45.3
 
27.5
22.8
 
97.6
46.1
 
29.9
26.5
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42.5
19.7
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800
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lines. The proteins present in the putative supercomplex are given with their respective MTH 
numbers.
To further investigate the presence of supercomplexes in the cytosolic and membrane 
fractions, proteins were solubilized using digitonin, which maintains weak protein-protein 
interactions that are normally disrupted by laurylmaltoside. The laurylmaltoside- and digitonin-
treated proteins were essentially identical, and no significant differences could be observed 
for cytosolic proteins. However, a pronounced difference in the apparent high molecular 
mass region could be observed when digitonin was used to solubilize membrane proteins. 
Although no complete ATP synthase complex was solubilized by digitonin, three forms of 
the A0 subcomplex of the ATP synthase at 600, 800, and 1,000 kDa were apparent that 
all contained the A0 ATP synthase subunit H (Fig. 2B). The E subunit, which overlapped 
with the subunit H of the methyltransferase complex, was also identified unambiguously 
in these gels using LC-MS/MS. The sodium-translocating methyltransferase complex 
appeared as a single complex of 900 kDa in laurylmaltoside-extracted preparations and 
migrated partly as a multimer of identical composition in digitonin-extracted preparations. To 
exclude multimerization of both complexes as an experimental artifact, the migration of both 
complexes was investigated after chemical cross-linking using a zero-length (Fig. 2C) and an 
8-Å linker chemical cross-linker (data not shown). These experiments showed that cross-
linked proteins extracted with laurylmaltoside contained monomers as well as multimers of 
the complexes mentioned, consistent with the complexes visualized after digitonin extraction. 
Therefore, the appearance of both ion-translocating complexes as multimers seems to 
be an intrinsic characteristic of both complexes and is not the result of an experimentally 
induced, aspecific interaction. Furthermore the chemical cross-linking experiments resulted 
in the appearance of a complex of 1.2 MDa containing both A0 ATP synthase subunits and 
methyltransferase subunits, which could reflect a supercomplex of these ion-translocating 
complexes, that is normally disrupted by solubilization with either laurylmaltoside or digitonin 
(Fig. 2C). However, it cannot be excluded that both multimeric forms co-migrate at this high 
apparent molecular weight.
Heteromeric Complexes Involved in Anabolic Processes
Next to enzyme complexes involved in catabolism, complexes that are involved in 
biosynthesis also were identified. A complex that migrated with an apparent molecular mass 
higher than 1.5 MDa, which could just be resolved with a bis-/acrylamide gradient starting at 
4% in the first dimension, was the core of the acetyl-CoA decarbonylase/synthase complex 
[281]. It contained the subunits α, β, and γ subunits (MTH1708, MTH1710, and MTH1713, 
respectively). The acetyl-CoA decarbonylase/synthase complex migrated with two proteins 
predicted to be involved in DNA repair and protein synthesis. Probably the observed 
associations of the proteins mentioned with the acetyl-CoA decarbonylase/synthase complex 
is due to the low resolving power at these extremely high apparent molecular weights.
Next to a complex involved in acetyl-CoA synthesis also a putative acetyl-CoA-converting 
complex was identified. The complex was composed of two proteins, MTH792 and MTH793, 
of which the encoding genes also constitute an operon. Both proteins appeared in a 1:1 ratio 
as was judged from their respective staining intensities. The MTH792 and MTH793 proteins 
are annotated as a 37-kDa 3-hydroxy-3-methylglutaryl-CoA synthase and a 40-kDa 
acetoacetyl-CoA thiolase, respectively, that consecutively would convert acetyl-CoA to 
3-hydroxy-3-methylglutaryl-CoA, a precursor for lipid biosynthesis. The apparent molecular 
In contrast to the methylviologen-reducing hydrogenase, the coenzyme F420-reducing 
hydrogenase complex was found exclusively as a separate, high molecular weight complex. 
It migrated with an apparent molecular mass of ~900 kDa, corresponding with the previously 
reported mass of 800 kDa [309], and consisted of three protein spots. The protein spots 
of 45, 30, and 25 kDa corresponded to subunits α, β, and γ, respectively. Despite a 
considerable amount of protein, the γ subunit could not be identified by peptide mass 
fingerprinting and was identified unambiguously by LC-MS/MS.
Next to the methanogenesis complexes (Table II), the archaeal ATP synthase was exclusively 
visualized in the membrane fraction by BN-PAGE. ATP synthase migrated as two separate 
subcomplexes containing either the membrane (A0) or catalytic part (A1) of the ATP synthase 
complex. Four protein bands corresponding to the A1 ATP synthase subunits A, B, D, and F 
migrated as one complex of 400 kDa. The membrane-embedded part or A0 segment of the 
ATP synthase migrated at a higher apparent molecular mass of 600 kDa and also contained 
four protein bands, which were identified as ATP synthase subunits C, E, H, and I. In contrast 
to the subunit topology determined for the Methanococcus jannaschii A0 and A1 ATP 
synthase subcomplexes, subunit C was only found in the A0 segment [280].
Supercomplexes
Interestingly A0 ATP synthase subunits I, C, and H were also identified migrating at 800 
kDa and 1 MDa as multimers of the proton-translocating segment of the ATP synthase 
subcomplex (Fig. 2A).
Figure 2. The A0 ATP synthase subcomplex and methyltransferase complex form multimers. 
The membrane fraction of MCR I cultured cells was solubilized with laurylmaltoside (A), digitonin (B), 
or laurylmaltoside after cross-linking with EDAC in the presence of NHSS (C) as described under 
“Experimental Procedures.” Five hundred micrograms of protein from each incubation were analyzed 
on 5–15% blue native gels in the first dimension (depicted horizontally) and 10% Tris-Tricine-SDS gels in 
the second dimension (depicted vertically). Gels were stained with colloidal Coomassie. Complexes are 
indicated with black, vertical lines. The proteins present in the putative supercomplex are given with their 
respective MTH numbers.
The A0 ATP synthase subcomplex and methyltransferase complex form multimers. 
The membrane fraction of MCR I cultured cells was solubilized with laurylmaltoside (A), 
digitonin (B), or laurylmaltoside after cross-linking with EDAC in the presence of NHSS (C) 
as described under “Experimental Procedures.” Five hundred micrograms of protein from 
each incubation were analyzed on 5–15% blue native gels in the first dimension (depicted 
horizontally) and 10% Tris-Tricine-SDS gels in the second dimension (depicted vertically). 
Gels were stained with colloidal Coomassie. Complexes are indicated with black, vertical 
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Figure 3. The exosome-like complex of M. thermautotrophicus. The cytosolic fraction of cells cultured 
under MCR I conditions was solubilized with laurylmaltoside as described under “Experimental 
Procedures.” Five hundred micrograms of protein was analyzed on a 5–15% blue native gel in the first 
dimension (depicted horizontally) and a 10% Tris-Tricine-SDS gel in the second dimension (depicted 
vertically) and stained with colloidal Coomassie. The constituents of the exosome-like complex are 
indicated with their respective MTH numbers.
The exosome-like complex of M. thermautotrophicus. The cytosolic fraction of cells cultured 
under MCR I conditions was solubilized with laurylmaltoside as described under 
“Experimental Procedures.” Five hundred micrograms of protein was analyzed on a 5–15% 
blue native gel in the first dimension (depicted horizontally) and a 10% Tris-Tricine-SDS gel in 
the second dimension (depicted vertically) and stained with colloidal Coomassie. The 
constituents of the exosome-like complex are indicated with their respective MTH numbers.
No evidence was found for the presence of the Cdc48, yeast Csl4, and chaperonin 
homologs that were identified in the exosome preparation of S. solfataricus 
immunoprecipitated from crude protein preparations [287]. Additionally a protein associated 
with the M. thermautotrophicus exosome with a significantly higher staining intensity relative 
to the core subunits in cytosolic protein from MCR I cells was found (Fig. 3). This exosome-
associated protein was identified as MTH250 encoding the tRNA-intron endonuclease [319]. 
A possible explanation for the great differences in staining intensities might be that the
M. thermautotrophicus exosome contains the four core subunits mentioned and associates 
with homomeric complexes of the tRNA-intron endonuclease subunits. 
This was corroborated by the relative staining intensities of the exosome subunits in cytosolic 
protein from MCR II cells. Here again the exosome core subunits had identical staining 
intensities, whereas the intron endonuclease was less prominently present (results not 
shown). Furthermore the association of the intron endonuclease as a separate complex with 
the exosome is consistent with the observation of the heterologous tRNA-intron 
endonuclease isolated from the closely related methanogen Methanococcus jannaschii 
associating spontaneously into homomeric tetramers [319]. In conclusion, the composition of 
the exosome revealed by BN-PAGE shows that, next to the core exosome subunits, the 
M. thermautotrophicus exosome contains or associates with previously unknown RNA 
processing activities, i.e. the intron endonuclease.
mass of 300 kDa of the complex suggests that it is composed of a tetramer of both subunits. 
Although this protein association has not been observed earlier, in radish seedlings, both 
activities are located in a single polypeptide [310].
Also MTH742 and MTH770 were found as a 300-kDa complex comprising the phenylalanine-
tRNA synthetase α and β subunits, respectively. MTH1501 represents an additional copy on 
the genome of the α chain, which was not found associated with MTH770, suggesting that 
MTH742 is the true phenylalanine-tRNA synthetase α subunit in the preparations tested.
The 28-kDa MTH1149 and 45-kDa MTH1150 annotated as ATP-binding cassette transporter 
subunits Ycf16 and Ycf24 formed a complex of 200 kDa in a 1:1 ratio. Both encoding genes 
constitute an operon and encode two homologs of the iron uptake system, SufC and SufB, 
of Escherichia coli (56 and 41% sequence similarity, respectively) and Thermotoga maritima 
(61 and 48% sequence similarity, respectively). These proteins are involved in the protection 
of iron-sulfur clusters of proteins under oxidative stress conditions [311, 312] and have been 
shown to interact but so far not in Archaea.
Heteromeric Complexes Involved in General Processes
Complexes also were identified that are involved in general cell processes of 
M. thermautotrophicus, i.e. the proteasome and exosome involved in protein and RNA 
processing, respectively [313]. A clearly visible complex was formed by the α and β subunits 
of the proteasome, MTH686 and MTH1202, respectively, migrating at an apparent molecular 
mass of 800 kDa [314]. Interestingly the proteasome-activating nucleotidase protein MTH728 
[315] was found in the same mass range as the proteasome but was not associated with the 
proteasome subunits [316, 317]. MTH728 migrated as an 800-kDa complex with MTH540 in 
a 1:1 ratio. Although the MTH540 protein is annotated as a homolog of the Rad50 protein 
involved in DNA repair, the Rad50 signature was not recognized at the Pfam website in the 
MTH540 protein sequence and therefore is unlikely to be the homolog of the Rad50 protein 
in M. thermautotrophicus. Next to the proteasome complex and its regulatory protein, also 
the RNA-processing exosome complex was visualized at 900 kDa. In higher eukaryotes, this 
complex is involved in the processing of coding and non-coding RNA [318]. 
The M. thermautotrophicus exosome complex consisted of four subunits corresponding to 
MTH682, MTH683, MTH684, and MTH891, which are the orthologs of the core subunits 
recognized previously in the Sulfolobus solfataricus exosome: Rrp42 (63% sequence 
similarity), Rrp41 (72% sequence similarity), Rrp4 (55% sequence similarity), and DnaG (68% 
sequence similarity), respectively [287]. In analogy with the S. solfataricus exosome, the four 
core subunits appeared with similar staining intensities and were identical to the exosome 
preparation from S. solfataricus after immunoprecipitation of an anion-exchange column-
enriched protein preparation (Fig. 3).
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hydrogen (MCR I) conditions. These results furthermore suggest that, next to a regulation at 
the expression level, the association of complexes also might be part of the adaptations of 
the primary metabolism to a change in substrate supply.
“Homomeric” supercomplexes could be recognized for the membrane-associated 
methyltransferase complex and the ATP synthase stalk subcomplexes, respectively. 
The observation that ATP synthase complexes form multimers has only been observed 
for ATP synthases isolated from mitochondria [291] and chloroplasts [321] but not for 
bacterial ATP synthases [322]. The multimerization of the M. thermautotrophicus ATP 
synthase subcomplex is therefore a unique observation for bacterial ATP synthases. 
However, to determine the exact function of the multimerization of the ATP synthase or the 
methyltransferase complex more research is required.
The present study has shown the ability of BN-PAGE to reproducibly separate individual 
proteins and reveal protein-protein interactions, consistent with the results obtained after 
independent, traditional purification procedures. Next to the identification of a considerable 
fraction of the predicted proteome, BN-PAGE can visualize the complexes involved in 
primary metabolism and in anabolic and general processes. Moreover BN-PAGE enables the 
comparison of the association of complexes between protein preparations obtained from 
cells cultured under different conditions. As such, BN-PAGE contributes considerably to the 
knowledge of the protein-protein interactions taking place and to the exact constituency of 
complexes that are involved in the major cell processes.
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Discussion
The phenotype of microorganisms is the result of the biochemical reactions and responses of 
the enzymes excreted in the medium and those present in the cytoplasm, membrane, and 
proteins associated with the cell wall. It is generally accepted that the enzymes and proteins 
are not merely inert, independent functional units but that proteins interact and in this way 
form an intricate network, enabling microorganisms to sense their environment and to 
translate environmental triggers into an adaptation of their enzyme content.
Currently many techniques are used to study the protein content of organisms on a 
proteome-wide scale and to study the change of the proteome constituency depending on 
the environmental conditions applied. However, only a limited number of techniques are 
available to visualize and identify the interaction of proteins in vivo and on a proteome-wide 
scale. One established method of visualizing protein-protein interactions is the use of 
BN-PAGE [256]. To date, this method is used to study specific complexes in combination 
with antibodies to identify proteins and to prove the multimeric nature of the protein complex 
under investigation [285].
Evaluating BN-PAGE as a Tool in Proteomics
In the study presented here we explored the use of BN-PAGE combined with mass 
spectrometry to visualize and identify interacting and individual proteins of 
M. thermautotrophicus on a proteome-wide scale. The obtained results show that BN-PAGE 
can compete with published proteome studies using traditional 2D gel electrophoresis and in 
fact surpasses the genome coverages obtained in most cases. Despite a relatively high 
coverage of predicted cytoplasmic proteins, parallel to traditional 2D gel electrophoresis 
[320], a low coverage was found for proteins containing one or more predicted 
transmembrane-spanning regions.
To visualize protein-protein interactions, the enzyme complexes involved in methanogenesis 
were used as internal standards because of the extensive biochemical research that has 
been performed on these enzyme complexes. All of the previously characterized protein 
complexes involved in the primary metabolism of M. thermautotrophicus were identified, 
indicating the mild nature of the method used, and furthermore showed that different bis-/
acrylamide gradients in the first dimension could be used to exclude any accidental co-
migration of proteins and as such identify members of uncharacterized complexes.
Supercomplexes
The association of complexes involved in methanogenesis that was observed earlier in 
M. marburgensis [279] also was reproduced by BN-PAGE. The heterodisulfide reductase 
complex was found as a separate complex and associated partly with the methylviologen-
reducing hydrogenase complex under MCR I culture conditions. A comparison of the protein 
preparations obtained from cells cultured under MCR I and MCR II conditions with regard 
to the individual and associated forms of the heterodisulfide reductase complex showed 
considerable differences. Under MCR I conditions a considerable amount of the individual 
heterodisulfide reductase and the supercomplex were present that were hardly detectable 
under MCR II conditions. Apparently MCR I conditions induced heterodisulfide reductase 
and methylviologen hydrogenase components and furthermore triggered a physical link 
between these two complexes. One possible explanation might be that the amount and the 
association of both complexes of which one consumes reducing equivalents and the other 
complex supplies reducing equivalents would ensure that the reaction proceeded under low 
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Abstract
Two-dimensional blue native/SDS-PAGE is widely applied to investigate native 
protein protein interactions, particularly those within membrane multi-protein 
complexes. MS has enabled the application of this approach at the proteome scale, 
typically by analysis of picked protein spots. Here, we investigated the potential of 
using LC-MS/MS as an alternative for SDS-PAGE in blue native (BN) analysis of 
protein complexes. By subjecting equal slices from BN gel lanes to label-free 
semi-quantitative LC-MS/MS, we determined an abundance profile for each protein 
across the BN gel, and used these profiles to identify potentially interacting proteins 
by protein correlation profiling. We demonstrate the feasibility of this approach by 
considering the oxidative phosphorylation complexes I–V in the native human 
embryonic kidney 293 mitochondrial fraction, showing that the method is capable of 
detecting both the fully assembled complexes as well as assembly/turnover 
intermediates of complex I (NADH:ubiquinone oxidoreductase). Using protein 
correlation profiling with a profile for subunits NDUFS2, 3, 7 and 8 we identified 
multiple proteins possibly involved in the biogenesis of complex I, including the 
recently implicated chaperone C6ORF66 and a novel candidate, C3ORF60.
 
Proteins rarely perform in solo, which makes identification of protein–protein interactions 
crucial to our understanding of cell biology. Two-dimensional blue native (BN)/SDS¬-PAGE 
analysis is widely applied to investigate native protein–protein interactions [323]. In this 
approach, following the first-dimensional BN separation, gel lanes are subjected to a 
denaturing second-dimensional SDS-PAGE separation where the diff erent components of 
protein complexes are allowed to dissociate. This is usually followed by immunoblotting to 
assess the possible interaction between proteins of interest. 
MS techniques have enabled the application of this approach at proteome scale, typically by 
analyzing protein spots picked from two-dimensional BN/SDS-PAGE separations, thus 
eliminating the need for specific antibodies and highly increasing throughput. We have 
previously demonstrated the ability of this technique to separate the complete native 
proteome of the archaeon Methanothermobacter thermautotrophicus, using a combination 
of 2-D BN PAGE and MALDI-TOF [324].
Fandino et al. [88] have demonstrated the accessibility of protein complexes isolated by 
one-dimensional BN for LC-MS/MS analysis. In this report, where we extend this method to 
cover the whole length of one-dimensional BN gel lanes, we show that the coupling of BN to 
LC-MS/MS is a powerful approach that enables computer-assisted analysis of native protein–
protein interactions in very complex samples. Shortly, the first dimensional BN gel is cut into 
equal slices that are subjected to standard, label-free, semi-quantitative LC-MS/MS analysis 
for the purpose of post hoc construction of protein profiles. Based on similarities, these 
protein profiles are used to identify potentially interacting proteins by protein correlation 
profiling (PCP) [48, 49, 325] as outlined in Fig. 1. 
To demonstrate the feasibility of this approach we analyzed the crude mitochondria-enriched 
fraction of human embryonic kidney 293 (HEK293) cells using 4–12 and 5–15% BN gradient 
gels. Focusing on the well-char¬acterized complexes of the oxidative phosphorylation 
(OXPHOS) system, we first evaluated whether we could correctly detect protein comigration 
using protein profiles. Next, by studying assembly/turnover intermediates of mitochondrial 
complex I we evaluated the ability of the method to identify lower abundant and more 
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dynamic protein complexes. Applicability of PCP with the data is shown via the identification 
of proteins that comigrate with intermediates of complex I.
 
Figure 1. General overview of our approach. Protein complexes are separated by BN PAGE and 
fractionated by cutting the gel lane into slices. Each slice is processed for MS analysis (LC MS/MS). 
Processed quantitative information (emPAI or XIC) is then used to generate abundancy traces for each 
protein, which can be used to identify protein complexes. Next, PCP is used to identify putative protein 
interactions (candidates) by correlation with protein traces of interest (template).
 
2 Materials and methods 
2.1 Cell culture 
HEK293 cells were cultured in DMEM (Biowhitaker) supplemented with 10% v/v FCS and 1% 
penicillin/strepto-mycin (v/v) Invitrogen). At ~80% confluence approximately 1 x 107 cells 
were harvested using PBS. A mitochondria enriched fraction was obtained by pottering in 
isotonic buffer and centrifugation as described in Vogel et al. [326].
2.2 Sample preparation 
The mitochondria-enriched pellet was solubilized by resus-pension in 200 mL of ACBT (1.5 
M aminocaproic acid, 75 mM Bis-Tris pH 7.0) and 22 mL of 20% wv n-dodecyl b-d-
maltoside (approx. 1 gr/gr protein), followed by incubation on ice for 10 min. Solubilized 
proteins were retained in the supernatant after centrifugation at 10 000 x g for 25 min at 41C. 
The protein concentration was determined using the MicroBCA protein assay kit (Pierce) and 
BN sample buffer was added for further analysis. 
2.3 BN gel electrophoresis 
BN 5–15 or 4–12% gradient gels were cast as described previously [326] using Bio-Rad mini 
PROTEAN® II systems (1.5 mm spacers, 7 mL gel volume) and run with 80 mg of protein per 
lane. Duplicate lanes were subjected to a second dimension 10% SDS-PAGE separation as 
described in [256] or processed for LC MS/MS analysis.
2.4 Western blotting and immunodetection 
Upon 2-D BN SDS-PAGE, proteins were transferred to a PROTRAN nitrocellulose membrane 
(Schleicher & Schuell). Immunodetection was performed using the following primary antibodies. 
Affinity purified C3ORF60 antibody was produced by Eurogentec using two peptides: 
1: APRRGHRLSPADDELY; 2: RQRGIAVEVQDTPNAC. The C6ORF66 antibody was provided 
by Prof. H. Lorber-boum-Galski, Jerusalem, Israël. Complex I: NDUFS3 (Invitrogen) and 
NDUFS2 (a gift from Prof. Brian Robinson, Canada). Complex IV: COXIV (Invitrogen). Secondary 
antibodies that were used are peroxidase-conjugated anti-mouse or anti-rabbit IgGs (Invitrogen). 
The signal was generated using ECL plus (Amersham Biosciences) and exposed to X-OMAT 
UV film (KODAK).
2.5 LC-MS/MS analysis 
Gel lanes were cut into 24 slices corresponding with 2 mm migration distance on the BN gel. 
Destaining, reduction, alkylation and trypsin digestion were performed as described 
elsewhere [88, 327]. Subsequent peptide solutions were desalted and concentrated using 
stop and go elution tips [127]. Sample analysis by LC-MS/MS was performed in duplo using 
an Agilent nanoflow 1100 liquid chromatograph coupled on-line via a nano-electrospray ion 
source (Proxeon) to a 7T linear ion trap Fourier transform ion cyclotron resonance mass 
spectrometer (LTQ FT, Thermo Scientific). Chromatographic separations were performed 
using a 15 cm fused silica emitter (New Objective, PicoTip™ Emitter, Tip: 8±1 mm, id: 100 
µm, FS360-100-8-N-5-C15) packed with reversed phase ReproSil-Pur C18AQ 3 µm resin 
(Dr. Maisch) [167]. Peptides were loaded directly onto the analytical column using eluens A 
(0.5% HAc) and were gradually eluted from the column using a 70 min gradient of 15–58% 
eluens B (80% ACN, 0.5% HAc). The mass spectrometer was operated in positive ion mode 
and was programmed to analyze the top four most-abundant ions from each precursor scan 
using dynamic exclusion. Precursor scans by the ICR cell were set to cover an m/z range of 
350–2000 at a resolution of R = 5E5. Data-dependent fragmentation of precursor ions in the 
linear ion trap used the following settings for CID: normalized collision energy: 27%, 
activation q = 0.250, activation time: 30 ms. The automatic gain control system was set to 
values of 1E6 and 1E4 ions and allowed maximum injection times of 500 and 400 ms for full 
MS1 and MS2 spectra, respectively.
2.6 Protein identification 
Raw spectra were converted to DTA files and combined into MASCOT generic peak lists. 
Protein identifications were performed by searching the RefSeq database (release 21) with 
MASCOT (version 2.1) using the following settings: tryptic peptides, precursor ion tolerance: 
10 ppm, MS/MS tolerance: 0.8 Da, maximal number of missed cleavages: 1, 
carbamidomethylation (C) as a fixed modification, and deamidation (NQ) and oxidation (M) as 
variable modifications. Combined MASCOT search results were validated and processed 
using the PROVALT software [121] allowing a false discovery rate of ≤1%. As an extra 
measure, proteins were required to be identified in both gradient gels and only proteins 
identified with at least two unique peptides were accepted. 
2.7 Quantitative data processing 
To ensure accurate quantitation, shared peptides were removed prior to any quantitative data 
processing. Label-free quantitation by either exponentially modified protein abundance index 
(emPAI [51]) or extracted ion chromatograms (XIC [328]) was evaluated for the ability to 
analyze BN migration patterns. To this end emPAI values were calculated according to 
Ishihama et al. [51] while XIC values were extracted with the MASIC software kit [329]. 
Processing of the XIC data and linking it to identification data was achieved using an 
in-house developed Perl script.
2.8 PCP 
The emPAI-based protein profiles were defined simply by the emPAI values for a given protein 
across all slices of the BN gel. The XIC-based protein profiles were calculated as the average 
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of the top five most-abundant peptide intensities (if available) from a given protein. Protein-
abundance profiles from the duplicate LC-MS/MS analyses were averaged and scaled 
between 0 and 1 by dividing the quantitative value for a given protein in each slice by the 
maximal quantitative value across all slices for that protein. PCP was performed with the 
normalized profiles, using Pearson’s coefficients as a measure for correlation. To search for 
proteins possibly involved in biogenesis of complex I, we performed PCP using the average 
profile of complex I subunits NDUFS2, 3, 7 and 8 from relevant slices (4–12% BN: slices 
5–22, 5–15% BN: slices 8–23) that contain complexes smaller than holocomplex I. Pearson’s 
correlations between each of these subunits were used to empirically determine a cut-off 
value of r ≥ 0.7, above which profiles retrieved by PCP were considered for further analysis. A 
protein identified by PCP was considered as a candidate when it had a Pearson’s correlation 
factor of r ≥ 0.7 in each BN gel for the template pattern (p<0.0001) and if it had a reported 
mitochondrial localization or predicted to be mitochondrial by at least two out of five 
mitochondrial prediction algorithms.
2.9 Miscellaneous 
The TIGR Multi Experiment Viewer (TMEV version 4) software [330] was used for graphical 
evaluation of protein profiles. MITOPROT II [331], Target P [332], Predotar [28], Mitop2 [32] 
and Wolf PSORT [333] were used for mitochondrial localization prediction. Experimental 
evidence for mitochondrial localization was retrieved via the Mitop2 database, gene ontology 
(GO) or literature. GO annotation was performed with DAVID software tool [334].
 
3 Results and discussion 
3.1 Data set characteristics 
We isolated a mitochondrial fraction of HEK293 cells through cell disruption followed by 
differential centrifugation. Upon duplicate BN PAGE of the HEK293 mitochondrial lysate on 
4–12 and 5–15% gradient gels, each BN lane was cut into 24 slices that were subjected to 
standard, labelfree, LC-MS/MS analysis as described in experimental procedures. In total 
1443 distinct proteins were identified across all measurements. On average accepted 
proteins were identified with more than nine unique peptides at 2 ppm mass accuracy. As 
expected, the 4–12% gradient gel showed a lower number of identified proteins for the high 
molecular mass range (slices 1 to 7) whereas the 5–15% gradient showed a lower number of 
protein identifications in the low molecular mass range (slices 17 to 24). 
Analysis of protein migration patterns and PCP requires reliable quantitation. A bottleneck of 
labeling strategies is the requirement for pairwise comparisons, which prevents retrospective 
analyses and complicates large-scale projects. Alternatively, efficient though less accurate 
label-free methods have been developed based on either spectral counts (e.g. emPAI) or 
integrated peak area intensity (XIC) [51, 328]. Here, to reduce complexity of workflow and to 
increase applicability, we have chosen a label-free setup combined with a simple 
normalization procedure to scale each abundance trace between 0 and 1. As summarized in 
Supporting Information Fig. 1, the two different quantitation methods yielded highly similar 
protein profiles (average r = 0.83±0.12 (±SD)), basically justifying the use of either one for the 
application described in this work, where we mainly considered XIC-protein profiles. 
To assess mitochondrial enrichment and to gain more insights in the other constituents of 
this fraction, the data set was sorted according to maximal emPAI value (as a measure for 
relative abundance) and binned in groups of 100 proteins. Using GO, the different groups 
were classified according to subcellular localization (i.e. cellular component terms). This is 
summarized in Supporting Information Fig. 2 for the most frequently observed terms for each 
bin, which indicates a clear mitochondrial enrichment that increases with increasing 
abundance of identified proteins. On average 30% of identified proteins shared the term 
mitochondrion compared with 14% for ER and 4% for Golgi apparatus. The relatively high 
contribution of ER proteins is in line with the recent report by Zhang et al. [45] that even when 
taking extreme care to prepare clean mouse cardiac mitochondria, a close association with 
the rough ER could not be disrupted without damage to the outer mitochondrial membrane.
3.2 Protein complexes 
Protein–protein interactions can be classified as relatively stable or dynamic. Examples of 
stable interactions are those within multi-subunit protein enzymes like complexes of the 
OXPHOS system, while the assembly/turnover intermediates of these are good examples of 
dynamic interactions. This makes OXPHOS a very useful model system to test the ability 
of the described approach to specifically investigate both types of interactions in the 
same experiment. 
Data of the identified subunits of OXPHOS complexes are summarized in Supporting 
Information Table 1. In general, most complexes were represented by a large number of 
subunits detected in both gradients: 32 out of 45 for complex I; 2 out of 4 for complex II; 6 
out of 11 for complex III; 8 out of 13 for complex IV; 11 out of 17 for complex V. Of note, 
missing subunits were often membrane subunits, possibly due to lower tryptic efficiency or 
physicochemical properties of the tryptic peptides. By plotting the average profiles for the 
detected subunits, we could readily detect the different OXPHOS complexes in the usual 
migration order (I, V, III, IV, II), in both gradients (Fig. 2A). As the resolution in the high 
molecular weight region of the 5–15% gel decreased (compared with the 4–12% gel), so did 
the relative distances of the complexes in this region, indicating that the determined apexes 
(maxima of the average profiles) correctly represented the corresponding protein complexes. 
Next, we analyzed protein profiles of individual subunits from nine different well-detected 
complexes that were located at different positions covering most of the BN separation range. 
The vast majority of subunits from individual complexes colocalized in both gradients (Fig. 
2B). These results show that a protein complex could be correctly identified by the apexes of 
its constituting subunits even in the presence of many background proteins. However, with 
the current setup, this is only true for well-known complexes, i.e. without prior knowledge, it 
is not possible to exclude colocalization of unrelated proteins. To overcome this issue, a 
possible strategy would be to use a combination of different conditions, like differential 
solubilization and/or cross-linking, as described previously [324].
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Figure 2. Identification of protein complexes. (A) The migration patterns of OXPHOS complexes in both 
gradients indicated by the average protein profiles of their subunits are shown. (B) A heatmap of 
normalized XIC traces for subunits from selected complexes in the 4–12 and 5–15% BN data sets, with 
proteins in rows and abundance by gray value in columns are shown. Abbreviations: CI, mitochondrial 
complex I; CCT, chaperonin containing TCP complex I; PSM, proteasome; CV, complex V; CIII, complex 
III; ARPC, actin-related protein 2/3 complex; HADH, mitochondrial trifunctional protein; CIV, complex IV; 
CII, complex II.
3.3 Mitochondrial complex I intermediate complexes 
The majority of subunits of a protein complex focus in a single slice, whereas others are also 
detected in lower or higher molecular weight associations (Fig. 2B). In general, it appears that 
those complexes are of lower abundance than the fully assembled complexes. They may 
originate from interactions between complexes or may be assembly or turnover intermediates 
of a particular complex. Such intermediate complexes are particularly observed for complex I 
subunits (see Fig. 2B, CI). BN PAGE analysis of comigration of complex I subunits has been 
performed previously, mainly in the context of the complex I assembly process. These studies 
have assessed the comigration of 11 [335], 8 [336], 9 [9] and 11 different complex I subunits 
[337], respectively, showing that the assembly of complex I involves at least six intermediates 
that contain at least subunits NDUFS2 and NDUFS3 [9, 335, 337]. A problem in studying 
additional subunits has been the absence of proper antibodies, which has been 
circumvented by studying the import and incorporation of 35S-labeled in vitro-translated 
complex I subunits [337, 338]. Our proteomics approach eliminates the need for either 
antibodies or radioactive labeling and allows the simultaneous investigation of the native 
migration of all protein complexes in the sample. Hence, with 32 consistently identified 
subunits, this study provides the most extensive framework for the analysis of complex I 
intermediates to date. In addition to holo-complex I, our analysis highlights comigration of 
predominantly membrane arm subunits of complex I in fraction 9 of the 4–12% and fraction 5 
of the 5–15% gradient (Fig. 3A). A similar intermediate has been previously demonstrated to 
accumulate upon increased temperature or detergent concentrations [9], suggesting that it is 
a breakdown product of holo-complex I rather than an assembly intermediate. In addition, we 
observed comigration of subunits NDUFS2, 3, 7 and 8 in both gradients (Fig. 3B). This is in 
agreement with previous studies that show comigration of the NDUFS2 and NDUFS3 
subunits in multiple intermediates [9, 335-338]. To correlate our data with previously 
described intermediates [9] we aligned NDUFS2, NDUFS3 and COXII patterns with 2-D BN 
SDS-PAGE Western blot immunodetections (Fig. 3B, immunodetection panels). This 
demonstrates the sensitivity of our method and indicates that the original resolution of the 
BN separations is sufficiently preserved with the size of fractions taken in this study (2 mm 
gel slices).
3.4 PCP 
The identification of complex I intermediates subsequently enables PCP to find proteins with 
identical or partially overlapping profiles. Such proteins are putatively involved in complex I 
biology, e.g. assembly or turnover. In the case of complex I assembly we could apply PCP to 
find putative assembly proteins as (i) previous studies have shown that complex I involves 
several intermediates containing at least subunits NDUFS2 and 3 and (ii) the migration 
patterns of subunits NDUFS2, 3, 7 and 8 are highly similar and feature a complex pattern 
that reduces the risk of false positives. Specific PCP was therefore performed using the 
average profile of these subunits corresponding to complexes smaller than holocomplex I 
(Figs. 4A and B, template). To minimize false positives, PCP was performed requiring a 
minimal Pearson’s correlation of 0.7 in each gel (p<0.0001). In this way, we found multiple 
proteins that comigrated with assembly intermediates of complex I. The list of candidates 
consists of seven proteins (Table 1 and Supporting Information Fig. 3) taking in silico and 
experimental support for mitochondrial localization into account.
Interestingly, five out of seven candidate proteins (C3ORF60, C6ORF66, DHX30, NIPSNAP1, 
YME1L1) were recently implicated in complex I disease biology based on a large-scale 
proteomics and bioinformatics study [50], supporting the feasibility of our approach. Of the 
seven candidates, thus far only C6ORF66 has been demonstrated to be required for 
complex I assembly [339]. Our data reveal its accurate comigration with complex I assembly 
intermediates (Fig. 4A). Another candidate protein, C3ORF60, showed a near identical 
migration pattern compared with C6ORF66 (Fig. 4B). To verify the comigration of C3ORF60 
and C6ORF66 we generated an antibody against the C3ORF60 protein and performed 2-D 
BN SDS-PAGE Western blot analysis for C3ORF60, C6ORF66 and complex I subunits 
NDUFS2 and NDUFS3. The results in Fig. 4C show that C3ORF60 accurately comigrates 
with C6ORF66 and with four out of the six complex I assembly intermediates containing 
NDUFS2 and NDUFS3 described in Vogel et al. [9]. Further experimental work is needed to 
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establish if and how each candidate is involved in complex I biogenesis. Notably, during the 
publication procedure of this report Saada et al. [95] have shown that C3ORF60 lead to 
complex I deficiency and that C3ORF60 indeed tightly interacts with C6ORF66 as well as 
several complex I subunits. This validates our results and underscores the potential of 
combining PCP with our BN LC MS/MS approach to highlight potentially interacting proteins.
 
Figure 3. Identification of complex I intermediates. Heatmap traces of multiple complex I subunits reveal 
two different comigration patterns. (A) Pattern 1, complex I (CI) and intermediate indicated with arrows. 
(B) Pattern 2, for which the average protein profile is shown below the heatmap, followed by an alignment 
of the peaks of the profile with immunodetections of NDUFS2, NDUFS3 and COXII on 2-D SDS PAGE 
Western blots. Holocomplex or assembly intermediates (6, 5, 4, 3 and 2) are indicated according to Vogel 
et al. [9]. Complex I and complex IV subunit COXII were used to align the blot results with the protein 
profiles.
Figure 4. Identification of putative assembly proteins. (A and B) Comigration of C3ORF60 and C6ORF66 
with assembly intermediates of complex I by PCP are shown. The template pattern used for correlation 
profiling is indicated with a dashed line whereas solid lines represent C3ORF60 or C6ORF66. (C) 2-D BN 
SDS PAGE Western blot results are shown, which validate the comigration of C3ORF60 and C6ORF66 
with assembly intermediates of complex I that contain NDUFS2 and NDUFS3.
4 Concluding remarks 
In summary, by coupling LC MS/MS to one-dimensional BN we were able to unambiguously 
detect protein complexes in relatively complex samples, to identify dynamic interactions like 
assembly/turnover intermediates and to identify potential assembly proteins using label-free 
PCP. Altogether, we believe that this relatively simple and straightforward approach might 
prove very useful in large-scale mapping projects of protein–protein interactions, warranted 
that issues like potential false positives and automatisation are adequately dealt with. In this 
context, one can reasonably assume that the chance on false positives could be drastically 
reduced by including different conditions (e.g. different detergents, gel-gradients and 
potential cross-linking), and our preliminary data indeed support this assumption. It should be 
noted that including more conditions does not complicate data processing significantly since 
the additional data points can simply be added to the protein profiles obtained under default 
conditions. Finally, to be fully compatible with large-scale mapping projects of protein–protein 
interactions, robust algorithms should be developed to minimize/exclude manual intervention. 
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Abstract
Complexome profi ling is a novel technique which uses shotgun proteomics to 
establish protein migration profi les from fractionated blue native electrophoresis 
gels. Here we present a dataset of blue native electrophoresis migration profi les for 
953 proteins by complexome profi ling. By analysis of mitochondrial ribosomal 
complexes we demonstrate its potential to verify putative protein-protein 
interactions identifi ed by affi  nity purifi cation – mass spectrometry studies. Protein 
complexes were extracted in their native state from a HEK293 mitochondrial 
fraction and separated by blue native gel electrophoresis. Gel lanes were cut into 
gel slices of even size and analyzed by shotgun proteomics. Subsequently, the 
acquired protein migration profi les were analyzed for co-migration via hierarchical 
cluster analysis. This dataset holds great promise as a comprehensive resource for 
de novo identifi cation of protein-protein interactions or to underpin and prioritize 
candidate protein interactions from other studies. To demonstrate the potential use 
of our dataset we focussed on the mitochondrial translation machinery. Our results 
show that mitoribosomal complexes can be analyzed by blue native gel 
electrophoresis, as at least four distinct complexes. Analysis of these complexes 
confi rmed that 24 proteins that had previously been reported to co-purify with 
mitoribosomes indeed co-migrated with subunits of the mitochondrial ribosome. 
Co-migration of several proteins involved in biogenesis of inner mitochondrial 
membrane complexes together with mitoribosomal complexes suggested the 
possibility of co-translational assembly in human cells. Our data also highlighted a 
putative ribonucleotide complex that potentially contains MRPL10, MRPL12 and 
MRPL53 together with LRPPRC and SLIRP.  
Introduction
Protein-protein interactions are essential for many diff erent cellular processes. Perturbed 
protein-protein interactions can have strong negative eff ects on cell viability, which in turn 
may have devastating eff ects in an organism. This is exemplifi ed by the severe clinical 
syndromes that are associated with assembly defects of the mitochondrial oxidative 
phosphorylation (OXPHOS) complexes [340, 341]. Other examples of disease that involve 
gained, lost or perturbated protein-protein interactions are Charcot-Marie-Tooth disease, 
Alzheimer’s disease, Huntington’s disease, multiple acyl-CoA dehydrogenation defi ciency, 
MCAD defi ciency, hereditary spastic paraplegia, and pathogen-host interactions [342-344]. 
Cataloguing of protein-protein interactions not only contributes to the fundamental 
understanding of cellular biology but also provide insight into the pathogenic mechanisms 
that underlie disease. Ultimately, such data can be used to develop pharmaceutical 
interventions in selected cases via targeted disruption of protein-protein interactions by 
antibodies, peptides, or even small molecules [342]. It is therefore important for 
fundamental-, clinical-, and pharmaceutical-research to unravel protein-protein interactions.
Blue native gel electrophoresis (BNE) has been developed to study native protein complexes 
[87, 323, 345]. In this procedure, protein complexes are solubilised in their native state, 
decorated with the charged dye Comassie Blue, and separated by size using electrophoresis 
in gradient acrylamide gels. Large-scale analysis of protein-protein interactions by BNE was 
previously performed by two dimensional blue native/ sodium dodecyl sulphate polyacryl 
amide gel electrophoresis (2D BN SDS-PAGE) combined with mass spectrometry. Protein 
complexes are separated in a fi rst dimension BNE followed by a second denaturing SDS-
PAGE step to resolve protein complexes into their respective subunits. Stained protein spots 
> Chapter 9
Analysis of 953 
human proteins 
from a mitochondrial 
HEK293 fraction by 
complexome proﬁ ling
Hans JCT Wessels , Rutger O Vogel, Robert N Lightowlers, Johannes N Spelbrink,
Richard J Rodenburg, Lambert P van den Heuvel, Alain J van Gool, Jolein Gloerich, 
Jan AM Smeitink, Leo G Nijtmans.
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are excised and submitted to tryptic digestion to identify each protein via its proteolytic 
peptides by mass spectrometry [324]. We have reported a method that omits the second 
dimension SDS-PAGE and spotpicking-based mass spectrometric identification of proteins 
by direct analysis of fractionated BNE gel lanes by liquid chromatography – tandem mass 
spectrometry [93]. This method applies labelfree semi-quantitative shotgun proteomics to 
blue native gel lanes that are cut into gel slices of equal size. The acquired mass 
spectrometry data is used for protein identification and to determine the relative abundance 
of each respective protein in the gel slices to cover the entire blue native separation length. 
This information is then used to assemble the in-silico protein migration profiles. The outline 
of this method is schematically shown in figure 1. Following its introduction, different groups 
have successfully applied the methodology to study protein-protein interactions [94, 103, 
346, 347]. By the application of hierarchical clustering Heide et al [103] extended this method 
to a true bottom-up proteomics approach coined complexome profiling.
One of the advantages of complexome profiling over the classical 2D BN SDS-PAGE method 
is that the electrophoretic profiles are stored in a data matrix of proteins (rows) with gel slices 
(columns) where each cell contains the respective relative abundance. This allows the 
unambiguous analysis of protein co-migration by computational methods such as protein 
correlation profiling [48, 49, 93] and clustering methods [94, 103, 347]. Once acquired, the 
dataset can be used to identify potential de novo protein-protein interactions or drive 
validation of predicted protein-protein interactions from e.g. affinity purification – mass 
spectrometry (AP-MS) experiments. The latter application is of particular interest as the mass 
spectrometric identification of co-purified proteins on itself does not provide physicochemical 
information about the actual interactions themselves or the size of the complexes [103]. 
In this paper we present the first complexome profiling dataset from human cells which can 
be used by researchers to support alleged protein-protein interactions, identify novel 
protein-protein interactions, or to prioritize candidate protein interactors. A small subset of 
the protein profiles generated via different quantitation methods was previously used to 
deliver the proof-of-principle for the approach [93] and identified at least two complex I 
assembly chaperones [93, 95, 339]. Following further advances in data processing methods 
(such as peptide selection based on profile similarity rather than intensity to construct protein 
profiles), we here describe the complete dataset of 953 protein migration profiles from a 
mitochondrial HEK293 fraction in two acrylamide (AA) gradient gels of 4-12% and 5-15% AA. 
Hierarchical clustering (HCL) was used to order the protein migration profiles for ease of use, 
which is also provided as a supplementary data with supporting evidence from STRING 
[348-350] and DAVID [351, 352] for protein relationships within each cluster.
Four of the HCL clusters were of particular interest as they contained proteins of the 28S and 
39S mitochondrial ribosome (mitoribosome) which has not been analyzed by BNE thus far. 
Recent publications reported interactions between many different proteins and the 
mitoribosome based on AP-MS results [98, 99, 101, 102]. To demonstrate the potential of 
our dataset to underpin AP-MS results we have analyzed the protein migration profiles from 
recently reported mitoribosome-interacting proteins for co-migration with mitoribosomal 
subunits. 
 
Figure 1: Schematic overview of the complexome profiling approach. Protein complexes are separated 
according to size by blue native gel electrophoresis after which the gel lane is cut into gel slices at even 
distance. Each gel slice is separately processed by tryptic in-gel digestion and subsequently analyzed by 
liquid chromatography combined with online tandem mass spectrometry. In the final steps, the peptide 
identifications with according relative abundance from each individual LC-MS/MS analysis are combined 
to reconstruct the migration profile for each protein that span the complete length of the blue native 
separation. Please note that two subunits of the large red complex were also available as a smaller 
complex in this example to include proteins that form multiple complexes.
Methods
Sample preparation
HEK293 cells grown in DMEM (Biowhitaker) supplemented with 10% (v/v) FCS and 1% (v/v) 
penicillin/streptomycin were harvested at ~80% confluency using PBS. Cells were disrupted 
by pottering in isotonic buffer and a mitochondrial enriched fraction was obtained by 
centrifugation according to Vogel [326]. Native protein complexes were extract from the 
mitochondria-enriched pellet by resuspension of the pellet in 200 µl ACBT (1.5M 
aminocaprioc acid, 75 mM Bis-Tris pH 7.0) and 22 µl of 20% (w/v) n-dodecyl b-d-
maltoside(approximately 1 gr/gr protein). The suspension was incubated for 10 minutes on 
ice to solubilize proteins and subsequently centrifuged at 10 000 x g for 25 minutes at 4°C. 
The concentration of solublilized proteins in the supernatant was determined using the 
MicroBCA protein assay kit (Pierce) prior to addition of BN sample buffer. BN gels (4-12% 
and 5-15% acryl amide gradient gels) were cast using Bio-Rad mini PROTEAN® II systems in 
combination with 1.5 mm spacers. Both gels were loaded with 80 µg of protein per lane and 
run till the dye front reached the end of each respective gel. 
The resulting gel lanes were cut into 24 gel slices at even distance and each gel slice was 
subjected to in-gel tryptic digestion essentially according to Heide [103]. Briefly, gel slices 
were cut into 1 x 1 mm cubes and transferred to a fresh 96-well plate. The gel particles were 
washed successively three times with 50mM ammonium bicarbonate (AHC), 50% (v/v) 
acetonitrile (ACN) and 100% (v/v) ACN for 20 minutes under gentle agitation. Gel particles 
were swelled in 10 mM dithiotreitol and incubated for 30 minutes at 56° C to reduce protein 
disulfide bonds. After removal of the reduction buffer, gel particles were shrunk in ACN for 20 
minutes at room temperature under gentle agitation. Alkylation of reduced cysteine residues 
was performed by incubating the gel particles for 30 minutes in alkylation buffer (50mM 
chloroacetamide in 50mM AHC) at room temperature in the dark. Following the alkylation 
step, gel particles were washed successively with 50mM AHC and ACN prior to the addition 
of 50µl 12.5 ng/µl trypsin (Promega: V511C) and overnight protein digestion at 37° C. 
Proteolytical peptides in the digestion buffer were recovered by transfer of the buffer solution 
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to a fresh 96-well plate. Remaining proteolytical peptides in the gel pieces were recovered by 
shrinking the gel particles in ACN for 30 minutes at room temperature under gentle agitation 
and subsequent transfer of the peptide-containing ACN solution to the 96-well plate. The 
combined peptide extracts were subjected to in vacuo centrifugation to remove acetonitrile. 
Subsequently, stop and go elution (STAGE) tips [127] were used to desalt and concentrate 
the peptide mixtures prior to LC-MS/MS measurements. 
Liquid chromatography – tandem mass spectrometry
Duplicate measurements for each gel slice were performed by nanoflow reversed-phase C18 
liquid chromatography (Agilent 1100 series) coupled online to a 7T linear ion trap Fourier-
Transform ion cyclotron resonance mass spectrometer (LTQ FT, Thermo Fisher Scientific) 
[128, 227]. Chromatographic separations were performed using a 15 cm long x 100 µm ID 
fused silica electrospray emitter (New Objective, PicoTip Emitter, FS360-100-8-N-5-C15) 
packed in-house at 100 bar with ReproSil-Pur C18AQ 3µm 140Å resin (Dr. Maisch) 
resuspended in methanol. Proteolytical peptides were loaded directly onto the analytical 
column using 0.5% (v/v) acetic acid at a flow rate of 600 nl/min. A linear gradient of 12-46% 
acetonitrile (ACN) with 0.5% (v/v) acetic acid as ion pair reagent was used to gradually elute 
peptides from the column at a flow rate of 300 nl/min. Following each analysis, the column 
was washed for 10 minutes with 80% ACN at 600 nl/min and conditioned using 0.5% acetic 
acid for 10 minutes at 600 nl/min. Intermittent blank injections were performed to minimize 
carry-over effects between samples. 
The mass spectrometer was operated in positive ion mode and programmed to acquire a 
single full MS survey scan in the ICR cell with up to four data dependent collision induced 
dissociation (CID) fragmentation spectra in parallel by the linear ion trap. The mass 
spectrometer was tuned on MRFA peptide (m/z 524) at 300 nl/min and calibrated using 
caffeine (m/z 195), MRFA (m/z 524) and Ultramark 1621 (m/z 1122, 1222, 1322, 1422, 1522, 
1622, 1722 and 1822) standards from the MSCAL5 ProteoMass™ LTQ/FT-Hybrid ESI 
Positive Mode CalMix kit (Sigma Aldrich). The ICR cell precursor scans were performed using 
a single microscan at 50 000 resolving power (FWHM at m/z 400) on 1E6 ions or 500 ms 
maximum injection time (whichever came first). Data dependent acquisition of MS/MS 
spectra by the linear ion trap used a single microscan at normal scan speed. The automatic 
gain control was set to 1E4 ions for MS/MS with 400 ms maximum injection time. Collision 
induced dissociation of precursor ions was performed at 27% normalized collision energy for 
30 msec and activation Q = 0.250. An isolation width of 3 Th was used to trap and isolate 
precursor ions for MS/MS experiments. Dynamic exclusion was enabled to minimize 
re-analysis of precursor ions (list size: 500, exclusion time: 300 sec, 1 repeat count, 1.5 amu 
precursor mass tolerance).
Database searches
Raw mass spectrometry data was converted into Mascot search engine compatible peak lists 
by ExtractMsn (Thermo Fisher Scientific) and an in-house developed Perl script. Mascot 
database searches were performed against the Homo sapiens RefSeq (release 44) database 
[193, 353] with added sequences of known contaminant proteins (e.g. trypsin). The decoy 
database used for false discovery rate (FDR) validation contained the reversed protein 
sequences. Mascot (Matrix Science) [115] database searches were performed with 15 ppm 
and 0.5 Da mass tolerance for precursor ions and fragment ions, respectively. 
Carbamidomethylation (Cys) was specified as fixed modification whereas acetylation (protein 
N-terminus) and oxidation (Met) were selected as variable modifications. A single missed tryptic 
cleavage was tolerated. Mascot database search results were exported as peptide XML files 
and validated according to Weatherly [121] to achieve a maximum 1% FDR at the protein level. 
Quantitation and generation of protein abundance profiles
Quantitative information was extracted for valid protein identifications as integrated ion current 
chromatograms of respective peptides by IDEAL-Q software [194] using mzXML files generated 
by the ReadW software tool [176]. Parameters used for IDEAL-Q data processing specified 30 
ppm mass tolerance, a minimal Mascot ion score of 25, and unique peptides only. Quantitative 
data were exported as peptide level results. An in-house developed Perl script was used to 
generate protein abundance profiles from IDEAL-Q output data. Figure 2 illustrates the different 
processing steps that were used to generate protein abundance profiles. For each protein, the 
integrated ion current chromatograms for all identified peptides were extracted from each gel 
slice. The peptide abundance profiles were scaled between 0 and 1 to ensure equal weight of 
each peptide abundance profile. Next, a similarity matrix was constructed from all peptide 
abundance profiles for each protein using Pearson’s correlation coefficients. Similarity scores 
for all peptides of a protein were calculated as the sum of all Pearson’s correlation coefficients 
from the similarity matrix. Aberrant peptide abundance profiles for each protein were excluded 
from further processing by a Grub’s outlier test (with significance p > 0.9) and remaining peptide 
abundance profiles were ranked by descending similarity score. Finally, the protein abundance 
profiles were generated as the average profile from the top 5 peptide abundance profiles with 
highest similarity scores. Protein abundance profiles from duplicate gel slice measurements 
were averaged for each acryl amide gradient. Finally, a core dataset of 953 protein abundance 
profiles was compiled that consists of proteins that were detected in both acryl amide 
gradients. 
Metadata
Protein identifiers, gene ontology information, and official gene symbols were obtain via DAVID 
[334] and ProteinCenter (Thermo Fisher Scientific). MITOP2 [32] was used to identify 
mitochondrial reference proteins and to map predicted mitochondrial proteins by the MITOP2 
SVM algorithm. For each experiment, the number of peptides and the average Pearson’s 
correlation coefficient from the selected top 5 peptide abundance profiles per protein are listed. 
Additionally, the Pearson’s correlation coefficients for duplicate protein abundance profiles from 
each acryl amide gradient are provided as additional quality control measure. Mass ranges as 
well as the average mass of each gel slice were calculated using the known molecular masses 
of OXPHOS complexes [354]. 
Hierarchical clustering analyses
Hierarchical clustering for all mitochondrial protein abundance profiles was performed by the 
multiple experiment viewer (MEV) software [330]. Uncentered Pearson’s correlation coefficients 
were used as distance metric for clustering in combination with complete linkage distance and 
optimized leaf order. Clusters were defined in MEV software using an arbitrary distance cut-off 
of 0.540892 for further analysis. Proteins from each cluster were analyzed by STRING and 
DAVID tools to mine available data sources for known protein relationships within clusters. To 
investigate the rate at which proteins cluster together by mere chance we compared the 
hierarchical clustering results for a set of 16 known mitochondrial complexes from the dataset 
with results obtained from 10 decoy matrices that contained shuffled abundance profiles. Here, 
the average number of clusters that contained two or more subunits as well as the average 
number of clustered proteins for each complex were used to assess the hierarchical 
clustering results.
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Co-migration of mitoribosomal proteins with previously reported interactors from affi  nity 
purifi cation – mass spectrometry experiments were analyzed by hierarchical clustering. 
Proteins reported by Rorbach [98], Richter [99], and He [101, 102] together with all detected 
mitoribosomal proteins were used to select protein abundance profi les for further analysis. 
Here, exclusively relevant gel slices for each of the four mitoribosomal complexes detected in 
the initial hierarchical clustering analysis were used to increase selectivity and sensitivity of the 
analysis for each respective complex. Hierarchical clustering was performed using Euclidian 
distance metric to minimize false positives from low abundance data. 
 
Figure 2: LC-MS/MS data processing and protein profi le generation. Figure 2A provides an overview for 
the main steps in LC-MS/MS data processing. The acquired mass spectrometry data is used to identify 
peptides and protein for each gel slice via database searches using the Mascot search engine. Resulting 
peptide identifi cations together with the LC-MS data are used as input for the label-free quantitation by 
the Ideal-Q software that integrates the chromatographic peak surfaces for each peptide from respective 
extracted ion currents. Quantitative information from all LC-MS/MS analyses is then used to determine 
the relative abundance for each peptide in every gel slice. The fi nal step in data processing uses the 
peptide profi les to reconstruct the migration profi le for each individual protein in the blue native gel 
separation. Details for the reconstruction of the protein migration profi les are shown in fi gure 2B with data 
for the cytochrome c oxidase subunit 6C protein. First, all peptide profi les of a protein are used to 
generate a similarity matrix that contains the Pearson’s correlation coeffi  cients between each peptide 
profi le. This information is then used to calculate a similarity score for each peptide which is defi ned as 
the sum of all the Pearson’s correlation coeffi  cients for the peptide from the similarity matrix. The next step 
uses a Grubb’s outlier test on the calculated similarity scores to discard peptide profi les that poorly 
correspond with the general peptide migration profi le. Finally, the peptide migration profi les are ranked in 
descending order of their similarity score of which the 5 highest scoring peptide profi les are used to 
construct the protein migration profi le by averaging.
Results 
Dataset description and characteristics
A combined total of 118760 MS/MS spectra were mapped to 3981 proteins or 1766 protein 
identifi cation groups. Proteins were identifi ed at ≤1% FDR with an average of 9 non-
redundant peptides and an average summed Mascot ion score of 417 (min: 43, max: 5765). 
Minimum Mascot ion score thresholds to achieve 1% protein FDR or better were determined 
to be 50, 27, 21, 21, 19 and 16 for proteins with coverage of 1, 2, 3, 4, 5 and ≥6 peptides, 
respectively. Peptides were identifi ed with an average Mascot ion score of 41 (min: 16, max: 
152) and an average precursor ion mass error of 4.85 ± 3.03 ppm. Analysis of the HEK293 
mitochondrial fraction by complexome profi ling using two acrylamide gradients resulted in a 
dataset of 953 proteins where migration profi les could be constructed for both the 4-12% 
and 5-15% acrylamide (AA) gels. Here, the use of two AA gradient gels allows for cross-
validation of protein co-migration and helps to distinguish between protein complexes of 
similar size. Valid protein and peptide identifi cation data is available from supplementary fi le 
S1. For the set of 953 proteins we have analyzed the molecular weight, isoelectric point and 
hydrophobicity (GRAVY) distributions with respect to the RefSeq Hs database to identify 
possible enrichment of protein classes based on these physicochemical properties. Results 
shown in supplementary fi le 2 indicate no selective enrichment of proteins based on 
molecular weight or isoelectric point as both relative distributions are virtually identical to 
those of the RefSeq Hs database (Pearson’s r = 0.991 and r = 0.994, respectively). However, 
the hydrophobicity distribution of proteins in our dataset shows a slight shift towards more 
hydrophobic proteins. This might be explained by the relative high abundance of 
mitochondrial membrane proteins in combination with the protein extraction and 
electrophoresis methods that were optimized for the analysis of membrane proteins. This is 
supported by a signifi cant enrichment for proteins with one or more transmembrane domains 
with respect to the RefSeq Hs database (53.62% versus 45.66%, FDR adjusted p-value = 
7.35E-7). The distribution of transmembrane domains for proteins in the dataset as well as 
the RefSeq Hs database is shown in fi gure 3A. In addition, we compared the hydrophobicity 
distribution of proteins in our dataset to that of mitochondrial proteins in the RefSeq Hs 
database (supplementary fi le S2). Interestingly, the hydrophobicity distribution of proteins in 
our dataset is more identical to that of the subset of mitochondrial proteins in the RefSeq Hs 
database compared to the hydrophobicity distribution of all RefSeq Hs proteins (Pearson’s 
r = 0.993 versus r = 0.927, respectively). 
Because a mitochondria enriched fraction was used in this study, the dataset not only 
contains mitochondrial proteins but also provides migration profi les of proteins that reside in 
other cellular organelles. Unfortunately, the mitochondrial localization of many proteins is still 
unknown, and we therefore included information from the MITOP2 database [32] besides GO 
annotation [355] to annotate predicted mitochondrial proteins. Proteins included in the 
MITOP2 mitochondrial reference dataset as well as predicted to be mitochondrial by the 
MITOP2 support vector machine approach were also considered as mitochondrial proteins in 
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this work. Based on GO annotations, proteins in our dataset predominantly localized to 
mitochondria (437 proteins), nucleus (250), cytosol (215 proteins), and endoplasmic reticulum 
(176 proteins). The relative distribution of proteins over cellular compartments is shown in 
fi gure 3B. Mitochondrial proteins were signifi cantly enriched in our dataset compared to the 
RefSeq Hs database based on GO annotations (45.95% versus 8.98%, FDR adjusted 
p-value = 5.65E-18). 
The protein profi les dataset is provided as supplementary fi le S3 for download and contains 
the protein abundance profi les with according meta-information for BNE AA gradients. 
Meta-information includes protein description, identifi ers (protein Gi code, NCBI RefSeq ID, 
Uniprot ID, offi  cial gene symbol), and cellular localization (Gene Ontology, MITOP2 reference 
set, MITOP2 SVM prediction). Additional information is provided that can be used to assess 
the robustness of the protein migration profi le. These include the number of peptides used to 
reconstruct the protein migration profi le, average Pearson’s correlation coeffi  cient of the 
peptide profi les with respect to the average (protein) profi le, and the Pearson’s correlation 
coeffi  cient for duplicate experiments from the same acrylamide gradient gel. 
 
Figure 3: Distributions of transmembrane domains and cellular compartments of proteins in the dataset. 
Figure 3A shows the tornado diagram of transmembrane domains in proteins from both the complexome 
profi ling dataset and the complete RefSeq Homo sapiens database. A relative enrichment of 8% more 
proteins with transmembrane domains was observed for the complexome dataset with respect to the 
RefSeq Hs database. The tornado diagram for the cellular compartment distribution of proteins in fi gure 
3B show an enrichment of mitochondrial proteins in our dataset compared to the RefSeq Hs database. 
Please note that proteins may have multiple cellular compartment GO annotations.
Co-migration of subunits from known complexes
Out of the 953 proteins, 209 proteins could be assigned to 24 known heteromeric complexes 
based on protein description or online information resources [103, 344, 356]. Subunits from 
protein complexes should theoretically co-localize at the respective migration distance of the 
protein complex in blue native gels. This was observed for the majority (88%) of subunits 
from known protein complexes in the dataset as shown in detail in supplementary fi le S4 and 
summarized in table 1. However, some subunits (12%) of several complexes did not 
co-localize as expected. This could be caused by solubilization or electrophoresis eff ects 
since data from both acryl amide gradients generally show similar profi les for most of these 
subunits. Nevertheless, the majority of subunits from known protein complexes co-localized 
as expected in both gradients, confi rming the reproducibility of the approach.
 
Hierarchical cluster analysis of mitochondrial protein profi les
Some of the mitochondrial proteins in the dataset were expected to form yet unknown 
protein complexes. Since the protein profi les were stored in a data matrix, the dataset 
allowed for the use of computer algorithms in the analysis of protein co-migration profi les. We 
applied hierarchical cluster analysis (HCL) to categorize the dataset for ease of use, similar to 
the approach of Heide [103]. Figure 4 shows the HCL analysis results which are provided as 
MS Excel fi le (Supplementary fi le S5). The HCL_clusters.xls fi le contains the large high-
resolution version of the HCL tree, individual clusters with according HCL and STRING 
images, as well as an index to look up proteins of interest within clusters. Supplementary fi le 
S6 is the MEV analysis fi le that contains both the HCL analysis as well as the analyzed data 
matrix for ease of use. The MEV software is freely available [330] and should be used to open 
this analysis fi le. As quality control measure for the HCL we summarized the results for 
known complexes in table 1. Ideally, one would expect that all subunits of a given complex 
would group together in a single cluster. This holds true for the majority of subunits listed in 
table 1. Subunits of complexes that did not group together in the same cluster are explained 
by the presence of those particular subunits at higher relative abundance in another gel slice. 
Nevertheless, nearly all subunits of the mitochondrial complexes in table 1 (except for the 
2-oxoglutarate dehydrogenase and pyruvate dehydrogenase complexes) were clustered 
correctly. 
 
146 147
Figure 4: Representative hierarchical clustering results of mitochondrial protein profiles. Profiles from 
proteins with mitochondrial annotation (MITOP2 reference dataset or Gene Ontology) or mitochondrial 
prediction (MITOP2 SVM) were subjected to hierarchical clustering (uncentered Pearson’s correlation 
metric, optimized leaf order, and complete linkage distance). Five representative clusters are shown that 
contain the five mitochondrial oxidative phosphorylation system (OXPHOS) complexes. Clusters that are 
referenced in the text are indicated in the HCL tree with numbers that correspond with cluster numbers 
defined by the MEV software.
 
Table 1. Co-localization and hierarchical clustering details for known protein complexes in the dataset. 
This table shows the number of available subunits in the dataset for each annotated protein complex with 
the according number of subunits that co-localize in each acryl amide gradient. Presented here are also 
the number of subunits that reside within the same cluster(s) for each mitochondrial protein complex from 
the hierarchical clustering analysis of the data. *Of the eight TCP complex subunits seven were predicted 
to be mitochondrial and were included in the HCL analysis.
Protein complex
Complex I - NADH dehydrogenase
Complex II - Succinate dehydrogenase
Complex III - Cytochrome bc1 complex
Complex V - ATP synthase
TCP containing chaperone complex
Isocitrate dehydrogenase
propionyl-CoA carboxylase
Prohibitin complex
Proteasome
Integrin complex
V-type proton ATPase: V1 part
V-type proton ATPase: V0 part
beta-hexosaminidase
2-oxoisovalerate dehydrogenase
electron transfer flavoprotein
Trifunctional enzyme
28S mitochondrial ribosome
Complex IV - Cytochrome C oxidase
dolichyl-diphosphooligosaccharide-
-protein glycosyltransferase
39S mitochondrial ribosome
40S Ribosome
2-oxoglutarate dehydrogenase
60S Ribosome
Pyruvate dehydrogenase
Detected 
subunits
28
2
7
11
8
4
2
2
7
6
3
3
2
2
2
2
24
7
6
29
16
3
32
3
4-12% AA
28
2
7
11
8
4
2
2
7
6
3
3
2
2
2
2
23
6
5
22
13
2
19
0
5-15% AA
 
28
2
7
11
8
4
2
2
7
6
3
3
2
2
2
2
23
6
5
22
10
3
26
0
Co-localized subunits
Proteins clustered 
together by HCL
HCL27: 22 (79%)
HCL 14: 2 (100%)
HCL 26: 6 (86%)
HCL 32: 10 (91%)
HCL27: 7 (100%)*
HCL 25: 4 (100%)
HCL 27: 2 (100%)
HCL 28: 2 (100%)
 
 
 
 
 
HCL 14: 2 (100%)
HCL 15: 2 (100%)
HCL 25: 2 (100%)
HCL 28: 13 (54%), HCL 
29: 3 (13%), HCL 31: 
6 (25%)
HCL 21: 5 (71%)
 
HCL1: 17 (59%), 
HCL23: 3 (10%)
 
0%
 
0%
Table 1
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To investigate the rate at which proteins cluster together by mere chance we constructed 10 
randomized matrices in which the abundance values were shuffl  ed for each respective AA 
gradient gel. For each randomized matrix we performed the same hierarchical cluster 
analysis that was used for the “real” dataset. To determine the rate at which proteins cluster 
together we focussed on the 16 known mitochondrial complexes described in table 1 and 
calculated the average number of clusters that contain two or more subunits from each 
complex as well as the average number of clustered proteins. Results in supplementary fi le 
S7 show that subunits from complexes in the randomized data cluster together at a much 
lower rate in comparison to the real dataset. On average, 12 subunits from three complexes 
in the randomized data clustered together versus 108 subunits from 14 complexes in the 
original dataset. The co-clustering of subunits in the randomized dataset concerned proteins 
that showed multiple features in their abundance profi les. Complex abundance profi les likely 
increase the probability for these proteins to cluster together with respect to proteins that are 
part of only a single protein complex. 
Four clusters from the HCL analysis were of particular interest as they contained multiple 28S 
and 39S subunits of the mitoribosome which are shown combined in fi gure 5 and table 2. 
Interestingly, the 28S and 39S HCL clusters contained 19 proteins of which eight were 
recently reported to associate or interact with the mitoribosome [98, 99, 101, 102, 344]. The 
28S subunits were found to co-migrate with SARM1, GPI, PTCD3, MIA3, ATAD3A, DARS, 
PHB, PHB2, FAM82A2, EPRS, PRDX6, and NDUFC2. Of these twelve proteins, four are 
reported interactors of the mitoribosome: PTCD3, ATAD3A, PHB, and PHB2 [99, 101, 102, 
344]. Likewise, the 39S cluster contained six co-migrating proteins of which four were 
previously found to co-purify with mitoribosomes: AFG3L2, DBT, ICT1, and STOML2 [98, 
101, 102, 344]. Interestingly, the 28S HCL cluster also showed the presence of a smaller 
complex of primarily 28S subunits with an approximate size around 300kDa (fi gure 5 and 
table 2). Another cluster was found that contained fi ve MRP proteins (MRPL10, MRPL12, 
MRPL45, MRPL53, MRPS21) together with LRPPRC, SLIRP (C14ORF156) and COX7A2 
(fi gure 5 and table 2), with a total approximate molecular mass of about 200 kDa. 
Figure 5: Identifi ed mitochondrial ribosomal complexes by hierarchical clustering. Subunits of the 
mitoribosome were predominantly found in 4 distinct complexes by the HCL analysis as shown in fi gure 
5A. Known subunits of the mitoribosome are bold red whereas proven interactors are in black and bold 
underlined. Proteins previously co-purifi ed with mitoribosomal subunits are italic. The majority of detected 
MRPL subunits co-migrate in a complex of about 3 MDa in size which is referred to as the 39S 
mitoribosome complex in this paper. Besides MRP subunits, six other proteins showed co-migration of 
which ICT1 is a proven interactor of the mitoribosome. The remaining three proteins DBT, STOML2, and 
CAD have previously been reported to co-purify with mitoribosomal proteins in affi  nity purifi cation – mass 
spectrometry studies. Similar to MRPL proteins, all but one of the 28S mitoribosomal MRPS subunits 
showed to co-migrate in a complex of about 1.6 MDa together with 12 other proteins that include the 
known mitoribosome interactor PTCD3. Four of the remaining 11 proteins have been reported to co-purify 
with mitoribosomal subunits in affi  nity purifi cations.This complex is referenced in the text as the 28S 
mitoribosome complex.Figure 5A also shows a smaller complex of about 300 kDa in size that includes 8 
MRPS and 3 MRPL subunits of the mitoribosome together with SARM1.Finally, another complex of about 
200 kDa in size was detected that appears to consist of fi ve mitoribosomal proteins together with 
LRPPRC, C14ORF156 (SLIRP), and COX7A2. Figure 5B shows the distribution of MRP subunits versus 
non-MRP proteins detected in any of the four complexes and Figure 5C shows the distribution of the 21 
non-MRP proteins in three classes: proven interactors, proteins co-purifi ed with mitoribosomal proteins in 
affi  nity purifi cation – mass spectrometry studies, and proteins that have thus far not been described in 
literature related to the mitochondrial ribosome.    
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Table 2. Mitochondrial ribosomal complexes identified by hierarchical clustering of all 
mitochondrial protein profiles. This table summarizes results from the HCL analysis of all 
mitochondrial proteins in the dataset. Subunits of the mitoribosome are marked with an 
asterisk and proven interactors are bold black and underlined. Proteins that were found to 
co-purify with mitoribosomal proteins in selected affinity purification – mass spectrometry 
studies are black italic.
Detailed analysis of mitoribosomal complexes and interactors
Results from the HCL analysis for mitoribosomal proteins prompted us to look at these 
complexes in more detail with respect to previously reported interacting proteins. All 
mitochondrial proteins that were previously reported to interact with the mitoribosome based 
on affinity purification studies by Rorbach [98], Richter [99], and He [101, 102] were 
exclusively selected for further analysis. Selection of proteins that co-purified with 
mitoribosomal proteins also provides supportive evidence for putative interactions between 
co-migrating proteins in our analysis. We focussed on four mitoribosomal complexes of 
interest: the 28S cluster, the 39S cluster, the 300 kDa complex, and the 200kDa complex. 
For the refined HCL analysis, we only used data from gel slices that corresponded with the 
molecular mass region of interest to prevent interference from data of non-relevant gel slices. 
For the analysis of the 28S and 39S HCL clusters we selected slices 3-7 and 1-5 from the 
4-12% AA and 5-15% AA gels, respectively. The HCL analysis shows the co-migration of 
eight and ten previously reported interactors with the 28S and 39S complexes, respectively. 
This analysis identified two additional proteins that co-migrate with the 39S subunits that 
were not readily identified via the HCL analysis of all mitochondrial protein profiles: ERLIN2 
and DLST (figure 6 and table 3). Hierarchical clustering analysis for the 300 kDa subcomplex 
was performed using slices 9-14 and 7-10 of the 4-12% AA and 5-15% AA gels, 
respectively. The HCL analysis identified eleven additional proteins that co-migrated with 
seven MRPS and a single MRPL protein (figure 6 and table 3). All of these eleven protein 
were not picked up in the HCL analysis of all mitochondrial protein profiles. Analysis of the 
200 kDa subcomplex by hierarchical clustering was performed using slices 8-18 from the 
4-12% AA gel and slices 6-14 from the 5-15% AA gel. Three of the 39S mitoribosomal 
subunits apparently co-migrated with C14ORF156 (SLIRP), LRPPRC and two cytochrome c 
oxidase subunits (figure 6 and table 3). This co-migration of cytochrome c oxidase subunits 
with MRP subunits was not observed in the HCL analysis of all mitochondrial protein profiles 
where the cytochrome c oxidase complex was present in a separate cluster. 
39S mitoribosome
MRPL1*
MRPL15*
MRPL17*
MRPL18*
MRPL2*
MRPL21*
MRPL22*
MRPL23*
MRPL24*
MRPL3*
MRPL37*
MRPL38*
MRPL39*
MRPL4*
MRPL44*
MRPL49*
MRPL9*
MRPS30*
AFG3L2
ICT1
DBT
CAD
CLTC
STOML2
28S mitoribosome
MRPL45*
MRPS10*
MRPS11*
MRPS14*
MRPS16*
MRPS17*
MRPS18B*
MRPS2*
MRPS21*
MRPS22*
MRPS23*
MRPS25*
MRPS27*
MRPS28*
DAP3 (MRPS29)*
MRPS31*
MRPS34*
MRPS5*
MRPS7*
MRPS9*
PTCD3
SARM1
GPI
MIA3
ATAD3A
DARS
PHB
PHB2
FAM82A2
EPRS
NDUFC2
PRDX6
300 kDa subcomplex
MRPL18*
MRPS30*
MRPL3*
MRPL2*
MRPS34*
MRPS18B*
MRPS22*
MRPS27*
MRPS25*
MRPS17*
MRPS16
SARM1
200 kDa subcomplex
MRPS21*
MRPL45*
MRPL53*
MRPL10*
MRPL12*
C14ORF156 (SLIRP)
LRPPRC
COX7A2
Table 2
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Table 3. Detected complexes of mitoribosomal proteins together with previously identified 
interactors by hierarchical clustering. Migration profiles from mitochondrial ribosomal proteins and 
previously identified interactors were subjected to hierarchical clustering analysis to examine possible 
co-migration. Proteins from the mitoribosome are marked with an asterisk and functionally validated 
interactors are bold and underlined. Co-purified proteins from selected AP-MS studies are italic.
 
Figure 6: Co-migration of mitoribosomal proteins with previously found interactors in selected 
affinity purification – mass spectrometry studies. Hierarchical clustering was applied to identify 
co-migration of previously identified mitoribosome interactors with ribonucleotide complexes. Only gel 
slices of interest that correspond with the detected mitoribosomal complexes were selected for HCL 
analysis of each complex to increase sensitivity and specificity of the HCL analysis.
 
39S mitoribosome
MRPL1*
MRPL13*
MRPL15*
MRPL17*
MRPL18*
MRPL2*
MRPL21*
MRPL22*
MRPL23*
MRPL24*
MRPL37*
MRPL38*
MRPL39*
MRPL4*
MRPL41*
MRPL43*
MRPL44*
MRPL49*
MRPL9*
MRPS30*
AFG3L2
DBT
DLST
ERLIN2
FASTKD5
GADD45GIP1
ICT1
STOML2
28S mitoribosome
MRPL45*
MRPS10*
MRPS11*
MRPS14*
MRPS15*
MRPS16*
MRPS17*
MRPS18B*
MRPS21*
MRPS22*
MRPS23*
MRPS24*
MRPS25*
MRPS27*
DAP3 (MRPS29)*
MRPS31*
MRPS34*
MRPS35*
MRPS5*
MRPS7*
MRPS9*
PHB
PHB2
PTCD3
300 kDa subcomplex
MRPL18*
MRPS16*
MRPS17*
MRPS18B*
MRPS25*
MRPS26*
MRPS27*
MRPS34*
ACAD9
TMEM126A
NDUFA4
PYCR1
PYCR2
VDAC1
VDAC3
CCDC109A
HADHA
HADHB
HSPD1
200 kDa subcomplex
MRPL10*
MRPL12*
MRPL53*
C14ORF156 (SLIRP)
LRPPRC
COX2
COX4L1
Table 3
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Discussion
The complexome profiling dataset provides a valuable resource to identify putative protein-
protein interactions or to prioritize proteins of interest on the basis of protein co-migration. 
Previously, protein co-migration has typically been analyzed by 2D BN SDS-PAGE in 
combination with western blotting. Technical difficulties associated with immuno detection 
aside, this approach suffers from low-throughput and high costs when many proteins need to 
be analyzed. The complexome profiling dataset of this study is essentially the equivalent of 
3812 two dimensional BN SDS-PAGE western blot detections (duplicate measurements of 
953 proteins from two acryl amide gradient gels) and in addition amenable to computational 
analysis. This allows simple comparisons of migration profiles between proteins of interest or 
the use of computer assisted analyses to identify proteins with similar migration profiles. This 
approach provides independent supportive evidence for protein-protein interactions 
suggested by other methods (e.g. bioinformatic or co-purification studies) and may thus be 
used for validation purposes and to prioritize candidate protein-protein interactions for 
functional validation studies. In addition, complexome profiling data can be used to identify 
putative protein-protein interactions from an independent and untargeted experiment. 
However, depending on the research question and setup of the complexome profiling 
experiment, additional experiments are likely required to prove protein-protein interactions 
since co-migration of non-interacting proteins may occur.
Here, we used our dataset to analyze co-migration profiles of mitoribosomal proteins and 
previously described interactors from co-purification studies. By now, several hundred 
proteins have been suggested to interact with the mitoribosome based on AP-MS studies. 
These are likely present in multiple complexes which probably include secondary interactions 
and false positives. As a first step to elucidate these interactions we looked for co-migrating 
proteins to support alleged interactions. As expected, our analysis showed that the majority 
of 28S and 39S mitoribosomal subunits co-localize in high molecular mass complexes 
together with previously reported (putative) interactors from AP-MS studies. 
For the 28S and 39S complexes, eight and three previously reported interactors from AP-MS 
studies were found to co-migrate, respectively. Of these, two proteins (ICT1, PTCD3) are 
known bona fide interactors or components of the mitoribosome [99, 357, 358]. ICT1 is a 
functional peptidyl-tRNA hydrolase which has been recruited into the mitochondrial ribosome 
[99] and PTCD3 has been reported to associate with the small ribosomal subunit to regulate 
translation [357]. The AFG3L2 protease was found to co-migrate with the 39S complex in 
our dataset. This protease is known to regulate assembly of the mitoribosome and 
biogenesis of its 39S component [358], which could explain its co-migration with the 39S 
complex. The AFG3L2 protein is known to form a heteromeric m-AAA protease complex 
together with paraplegin [359], which we could not confirm since paraplegin was not 
available in our dataset. Prohibitin (PHB), prohibitin 2 (PHB2) and STOML2 were found to 
co-migrate with the 28S and 39S mitoribosomal complexes. STOML2 is a mitochondrial 
inner membrane protein of unknown function that is suggested to recruit prohibitins to 
cardiolipin to form microdomains for optimal assembly of OXPHOS complexes [360, 361]. 
Interaction of PHB and PHB2 with the mitoribosome was expected as He et al reported that 
both proteins contribute to mitochondrial translation [102]. Interestingly, GADD45GIP1 was 
recently shown to be essential for synthesis and insertion of mtDNA encoded OXPHOS 
components [362]. In addition, knockdown of GADD45GIP1 was shown to result in reduced 
mitochondrial protein synthesis [102]. Collectively, the co-migration and co-purification of 
these proteins suggests that protein biogenesis and complex assembly are performed in 
close vicinity. Combined localization of these processes would most likely occur for efficient 
generation of the inner membrane proteins and complexes. However, further research is 
required to confirm this hypothesis which is beyond the scope of this paper. 
The 300 kDa ribosomal complex is rather difficult to put into context. First of all, several 
proteins were found to co-migrate which might be part of other complexes of similar size. 
Both VDAC proteins as well as PYCR1 and PYCR2 are known to form homomeric 
complexes of about 300 kDa. Similarly, both HADHA and HADHB are components of the 
hydroxacyl-CoA dehydrogenase complex for which the determined size corresponds with the 
α2β2 configuration of the enzyme. Interaction of the CCDC109A protein product with the 
mitoribosome seems unlikely from a biochemical point of view as it encodes the 
mitochondrial calcium uniporter [363]. ACAD9 and TMEM126B have recently been reported 
to form a complex I assembly complex together with ECSIT and NDUFAF1 (NDUFAF1 and 
TMEM126B were not detected in our study) with an approximate size of 300 kDa as 
determined by complexome profiling [103]. Interestingly, ACAD9 was found here associated 
with TMEM126A in the 300 kDa complex together with mitoribosomal proteins. Please note 
that also ECSIT did co-migrate with ACAD9 and TMEM126A in our dataset but was not 
included in this refined analysis as it was not identified in the affinity purification studies that 
were used to filter the dataset and is therefore not shown in figure 5. TMEM126A and 
TMEM126B share an 87% amino acid sequence similarity (32% identity) which, together with 
its co-migration with ACAD9 and ECSIT, suggests a possible role for TMEM126A in complex 
I assembly. Detection of NDUFA4 at 300 kDa was rather surprising. This particular protein 
was recently shown to be a subunit of complex IV rather than complex I [364]. In the same 
paper the authors show that NDUFA4 contributes to the activity and biogenesis of the 
holocomplex. In our dataset however, we observed that NDUFA4 was dominantly detected 
at 300 kDa with only minor abundance at the height of complex I (~ 1 MDa) and complex IV 
(~ 200 kDa). This discrepancy might result from the fact that different detergents were used 
for solubilization between both studies (lauryl maltoside versus digitonin) which requires 
further research. Interaction of the protein HSPD1 with the 300 kDa ribonucleotide complex 
might be relevant given its chaperone functionality [365].
Our analyses highlighted a putative 200 kDa ribonucleotide complex that appears to contain 
three MRPL subunits together with LRPPRC, SLIRP and cytochrome c oxidase (COX) 
subunits. Recent studies demonstrated that LRPPRC and SLIRP interact in a 
ribonucleoprotein complex involved in posttranscriptional gene expression regulation in 
mitochondria [366-368]. Work of Sasarman et al. showed that knockdown of LRPPRC 
results in an isolated COX deficiency whereas further knockdown of LRPPRC induces a 
generalized defect of OXPHOS complexes [366]. Co-purification of LRPPRC and SLIRP was 
confirmed by immunodetection and by 2D BN SDS-PAGE immunoblotting. These analyses 
showed that LRPPRC and SLIRP form a complex of approximately 250 kDa, which is 
concordant with our data [366]. The data also showed co-migration of the MRPL proteins 
with COX subunits (figures 5 and 6) which is presumably caused by overlapping co-
localization of both complexes within some of the gel slices. The minimal theoretical mass of 
a complex that consists of MRPL10, MRPL12, MRPL53, SLIRP and LRPPRC, after removal 
of mitochondrial transit peptides and assuming 1:1 stoichiometry for all proteins, is 220 kDa 
which fits the estimated 200 – 231 kDa mass of the complex in our data. Considering the 
function of the LRPPRC/SLIRP complex to regulate post transcriptional gene expression one 
could expect mRNA to be present in this complex. The minimal theoretical mass of the 
putative MRPL10/MRPL12/MRPL53/SLIRP/LRPPRC complex rules out the possibility of any 
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mitochondrial mRNA to be present in the complex on gel, unless the electrophoretic mobility 
of the complex is higher than expected. Interestingly, the approximate mass of a complex 
composed of exclusively LRPPRC (152 kDa), SLIRP (12 kDa) and an average mitochondrial 
mRNA (300 kDa) is about 460 kDa in theory. Assuming normal electrophoretic mobility of the 
LRPPRC/SLIRP complex, one would expect additional proteins to be present rather than 
mRNA with respect to the electrophoretic migration distance of the LRPPRC/SLIRP complex. 
Nevertheless, further research is required to prove the potential interaction between the 
MRPL subunits and the previously established LRPPRC/SLIRP complex to rule out the 
possibility that both complexes co-migrated as non-related, individual complexes. 
Our dataset provides the fi rst available analysis of protein complexes in human cells by 
complexome profi ling. The complexome profi ling dataset presented in this paper is not 
exclusively limited to the analysis of mitochondrial protein-protein interactions since a 
mitochondrial enriched fraction was used. Data for several hundred non-mitochondrial 
proteins is also available from our dataset that can be used to analyze protein complexes in 
other cellular compartments. Although this dataset contains a lot of information, future 
complexome profi ling experiments need to be performed in diff erent cell types, tissues, and 
diff erential conditions to completely elucidate the composition of mitochondrial protein 
complexes in humans. Ideally, future complexome profi ling datasets should be merged with 
existing datasets in order to fully understand the complex dynamics of protein-protein 
interactions. To this end, the fact that protein electrophoretic migration profi les are stored 
within a data matrix readily facilitates the combination of present and future datasets. 
Conclusions
We have generated a collection of BNE profi les for 953 proteins that can be used to identify 
novel protein-protein interaction and to underpin or prioritize candidate protein-protein 
interactions. As an example we have used our dataset to analyze mitoribosomal complexes. 
Our analysis showed for the fi rst time that mitoribosomal complexes can be analyzed by blue 
native electrophoresis as demonstrated via detection of at least four distinct complexes that 
are composed of mitoribosomal subunits together with potentially novel and previously 
reported interactors. In addition, co-migration of multiple proteins associated with the 
biogenesis of inner membrane complexes together with the 39S and 28S mitoribosomal 
complexes is supportive of co-translational assembly in human cells. Our analysis also 
exposed a putative 200 kDa ribonucleoprotein complex that potentially contains LRPPRC 
and SLIRP together with three MRPL subunits. Finally, our data highlights TMEM126A as a 
putative complex I assembly factor based on co-migration with two known CI assembly 
chaperones and its sequence similarity with the CI assembly factor TMEM126B which is 
known to interact with the same two CI assembly factors in other cell types.
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Introduction
Macromolecular assemblies of proteins into complexes as well as dynamic interactions 
between proteins are essential in many diff erent cellular processes. Our current 
understanding of what, how, when, and why many of the estimated 200.000 to 300.000 
unique proteins in humans interact with one another is still very limited. Detailed knowledge 
about the inventory of cellular protein-protein interactions (PPIs) needs to be expanded in 
order to better understand cellular adaptations induced by pathogenic mutations. Analysis of 
protein interaction networks in large cohorts of samples are key to comprehend genotype-
phenotype relationships since proteins rarely perform solo. Ultimately, mapped protein-
protein interactions may serve as therapeutic targets in intervention studies through targeted 
disruption of interactions by pharmacological compounds. 
Current estimates for the total number of PPIs (the ‘interactome’) in human cells are in 
the order of 154.000 – 369.000 physical interactions [369]. This overwhelming number 
of interactions pose a signifi cant challenge in terms of required throughput for current 
methodologies to study PPIs. In addition, the possibility of tissue specifi c composition, 
alternative splicing, post-translational modifi cations, and dynamic nature of protein-protein 
interactions increase the complexity of the system even further. This requires the analysis 
of protein-protein interactions to be performed in a variety of tissues and under diff erential 
conditions to unravel the human interactome. 
Large-scale qualitative and quantitative analysis of protein-protein interactions is still in 
its infancy. Current methodologies need to be developed further to increase throughput, 
precision and accuracy in order to cope with the complexity of biological systems. The 
development and application of a novel approach to study protein-protein interactions 
by combining blue native gel electrophoresis with shotgun proteomics (complexome 
profi ling) [92-94, 103], described in part II of this thesis, is one of the few currently available 
methodologies that hold the potential to signifi cantly contribute to our understanding of 
the dynamic interactome. This chapter will discuss the merits and current limitations of 
complexome profi ling. It also aims to provide directions for future research to optimize the 
complexome profi ling approach to reach its full potential.
 
Complexome profi ling
At the onset of the experimental work described in this thesis, the combination of two 
dimensional blue native sodium dodecyl sulphate polyacryl amide gel electrophoresis (2D 
BN SDS-PAGE) with mass spectrometric protein identifi cation had just been established 
[286]. To setup and evaluate this technology for analysis of the mitochondrial interactome, 
we fi rst examined the protein complexes of the model organism Methonthermobacter 
thermautotrophicus strain delta H by 2D BN SDS-PAGE and matrix assisted laser desorption 
ionization time-of-fl ight (MALDI-TOF) mass spectrometry in chapter 7 [324]. This study not 
only provided novel insights into the molecular composition of protein complexes in 
M. thermautotrophicus, but also highlighted some of the limitations of this approach. These 
limitations were even more prominent with the analysis of more challenging samples such as 
the mitochondrial interactome from fi broblast cells and skeletal muscle (unpublished data): 
(i) Separation of protein complexes into their respective subunits in the second dimension 
SDS-PAGE step reduced the resolution of the fi rst dimension BNE separation. 
(ii) Identifi cation of multiple proteins within a single or merged gel spot complicate assignment 
of these proteins to a specifi c complex (fi gure 1). 
(iii) resolution of the technique does not always allow straight forward annotation of proteins 
> Chapter 10
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to complexes in gel areas crowded by protein spots and partially overlapping protein stain 
signals. (iv) Protein complexes are inferred by manual interpretation of the data which can be 
ambiguous and time consuming. Most of the issues listed here can be resolved by specific 
protein detection via immunoblotting. This established method is, however, not compatible 
with the large-scale analysis of protein co-migration considering the costs and low-
throughput of the technique. Moreover, the use of antibodies for specific protein detection 
limits the technique to selected protein targets, which excludes unexpected proteins. 
Complexome profiling resolves or improves all of the issues mentioned above via ‘direct’ 
analysis of proteins from native electrophoresis gels by shotgun proteomics. In complexome 
profiling, protein complexes are separated by blue native gel electrophoresis after which the 
gel lane is cut into gel slices of even size. Each individual gel slice is subsequently analyzed 
by shotgun proteomics to determine the relative abundance of each identified protein over 
the entire blue native gel lane (protein migration profile). By doing so, complexome profiling 
eliminates the need for a second dimension gel electrophoresis step and preserves the 
resolution of the native electrophoresis step as long as the width of the gel slices does 
not exceed the width of the electrophoretic protein bands. The most important advantage 
that complexome profiling offers over 2D BN SDS-PAGE MS is that each protein profile is 
specifically acquired without any crosstalk of detection signals between proteins (figure 1). 
Finally, computational analysis can be performed on the data to infer protein complexes, 
which eliminates the ambiguous and time consuming manual assignment of protein spots to 
complexes in 2D BN SDS-PAGE MS.
 
Fig1. Advantage of protein specific detection by complexome profiling over two dimensional blue native 
SDS-PAGE mass spectrometry. In this example, two protein complexes are separated by blue native 
gel electrophoresis. With the 2D BN SDS-PAGE MS approach, two adjacent protein spots (proteins C 
& D) are merged and cannot be discerned by protein stain signal or mass spectrometric identification. 
In contrast, complexome profiling is able to resolve protein C from protein D due to the fact that protein 
profiles are acquired without any crosstalk of signals. Crosstalk between protein profiles is cancelled out 
since peptides unique to a single protein are used to generate protein profiles.
Complexome profiling of mitochondrial protein complexes
The basic concept of shotgun proteomics to establish protein migration profiles directly from 
blue native gel separations was introduced in chapter 8 [93]. Here, a mitochondrial enriched 
fraction of HEK293 cells was analyzed using two complementary acryl amide gradient gels. 
Data analysis showed that subunits from 9 selected complexes were found to co-migrate 
at the expected electrophoretic migration distance of each respective complex in both gels, 
thereby confirming the validity of the approach. In the same chapter, the use of computer 
assisted data analysis to identify proteins of interest was demonstrated via the identification 
of 1 established and 6 novel putative complex I assembly factors. These seven proteins were 
identified by protein correlation profiling (PCP), which selectively identified proteins that co-
migrated with most of the assembly intermediates of complex I. Interestingly, five out of seven 
candidate CI assembly chaperones have previously been implicated in CI disease biology 
in work of Pagliarina et al [50]. Later work of Saada et al confirmed that one of these novel 
proteins (C3ORF60 / NDUFAF4) is a bona fide complex I assembly chaperone [95]. 
The success of the PCP approach that was used here was in part due to the fact that the 
assembly intermediates profile was rather unique so that only a few high-ranking candidates 
were identified. Use of the PCP approach to identify CI assembly factors that co-migrate with 
only a single assembly intermediate was not specific enough and yielded too many candidate 
proteins for subsequent functional validation studies (unpublished data). This illustrates one 
of the limitations of PCP and the need for alternative computational approaches to identify 
protein-protein interactions from blue native shotgun proteomics data. In addition, PCP 
is a targeted method that is used to exclusively identify proteins in the dataset that have 
a similar profile compared to the profile of interest, which is not suited to infer all available 
complexes from the data. Later work of Remmerie [347] and Heide [103] used hierarchical 
clustering (HCL) methods to identify protein complexes from BNE shotgun proteomics data, 
which was coined complexome profiling by Heide et al. In the work of Heide, mitochondrial 
protein complexes from rat liver were analyzed by complexome profiling which lead to the 
identification of a novel CI assembly factor TMEM126B. Interestingly, the HCL approach was 
able to identify TMEM126A as novel CI assembly factor via its co-migration with a single CI 
assembly intermediate complex. Complexome profiling was also used in chapter 9 of this 
thesis [92] to catalogue human mitochondrial complexes in HEK293 cells. 
In the same chapter, four mitochondrial ribosomal complexes were studied in more detail by 
HCL analyses of protein migration profiles from selected gel slices of interest (restricted 
mass ranges). 
Both complexome profiling studies of Heide and Wessels demonstrated the great sensitivity 
and high resolution of the technique for protein complexes. For instance, both studies 
established migration profiles for hundreds of proteins (539 and 950 proteins, respectively) 
that include several low abundant protein complexes such as mitochondrial protein import 
complexes. Nevertheless, several aspects of the complexome profiling approach can be 
improved to achieve higher resolution, more accurate protein migration profiles, higher 
coverage of protein complexes, multi-sample comparisons and molecular characterization 
of individual subunits. The following paragraphs will discuss these aspects and present 
possible improvements. 
Generation of protein migration profiles
The generation of protein migration profiles from blue native gels can be divided into four 
consecutive stages:
Stage I: Sample preparation (BNE gel fractionation and proteolytical digestion)
Stage II: Shotgun proteomics of the proteolytical peptide mixtures 
Stage III: Protein and peptide identification from tandem mass spectrometry data
Stage IV: Quantitative data extraction and assembly of protein migration profiles
It is critical in complexome profiling to cut the blue native gel lane as precise and reproducible 
as possible. In addition, the width of the gel slices should ideally not exceed that of the 
electrophoretic protein bands to achieve optimal resolution. Manual gel slicing used in 
chapters 8 and 9 is not ideal in this sense, as it might prove challenging to achieve straight 
cuts at even distance. Any variation in gel slicing lowers resolution and might even introduce 
162 163
artifacts in protein migration profi les. Recent work of Schwenk used a microcryotome to 
fractionate blue native gels [346]. This not only ensures reproducible and straight cut gel 
slicing but also enables gel slices to be cut with sub millimeter width. Decreasing the gel slice 
width holds several advantages. First of all, the achieved higher resolution helps in discerning 
complexes of similar molecular size (fi g 2). Secondly, it also allows to better determine 
the focusing width of complexes which can be used as a “footprint” to identify individual 
complexes that share an identical migration distance (fi g 3). However, smaller gel slices 
subsequently result in lower peptide amounts per gel slice for LC-MS/MS analyses. Here, the 
optimal width of gel slices needs to be empirically determined as the protein amount loaded 
on BNE gels as well as the sample composition, BNE resolution and LC-MS/MS sensitivity 
are all factors that may determine the optimal gel slice width in an experiment. Analogous 
to the process of gel slicing, in-gel protein digestion and subsequent processing steps for 
LC-MS/MS analyses need to be as reproducible as possible with optimal peptide recovery. 
Here, automated sample processing by robotics likely off ers an adequate solution, especially 
considering the increased number of gel slices that need to be processed when minimizing 
the width of the gel slices. 
 
Fig. 2. Smaller gel slice width increases complexome profi ling resolution to better resolve complexes with 
analogous molecular mass. Two homomeric proteins complexes, A and B, are separated by blue native 
gel electrophoresis and analyzed by shotgun proteomics in this example. Here, smaller gel slice width 
eff ectively increases the resolution of protein profi les such that both complexes are resolved.
 
Fig 3. High resolution protein profi les can be used to resolve protein complexes with identical molecular 
mass. This fi gure shows an example of two complexes, I & II, that are not resolved by blue native gel 
electrophoresis. Nevertheless, the high resolution protein profi les allow both complexes to be resolved on 
the basis of their respective focusing width in the blue native gel.
Shotgun proteomics analysis of the proteolytical peptide fractions require high-throughput, 
quantitative accuracy, sensitivity, reproducibility, and high tandem mass spectrometry 
effi  ciency. These are all generic requirements in most LC-MS/MS experiment and generally 
improve with the introduction of each new generation of mass spectrometers, liquid 
chromatography systems, chromatographic columns and data processing methods. 
Nevertheless, the tradeoff  between throughput and complexome coverage will likely remain 
an important consideration in spite of technical advances.
Peptide and protein identifi cation via protein sequence database searching of tandem 
mass spectrometry data is the third stage in the generation of protein migration profi les. 
First, a database search is performed that attempts to match each individual tandem mass 
spectrum with a single peptide sequence. Next, all peptide matches are clustered to proteins 
and validation criteria are applied to control the rate of false positive protein identifi cations. 
These steps determine to a large extent the percentage of matched tandem mass 
spectrometry data, and thus output quantity and robustness. First of all, optimal database 
search software or algorithms should be used to match as many tandem mass spectra 
with peptide sequences as possible. In addition, the database search software should also 
maximize the scoring diff erence between true and false positive matches for effi  cient data 
validation. Validation of database search results is required to control the false discovery 
rate (FDR) whilst maximizing the number of protein and peptide identifi cations. Recent FDR 
based validation strategies (e.g. Mascot Percolator [144, 145] and MaxQuant [143]) achieve 
higher recovery of peptide and protein matches at specifi ed FDR tolerances compared to 
the validation methods used in complexome profi ling thus far. Besides advances in validation 
strategies, higher FDR tolerances lower robustness of the data, but signifi cantly enhance 
the number of identifi ed proteins and peptides from tandem mass spectrometry data. The 
optimal FDR tolerance for complexome profi ling studies has not been determined thus far, 
and may depend on the method that is used to assemble the protein migration profi les. For 
instance, spectral count methods that determine the protein abundance in each individual 
gel slice may require more stringent FDR control than the method described in chapter 9, 
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which uses coherent peptide abundance profiles constructed from all gel slices to assemble 
protein migration profiles. The use of coherent peptide abundance profiles to assemble 
protein migration profiles is based on the hypothesis that true peptide identifications from a 
single protein all share the same abundance profile. Here, false positive peptide identifications 
should have minimal effect on the protein migration profile as long as the majority of peptide 
identification for a protein are true positive results: aberrant peptide abundance profiles 
are removed via outlier detection in this method and only the top N most coherent peptide 
abundance profiles are used to assemble the protein migration profile. This is also supported 
by the fact that random peptide matches cluster to the same protein at a lower rate than 
true positive peptide matches [121]. Conceivably, the similarity between peptide abundance 
profiles from a single protein can be used as an additional parameter to better discriminate 
between true- and false positive identifications in FDR validation strategies. Hence, false 
positive protein identifications result from random peptide identifications which are less likely 
to share similar peptide abundance profiles than true positive peptide identifications (provided 
that they are not exclusively detected in a single gel slice). Further research is required to 
test this hypothesis and to determine the optimal FDR tolerance to maximize the number of 
peptide identifications obtained from a single complexome profiling experiment. 
The final stage in data processing is the assembly of protein migration profiles from 
quantitative data. Different methods are available to extract quantitative information at the 
peptide or protein level for each individual gel slice to assemble protein migration profiles. 
Spectral count methods that use the number of matched tandem mass spectra as measure 
for protein abundance in individual gel slices can be used to assemble protein migration 
profiles [93, 370]. Such methods in general suffer from poor quantitative resolution and are 
known to be inaccurate for proteins that are covered by a low number of unique peptide 
matches (e.g. low abundant or small proteins). Nevertheless, spectral count methods 
are easily implemented and when normalized for the number of theoretically observable 
peptides for each protein allow to compare abundances between different proteins [51]. 
Other methods use extracted ion currents (XIC) to determine the abundance of individual 
peptides in each gel slice. Here, area under the curve from XICs at the MS level [92, 93, 
113] or MS/MS level [325] can be used. Advantage of these methods over spectral count 
methods include increased accuracy and higher quantitative resolution. XIC based methods 
are therefore better suited to analyze proteins that are covered by only a few peptide 
matches. However, without any further corrections or internal standards these methods 
cannot be used to compare abundances between different proteins. Please note that 
the use of multiple reaction monitoring (MS/MS level) in combination with stable isotope 
coded peptide standards is able to determine the absolute protein amount in individual gel 
slices with great precision which can be used to accurately determine the stoichiometry of 
individual subunits. Recently, intensity based absolute quantitation (iBAQ) was introduction as 
a hybrid method that corrects MS level extracted ion current for the number of theoretically 
detectable peptides [371]. This method combines the merits of both XIC and spectral 
count based quantitation methods as it uses accurate XIC values and allows for abundance 
comparisons between different proteins. Finally, for XIC based peptide quantitation methods 
(except iBAQ) different approaches can be used to assemble protein migration profiles. The 
most straightforward method uses exclusively the XIC values of the three most abundant 
peptides at the MS level for each protein to assemble protein migration profiles (Chapter 8). 
Chapter 9 describes an alternative method that selects the top N most coherent peptide 
abundance profiles for the generation of protein migration profiles to minimize the impact 
of quantitation artifacts, false positive peptide identifications and quasi-random nature of 
peptide identification on the protein migration profile. Despite the advantages of this XIC 
based protein migration profile assembly method over spectral count methods, the use of 
iBAQ in complexome profiling should be evaluated as it could provide valuable information on 
subunit stoichiometry and relative abundance of complexes within and between samples.
Computer assisted identification of protein co-migration
The identification of protein complexes by computer assisted analysis of protein migration 
profiles is a critical and challenging step in complexome profiling. Up to several thousand 
proteins can be detected within a single experiment which is further complicated by the fact 
that a single protein can be part of multiple complexes that may greatly vary in abundance. 
Hierarchical clustering (HCL) of protein migration profiles has been successfully used to 
identify protein complexes [92, 103, 347]. However, current HCL approaches use the total 
protein migration profile to calculate similarity or dissimilarity between protein migration 
profiles to generate clusters, which is not ideal considering the fact that a single protein may 
be part of multiple distinct complexes. This may lead to overlooked protein complexes when 
proteins that interact are assigned to different clusters due to their additional presence in 
other gel slices. An example hereof is shown in figure 4 using complexome profiling data from 
chapter 9. The complex I subunit NDUFA10 was assigned to cluster 19 instead of cluster 
22 which contained the vast majority of complex I subunits. Here, the separate clustering of 
NDUFA10 from other CI subunits is caused by the high abundance if the monomeric form of 
NDUFA10. Therefore, optimized distance metrics and dendogram construction methods for 
HCL analysis are needed that maximize the extracted amount of information that is readily 
available from complexome profiles. Conceivably, the use of individual features extracted from 
protein migration profiles could be used to identify multiple interactions for a single protein. 
Another challenge in complexome profiling is that non-interacting protein complexes of 
similar size may not be discerned on the basis of their migration profiles. An example hereof 
is the co-migration of mitochondrial complex I with the cytosolic T-complex in chapter 9. 
Recent work of Havugimana used a bioinformatics approach to infer a high-confidence 
interactome from protein abundance profiles acquired by biochemical separations of native 
complexes [370]. Weighted functional association evidence assembled from literature and 
public databases was combined with the protein abundance profiles using a random forest 
classifier and a training set of reference complexes. Such an approach would allow to 
differentiate between co-migrating but non-interacting protein complexes and would also 
increase confidence in inferred protein-protein interactions. Possible disadvantage from the 
use of available evidence to assess detected protein-protein interactions is that true de novo 
interactions might be filtered out. Nevertheless, the approach of Hayugimana should 
be assessed for complexome profiling as it may hold several advantages over current 
analysis methods.
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Fig. 4. Protein profi les with multiple features complicate hierarchical clustering. Hierarchical clustering 
results from chapter X are used in this example to illustrate limitations for the analysis of protein profi les 
with multiple local maxima (features). Protein NDUFA10 is a subunit of mitochondrial complex I which 
localizes in slice 6 from 4-12% acryl amide gel and slices 3 and 4 from the 5-15% acryl amide gel. 
Hierarchical clustering analysis of the protein profi les assigned NDUFA10 to cluster 19. The vast majority 
of complex I subunits, however, were assigned to cluster 21. Here, NDUFA10 was assigned to a diff erent 
cluster with respect to other complex I subunits due to its high abundant monomeric form in slice 24 of 
the 4-12% acryl amide gel and slice 22 of the 5-15% acryl amide gel. 
Multi sample comparisons
Diff erential analysis of multiple samples by complexome profi ling enables the large-
scale analysis of cellular adaptations at the level of protein complexes. This requires the 
assessment of both qualitative and quantitative changes between samples, including 
post-translational modifi cations. There are at least two major challenges in quantitative 
complexome profi ling of multiple samples. First, quantitation needs to be accurate and robust 
between samples. Secondly, data analysis and visualization of the acquired complexome 
profi les should facilitate straight forward identifi cation of qualitative and quantitative 
diff erences between samples, preferably with statistical confi dence indices. 
Quantitative comparisons between complexome profi les can be achieved via label-free and 
stable isotope labeling by amino acids in culture (SILAC) [54, 94] approaches. Of these, 
SILAC has several important advantages over the label-free approach as it eff ectively 
eliminates any variation introduced by protein extraction, blue native gel electrophoresis, 
sample preparation and subsequent shotgun proteomics. With SILAC, cells can be mixed 
prior to protein extraction and blue native gel electrophoresis as proteins are labeled in-vivo 
with stable isotope coded amino acids. Multiplexed samples are separated on a single 
blue native gel electrophoresis lane which eliminates gel-to-gel variations. A disadvantage 
of SILAC is that the technique is best performed with living cells or organisms that in-vivo 
incorporate the stable isotope coded amino acids. In addition, SILAC labeling of model 
organisms such as mice may prove too costly to implement in most research projects. 
Subsequently, quantitative complexome profi ling of non-cultured tissues or model organisms 
relies on label-free quantitation approaches which are more challenging to implement. 
First of all, gel-to-gel variation should be minimal between experiments and would require 
alignment of complexome profi les between samples in the blue native gel dimension. 
Secondly, normalization of the quantitative data between complexome profi les has to be 
achieved without the use of internal standards. 
Both the analysis and visualization of qualitative and quantitative diff erences between 
complexome profi les is not trivial. Complexes may diff er in both composition and abundance 
between samples. This complicates the quantitation of proteins between samples 
when shifts in the blue native dimension occur due to loss or gain of interactions. This 
is exemplifi ed in fi gure 5 where a hypothetical protein complex (Protein A & B) is equally 
abundant between samples A and B but the complex gained an interactions partner (Protein 
C) in sample A. The quantitative comparison of this complex between both samples should 
thus be performed using data from diff erent gel slices due to the mass shift of the complex. 
Here, manual interpretation of the data is required to ascertain that the correct complexes are 
quantitatively compared between samples. This might prove challenging with respect to data 
complexity caused by the number of protein profi les within each experiment and analyzed 
samples. Visualization of the data from experiments by overlaying the profi les with diff erent 
colors to indicate abundance would help with data interpretation (fi g 5).
 
Fig. 5. Multi sample comparison by complexome profi ling via overlaid protein profi les. This example 
shows theoretical complexome profi ling data for three complexes from sample A and sample B. The fi rst 
complex that consists of proteins A, B and C is equally abundant in both samples but lost interaction 
partner protein C in sample B. A second complex consists of proteins α and β and is equally abundant 
between both samples. Finally, a third complex that consists of proteins i, ii, iii, iv and v is more abundant 
in sample A compared to sample B. An overlay of protein profi les from both samples enables quick and 
unambiguous detection of both qualitative and quantitative diff erences between samples. 
In-depth molecular characterization of protein complexes
Regulation of the activity and function of protein complexes can also be achieved through 
post-translation modifi cations (PTMs) of subunits. Moreover, subunits may require post-
translational modifi cations in order to be assembled into a functional holocomplex. Analysis 
of PTMs is typically performed by tandem mass spectrometry experiments at the peptide 
level. The possibility to identify and monitor PTMs of proteins assembled into complexes as 
well as in their monomeric form by complexome profi ling helps to elucidate the function of a 
specifi c PTM. In addition, this approach does not suff er from the mixed results obtained by 
typical shotgun proteomics of denatured samples: in complexome profi ling PTMs that are 
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specifi c for the state of a protein (either incorporated within a complex or monomeric) can be 
analyzed individually.
The application of mass spectrometry in complexome profi ling can be exploited even further 
for the analysis of PTMs. Recent advances in mass spectrometry technology enable the 
direct analysis of intact proteins for accurate mass determination and structural analysis via 
tandem mass spectrometry experiments. Analysis of PTMs through a combination of intact 
protein (tandem)mass spectrometry and typical shotgun proteomics provides far greater 
detail and coverage that could ever be achieved by shotgun proteomics alone. First of all, 
diff erent modifi ed forms of a single protein cannot be discerned through analysis at the 
peptide level by tandem mass spectrometry (fi gure 6). Hence, all information that linked 
modifi ed peptides to a specifi c protein form is lost when diff erent protein forms are cut into 
peptides and mixed together. Therefore, one cannot deduce which modifi ed forms of a 
protein were present when multiple PTMs were identifi ed. Liquid chromatography with online 
mass spectrometry analysis at the intact protein level may solve this problem as each protein 
form is separately detected, provided that they diff er in mass or chromatographic retention 
time. Finally, complete sequence coverage of a protein at the peptide level would be required 
to rule out the potential issue of overlooked modifi cations. Complete sequence coverage 
is diffi  cult to achieve for many proteins in general, and may well be impossible in specifi c 
cases [372]. Accurate mass determination at the intact protein level may help to rule out the 
possibility of overlooked modifi cations since the measured protein mass should correspond 
to that of the protein sequence with its modifi cations. At present, sequence coverage by 
tandem mass spectrometry experiments of intact proteins is generally not suffi  cient to identify 
and map all PTMs for a given protein. Intact protein mass spectrometry should therefore be 
combined with shotgun proteomics for in-depth molecular characterization of proteins. This 
can be achieved by liquid chromatography – mass spectrometry analysis of intact proteins 
combined with parallel fractionation and subsequent shotgun proteomics analysis of the 
acquired fractions. This approach could be interfaced with blue native gel electrophoresis 
when appropriate methods are used to extract intact proteins from a gel slice of interest (e.g. 
by electroelution or diff usion). 
 
Fig 6. Possible protein forms as a function of identifi ed peptide forms in shotgun proteomics. This fi gure 
shows that the identifi cation of three diff erent peptides in their processed and unprocessed form could 
originate from multiple combinations of diff erent protein forms. In this example, the three peptides account 
for 100% amino acid sequence coverage of the protein to rule out potential unknown modifi cations due to 
missed peptides. Modifi cations: (P)  phosphorylation; (M) Methylation, (A) acetylation.
Future perspectives
Complexome profi ling is a powerful approach for the large-scale analysis of protein-protein 
interactions. In this thesis, complexome profi ling was used to identify novel complex I 
assembly factors and mitochondrial ribosomal interactions. Conceivably, the published 
HEK293 mitochondrial complexome profi ling data set will proof to be a valuable tool for 
the research community to verify or discover de novo protein-protein interactions. Future 
technical advances in complexome profi ling methodology will enhance the potential of this 
technique to unravel multiprotein complexes in cellular systems. 
Analysis of protein regulation at the complexome level is key to understand cellular biology as 
the majority of proteins do not perform solo. This is stressed by the fact that protein function 
may be determined via interaction partners which underlines the necessity to perform 
diff erential proteomics at the level of native complexes. it is therefore critical to know exactly 
what protein form is diff erentially regulated in disease to formulate hypotheses about the 
biological implication of altered protein expression. Please note that interactions between 
proteins or complexes can play a signifi cant role in cellular adaptations that may not require 
any change in the expression levels of the interaction partners. Cellular adaptations through 
protein-protein interactions that do not rely on altered expression of interacting proteins 
are not detected by conventional shotgun proteomics of denatured and digested protein 
samples. Qualitative and quantitative complexome profi ling could thus be used to better 
understand genotype-phenotype relationships. 
We believe that the application of complexome profi ling in clinical proteomics will lead to the 
identifi cation of disease specifi c complexes as key players in cellular networks. Such protein-
protein interactions may serve as biomarkers and help to better understand genotype-
phenotype relationships in patients. In addition, complexome profi ling is expected to identify 
novel protein interaction partners as disease gene candidates for diagnostics. Ultimately, 
comprehensive understanding of protein-protein interactions in relationship with disease may 
lead to the identifi cation of drug targets for therapeutic interventions.
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Summary
Mitochondria are at the heart of various cellular processes that extend the role of this 
organelle beyond that of “mere” ATP generation. It is therefore not surprising that 
mitochondrial functions are involved in a multitude of disorders such as cancer, diabetes, 
Alzheimer’s disease and Parkinson’s disease. Moreover, mitochondrial dysfunction often 
result in complex multisystemic disorders with diff erent severity and heterogeneous 
symptoms in patients. 
Proteins are the functional output of a cell’s genomic blueprint that ultimately determine its 
cellular phenotype, function and to a large extend cellular state. It is therefore key to study 
mitochondrial proteins in order to fathom the complex genotype-phenotype relationships in 
patients with mitochondrial disorders and to elucidate the exact role of this organelle in other 
diseases.
A fi rst step to study mitochondrial proteins is to “simply” determine what proteins are 
localized within or at mitochondria. Secondly, it is eminent to determine the function, three 
dimensional structure, expression levels, post-translational modifi cations and interactions 
of these proteins in various tissues and cellular states. This information is crucial to fully 
understand how these proteins function and how they are controlled under various cellular 
conditions in diff erent tissues. Such knowledge can be used to improve diagnostics and to 
identify reliable biomarkers but may also lead to the rational design of drug interventions and 
treatments.
At present, the large scale analysis of proteins is driven by mass spectrometry based 
methods within the fi eld of proteomics. Chapter one introduces the reader to mitochondria, 
the mitochondrial proteome, and the basic concepts behind proteomics technologies that are 
used to study this sub proteome. It also provides an overview of some important proteomics 
datasets that contributed to our current understanding of the mitochondrial proteome. 
Hyphenated techniques such as liquid chromatography with online tandem mass 
spectrometry (LC-MS/MS) are commonly used in proteomics. Typical “shotgun” experiments 
use proteases to cut proteins into smaller peptides which are more amenable for amino acid 
sequence analysis by tandem mass spectrometry. Fragmentation spectra from tandem mass 
spectrometry experiments are subsequently matched to available peptide sequences in a 
database to infer protein identifi cations. In general, LC-MS/MS experiments produce large 
amounts of data that are in the order of several thousand up to millions of fragmentation 
spectra. Processing of peptide identifi cation data from such database searches is not a 
trivial matter and requires specialized software to discern between true and false (poly)
peptide identifi cations. In addition, the software is also used to map and cluster the identifi ed 
peptide sequences back to proteins in the database in or between experiments. Chapter 
two describes some of the principles behind these data processing steps and introduces 
our in-house developed software tool “PROTON” (PROteomics TOols Nijmegen). PROTON 
was used for data processing in most of the experimental chapters in this thesis and laid the 
foundation for 19 papers that have been published in peer-reviewed journals. 
Chapter three describes the typical sample processing steps and hardware setup that 
were used in most chapters of this thesis to perform shotgun proteomics by LC-MS/
MS. Although this chapter is focussed on proteomics of the aerobic ammonium-oxidizing 
bacterium Nitrosomonas eutropha, the methodology and hardware setup are used in an 
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identical fashion to study many other species such as human. This chapter provides the 
minimal background information to understand the typical sample processing steps and 
mass spectrometry instrument setup that was used for most the experimental chapters in 
this thesis.
The identification of peptides that discriminate between samples cohorts is a challenging 
task in proteomics due to sample complexity, data amount and imperfections in the 
analytical data. However, such analyses are paramount to identify (poly)peptides that 
may serve as biomarkers for diagnostic and prognostic purposes as well as disease 
state monitoring. At present, most LC-MS/MS approaches start with the identification 
of (poly)peptides in the samples. Subsequently, the relative abundance of all respective 
compounds that were identified in the previous step is then extracted from the data to 
identify discriminating proteins or peptides. A major drawback of this approach is that it fails 
to discover discriminating peptides that were not readily identified via database searches 
of the “randomly” acquired tandem mass spectrometry data. To overcome this problem we 
generated a comprehensive benchmark dataset in chapter four that was used to develop an 
alternative approach in chapter five that first identifies the discriminating peptides between 
the sample cohorts which is then used to target the mass spectrometer to selectively identify 
(poly)peptides of interest in subsequent analyses. This approach minimizes the risk of not 
detecting low abundant discriminating peptide ions and maximizes the likelihood to identify 
these discriminating peptides as the mass spectrometer selectively targets only peptides of 
interest using instrument settings that are optimized for sensitivity and spectral quality instead 
of fragmentation spectra quantity.
Chapters 6 to 9 focus on physical interactions between proteins that are organized 
into complexes or interaction networks. Many protein-protein interactions are crucial to 
sustain important cellular processes which makes it evident to catalogue and functionally 
characterize these interactions to ultimately understand genotype-phenotype relationships in 
patients with mitochondrial disorders. 
Mitochondrial protein synthesis is an important cellular process that synthesizes the 
mitochondrial DNA encoded proteins that are required to assemble all but one of the 
oxidative phosphorylation system complexes. Hereto, genetic information contained 
in mitochondrial messenger RNA (mRNA) is converted into proteins by the translation 
machinery. Mitochondrial ribosomal complexes perform a crucial task in this process to allow 
transfer RNA’s (tRNA) to dock and recognize each specific codon on the bound mRNA, 
after which the amino acid is released from the corresponding tRNA and attached to the 
growing peptide chain at the ribosome. Various other proteins interact with the ribosome at 
the initiation, elongation and termination phases of translation. At present, not all proteins 
that interact with mitochondrial ribosomes are known. In Chapter six we identified the 
mitochondrial ribosomal release factor (mtRRF) that is responsible for the disassembly of the 
fully assembled ribosome into its respective small and large subunits at the end of translation. 
This process recycles both parts of the ribosome so that they can be reassembled to 
initiate another round of protein synthesis. Here, proteomics was used to identify proteins 
that interacted with expressed affinity tagged mtRRF which included many novel putative 
interactors that may play a role in mitochondrial protein synthesis. Interestingly, nearly all 
of the previously published nucleoid proteins were identified which highlighted a putative 
physical link between transcription and translation processes. 
Analysis of protein-protein interactions by affinity or immuno purification in combination 
with tandem mass spectrometry is a powerful method to map protein interaction networks. 
However, the affinity purification tag may interfere with native interactions. Similarly, antibody 
based purification of a specific target protein together with its interactors may fail for various 
reasons. Another drawback of both targeted methodologies is that current technology 
prohibits high-throughput large scale screens of protein-protein interactions. Therefore, 
holistic approaches which separate protein complexes and use high-throughput proteomics 
technology to identify co-migrating or co-eluting proteins provide an attractive alternative.
 
In chapter seven we used a combination of two dimensional blue native sodium dodecyl 
sulphate polyacrylamide gel electrophesis (2D BN/SDS PAGE) and matrix assisted laser 
desorption ionization time-of-flight (MALDI TOF) mass spectrometry to identify protein 
complexes in the thermophylic archaeon Methanothermobacter thermautotrophocus 
strain delta H. This organism has been used previously as a model organism for numerous 
biochemical studies. Its well annotated genome, available biochemical knowledge and 
large quantities of biomass made it an exceptional model to setup and evaluate this 
proteomics methodology. Here, blue native electrophoresis was used to separate native 
protein complexes by size which was followed by a second dimension denaturing SDS 
PAGE separation step that separates the subunits of each complex into each respective 
subunits. Proteins that migrated together as a complex in the first dimension blue native gel 
electrophoresis appear as vertical “ladders” of spots in the second dimension SDS PAGE 
separation after protein staining. Individual protein spots were excised and following in-gel 
tryptic digestion subjected to MALDI TOF mass spectrometry analysis. Despite the fact 
that this methodology allowed us to identify many of the known as well as novel protein 
complexes in this organism, it also highlighted some of the drawbacks of this approach. 
First of all, the sample processing steps that are required to pick and prepare a protein spot 
for MALDI TOF MS analysis make this approach labor intensive and lowers throughput. 
Secondly, non-straight protein migration of proteins in the second dimension SDS PAGE step 
as well as the non-specific protein detection signal in crowded parts of the gel may lead to 
ambiguous assignment of proteins to complexes. Finally, identification of multiple proteins 
within a single spot further complicates assignment of a protein to a specific complex. 
To solve these issues we devised a novel approach in chapter eight that omits the second 
dimension SDS PAGE, staining and spot picking steps by subjecting a blue native PAGE 
lane directly to shotgun proteomics. In this approach, protein complexes are separated in 
their native form by blue native gel electrophoresis after which the gel lane is cut into small 
gel slices at even distance that cover the whole gel lane. Each gel slice is subjected to in-gel 
tryptic digestion and subsequently analyzed by LC-MS/MS. Acquired mass spectrometry 
data is then used to identify each protein and to determine its relative abundance within each 
individual gel slice of the blue native PAGE separation. This approach not only increases the 
overall throughput of the holistic blue native proteomics approach but also provides specific 
detection of individual protein forms. In addition, the method is much more sensitive than 2D 
BN/SDS PAGE MS since protein detection by mass spectrometry is much more sensitive 
than any available protein staining method that can be used to visualize protein spots on 
2D BN/SDS PAGE gels for spot picking. Another improvement is that the protein migration 
data is stored within a data matrix that is amenable to computer assisted analysis to 
unambiguously identify protein co-migration. We applied this approach to human embryonic 
kidney 293 (HEK293) cells to deliver the proof of principle for this methodology in chapter 
eight where we showed that nearly all subunits of each respective oxidative phosphorylation 
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complex were found to comigrate as expected. In addition, we also showed that the 
resolution and sensitivity of this approach even allowed for the analysis of (known) assembly 
intermediate complexes. Using the acquired data we were able to identify novel putative 
complex I assembly factors of which two (C3ORF60 and C6ORF66) were shown to be bone 
fide molecular chaperones in other studies.
After publication of the proof of principle for the blue native LC-MS/MS approach we 
have made several enhancements to the data processing steps that are used to generate 
protein migration profiles from the individual peptide abundance profiles. In chapter nine 
we present the full re-processed data set from chapter eight which we used to validate 
putative mitochondrial ribosomal interactors (a.o. the list of putative mitochondrial ribosome 
interacting proteins from chapter six). Our analysis showed for the first time that ribosomal 
complexes can be analyzed by blue native gel electrophoresis and highlighted multiple 
known as well as novel (putative) interactors of the mitochondrial ribosome. Interestingly, 
multiple proteins associated with the biogenesis of the mitochondrial inner membrane 
complexes were found to comigrate with mitochondrial ribosomal complexes which is 
supportive of co-translational assembly in human cells. This dataset was made publically 
available as a comprehensive resource to the research community to verify or discover de 
novo protein-protein interactions. Chapter nine mainly discusses the merits and current 
limitations of the blue native LC-MS/MS (or complexome profiling) approach and provides 
several leads to further enhance this methodology for future research.
 
Samenvatting
Mitochondriën zijn de kern van verschillende cellulaire processen waardoor de rol van dit 
organel niet enkel ATP generatie betreft. Het is daarom niet verwonderlijk dat mitochondriale 
functies betrokken zijn bij tal van aandoeningen zoals kanker, diabetes, ziekte van 
Alzheimer en Parkinson. Bovendien leidt mitochondriale dysfunctie vaak tot ingewikkelde 
multisystemische aandoeningen met een grote heterogeniteit aan symptomen en variabele 
ernst van de ziekte bij patiënten.
Eiwitten zijn de functionele output van de genomische blauwdruk van een cel die uiteindelijk 
het cellulaire fenotype, functie en voor een belangrijk deel de cellulaire staat bepalen. Het 
is daarom cruciaal om mitochondriale eiwitten te bestuderen om de complexe genotype-
fenotype relaties in patiënten met mitochondriale aandoeningen te doorgronden. Tevens 
maakt het onderzoeken van deze eiwitten het mogelijk om de rol van mitochondriën in 
andere ziekten op te helderen.
Een eerste stap om mitochondriale eiwitten te bestuderen is om “simpelweg” te bepalen 
welke eiwitten zich in het mitochondrion bevinden. Ten tweede is het eminent om de functie, 
tertiaire structuur, expressie profielen, post-translationele modificaties en interacties van 
deze eiwitten te bepalen in verschillende weefsels en cellulaire toestanden. Deze informatie 
is cruciaal om te begrijpen hoe deze eiwitten functioneren en hoe ze geregeld worden onder 
verschillende omstandigheden in relevante weefsels. Dergelijke kennis kan gebruikt worden 
om diagnose te verbeteren en om betrouwbare biomarkers te vinden maar kan ook leiden tot 
de rationele ontwikkeling van geneesmiddelen en behandelingen.
Op dit moment wordt de grootschalige analyse van eiwitten uitgevoerd met massa-
spectrometrische methoden binnen het proteomics onderzoeksveld. Hoofdstuk één 
introduceert de lezer in mitochondriën, het mitochondriale proteoom, en de basisconcepten 
achter proteomics technieken die worden gebruikt om dit sub proteoom te bestuderen. Het 
biedt ook een overzicht van enkele belangrijke proteomics datasets die hebben bijgedragen 
aan onze huidige kennis van het mitochondriale proteoom. 
Gekoppelde technieken zoals vloeistofchromatografie met online tandem massa-
spectrometrie (LC-MS/MS) worden vaak gebruikt in proteomics. Typische “shotgun” 
experimenten gebruiken proteases om eiwitten in kleinere peptide fragmenten te knippen 
welke beter afgestemd zijn voor de analyse van aminozuursequenties door tandem 
massaspectrometrie. Fragmentatie spectra van tandem massaspectrometrie experimenten 
worden vervolgens gekoppeld aan peptidensequenties in een database om eiwitidentificaties 
af te leiden. In het algemeen produceren LC-MS/MS experimenten grote hoeveelheden 
gegevens in de orde van enkele duizenden tot zelfs miljoenen fragmentatie spectra. 
Verwerking van peptide identificatie gegevens vanuit databank zoekopdrachten is geen 
triviale zaak en vereist gespecialiseerde software om onderscheid te maken tussen ware 
en valse (poly)peptide identificaties. Tevens wordt deze software gebruikt om de peptide 
identificaties opnieuw te classificeren naar eiwit identificaties in de databank binnen of 
tussen experimenten. Hoofdstuk twee beschrijft een aantal van de principes achter deze 
gegevensverwerking stappen en introduceert het door ons ontwikkelde software programma 
“PROTON” (PROteomics TOols Nijmegen). PROTON werd gebruikt voor de verwerking van 
gegevens in het merendeel van de experimentele hoofdstukken in dit proefschrift en heeft 
aan de basis gestaan van 19 wetenschappelijke artikelen die gepubliceerd zijn in peer-
reviewed tijdschriften.
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Hoofdstuk drie beschrijft de typische monster verwerking stappen en hardware set-up die 
werden gebruikt in de meeste hoofdstukken van dit proefschrift voor LC-MS/MS analyses. 
Hoewel dit hoofdstuk gericht is op proteoom analyse van de aerobe ammonium oxiderende 
bacterie Nitrosomonas eutropha, worden de methoden en hardware configuratie op dezelfde 
wijze gebruikt om eiwitten vanuit vele andere organismen te bestuderen zoals de mens. Dit 
hoofdstuk geeft de minimale achtergrondinformatie die benodigd is om de typische monster 
voorbewerking stappen en hardware configuratie te begrijpen die in de meeste hoofdstukken 
van dit proefschrift gebruikt zijn.
De identificatie van peptiden die het onderscheid maken tussen monster cohorten is een 
grote uitdaging in proteoom analyses vanwege de complexiteit, grote hoeveelheid gegevens 
en onvolkomenheden in de gegevens. Echter zijn dergelijke analyses van cruciaal belang 
om peptiden te identificeren die kunnen dienen als biomarkers voor diagnostische en 
prognostische doeleinden of het volgen van ziektestadia. Momenteel beginnen de meeste 
LC-MS/MS aanpakken met de identificatie van peptiden in de monsters. Vervolgens 
wordt de relatieve hoeveelheid van alleen de geïdentificeerde peptiden geëxtraheerd uit de 
brongegevens om discriminerende eiwitten of peptiden te vinden. Een belangrijk nadeel van 
deze aanpak is dat deze niet in staat is om discriminerende peptiden te ontdekken waarvan 
de identiteit onbekend is na databank zoekopdrachten van de “willekeurig” opgenomen 
tandem massaspectrometrie gegevens. Om dit probleem op te lossen hebben wij een 
omvangrijke referentie dataset gegenereerd in hoofdstuk vier welke gebruikt is om een 
alternatieve benadering in hoofdstuk vijf te ontwikkelen. Deze alternatieve methode bepaalt 
allereerst welke peptide signalen discriminerend zijn tussen de monster cohorten om deze 
in vervolg experimenten gericht te analyseren om tot identificatie van deze signalen te 
kunnen komen. Deze aanpak minimaliseert het risico om discriminerende peptiden van lage 
intensiteit over het hoofd te zien. Tevens vergroot het de kans aanzienlijk om deze peptiden 
te kunnen identificeren doordat de massa spectrometer exclusief peptiden van interesse 
fragmenteert waardoor instrument instellingen gebruikt kunnen worden die geoptimaliseerd 
zijn voor gevoeligheid en spectrale kwaliteit in plaats van hoge acquisitie snelheid.
De hoofdstukken zes tot negen richten zich op fysieke interacties tussen eiwitten die 
georganiseerd zijn in eiwit complexen of interactie netwerken. Veel eiwit-eiwit interacties zijn 
essentieel voor belangrijke cellulaire processen waardoor het evident is om deze in kaart 
te brengen en functioneel te karakteriseren om uiteindelijk de genotype-fenotype relaties in 
patiënten met mitochondriale aandoeningen te begrijpen.
Mitochondriale eiwitsynthese is een belangrijk cellulair proces dat verantwoordelijk is voor de 
synthese van mitochondriaal DNA gecodeerde eiwitten die benodigd zijn voor de aanmaak 
van vier van de vijf enzym complexen van het oxidatieve fosforylering systeem. Hiertoe 
wordt genetische informatie die opgeslagen is in mitochondriaal messenger RNA (mRNA) 
gebruikt door mitochondriale vertaal machines om eiwitten aan te maken. Mitochondriale 
ribosomale complexen vervullen een cruciale rol bij dit proces die het mogelijk maken om 
transport-RNA’s (tRNA) aan te laten meren die vervolgens ieder specifiek codon herkennen 
van het gebonden mRNA. Na herkenning van het codon wordt het aminozuur van de 
corresponderende tRNA los gelaten en wordt deze bevestigd aan de groeiende peptide 
keten van het eiwit bij het ribosoom. Diverse eiwitten gaan interacties aan met het ribosoom 
in de initiatie, verlenging en beëindiging fasen van translatie. Nog niet alle eiwitten die 
interacties aangaan met het ribosoom zijn tot op heden bekend. In hoofdstuk zes hebben 
wij de mitochondriale ribosomale vrijgifte factor (mitochondrial ribosomal release factor; 
mtRRF) geïdentificeerd dat er voor zorgt dat het complete ribosoom zich opsplitst in de 
respectievelijk kleine en grote subeenheden (small and large subunits). Dit proces recyclet 
beide subeenheden van het ribosoom zodat ze opnieuw samengevoegd kunnen worden om 
een volgende eiwit synthese ronde te initiëren. In dit onderzoek werd proteomics gebruikt 
om eiwitten te identificeren die interacties aangingen met mtRRF dat voorzien was van een 
affiniteitzuivering label. Dit onderzoek heeft geleid tot de identificatie van vele kandidaat 
interactors die mogelijk een rol spelen in de mitochondriale eiwit synthese. Interessant 
genoeg werden vrijwel alle eerder gerapporteerde nucleoid eiwitten geïdentificeerd in deze 
monsters wat mogelijk duid op een fysieke verbinding tussen transcriptie en translatie 
processen.
Analyse van eiwit-eiwit interacties door affiniteit of immuno zuivering in combinatie met 
tandem massaspectrometrie is een krachtige methode om eiwit interactie netwerken in kaart 
te brengen. Echter kan de affiniteit zuivering label interfereren met natieve interacties. Evenzo 
kunnen antilichaam gebaseerde zuiveringen van specifieke eiwit interacties om diverse 
technische redenen mislukken. Een ander nadeel van beide selectieve zuiveringsmethoden 
is dat deze niet geschikt zijn om snel of op grote schaal eiwit-eiwit interacties te bepalen. 
Vandaar dat holistische methoden die berusten op de combinatie van eiwit complex 
scheiding en high-throughput proteomics technologie voor de identificatie van comigrerende 
of coeluerende eiwitten een aantrekkelijk alternatief bieden.
In hoofdstuk zeven hebben wij een combinatie van twee dimensionale blue native 
natrium dodecyl sulfaat polyacrylamide gel elektroforese (2D BN/SDS PAGE) en matrix 
assisted laser desorption ionization time-of-flight (MALDI TOF) massaspectrometrie gebruikt 
om eiwit complexen te identificeren in de thermofiele archaeon Methanothermobacter 
thermautotrophicus stam delta H. Dit organisme is eerder gebruikt als model systeem voor 
tal van biochemische studies. Het goed geannoteerde genoom, beschikbare biochemische 
kennis en grote hoeveelheden biomassa maakte het een uitzonderlijk modelorganisme om 
deze proteomics technologie mee op te zetten en te valideren. Hiertoe werd blue native 
elektroforese gebruikt om eiwit complexen te scheiden op basis van grootte waarna in 
een tweede dimensie denaturerende SDS PAGE scheiding deze complexen uiteenvallen 
in afzonderlijke subeenheden die weer van elkaar gescheiden worden. Eiwitten die 
samen migreerden als een complex in de eerste dimensie blue native elektroforese stap 
verschijnen als verticale “ladders” van spots in de tweede dimensie SDS PAGE scheiding 
na eiwitkleuring. Individuele eiwit spots worden uitgesneden en na in-gel tryptische digestie 
aan MALDI-TOF massaspectrometrie onderworpen. Hoewel dit ons in staat stelde om 
veel van de bekende alsook nieuwe onbekende eiwit complexen van dit organisme op 
te helderen, werden ook de nadelen duidelijk van deze techniek. Ten eerste zijn de vele 
monster opwerkingsstappen om eiwitten vanuit de gel te prepareren voor MALDI-TOF 
massaspectrometrie erg arbeidsintensief wat een relatief lage throughput tot gevolg heeft. 
Ten tweede migreren eiwitten in de tweede dimensie SDS PAGE stap niet altijd recht onder 
elkaar of kunnen de signalen van naburige eiwit spots in elkaar overlopen waardoor het soms 
niet mogelijk is om eiwitten eenduidig toe te kennen aan een zeker complex. Tenslotte kan de 
identificatie van meerdere eiwitten vanuit een enkele eiwit spot de toewijzing van eiwitten aan 
complexen verder bemoeilijken. 
Om deze problemen op te lossen hebben wij een nieuwe techniek geïntroduceerd in 
hoofdstuk acht waarbij de tweede dimensie SDS PAGE scheiding, aankleuren van eiwitten 
en uitsnijden van de afzonderlijke eiwit spots vervangen is door shotgun proteomics. 
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Met deze nieuwe methodiek worden wederom eiwit complexen gescheiden op basis 
van grootte door middel van blue native elektroforese. Hierna wordt de gehele gel laan 
in opeenvolgende kleine plakjes van gelijke grootte gesneden. Ieder van deze gel plakjes 
wordt vervolgens aan in-gel tryptische digestie onderworpen om vervolgens geanalyseerd te 
worden met behulp van LC-MS/MS. De verkregen tandem massaspectrometrie data wordt 
vervolgens gebruikt om eiwitten te identificeren en om de relatieve hoeveelheid van elk eiwit 
in ieder van de gel plakjes en dus over de gehele gel laan te bepalen. Deze nieuwe techniek 
vergroot niet alleen de throughput van de holistische blue native gebaseerde proteomics 
techniek maar gebruikt ook eiwit specifieke detectie. Bovendien is de methode ook veel 
gevoeliger dan de 2D BN/SDS PAGE MALDI-TOF MS methode gezien LC-MS/MS qua 
eiwit detectie vele malen gevoeliger is dan alle beschikbare eiwit aankleuringsmethoden die 
gebruikt moeten worden om eiwit spots te visualiseren alvorens ze uit te kunnen snijden. 
Een additionele belangrijke verbetering is dat de migratie profielen van eiwitten opgeslagen 
worden in een data matrix welke geanalyseerd kan worden met behulp van de computer 
om eiwitten die samen migreren op te sporen. Wij hebben deze nieuwe methode toegepast 
op humane embryonale nier 293 cellen (HEK293) om het proof of principle te leveren voor 
deze techniek in hoofdstuk acht. Hier lieten wij zien dat vrijwel alle subeenheden van elk 
oxidatief fosforylering complex zoals verwacht comigreerden. Tevens bleek dat de resolutie 
en gevoeligheid van deze techniek ons in staat stelde om (bekende) eiwit assemblage 
intermediairen te analyseren. Met behulp van de verkregen gegevens was het zelfs mogelijk 
om nieuwe vermoedelijk complex I assemblage factoren te identificeren waarvan twee 
eiwitten (C3ORF60 en C6ORF66) bonafide moleculaire chaperonnes bleken te zijn in andere 
studies. 
Na publicatie van het proof of principle voor de blue native LC-MS/MS methode zijn er 
verscheidene verbeteringen ontwikkeld van de data verwerkingsstappen die gebruikt worden 
om de eiwit migratie profielen vanuit de individuele peptide abundantie profielen te genereren. 
In hoofdstuk negen presenteren wij voor het eerst de volledige en opnieuw verwerkte 
dataset van hoofdstuk acht welke hier gebruikt is om vermoedelijke mitochondriaal 
ribosomale interactoren te valideren (waaronder de lijst van vermoedelijke interactoren vanuit 
hoofdstuk zes). Onze analyse laat voor de eerste keer zien dat ribosomale complexen 
geanalyseerd kunnen worden met behulp van blue native elektroforese. Tevens bracht de 
data analyse verschillende bekende en onbekende eiwitten aan het licht die vermoedelijk 
interacties hebben met het mitochondriaal ribosoom. Verrassend hieraan was dat meerdere 
eiwitten die betrokken zijn bij de biogenese van mitochondriale binnen membraan complexen 
comigreerden met ribosomale eiwitten. Deze observatie ondersteund de hypothese dat 
translatie en assemblage processen collectief uitgevoerd kunnen worden in humane 
mitochondria. Deze dataset is publiekelijk gemaakt als een veelomvattende hulpbron voor 
de onderzoekers om de novo eiwit-eiwit interacties te ontdekken of te valideren. Hoofdstuk 
negen bespreekt met name de voordelen en huidige limitaties van de blue native LC-MS/MS 
ofwel complexome profiling techniek en geeft enkele leads voor toekomstig onderzoek om 
deze techniek verder te kunnen verbeteren.
 
Dankwoord
In ieders lijf klopt het hart van een onderzoeker. Iedereen verwondert zich over zaken en vraagt 
zich geregeld af hoe dingen in elkaar steken. Men stelt hypotheses op die een mogelijke 
verklaring geven voor observaties of levensvragen. Sinds kort ben ik stellig van mening dat 
kinderen wellicht de best gemotiveerde wetenschappers zijn daar zij bij werkelijk iedere 
observatie, hoe klein dan ook, vergaarde kennis en verbeeldingskracht gebruiken om de wereld 
om zich heen te begrijpen. 
Belangrijke vragen als “Waarom is die bloem rood pappa?” (citatie: Karin Kragt) of “pappa, 
waarom wordt je ziek van beestjes in je lijf?” (citatie: Lieke Kragt) zijn slechts enkele van de 
vele voorbeelden die de hunkering naar het begrijpen van de wereld illustreren. De verklaringen 
die pappa in “Woezel en Pip” stijl probeert te geven worden vervolgens kritisch getoetst en 
geregeld verworpen met een stellig “Nee pappa, dat is toch een beetje gek?!”.
En dan bedenk ik mij vaak dat een zeer kleine “waarom?” vraag alleen beantwoord kan worden 
dankzij samenwerking tussen onderzoekers en het delen van eeuwenlange opgedane kennis. 
De verkregen resultaten en antwoorden in dit proefschrift zijn daarop zeker geen uitzondering 
en vallen mede toe te schrijven aan de vele mensen met wie ik de afgelopen jaren heb mogen 
samenwerken of die mij op een andere manier ondersteund hebben. Dit hoofdstuk geeft mij de 
gelegenheid een aantal van jullie te bedanken. 
Allereerst wil ik graag mijn promotor Jan Smeitink bedanken. Beste Jan, hartelijk dank voor de 
geboden kans om te promoveren en de geweldige steun en motivatie. Je was er altijd voor 
me wanneer dat nodig was met raad en daad. Ook ben ik zeer blij met de wijze waarop je mijn 
begeleiding vertolkte. De geboden vrijheid en verantwoordelijkheid om zelfstandig onderzoek 
te doen en hierbij ongebaande wegen in te slaan was geweldig. Tevens is je inzet en de 
ambitie die je uitstraalt erg motiverend en ik ben dan ook blij dat we in de toekomst nog samen 
onderzoek zullen verrichten. 
Uiteraard wil ik ook graag mijn tweede promotor Bert van den Heuvel bedanken. Jouw 
begeleiding was net als die van Jan mij op het lijf geschreven. Onze discussies over schijnbaar 
triviale technische zaken waren altijd plezierig en ik dank je voor het vertrouwen dat je altijd in 
mij had. Uiteraard ben ik je ook erg dankbaar voor de geboden kans om binnen de proteomics 
groep te komen werken. Je inzet en betrokkenheid bij de proteomics binnen het ziekenhuis is 
de fundering geweest waarop de huidige groep en infrastructuur gebouwd is. 
Ook mijn beide copromotoren Richard Rodenburg en Jolein Gloerich hebben een aanzienlijke 
bijdrage geleverd aan dit proefschrift. Ik wil jullie dan ook hartelijk danken voor de goede 
samenwerking en begeleiding die jullie mij geboden hebben. Onze gezamenlijke discussies en 
werkbesprekingen waren uiteraard nuttig maar bovenal ook leuk en inspirerend. De gedeelde 
passie en enthousiasme over behaalde onderzoeksresultaten was altijd erg motiverend.
Om nog even bij de “proteomics groep” te blijven wil ik maar wat graag Maurice van Dael 
en Alain van Gool noemen. Maurice, we hebben samen veel lol gehad en frustratie gedeeld 
over technische “uitdagingen” die de apparatuur soms met zich meebrengt. Ook onze 
Bremen avonturen waren telkens weer geweldig, met uitzondering van die boemel trein naar 
Bremen of de gestrande trein met door de hitte flauwvallende mensen dan… Bedankt voor 
de samenwerking en je praktische hulp waarvan een deel in een aantal hoofdstukken van dit 
boekje terecht is gekomen. Dan wil ik natuurlijk nog ons opperhoofd van de proteomics groep 
200 201
noemen: Alain van Gool. Beste Alain, hartelijk dank voor je wijze raad en betrokkenheid bij mijn 
promotie. Ook jouw steun is van grote waarde geweest om dit (eindelijk) af te ronden. Tevens 
wil ik je danken voor het delen van opgedane ervaring en adviezen die mij zeker helpen op mijn 
wetenschappelijke pad na de promotie.
Graag wil ik alle collega’s van het Translationeel Metabool Laboratium en het Nijmegen 
Centre for Mitochondrial Disorders bedanken voor de praktische hulp en adviezen. De goede 
sfeer, onvergetelijke feesten en andere activiteiten slepen menig onderzoeker door moeilijke 
fases heen! We zijn een groot team en het is helaas niet mogelijk om iedereen afzonderlijk 
te bedanken zonder dat dit proefschrift werkelijk bijbelse proporties aanneemt. Toch zijn 
er enkele mensen die ik wel in het bijzonder nog wil noemen. Een lab bestaat uit mensen, 
infrastructuur en chemicaliën. Het draaiend houden en verbeteren van deze omgeving is 
cruciaal ter ondersteuning van ieder onderzoek. Hiervoor wil ik graag Wilmien Heys bedanken 
die zich hier meer dan 100% voor inzet. Ook de samenwerking met Murtada Farhoud is 
cruciaal geweest voor dit proefschrift. Jij hebt het mede mogelijk gemaakt voor mij om 
deze promotie kans te grijpen en ik heb veel van je geleerd. Ook Leo Nijtmans wil ik graag 
bedanken voor de leuke en inspirerende samenwerking. Tevens wil ik je graag bedanken 
voor de mogelijkheid die je me gaf om college te kunnen geven aan MMD studenten. Ik heb 
hier erg van genoten. Prof. dr. Ron Wevers wil ik graag bedanken voor de mogelijkheid mijn 
thesis af te ronden binnen het lab TML. I would also like to thank professor Ulrich Brandt for 
his valuable input in this thesis and for the stimulating collaboration in pursuit of our shared 
interests. 
During my PhD study I had the privelege to supervise two excellent students. First of all I 
want to thank Carola Wormuth for her brilliant efforts on improving the mass spectrometric 
analysis of proteins from affinity purifications and for all the fun times we had in the lab. 
I am happy that you now embarked on your own queeste in science, I am sure that you 
will succeed. Of course I also want to thank Jozefi Hortulanus for all her hard work and 
efforts on downsizing size exclusion columns for proteomics. Results from both of your 
internships provided a technical foundation from which many succeeding proteomics studies 
have benefited.
Onderzoek is hobby en hobby’s deel je met vrienden. Beste Rutger, in de loop van de jaren 
ben je een ontzettend goede vriend van mij geworden en ik heb erg genoten van onze 
gezamenlijke onderzoeken. Onze bier en game avonden waren altijd episch en ik wil je 
bedanken voor je vriendschap en onze gesprekken. 
Ook Tom Bloemberg wil ik graag bedanken voor de geweldige samenwerking de afgelopen 
jaren waarvan een gedeelte in dit proefschrift staat. Ik hoop dat we in de toekomst nog de 
nodige uitdagingen qua data analyse samen aan kunnen gaan.
Dear Bob and Zosia Lightowlers, I would like to thank you for the fantastic collaborations and 
discussions we shared in the past. I really enjoyed our meetings and I can only look forward 
to meet and collaborate again in the near future! 
Ook de afdeling Microbiologie van de Radboud universiteit verdient absoluut een vermelding 
in dit dankwoord. De eerste stappen in proteomics binnen de Radboud universiteit zijn een 
samenspel geweest van onze afdelingen. Deze samenwerking staat dus aan de wieg van het 
al het proteomics werk dat uitgevoerd wordt en enkele van onze gezamenlijke onderzoeken 
zijn de basis van dit boekje geworden. Graag maak ik van de gelegenheid gebruik om 
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